OG_ID,loading,group_id,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_01712,0.8042547108453221,OG_01712,FUN_006986-T1,Peve_00009622,Pocillopora_meandrina_HIv1___RNAseq.g20224.t1,three_way,77.79516666666666,FUN_006986-T1,O60841,IF2P_HUMAN,,Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2),Homo sapiens (Human),72.7,593.0,6e-261,902.5,sp|O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4,GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872,regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0016787,RNA binding; catalytic activity; GTPase activity; cytosol; hydrolase activity
OG_10051,0.7965056158575361,OG_10051,FUN_043325-T1,Peve_00043035,Pocillopora_meandrina_HIv1___RNAseq.g8952.t1,three_way,72.11733333333333,FUN_043325-T1,Q2HWF0,FBP1L_RAT,,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),Rattus norvegicus (Rat),31.6,604.0,1.9000000000000002e-74,281.6,sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320,autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886],GTPase binding [GO:0051020]; lipid binding [GO:0008289],GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0008289; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0061024,cytosol; cytoskeleton; plasma membrane; autophagy; lipid binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; membrane organization
OG_04141,0.7788763627774252,OG_04141,FUN_016596-T1,Peve_00033776,Pocillopora_meandrina_HIv1___RNAseq.g481.t1,three_way,74.769,FUN_016596-T1,O46385,,,,,34.0,1119.0,3.3e-163,578.6,sp|O46385|SVIL_BOVIN Supervillin OS=Bos taurus OX=9913 GN=SVIL PE=1 SV=2,,,,,,
OG_06119,0.772594039978434,OG_06119,FUN_027850-T1,Peve_00024333,Pocillopora_meandrina_HIv1___TS.g11653.t1,three_way,77.86916666666667,,,,,,,,,,,,,,,,,
OG_00295,0.7720037555683666,OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),65.8,225.0,9.999999999999999e-33,143.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_00295,0.7720037555683666,OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),81.6,38.0,1.9e-07,59.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_04464,0.7697142790419219,OG_04464,FUN_019346-T1,Peve_00032914,Pocillopora_meandrina_HIv1___RNAseq.g20864.t1,three_way,58.6805,FUN_019346-T1,Q80XP9,WNK3_MOUSE,,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),Mus musculus (Mouse),68.5,378.0,6e-143,510.8,sp|Q80XP9|WNK3_MOUSE Serine/threonine-protein kinase WNK3 OS=Mus musculus OX=10090 GN=Wnk3 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005912; GO:0005923; GO:0006884; GO:0007231; GO:0010765; GO:0010800; GO:0035633; GO:0043066; GO:0044325; GO:0050801; GO:0051928; GO:0070294; GO:0071474; GO:0072659; GO:0090188; GO:0090279; GO:0106310; GO:0140693; GO:0140694; GO:0141109; GO:1903077; GO:1903078; GO:1904062; GO:2000651,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; maintenance of blood-brain barrier [GO:0035633]; membraneless organelle assembly [GO:0140694]; monoatomic ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; osmosensory signaling pathway [GO:0007231]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of calcium ion import [GO:0090279]; regulation of monoatomic cation transmembrane transport [GO:1904062]; renal sodium ion absorption [GO:0070294],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transmembrane transporter binding [GO:0044325]; transporter activator activity [GO:0141109],GO:0003014; GO:0003824; GO:0016740; GO:0060090; GO:0072659; GO:0098772; GO:0140096,"renal system process; catalytic activity; transferase activity; molecular adaptor activity; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05241,0.7566911918267408,OG_05241,FUN_023682-T1,Peve_00014139,Pocillopora_meandrina_HIv1___RNAseq.g17753.t1,three_way,78.52883333333334,FUN_023682-T1,A7SK48,EIF3A_NEMVE,,Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10),Nematostella vectensis (Starlet sea anemone),73.3,786.0,8.7e-296,1018.1,sp|A7SK48|EIF3A_NEMVE Eukaryotic translation initiation factor 3 subunit A OS=Nematostella vectensis OX=45351 GN=v1g190699 PE=3 SV=2,GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0016282; GO:0033290; GO:0043614; GO:0071540; GO:0071541,formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188],"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]",mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_09075,0.7525652018273512,OG_09075,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_09963,0.7420015272141521,OG_09963,FUN_043144-T1,Peve_00034957,Pocillopora_meandrina_HIv1___RNAseq.g6886.t1,three_way,84.25150000000001,FUN_043144-T1,Q26481,,,,,73.1,279.0,2e-116,420.2,sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3,,,,,,
OG_08721,0.7414008102414601,OG_08721,FUN_037974-T1,Peve_00013894,Pocillopora_meandrina_HIv1___RNAseq.g26183.t1,three_way,56.88933333333333,FUN_037974-T1,Q3UHR0,,,,,27.2,746.0,2.1e-45,187.6,sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2,,,,,,
OG_01155,0.7412224443719281,OG_01155,FUN_004766-T1,Peve_00019319,Pocillopora_meandrina_HIv1___RNAseq.g6698.t2,three_way,68.8935,FUN_004766-T1,Q5R4N8,,,,,40.4,779.0,6.3e-146,519.6,sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1,,,,,,
OG_05916,0.7384351047166061,OG_05916,FUN_026108-T1,Peve_00014996,Pocillopora_meandrina_HIv1___RNAseq.g10317.t1,three_way,87.78083333333333,FUN_026108-T1,Q9HD67,MYO10_HUMAN,,Unconventional myosin-X (Unconventional myosin-10),Homo sapiens (Human),45.4,2065.0,0.0,1582.8,sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3,GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002,cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]",GO:0003774; GO:0003824; GO:0005730; GO:0005829; GO:0005886; GO:0008092; GO:0008289; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleolus; cytosol; plasma membrane; cytoskeletal protein binding; lipid binding; isomerase activity; organelle; ATP-dependent activity
OG_04647,0.7374482515955725,OG_04647,FUN_022379-T1,Peve_00013225,Pocillopora_meandrina_HIv1___RNAseq.g9304.t1,three_way,65.24716666666666,FUN_022379-T1,Q13439,,,,,31.5,124.0,1.8e-06,57.0,sp|Q13439|GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=1,,,,,,
OG_09944,0.7373867494127735,OG_09944,FUN_043111-T1,Peve_00014954,Pocillopora_meandrina_HIv1___RNAseq.g7894.t1,three_way,96.616,FUN_043111-T1,Q8JGS9,,,,,89.1,101.0,5.5e-47,188.0,sp|Q8JGS9|RS18_DANRE Small ribosomal subunit protein uS13 OS=Danio rerio OX=7955 GN=rps18 PE=1 SV=1,,,,,,
OG_08301,0.7274381511828125,OG_08301,FUN_036251-T1,Peve_00045290,Pocillopora_meandrina_HIv1___RNAseq.g27588.t1,three_way,74.035,FUN_036251-T1,P20042,IF2B_HUMAN,,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta),Homo sapiens (Human),85.7,168.0,3.3000000000000003e-80,300.1,sp|P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2,GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0008270; GO:0008584; GO:0031369; GO:0045202,cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202],"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]",GO:0003723; GO:0005829; GO:0022414; GO:0048856; GO:0065003,RNA binding; cytosol; reproductive process; anatomical structure development; protein-containing complex assembly
OG_09808,0.7269299726760843,OG_09808,FUN_042630-T1,Peve_00033746,Pocillopora_meandrina_HIv1___RNAseq.g11507.t1,three_way,66.90383333333334,FUN_042630-T1,Q8TEK3,DOT1L_HUMAN,,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",Homo sapiens (Human),42.8,636.0,2.0999999999999998e-129,465.7,"sp|Q8TEK3|DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 specific OS=Homo sapiens OX=9606 GN=DOT1L PE=1 SV=3",GO:0000077; GO:0000781; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0010467; GO:0031151; GO:0031509; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0032200; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; telomere organization; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_08709,0.7198785057540421,OG_08709,FUN_037961-T1,Peve_00009703,Pocillopora_meandrina_HIv1___RNAseq.g26230.t1,three_way,75.68066666666667,FUN_037961-T1,A7RKS5,RSSA_NEMVE,,Small ribosomal subunit protein uS2 (40S ribosomal protein SA),Nematostella vectensis (Starlet sea anemone),75.9,257.0,1e-107,391.3,sp|A7RKS5|RSSA_NEMVE Small ribosomal subunit protein uS2 OS=Nematostella vectensis OX=45351 GN=v1g198553 PE=3 SV=1,GO:0000028; GO:0002181; GO:0003735; GO:0022627,cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028],cytosolic small ribosomal subunit [GO:0022627],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0065003,cytoplasmic translation; structural molecule activity; protein-containing complex assembly
OG_02734,0.7171655350533619,OG_02734,FUN_011264-T1,Peve_00030536,Pocillopora_meandrina_HIv1___RNAseq.g22310.t1,three_way,79.29683333333332,FUN_011264-T1,P02401,,,,,70.6,68.0,7.3e-19,94.7,sp|P02401|RLA2_RAT Large ribosomal subunit protein P2 OS=Rattus norvegicus OX=10116 GN=Rplp2 PE=1 SV=2,,,,,,
OG_07118,0.7136219669553779,OG_07118,FUN_032395-T1,Peve_00036447,Pocillopora_meandrina_HIv1___RNAseq.g29833.t1,three_way,64.09349999999999,FUN_032395-T1,Q76LC6,RBM24_DANRE,,RNA-binding protein 24 (RNA-binding motif protein 24) (RNA-binding protein SEB-4),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,89.0,7.2e-27,122.5,sp|Q76LC6|RBM24_DANRE RNA-binding protein 24 OS=Danio rerio OX=7955 GN=rbm24 PE=2 SV=1,GO:0000381; GO:0001654; GO:0001756; GO:0001947; GO:0003228; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006974; GO:0007519; GO:0008380; GO:0010830; GO:0010831; GO:0035315; GO:0035925; GO:0043488; GO:0045663; GO:0048255; GO:0048702; GO:0060297; GO:0060298; GO:0061157; GO:0061158; GO:0071599; GO:0072359; GO:0097157; GO:1902811; GO:1905870; GO:1990715; GO:1990825; GO:2000738; GO:2000766,"3'-UTR-mediated mRNA destabilization [GO:0061158]; atrial cardiac muscle tissue development [GO:0003228]; circulatory system development [GO:0072359]; DNA damage response [GO:0006974]; embryonic neurocranium morphogenesis [GO:0048702]; eye development [GO:0001654]; hair cell differentiation [GO:0035315]; heart looping [GO:0001947]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; otic vesicle development [GO:0071599]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; regulation of sarcomere organization [GO:0060297]; RNA splicing [GO:0008380]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0030154; GO:0043226; GO:0048856,RNA binding; nucleus; cytosol; mRNA metabolic process; cell differentiation; organelle; anatomical structure development
OG_08647,0.7114726423238761,OG_08647,FUN_037838-T1,Peve_00000575,Pocillopora_meandrina_HIv1___TS.g22869.t1,three_way,95.46833333333332,FUN_037838-T1,P62265,,,,,88.2,152.0,1.3e-68,260.4,sp|P62265|RS14_CRIGR Small ribosomal subunit protein uS11 OS=Cricetulus griseus OX=10029 GN=RPS14 PE=2 SV=3,,,,,,
OG_06611,0.7111345620262277,OG_06611,FUN_029761-T1,Peve_00019503,Pocillopora_meandrina_HIv1___RNAseq.g17322.t1,three_way,61.18983333333333,FUN_029761-T1,Q8NC51,SERB1_HUMAN,,SERPINE1 mRNA-binding protein 1 (PAI1 RNA-binding protein 1) (PAI-RBP1) (Plasminogen activator inhibitor 1 RNA-binding protein),Homo sapiens (Human),31.6,152.0,5e-06,53.9,sp|Q8NC51|SERB1_HUMAN SERPINE1 mRNA-binding protein 1 OS=Homo sapiens OX=9606 GN=SERBP1 PE=1 SV=2,GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0017148; GO:0030371; GO:0030578; GO:0032183; GO:0043022; GO:0043488; GO:0045296; GO:0048471; GO:0061770; GO:0070062; GO:0141014,negative regulation of translation [GO:0017148]; PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488]; ribosome hibernation [GO:0141014],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; translation elongation factor binding [GO:0061770]; translation repressor activity [GO:0030371],GO:0003723; GO:0005634; GO:0005829; GO:0043226; GO:0045182,RNA binding; nucleus; cytosol; organelle; translation regulator activity
OG_07251,0.7107817938877005,OG_07251,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_02708,0.7090640623017531,OG_02708,FUN_010985-T1,Peve_00013387,Pocillopora_meandrina_HIv1___RNAseq.g22008.t1,three_way,72.90966666666667,FUN_010985-T1,Q96JM7,,,,,33.9,840.0,2.0999999999999998e-129,464.9,sp|Q96JM7|LMBL3_HUMAN Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens OX=9606 GN=L3MBTL3 PE=1 SV=2,,,,,,
OG_03321,0.7043637826937806,OG_03321,FUN_013400-T1,Peve_00028081,Pocillopora_meandrina_HIv1___RNAseq.g22939.t1,three_way,70.60533333333333,FUN_013400-T1,B5DE31,YBOX1_DANRE,,Y-box-binding protein 1 (YB-1) (ZfY1) (Y-box transcription factor),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,107.0,1e-40,168.7,sp|B5DE31|YBOX1_DANRE Y-box-binding protein 1 OS=Danio rerio OX=7955 GN=ybx1 PE=1 SV=1,GO:0000932; GO:0001556; GO:0003676; GO:0003723; GO:0005634; GO:0006397; GO:0007343; GO:0008190; GO:0008327; GO:0008380; GO:0008544; GO:0010468; GO:0017148; GO:0035198; GO:0043009; GO:0045947; GO:0048025; GO:0048255; GO:0048598; GO:0050658; GO:0050686; GO:0051031; GO:0051236; GO:0062153; GO:0070062; GO:1990428; GO:2000773,"chordate embryonic development [GO:0043009]; egg activation [GO:0007343]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; establishment of RNA localization [GO:0051236]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of mRNA processing [GO:0050686]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; oocyte maturation [GO:0001556]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]",extracellular exosome [GO:0070062]; nucleus [GO:0005634]; P-body [GO:0000932],C5-methylcytidine-containing RNA reader activity [GO:0062153]; eukaryotic initiation factor 4E binding [GO:0008190]; methyl-CpG binding [GO:0008327]; miRNA binding [GO:0035198]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0060090,DNA binding; RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development; molecular adaptor activity
OG_02158,0.7022957136562805,OG_02158,FUN_008490-T1,Peve_00028832,Pocillopora_meandrina_HIv1___RNAseq.g30381.t1,three_way,71.13933333333334,FUN_008490-T1,Q6A070,TGRM1_MOUSE,,TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B),Mus musculus (Mouse),27.4,2074.0,5.2e-149,531.2,sp|Q6A070|TGRM1_MOUSE TOG array regulator of axonemal microtubules protein 1 OS=Mus musculus OX=10090 GN=Togaram1 PE=1 SV=3,GO:0005737; GO:0005929; GO:0031116; GO:0035082; GO:0036064; GO:1905515,axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005815; GO:0005929; GO:0007010; GO:0043226; GO:0044782,microtubule organizing center; cilium; cytoskeleton organization; organelle; cilium organization
OG_04759,0.7022649814578414,OG_04759,FUN_022649-T1,Peve_00019793,Pocillopora_meandrina_HIv1___RNAseq.g4450.t2,three_way,87.07466666666667,FUN_022649-T1,Q6ZWH5,NEK10_HUMAN,,Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10),Homo sapiens (Human),45.7,1046.0,4.3e-211,736.5,sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911,mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372],extracellular region [GO:0005576]; protein kinase complex [GO:1902911],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003016; GO:0003824; GO:0005576; GO:0007018; GO:0016740; GO:0140096,"respiratory system process; catalytic activity; extracellular region; microtubule-based movement; transferase activity; catalytic activity, acting on a protein"
OG_02321,0.7008418933754464,OG_02321,FUN_008913-T1,Peve_00033015,Pocillopora_meandrina_HIv1___RNAseq.g3978.t1,three_way,86.956,FUN_008913-T1,Q56K14,RLA1_BOVIN,,Large ribosomal subunit protein P1 (60S acidic ribosomal protein P1),Bos taurus (Bovine),67.7,65.0,1.8e-17,90.1,sp|Q56K14|RLA1_BOVIN Large ribosomal subunit protein P1 OS=Bos taurus OX=9913 GN=RPLP1 PE=3 SV=1,GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0030295; GO:0043021,cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414],cytosolic large ribosomal subunit [GO:0022625],protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0098772,cytoplasmic translation; structural molecule activity; molecular function regulator activity
OG_00540,0.698719419820759,OG_00540,FUN_001562-T1,Peve_00013899,Pocillopora_meandrina_HIv1___RNAseq.g2018.t1,three_way,83.21833333333333,FUN_001562-T1,Q8IWZ3,,,,,58.1,812.0,4.4e-82,308.9,sp|Q8IWZ3|ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKHD1 PE=1 SV=1,,,,,,
OG_02855,0.6977793442033999,OG_02855,FUN_011893-T1,Peve_00008033,Pocillopora_meandrina_HIv1___TS.g16684.t2,three_way,72.4585,FUN_011893-T1,Q9WVE9,ITSN1_RAT,,Intersectin-1 (EH domain and SH3 domain regulator of endocytosis 1),Rattus norvegicus (Rat),40.1,1088.0,5.1e-58,228.0,sp|Q9WVE9|ITSN1_RAT Intersectin-1 OS=Rattus norvegicus OX=10116 GN=Itsn1 PE=1 SV=2,GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007267; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0042734; GO:0043025; GO:0043195; GO:0043197; GO:0043524; GO:0044305; GO:0048488; GO:0051402; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098843; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288,cell-cell signaling [GO:0007267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase-mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488],apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone [GO:0098833]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; terminal bouton [GO:0043195],calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064],GO:0005635; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0060090; GO:0098772,nuclear envelope; endosome; cytosol; cytoskeleton; plasma membrane; programmed cell death; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular function regulator activity
OG_03941,0.6974931455061698,OG_03941,FUN_016076-T1,Peve_00021921,Pocillopora_meandrina_HIv1___RNAseq.g21616.t1,three_way,70.497,FUN_016076-T1,Q9C9C6,,,,,49.4,180.0,1.2e-34,147.9,sp|Q9C9C6|RL62_ARATH Large ribosomal subunit protein eL6y OS=Arabidopsis thaliana OX=3702 GN=RPL6B PE=2 SV=1,,,,,,
OG_08289,0.6970553721468665,OG_08289,FUN_036224-T1,Peve_00025944,Pocillopora_meandrina_HIv1___RNAseq.g27547.t1,three_way,76.61933333333333,FUN_036224-T1,P41123,,,,,62.6,211.0,9e-68,258.1,sp|P41123|RL13_RAT Large ribosomal subunit protein eL13 OS=Rattus norvegicus OX=10116 GN=Rpl13 PE=1 SV=2,,,,,,
OG_02762,0.6959910929200345,OG_02762,FUN_011699-T1,Peve_00018060,Pocillopora_meandrina_HIv1___RNAseq.g23827.t1,three_way,86.615,FUN_011699-T1,P47836,,,,,73.9,241.0,3.3e-106,386.0,sp|P47836|RS4_CHICK Small ribosomal subunit protein eS4 OS=Gallus gallus OX=9031 GN=RPS4 PE=1 SV=2,,,,,,
OG_06626,0.6948227757050784,OG_06626,FUN_030056-T1,Peve_00040199,Pocillopora_meandrina_HIv1___RNAseq.g17348.t1,three_way,57.199666666666666,,,,,,,,,,,,,,,,,
OG_01161,0.6937142534012833,OG_01161,FUN_004780-T1,Peve_00037744,Pocillopora_meandrina_HIv1___RNAseq.g6689.t1,three_way,84.39833333333334,FUN_004780-T1,Q6P3J5,EF2_DANRE,,Elongation factor 2b (EF-2) (EC 3.6.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,858.0,0.0,1342.8,sp|Q6P3J5|EF2_DANRE Elongation factor 2b OS=Danio rerio OX=7955 GN=eef2b PE=1 SV=1,GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0006414; GO:0043009; GO:0043022; GO:0071466; GO:1990904,cellular response to xenobiotic stimulus [GO:0071466]; chordate embryonic development [GO:0043009]; translational elongation [GO:0006414],cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development
OG_07669,0.6924705704370617,OG_07669,FUN_034724-T1,Peve_00033264,Pocillopora_meandrina_HIv1___RNAseq.g28719.t1,three_way,89.57333333333334,FUN_034724-T1,P39023,RL3_HUMAN,,Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (HIV-1 TAR RNA-binding protein B) (TARBP-B),Homo sapiens (Human),72.8,397.0,2.4e-170,599.7,sp|P39023|RL3_HUMAN Large ribosomal subunit protein uL3 OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=2,GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0022625; GO:0022626; GO:0032991; GO:0070062; GO:0071353,cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198; GO:0005634; GO:0005730; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; RNA binding; structural molecule activity; nucleus; nucleolus; cytosol; ribosome; organelle
OG_05025,0.69028133063608,OG_05025,FUN_023188-T1,Peve_00009990,Pocillopora_meandrina_HIv1___RNAseq.g670.t1,three_way,70.7675,,,,,,,,,,,,,,,,,
OG_01505,0.6902002237501439,OG_01505,FUN_006237-T1,Peve_00030695,Pocillopora_meandrina_HIv1___RNAseq.g20447.t1,three_way,90.30166666666666,FUN_006237-T1,Q9GP16,,,,,72.4,123.0,3.5e-48,192.2,sp|Q9GP16|RL31_HELVI Large ribosomal subunit protein eL31 OS=Heliothis virescens OX=7102 GN=RpL31 PE=2 SV=1,,,,,,
OG_09573,0.6884009008118261,OG_09573,FUN_041705-T1,Peve_00001480,Pocillopora_meandrina_HIv1___RNAseq.g13973.t1,three_way,45.37833333333334,FUN_041705-T1,Q95VY2,,,,,43.7,174.0,1.7000000000000002e-32,140.6,sp|Q95VY2|TCTP_BRABE Translationally-controlled tumor protein homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1,,,,,,
OG_09850,0.6881416807593147,OG_09850,FUN_042841-T1,Peve_00007267,Pocillopora_meandrina_HIv1___RNAseq.g7258.t1,three_way,84.73333333333333,FUN_042841-T1,Q2TBQ5,RL7A_BOVIN,,Large ribosomal subunit protein eL8 (60S ribosomal protein L7a),Bos taurus (Bovine),63.1,263.0,3.5e-85,316.2,sp|Q2TBQ5|RL7A_BOVIN Large ribosomal subunit protein eL8 OS=Bos taurus OX=9913 GN=RPL7A PE=2 SV=3,GO:0000470; GO:0003723; GO:0003735; GO:0005730; GO:0016020; GO:0022625; GO:0045202,maturation of LSU-rRNA [GO:0000470],cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; synapse [GO:0045202],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_04073,0.6880465042199512,OG_04073,FUN_016396-T1,Peve_00006415,Pocillopora_meandrina_HIv1___RNAseq.g9761.t1,three_way,59.46566666666667,FUN_016396-T1,Q9NXE8,CWC25_HUMAN,,Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25),Homo sapiens (Human),58.0,143.0,1.2e-36,156.0,sp|Q9NXE8|CWC25_HUMAN Pre-mRNA-splicing factor CWC25 homolog OS=Homo sapiens OX=9606 GN=CWC25 PE=1 SV=1,GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0016607; GO:0071006,"mRNA splicing, via spliceosome [GO:0000398]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684],,GO:0005634; GO:0005654; GO:0016071; GO:0043226,nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_01295,0.6868048737068564,OG_01295,FUN_005120-T1,Peve_00026681,Pocillopora_meandrina_HIv1___TS.g20003.t1,three_way,92.25233333333334,FUN_005120-T1,P37380,,,,,81.6,185.0,9.3e-77,287.7,sp|P37380|RL17_PODCA Large ribosomal subunit protein uL22 OS=Podocoryna carnea OX=6096 GN=RPL17 PE=2 SV=1,,,,,,
OG_02560,0.6861685793997819,OG_02560,FUN_010659-T1,Peve_00031472,Pocillopora_meandrina_HIv1___RNAseq.g21313.t1,three_way,90.361,FUN_010659-T1,Q76I81,,,,,81.8,121.0,1.5999999999999996e-53,209.9,sp|Q76I81|RS12_BOVIN Small ribosomal subunit protein eS12 OS=Bos taurus OX=9913 GN=RPS12 PE=2 SV=1,,,,,,
OG_02331,0.6858004496957049,OG_02331,FUN_008924-T1,Peve_00028630,Pocillopora_meandrina_HIv1___RNAseq.g14267.t1,three_way,80.87533333333333,FUN_008924-T1,O76756,,,,,75.1,209.0,9.500000000000001e-86,317.8,sp|O76756|RS8_APIME Small ribosomal subunit protein eS8 OS=Apis mellifera OX=7460 GN=RpS8 PE=2 SV=2,,,,,,
OG_08405,0.6849993358841268,OG_08405,FUN_037056-T1,Peve_00018389,Pocillopora_meandrina_HIv1___RNAseq.g26785.t1,three_way,92.43566666666666,FUN_037056-T1,P23358,,,,,79.1,163.0,2.6e-70,266.2,sp|P23358|RL12_RAT Large ribosomal subunit protein uL11 OS=Rattus norvegicus OX=10116 GN=Rpl12 PE=2 SV=1,,,,,,
OG_02472,0.6849513225172237,OG_02472,FUN_009674-T1,Peve_00009258,Pocillopora_meandrina_HIv1___RNAseq.g24570.t1,three_way,65.10866666666666,FUN_009674-T1,Q7ZW47,,,,,34.7,625.0,1.4e-71,272.3,sp|Q7ZW47|STAU2_DANRE Double-stranded RNA-binding protein Staufen homolog 2 OS=Danio rerio OX=7955 GN=stau2 PE=2 SV=2,,,,,,
OG_01390,0.6826019252783488,OG_01390,FUN_005365-T1,Peve_00016036,Pocillopora_meandrina_HIv1___RNAseq.g8222.t1,three_way,83.86883333333333,FUN_005365-T1,O01727,,,,,80.4,189.0,2.900000000000001e-86,319.7,sp|O01727|RS6_BRAFL Small ribosomal subunit protein eS6 OS=Branchiostoma floridae OX=7739 GN=RPS6 PE=3 SV=1,,,,,,
OG_07889,0.6816975104746871,OG_07889,FUN_035267-T1,Peve_00032639,Pocillopora_meandrina_HIv1___RNAseq.g27876.t1,three_way,69.10499999999999,FUN_035267-T1,Q4R7K1,MCES_MACFA,,mRNA cap guanine-N(7) methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),55.7,334.0,8e-103,375.9,sp|Q4R7K1|MCES_MACFA mRNA cap guanine-N(7) methyltransferase OS=Macaca fascicularis OX=9541 GN=RNMT PE=2 SV=1,GO:0003723; GO:0004482; GO:0005634; GO:0006370; GO:0160130,7-methylguanosine mRNA capping [GO:0006370],mRNA cap methyltransferase RNMT:RAMAC complex [GO:0160130]; nucleus [GO:0005634],mRNA 5'-cap (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_02474,0.6805285376072491,OG_02474,FUN_009677-T1,Peve_00024097,Pocillopora_meandrina_HIv1___RNAseq.g24567.t1,three_way,78.88666666666667,FUN_009677-T1,Q54LV8,,,,,59.6,94.0,9.6e-25,114.0,sp|Q54LV8|RL34_DICDI Large ribosomal subunit protein eL34 OS=Dictyostelium discoideum OX=44689 GN=rpl34 PE=3 SV=1,,,,,,
OG_07128,0.6798491890107944,OG_07128,FUN_032428-T1,Peve_00007849,Pocillopora_meandrina_HIv1___RNAseq.g24119.t1,three_way,84.269,FUN_032428-T1,P14148,RL7_MOUSE,,Large ribosomal subunit protein uL30 (60S ribosomal protein L7),Mus musculus (Mouse),78.3,180.0,4.8e-79,295.8,sp|P14148|RL7_MOUSE Large ribosomal subunit protein uL30 OS=Mus musculus OX=10090 GN=Rpl7 PE=1 SV=2,GO:0000463; GO:0002181; GO:0003677; GO:0003729; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0022625; GO:0042802; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1990904,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003677; GO:0003723; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; DNA binding; RNA binding; structural molecule activity; cytosol; ribosome; organelle
OG_07474,0.6794463710363992,OG_07474,FUN_033989-T1,Peve_00004922,Pocillopora_meandrina_HIv1___RNAseq.g26102.t1,three_way,69.42083333333333,FUN_033989-T1,E9Q2Z1,CECR2_MOUSE,,Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2 homolog),Mus musculus (Mouse),46.8,571.0,1.8e-84,316.2,sp|E9Q2Z1|CECR2_MOUSE Chromatin remodeling regulator CECR2 OS=Mus musculus OX=10090 GN=Cecr2 PE=1 SV=1,GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006338; GO:0007338; GO:0021915; GO:0031010; GO:0060122; GO:0090102; GO:0090537; GO:0097194; GO:0140658,chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338],CERF complex [GO:0090537]; euchromatin [GO:0000791]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634],ATP-dependent chromatin remodeler activity [GO:0140658],GO:0003824; GO:0005634; GO:0006325; GO:0022414; GO:0043226; GO:0048856; GO:0140097; GO:0140657,"catalytic activity; nucleus; chromatin organization; reproductive process; organelle; anatomical structure development; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03145,0.6790947245518534,OG_03145,FUN_012531-T1,Peve_00013910,Pocillopora_meandrina_HIv1___RNAseq.g23956.t1c,three_way,73.822,FUN_012531-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),71.5,583.0,2.8e-132,473.8,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_03230,0.6748944226076027,OG_03230,FUN_012772-T1,Peve_00007600,Pocillopora_meandrina_HIv1___RNAseq.g13653.t1,three_way,86.02266666666667,FUN_012772-T1,Q9DFQ7,,,,,76.6,111.0,5.199999999999999e-43,175.6,sp|Q9DFQ7|RL24_GILMI Large ribosomal subunit protein eL24 OS=Gillichthys mirabilis OX=8222 GN=rpl24 PE=2 SV=2,,,,,,
OG_02517,0.6748942312317523,OG_02517,FUN_010576-T1,Peve_00032735,Pocillopora_meandrina_HIv1___RNAseq.g21522.t1,three_way,61.242666666666665,,,,,,,,,,,,,,,,,
OG_02355,0.6735089657939097,OG_02355,FUN_008958-T1,Peve_00021624,Pocillopora_meandrina_HIv1___RNAseq.g4045.t1,three_way,88.27633333333334,FUN_008958-T1,P36241,,,,,80.5,77.0,5.2e-27,121.7,sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2,,,,,,
OG_03205,0.6734286325443617,OG_03205,FUN_012696-T1,Peve_00016827,Pocillopora_meandrina_HIv1___RNAseq.g22856.t1,three_way,62.6505,FUN_012696-T1,Q5F3A1,,,,,56.6,290.0,9.4e-52,205.7,sp|Q5F3A1|SEC62_CHICK Translocation protein SEC62 OS=Gallus gallus OX=9031 GN=SEC62 PE=2 SV=1,,,,,,
OG_06103,0.6724377223103372,OG_06103,FUN_027804-T1,Peve_00036486,Pocillopora_meandrina_HIv1___RNAseq.g13899.t1,three_way,84.46000000000001,FUN_027804-T1,Q9U9L2,,,,,82.8,250.0,9.3e-123,441.0,sp|Q9U9L2|RL8_ANOGA Large ribosomal subunit protein uL2 OS=Anopheles gambiae OX=7165 GN=RpL8 PE=2 SV=2,,,,,,
OG_02602,0.6724212115925298,OG_02602,FUN_010728-T1,Peve_00038973,Pocillopora_meandrina_HIv1___RNAseq.g20945.t1,three_way,73.28566666666667,FUN_010728-T1,Q503V9,,,,,57.0,186.0,2.6e-54,213.4,sp|Q503V9|ENDUB_DANRE Uridylate-specific endoribonuclease B OS=Danio rerio OX=7955 GN=endoub PE=2 SV=1,,,,,,
OG_07978,0.6715589849276326,OG_07978,FUN_035600-T1,Peve_00027480,Pocillopora_meandrina_HIv1___RNAseq.g28038.t1,three_way,84.73833333333333,FUN_035600-T1,Q9T043,,,,,54.9,133.0,1.4e-32,140.6,sp|Q9T043|RL142_ARATH Large ribosomal subunit protein eL14y OS=Arabidopsis thaliana OX=3702 GN=RPL14B PE=1 SV=1,,,,,,
OG_05430,0.6711606989117072,OG_05430,FUN_024376-T1,Peve_00020239,Pocillopora_meandrina_HIv1___RNAseq.g18601.t1,three_way,98.059,FUN_024376-T1,Q3T169,RS3_BOVIN,,Small ribosomal subunit protein uS3 (EC 4.2.99.18) (40S ribosomal protein S3),Bos taurus (Bovine),90.4,239.0,1.4e-120,433.7,sp|Q3T169|RS3_BOVIN Small ribosomal subunit protein uS3 OS=Bos taurus OX=9913 GN=RPS3 PE=2 SV=1,GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235,apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003677; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005730; GO:0006281; GO:0012501; GO:0016829; GO:0043226; GO:0140097,"DNA binding; RNA binding; catalytic activity; structural molecule activity; nucleus; nucleolus; DNA repair; programmed cell death; lyase activity; organelle; catalytic activity, acting on DNA"
OG_07906,0.6701124867223074,OG_07906,FUN_035349-T1,Peve_00032934,Pocillopora_meandrina_HIv1___RNAseq.g12261.t1,three_way,88.37633333333333,FUN_035349-T1,P11387,TOP1_HUMAN,,DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I),Homo sapiens (Human),67.5,511.0,6.8e-202,704.9,sp|P11387|TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens OX=9606 GN=TOP1 PE=1 SV=2,GO:0000932; GO:0000978; GO:0001650; GO:0001651; GO:0001673; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003723; GO:0003917; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007623; GO:0008301; GO:0009266; GO:0009303; GO:0009410; GO:0010332; GO:0012501; GO:0018105; GO:0019904; GO:0031100; GO:0031490; GO:0032922; GO:0032993; GO:0040016; GO:0043204; GO:0044877; GO:0051591; GO:0071373; GO:0097100,animal organ regeneration [GO:0031100]; cellular response to luteinizing hormone stimulus [GO:0071373]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; programmed cell death [GO:0012501]; response to cAMP [GO:0051591]; response to gamma radiation [GO:0010332]; response to temperature stimulus [GO:0009266]; response to xenobiotic stimulus [GO:0009410]; rRNA transcription [GO:0009303],chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993],"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006325; GO:0006351; GO:0007059; GO:0012501; GO:0016740; GO:0016853; GO:0043226; GO:0048856; GO:0140096; GO:0140097,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA replication; chromatin organization; DNA-templated transcription; chromosome segregation; programmed cell death; transferase activity; isomerase activity; organelle; anatomical structure development; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_00071,0.6698735421148087,OG_00071,FUN_000393-T1,Peve_00033591,Pocillopora_meandrina_HIv1___RNAseq.g2528.t1,three_way,82.34016666666666,FUN_000393-T1,P08429,,,,,65.9,349.0,9.9e-131,468.0,sp|P08429|RL4A_XENLA Large ribosomal subunit protein uL4A OS=Xenopus laevis OX=8355 GN=rpl4-a PE=2 SV=2,,,,,,
OG_03369,0.6685807050986855,OG_03369,FUN_013615-T1,Peve_00002656,Pocillopora_meandrina_HIv1___RNAseq.g13534.t1,three_way,66.598,FUN_013615-T1,Q6Y7W8,,,,,35.4,621.0,1.4999999999999999e-40,170.2,sp|Q6Y7W8|GGYF2_MOUSE GRB10-interacting GYF protein 2 OS=Mus musculus OX=10090 GN=Gigyf2 PE=1 SV=2,,,,,,
OG_09621,0.6679370337855335,OG_09621,FUN_041784-T1,Peve_00025206,Pocillopora_meandrina_HIv1___RNAseq.g15487.t1,three_way,95.13633333333333,FUN_041784-T1,P16912,KAPC3_DROME,,cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2),Drosophila melanogaster (Fruit fly),66.2,314.0,8.1e-132,471.5,sp|P16912|KAPC3_DROME cAMP-dependent protein kinase catalytic subunit 3 OS=Drosophila melanogaster OX=7227 GN=Pka-C3 PE=2 SV=2,GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0007155; GO:0007165; GO:0007476; GO:0106310,cell adhesion [GO:0007155]; imaginal disc-derived wing morphogenesis [GO:0007476]; signal transduction [GO:0007165],cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829],ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005829; GO:0007155; GO:0016740; GO:0140096,"catalytic activity; cytosol; cell adhesion; transferase activity; catalytic activity, acting on a protein"
OG_06809,0.6677559713762761,OG_06809,FUN_031708-T1,Peve_00002669,Pocillopora_meandrina_HIv1___RNAseq.g5756.t1,three_way,77.23333333333333,FUN_031708-T1,P26642,,,,,62.6,436.0,1.7000000000000001e-134,480.7,sp|P26642|EF1GA_XENLA Elongation factor 1-gamma-A OS=Xenopus laevis OX=8355 GN=eef1g-a PE=1 SV=1,,,,,,
OG_01995,0.6665680511005808,OG_01995,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_00703,0.6663445586152005,OG_00703,FUN_002453-T1,Peve_00023668,Pocillopora_meandrina_HIv1___RNAseq.g14891.t1,three_way,78.35433333333334,,,,,,,,,,,,,,,,,
OG_04351,0.6661802127862442,OG_04351,FUN_017990-T1,Peve_00037470,Pocillopora_meandrina_HIv1___RNAseq.g25285.t1,three_way,80.066,FUN_017990-T1,Q16665,,,,,40.2,388.0,3.2e-77,291.2,sp|Q16665|HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens OX=9606 GN=HIF1A PE=1 SV=1,,,,,,
OG_08861,0.6656109955394621,OG_08861,FUN_038247-T1,Peve_00007988,Pocillopora_meandrina_HIv1___RNAseq.g923.t1,three_way,78.74566666666666,FUN_038247-T1,P15170,ERF3A_HUMAN,,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (EC 3.6.5.-) (G1 to S phase transition protein 1 homolog),Homo sapiens (Human),71.9,427.0,3.8e-190,666.0,sp|P15170|ERF3A_HUMAN Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens OX=9606 GN=GSPT1 PE=1 SV=1,GO:0000082; GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006412; GO:0006415; GO:0006449; GO:0006479; GO:0018444; GO:0022626,"G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; translation release factor complex [GO:0018444],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0005840; GO:0016071; GO:0016787; GO:0043226,RNA binding; catalytic activity; GTPase activity; cytosol; ribosome; mRNA metabolic process; hydrolase activity; organelle
OG_01639,0.6652613846439704,OG_01639,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,35.5,262.0,1.3000000000000001e-30,136.3,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_01639,0.6652613846439704,OG_01639,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,54.2,72.0,2.9e-14,82.0,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_04633,0.6647381715305234,OG_04633,FUN_022346-T1,Peve_00018538,Pocillopora_meandrina_HIv1___RNAseq.g4661.t1,three_way,98.06033333333332,FUN_022346-T1,Q3T057,RL23_BOVIN,,Large ribosomal subunit protein uL14 (60S ribosomal protein L23),Bos taurus (Bovine),92.1,139.0,2.0999999999999997e-68,259.6,sp|Q3T057|RL23_BOVIN Large ribosomal subunit protein uL14 OS=Bos taurus OX=9913 GN=RPL23 PE=2 SV=2,GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0045202; GO:0050821; GO:0070180; GO:0070314; GO:0072717; GO:1901798; GO:1903450; GO:1990948; GO:2000059,cellular response to actinomycin D [GO:0072717]; G1 to G0 transition [GO:0070314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; regulation of G1 to G0 transition [GO:1903450]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202],large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005198; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0098772,RNA binding; structural molecule activity; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_09847,0.6616899939855625,OG_09847,FUN_042837-T1,Peve_00007263,Pocillopora_meandrina_HIv1___RNAseq.g7264.t1,three_way,78.92983333333333,FUN_042837-T1,Q32S26,BRD2_BOVIN,,Bromodomain-containing protein 2,Bos taurus (Bovine),50.9,737.0,1.5e-137,492.3,sp|Q32S26|BRD2_BOVIN Bromodomain-containing protein 2 OS=Bos taurus OX=9913 GN=BRD2 PE=3 SV=1,GO:0000785; GO:0005634; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0070577; GO:0071168; GO:0140012; GO:0140588; GO:2000330,chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; nucleosome assembly [GO:0006334]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein localization to chromatin [GO:0071168]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],histone H4K5ac reader activity [GO:0140012]; lysine-acetylated histone binding [GO:0070577],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0065003,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly
OG_01905,0.6600861086142839,OG_01905,FUN_007919-T1,Peve_00040675,Pocillopora_meandrina_HIv1___RNAseq.g30121.t1,three_way,90.73183333333331,FUN_007919-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),63.3,608.0,1.6e-207,724.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_08400,0.6597719985192072,OG_08400,FUN_037048-T1,Peve_00032330,Pocillopora_meandrina_HIv1___RNAseq.g26794.t1,three_way,85.69433333333333,FUN_037048-T1,Q56JU9,,,,,76.4,127.0,1e-40,167.5,sp|Q56JU9|RS24_BOVIN Small ribosomal subunit protein eS24 OS=Bos taurus OX=9913 GN=RPS24 PE=2 SV=2,,,,,,
OG_06372,0.6596472876634498,OG_06372,FUN_028977-T1,Peve_00014804,Pocillopora_meandrina_HIv1___RNAseq.g25607.t1,three_way,64.57616666666667,FUN_028977-T1,Q3UG20,KMT2E_MOUSE,,Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog),Mus musculus (Mouse),30.4,460.0,1e-47,194.1,sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2,GO:0000791; GO:0002446; GO:0003713; GO:0005737; GO:0005813; GO:0008270; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:1900087,epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; retinoic acid receptor signaling pathway [GO:0048384],centrosome [GO:0005813]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005815; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"immune system process; catalytic activity; microtubule organizing center; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_05401,0.6592225947685578,OG_05401,FUN_024332-T1,Peve_00016315,Pocillopora_meandrina_HIv1___RNAseq.g18928.t1,three_way,91.02566666666668,FUN_024332-T1,A7S3J7,,,,,82.1,263.0,2.4e-123,443.0,sp|A7S3J7|RS3A_NEMVE Small ribosomal subunit protein eS1 OS=Nematostella vectensis OX=45351 GN=v1g242621 PE=3 SV=1,,,,,,
OG_05387,0.658186506347055,OG_05387,FUN_024208-T1,Peve_00031873,Pocillopora_meandrina_HIv1___RNAseq.g18905.t1b,three_way,71.887,FUN_024208-T1,O09167,RL21_MOUSE,,Large ribosomal subunit protein eL21 (60S ribosomal protein L21),Mus musculus (Mouse),65.0,160.0,4.7e-52,206.1,sp|O09167|RL21_MOUSE Large ribosomal subunit protein eL21 OS=Mus musculus OX=10090 GN=Rpl21 PE=1 SV=4,GO:0002181; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098794,cytoplasmic translation [GO:0002181],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; postsynapse [GO:0098794]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005783; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; endoplasmic reticulum; cytosol; ribosome; organelle
OG_04930,0.6580207039196123,OG_04930,FUN_022997-T1,Peve_00006903,Pocillopora_meandrina_HIv1___RNAseq.g3793.t1,three_way,49.0015,,,,,,,,,,,,,,,,,
OG_05647,0.6579077468632699,OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),40.8,610.0,6.4e-84,314.3,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_05647,0.6579077468632699,OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),61.2,188.0,5.7e-56,221.5,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_04407,0.6576140908926253,OG_04407,FUN_018425-T1,Peve_00031687,Pocillopora_meandrina_HIv1___RNAseq.g10172.t1,three_way,90.69833333333332,FUN_018425-T1,Q9GT45,,,,,81.4,113.0,5.400000000000001e-44,178.3,sp|Q9GT45|RS26_ANOGA Small ribosomal subunit protein eS26 OS=Anopheles gambiae OX=7165 GN=RpS26 PE=3 SV=2,,,,,,
OG_03674,0.6573132094771383,OG_03674,FUN_014925-T1,Peve_00006270,Pocillopora_meandrina_HIv1___RNAseq.g21082.t1,three_way,77.86116666666666,FUN_014925-T1,Q9I9E0,,,,,43.7,581.0,9.9e-52,206.5,sp|Q9I9E0|TAOK3_CHICK Serine/threonine-protein kinase TAO3 OS=Gallus gallus OX=9031 GN=TAOK3 PE=2 SV=2,,,,,,
OG_07832,0.6569019859765107,OG_07832,FUN_035154-T1,Peve_00006880,Pocillopora_meandrina_HIv1___RNAseq.g27634.t1,three_way,56.06466666666667,FUN_035154-T1,Q9UKV3,,,,,30.4,280.0,5e-24,114.8,sp|Q9UKV3|ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens OX=9606 GN=ACIN1 PE=1 SV=2,,,,,,
OG_06366,0.6561142484862286,OG_06366,FUN_028970-T1,Peve_00006113,Pocillopora_meandrina_HIv1___RNAseq.g25636.t1,three_way,82.70400000000001,FUN_028970-T1,P13195,HEM1_RAT,,"5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)",Rattus norvegicus (Rat),52.0,611.0,1.8e-169,597.4,"sp|P13195|HEM1_RAT 5-aminolevulinate synthase, non-specific, mitochondrial OS=Rattus norvegicus OX=10116 GN=Alas1 PE=2 SV=2",GO:0001666; GO:0003870; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0009635; GO:0010045; GO:0030170; GO:0031667; GO:0032025; GO:0032869; GO:0034698; GO:0042541; GO:0042802; GO:0045471; GO:0048034; GO:0048821; GO:0051591; GO:0070541; GO:1903412,cellular response to insulin stimulus [GO:0032869]; erythrocyte development [GO:0048821]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to platinum ion [GO:0070541]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleoplasm; mitochondrion; cytosol; transferase activity; organelle; anatomical structure development
OG_06689,0.6556749098406529,OG_06689,FUN_031221-T1,Peve_00043066,Pocillopora_meandrina_HIv1___RNAseq.g5197.t1,three_way,64.83466666666666,FUN_031221-T1,P51901,,,,,29.0,635.0,6.1e-63,245.0,sp|P51901|ANXA6_CHICK Annexin A6 OS=Gallus gallus OX=9031 GN=ANXA6 PE=2 SV=1,,,,,,
OG_01221,0.6550643109490698,OG_01221,FUN_004903-T1,Peve_00028646,Pocillopora_meandrina_HIv1___RNAseq.g8331.t1,three_way,93.306,FUN_004903-T1,A5PK63,,,,,79.9,134.0,9.9e-55,214.2,sp|A5PK63|RS17_BOVIN Small ribosomal subunit protein eS17 OS=Bos taurus OX=9913 GN=RPS17 PE=2 SV=1,,,,,,
OG_00528,0.6548883120634426,OG_00528,FUN_001532-T1,Peve_00000627,Pocillopora_meandrina_HIv1___RNAseq.g2048.t1,three_way,76.9355,FUN_001532-T1,Q80W14,,,,,53.5,593.0,3.1e-96,354.8,sp|Q80W14|PR40B_MOUSE Pre-mRNA-processing factor 40 homolog B OS=Mus musculus OX=10090 GN=Prpf40b PE=1 SV=2,,,,,,
OG_00581,0.6548493662689562,OG_00581,FUN_001654-T1,Peve_00038365,Pocillopora_meandrina_HIv1___RNAseq.g29407.t1,three_way,87.83066666666666,FUN_001654-T1,Q4R7Y4,GBLP_MACFA,,"Small ribosomal subunit protein RACK1 (Guanine nucleotide-binding protein subunit beta-2-like 1) [Cleaved into: Small ribosomal subunit protein RACK1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),83.1,313.0,2.1e-132,473.4,sp|Q4R7Y4|GBLP_MACFA Small ribosomal subunit protein RACK1 OS=Macaca fascicularis OX=9541 GN=GNB2L1 PE=2 SV=3,GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005840; GO:0006915; GO:0007369; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0042169; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0045182; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:1990904; GO:2000114; GO:2000543,apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840],protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; translation regulator activity [GO:0045182],GO:0005634; GO:0005840; GO:0012501; GO:0043226; GO:0045182; GO:0098772,nucleus; ribosome; programmed cell death; organelle; translation regulator activity; molecular function regulator activity
OG_08795,0.6547593261402518,OG_08795,FUN_038091-T1,Peve_00007109,Pocillopora_meandrina_HIv1___RNAseq.g818.t1,three_way,94.97433333333332,FUN_038091-T1,A6QLG5,RS9_BOVIN,,Small ribosomal subunit protein uS4 (40S ribosomal protein S9),Bos taurus (Bovine),90.0,170.0,6.9e-83,308.1,sp|A6QLG5|RS9_BOVIN Small ribosomal subunit protein uS4 OS=Bos taurus OX=9913 GN=RPS9 PE=2 SV=1,GO:0003735; GO:0005730; GO:0006412; GO:0019843; GO:0022627; GO:0032040; GO:0042274; GO:1990904,ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_08842,0.6540318336188298,OG_08842,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_09390,0.6521323950301526,OG_09390,FUN_040686-T1,Peve_00007674,Pocillopora_meandrina_HIv1___RNAseq.g6452.t1,three_way,90.56466666666668,FUN_040686-T1,G1U0Q2,,,,,80.8,146.0,1.8e-62,240.0,sp|G1U0Q2|RS15_RABIT Small ribosomal subunit protein uS19 OS=Oryctolagus cuniculus OX=9986 GN=RPS15 PE=1 SV=1,,,,,,
OG_09902,0.650719851820576,OG_09902,FUN_042998-T1,Peve_00015176,Pocillopora_meandrina_HIv1___RNAseq.g7022.t1,three_way,83.66866666666667,FUN_042998-T1,Q6ZWV7,RL35_MOUSE,,Large ribosomal subunit protein uL29 (60S ribosomal protein L35),Mus musculus (Mouse),78.7,122.0,6.5e-42,171.4,sp|Q6ZWV7|RL35_MOUSE Large ribosomal subunit protein uL29 OS=Mus musculus OX=10090 GN=Rpl35 PE=1 SV=1,GO:0000463; GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; cytosol; ribosome; organelle
OG_02323,0.6496916507271367,OG_02323,FUN_008915-T1,Peve_00033002,Pocillopora_meandrina_HIv1___RNAseq.g3980.t1,three_way,93.944,FUN_008915-T1,P58375,,,,,80.4,112.0,2.2e-45,183.0,sp|P58375|RL30_SPOFR Large ribosomal subunit protein eL30 OS=Spodoptera frugiperda OX=7108 GN=RpL30 PE=3 SV=1,,,,,,
OG_07880,0.6494332529949983,OG_07880,FUN_035243-T1,Peve_00042228,Pocillopora_meandrina_HIv1___RNAseq.g27896.t1,three_way,91.40466666666669,FUN_035243-T1,Q6Q137,SEPT7_BOVIN,,Septin-7 (CDC10 protein homolog),Bos taurus (Bovine),67.9,330.0,2.1999999999999997e-129,463.8,sp|Q6Q137|SEPT7_BOVIN Septin-7 OS=Bos taurus OX=9913 GN=SEPTIN7 PE=2 SV=2,GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005930; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0042802; GO:0060090; GO:0060271; GO:0061640; GO:0097227; GO:0097730; GO:1902857,cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],GO:0000910; GO:0003824; GO:0003924; GO:0005634; GO:0005856; GO:0005929; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0060090,cytokinesis; catalytic activity; GTPase activity; nucleus; cytoskeleton; cilium; hydrolase activity; reproductive process; cell differentiation; organelle; cilium organization; molecular adaptor activity
OG_03139,0.6488061896985704,OG_03139,FUN_012521-T1,Peve_00029780,Pocillopora_meandrina_HIv1___RNAseq.g23961.t1,three_way,79.82916666666667,FUN_012521-T1,Q3SZ90,RL13A_BOVIN,,Large ribosomal subunit protein uL13 (60S ribosomal protein L13a),Bos taurus (Bovine),63.1,195.0,5.899999999999999e-68,259.6,sp|Q3SZ90|RL13A_BOVIN Large ribosomal subunit protein uL13 OS=Bos taurus OX=9913 GN=RPL13A PE=2 SV=3,GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0032496; GO:0042592; GO:0045202; GO:0048246; GO:0060425; GO:0071346; GO:0097452; GO:1901194,cellular response to type II interferon [GO:0071346]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; synapse [GO:0045202],mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002376; GO:0003723; GO:0005198; GO:0005840; GO:0043226; GO:0048870,immune system process; RNA binding; structural molecule activity; ribosome; organelle; cell motility
OG_03826,0.6483173168217109,OG_03826,FUN_015256-T1,Peve_00014304,Pocillopora_meandrina_HIv1___RNAseq.g22207.t1,three_way,71.4415,FUN_015256-T1,G1SE76,,,,,76.7,146.0,2.9999999999999995e-54,213.0,sp|G1SE76|RL23A_RABIT Large ribosomal subunit protein uL23 OS=Oryctolagus cuniculus OX=9986 GN=RPL23A PE=1 SV=1,,,,,,
OG_05470,0.6479094230718001,OG_05470,FUN_024453-T1,Peve_00010317,Pocillopora_meandrina_HIv1___RNAseq.g18578.t1,three_way,82.89666666666666,FUN_024453-T1,Q3SYR7,,,,,65.0,177.0,1.7e-59,230.3,sp|Q3SYR7|RL9_BOVIN Large ribosomal subunit protein uL6 OS=Bos taurus OX=9913 GN=RPL9 PE=2 SV=1,,,,,,
OG_01216,0.6478330158149115,OG_01216,FUN_004897-T1,Peve_00015867,Pocillopora_meandrina_HIv1___RNAseq.g8671.t1,three_way,80.57000000000001,FUN_004897-T1,Q9Y3U8,,,,,63.4,93.0,7.6e-25,114.4,sp|Q9Y3U8|RL36_HUMAN Large ribosomal subunit protein eL36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3,,,,,,
OG_06491,0.646019433802725,OG_06491,FUN_029269-T1,Peve_00002504,Pocillopora_meandrina_HIv1___RNAseq.g25417.t1,three_way,91.27916666666668,FUN_029269-T1,P08110,,,,,69.4,779.0,1.7e-282,973.4,sp|P08110|ENPL_CHICK Endoplasmin OS=Gallus gallus OX=9031 GN=HSP90B1 PE=1 SV=1,,,,,,
OG_07718,0.645556234184158,OG_07718,FUN_034873-T1,Peve_00005762,Pocillopora_meandrina_HIv1___RNAseq.g27162.t1,three_way,90.15966666666668,FUN_034873-T1,A1L3F5,,,,,44.8,724.0,1.6e-163,577.8,sp|A1L3F5|CMIP_XENLA C-Maf-inducing protein OS=Xenopus laevis OX=8355 GN=cmip PE=2 SV=2,,,,,,
OG_09412,0.6454619379649803,OG_09412,FUN_040923-T1,Peve_00012313,Pocillopora_meandrina_HIv1___RNAseq.g27560.t1,three_way,85.5445,FUN_040923-T1,Q4G0P3,HYDIN_HUMAN,,Hydrocephalus-inducing protein homolog,Homo sapiens (Human),43.3,3001.0,0.0,2169.8,sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3,GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718,axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0043226; GO:0048856,cilium; microtubule-based movement; organelle; anatomical structure development
OG_08517,0.6443099573653971,OG_08517,FUN_037447-T1,Peve_00027251,Pocillopora_meandrina_HIv1___RNAseq.g10986.t1,three_way,85.654,FUN_037447-T1,Q3T0V4,,,,,75.0,156.0,5.1999999999999995e-61,235.3,sp|Q3T0V4|RS11_BOVIN Small ribosomal subunit protein uS17 OS=Bos taurus OX=9913 GN=RPS11 PE=2 SV=3,,,,,,
OG_03671,0.6430019221797785,OG_03671,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_05724,0.6427401813567319,OG_05724,FUN_025643-T1,Peve_00002527,Pocillopora_meandrina_HIv1___TS.g15983.t1,three_way,64.00683333333333,FUN_025643-T1,Q04637,IF4G1_HUMAN,,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),Homo sapiens (Human),39.4,1020.0,1.2e-159,566.2,sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4,GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016020; GO:0016281; GO:0030182; GO:0030307; GO:0031369; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0060090; GO:0080135; GO:0097009; GO:1900087; GO:1904377; GO:1905537; GO:1905606; GO:1905612,behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840],"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]",GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0030154; GO:0031047; GO:0043226; GO:0060090,RNA binding; nucleus; cytosol; ribosome; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity
OG_03839,0.6424540597570226,OG_03839,FUN_015298-T1,Peve_00004801,Pocillopora_meandrina_HIv1___RNAseq.g22106.t1,three_way,63.3705,FUN_015298-T1,Q8QFX1,,,,,28.4,1242.0,2.3999999999999997e-83,313.2,sp|Q8QFX1|RIMB2_CHICK RIMS-binding protein 2 OS=Gallus gallus OX=9031 GN=RIMBP2 PE=1 SV=1,,,,,,
OG_05672,0.6422004318047972,OG_05672,FUN_025466-T1,Peve_00043837,Pocillopora_meandrina_HIv1___RNAseq.g13240.t1,three_way,86.86633333333333,FUN_025466-T1,Q8VDJ3,,,,,52.2,1291.0,0.0,1320.8,sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1,,,,,,
OG_01583,0.6408772486494203,OG_01583,FUN_006619-T1,Peve_00040865,Pocillopora_meandrina_HIv1___RNAseq.g20179.t1,three_way,71.24033333333334,FUN_006619-T1,Q92598,HS105_HUMAN,,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) (Heat shock protein family H member 1),Homo sapiens (Human),51.3,686.0,5.6e-181,636.0,sp|Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:0140662,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0008092; GO:0043226; GO:0044183; GO:0098772; GO:0140657,extracellular region; nucleus; nucleoplasm; cytosol; protein folding; cytoskeletal protein binding; organelle; protein folding chaperone; molecular function regulator activity; ATP-dependent activity
OG_09216,0.6403721216206067,OG_09216,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_01884,0.6402376534978638,OG_01884,FUN_007860-T1,Peve_00044448,Pocillopora_meandrina_HIv1___TS.g21287.t1,three_way,81.536,FUN_007860-T1,Q6ZPV2,,,,,48.0,1450.0,1.3e-305,1051.2,sp|Q6ZPV2|INO80_MOUSE Chromatin-remodeling ATPase INO80 OS=Mus musculus OX=10090 GN=Ino80 PE=1 SV=2,,,,,,
OG_07947,0.6402029101336963,OG_07947,FUN_035468-T1,Peve_00012132,Pocillopora_meandrina_HIv1___TS.g14397.t1,three_way,83.6845,FUN_035468-T1,Q8BH04,PCKGM_MOUSE,,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",Mus musculus (Mouse),65.5,611.0,6.100000000000001e-248,858.2,"sp|Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Mus musculus OX=10090 GN=Pck2 PE=1 SV=1",GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0030145; GO:0032024; GO:0032496; GO:0071333; GO:0071356; GO:0071548,cellular response to glucose stimulus [GO:0071333]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; pyruvate metabolic process [GO:0006090]; response to dexamethasone [GO:0071548]; response to lipopolysaccharide [GO:0032496],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],GO:0003824; GO:0005739; GO:0005975; GO:0016829; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lyase activity; organelle
OG_07435,0.6400376689044474,OG_07435,FUN_033924-T1,Peve_00022623,Pocillopora_meandrina_HIv1___RNAseq.g26586.t2,three_way,66.44966666666667,FUN_033924-T1,Q14444,CAPR1_HUMAN,,Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105),Homo sapiens (Human),38.3,180.0,4.2e-27,123.2,sp|Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2,GO:0000932; GO:0003723; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0007416; GO:0008298; GO:0010494; GO:0016020; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0035591; GO:0043232; GO:0045202; GO:0048699; GO:0050775; GO:0061003; GO:0062029; GO:0106288; GO:0140677; GO:0140693; GO:0140694,generation of neurons [GO:0048699]; intracellular mRNA localization [GO:0008298]; membraneless organelle assembly [GO:0140694]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of stress granule assembly [GO:0062029]; regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106288]; synapse assembly [GO:0007416],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membraneless organelle [GO:0043232]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; synapse [GO:0045202],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling adaptor activity [GO:0035591],GO:0003723; GO:0005829; GO:0030154; GO:0034330; GO:0043226; GO:0060090; GO:0098772,RNA binding; cytosol; cell differentiation; cell junction organization; organelle; molecular adaptor activity; molecular function regulator activity
OG_06452,0.6389888986573675,OG_06452,FUN_029173-T1,Peve_00015170,Pocillopora_meandrina_HIv1___RNAseq.g25496.t1,three_way,85.54066666666667,FUN_029173-T1,Q3T003,,,,,65.9,176.0,1.4e-69,263.8,sp|Q3T003|RL18A_BOVIN Large ribosomal subunit protein eL20 OS=Bos taurus OX=9913 GN=RPL18A PE=1 SV=1,,,,,,
OG_08049,0.6387262933796792,OG_08049,FUN_035737-T1,Peve_00044088,Pocillopora_meandrina_HIv1___RNAseq.g11864.t1,three_way,77.52216666666666,FUN_035737-T1,Q8BYH8,CHD9_MOUSE,,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.-) (ATP-dependent helicase CHD9) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),Mus musculus (Mouse),43.2,2161.0,0.0,1496.1,sp|Q8BYH8|CHD9_MOUSE Chromodomain-helicase-DNA-binding protein 9 OS=Mus musculus OX=10090 GN=Chd9 PE=1 SV=2,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005829; GO:0006325; GO:0016887,chromatin organization [GO:0006325],cytosol [GO:0005829]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; nucleoplasm; cytosol; chromatin organization; hydrolase activity; isomerase activity; ATP-dependent activity
OG_02930,0.6386114621252271,OG_02930,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_00756,0.638584321629912,OG_00756,FUN_002871-T1,Peve_00013073,Pocillopora_meandrina_HIv1___TS.g15581.t1,three_way,81.83266666666667,FUN_002871-T1,Q21086,GNL3_CAEEL,,Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1),Caenorhabditis elegans,46.8,457.0,2.7e-109,397.5,sp|Q21086|GNL3_CAEEL Guanine nucleotide-binding protein-like 3 homolog OS=Caenorhabditis elegans OX=6239 GN=nst-1 PE=3 SV=1,GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127,germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0022414; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; reproductive process; organelle; anatomical structure development
OG_08673,0.6374425875650818,OG_08673,FUN_037909-T1,Peve_00020691,Pocillopora_meandrina_HIv1___RNAseq.g1145.t1,three_way,93.333,FUN_037909-T1,P48149,,,,,84.6,130.0,6.6e-61,234.6,sp|P48149|RS15A_DROME Small ribosomal subunit protein uS8A OS=Drosophila melanogaster OX=7227 GN=RpS15Aa PE=1 SV=2,,,,,,
OG_06763,0.6348420349177777,OG_06763,FUN_031595-T1,Peve_00012520,Pocillopora_meandrina_HIv1___RNAseq.g5058.t1,three_way,67.68833333333333,FUN_031595-T1,A2CG63,ARI4B_MOUSE,,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180),Mus musculus (Mouse),27.0,562.0,3e-13,79.0,sp|A2CG63|ARI4B_MOUSE AT-rich interactive domain-containing protein 4B OS=Mus musculus OX=10090 GN=Arid4b PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006366; GO:0007283; GO:0030336; GO:0030512; GO:0045944; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459,chromatin organization [GO:0006325]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development
OG_05385,0.6343394223247879,OG_05385,FUN_024206-T1,Peve_00031875,Pocillopora_meandrina_HIv1___RNAseq.g18903.t1,three_way,91.63933333333333,FUN_024206-T1,P61221,ABCE1_HUMAN,,ATP-binding cassette sub-family E member 1 (EC 3.6.5.-) (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I),Homo sapiens (Human),81.8,598.0,6e-290,997.7,sp|P61221|ABCE1_HUMAN ATP-binding cassette sub-family E member 1 OS=Homo sapiens OX=9606 GN=ABCE1 PE=1 SV=1,GO:0003924; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0006417; GO:0016020; GO:0016887; GO:0017111; GO:0022626; GO:0032790; GO:0043024; GO:0043273; GO:0051539; GO:0060698; GO:0060702; GO:0072344,negative regulation of endoribonuclease activity [GO:0060702]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; translational initiation [GO:0006413]; translational termination [GO:0006415],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTPase activity [GO:0043273]; endoribonuclease inhibitor activity [GO:0060698]; GTPase activity [GO:0003924]; iron ion binding [GO:0005506]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]",GO:0003824; GO:0003924; GO:0005739; GO:0005829; GO:0005840; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; mitochondrion; cytosol; ribosome; hydrolase activity; organelle; molecular function regulator activity
OG_07364,0.6339109145112266,OG_07364,FUN_033776-T1,Peve_00005287,Pocillopora_meandrina_HIv1___RNAseq.g26654.t1,three_way,88.918,FUN_033776-T1,P47830,,,,,77.0,148.0,7.8e-42,171.4,sp|P47830|RL27A_XENLA Large ribosomal subunit protein uL15 OS=Xenopus laevis OX=8355 GN=rpl27a PE=2 SV=2,,,,,,
OG_00878,0.6331193042811483,OG_00878,FUN_004171-T1,Peve_00031567,Pocillopora_meandrina_HIv1___TS.g17567.t1,three_way,78.7845,FUN_004171-T1,Q865S1,,,,,55.2,1283.0,0.0,1110.1,sp|Q865S1|AP3D1_BOVIN AP-3 complex subunit delta-1 OS=Bos taurus OX=9913 GN=AP3D1 PE=1 SV=2,,,,,,
OG_01487,0.632393717768841,OG_01487,FUN_006163-T1,Peve_00023605,Pocillopora_meandrina_HIv1___RNAseq.g20424.t1,three_way,83.34083333333334,FUN_006163-T1,Q8NI27,,,,,59.9,1202.0,0.0,1382.1,sp|Q8NI27|THOC2_HUMAN THO complex subunit 2 OS=Homo sapiens OX=9606 GN=THOC2 PE=1 SV=2,,,,,,
OG_06192,0.6313941441419048,OG_06192,FUN_028114-T1,Peve_00019695,Pocillopora_meandrina_HIv1___RNAseq.g15565.t1,three_way,50.1775,FUN_028114-T1,P56182,RRP1_HUMAN,,Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein),Homo sapiens (Human),33.4,347.0,2.3e-47,191.8,sp|P56182|RRP1_HUMAN Ribosomal RNA processing protein 1 homolog A OS=Homo sapiens OX=9606 GN=RRP1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0006364; GO:0030688,rRNA processing [GO:0006364],"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]",RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0043226,RNA binding; nucleus; chromosome; nucleolus; organelle
OG_04671,0.6298608276699976,OG_04671,FUN_022429-T1,Peve_00037610,Pocillopora_meandrina_HIv1___TS.g21752.t1,three_way,84.66583333333334,FUN_022429-T1,Q5ZLT7,,,,,58.7,421.0,3.5e-135,483.0,sp|Q5ZLT7|5MP2_CHICK eIF5-mimic protein 2 OS=Gallus gallus OX=9031 GN=BZW1 PE=2 SV=1,,,,,,
OG_08781,0.6297868641764238,OG_08781,FUN_038067-T1,Peve_00010945,Pocillopora_meandrina_HIv1___RNAseq.g787.t1,three_way,64.63766666666666,,,,,,,,,,,,,,,,,
OG_04003,0.6292784940927922,OG_04003,FUN_016299-T1,Peve_00025246,Pocillopora_meandrina_HIv1___RNAseq.g9888.t1,three_way,47.610166666666665,FUN_016299-T1,Q64337,SQSTM_MOUSE,,Sequestosome-1 (STONE14) (Ubiquitin-binding protein p62),Mus musculus (Mouse),47.7,44.0,4.8e-06,55.5,sp|Q64337|SQSTM_MOUSE Sequestosome-1 OS=Mus musculus OX=10090 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0003712; GO:0005080; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016235; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225],identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; transcription coregulator activity [GO:0003712]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140110; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; transcription regulator activity; molecular sequestering activity
OG_02918,0.6274628303405223,OG_02918,FUN_012001-T1,Peve_00000536,Pocillopora_meandrina_HIv1___RNAseq.g24024.t1,three_way,59.24283333333334,FUN_012001-T1,Q60902,EP15R_MOUSE,,Epidermal growth factor receptor substrate 15-like 1 (Epidermal growth factor receptor pathway substrate 15-related sequence) (Eps15-rs) (Eps15-related protein) (Eps15R),Mus musculus (Mouse),34.3,137.0,4.6e-13,78.6,sp|Q60902|EP15R_MOUSE Epidermal growth factor receptor substrate 15-like 1 OS=Mus musculus OX=10090 GN=Eps15l1 PE=1 SV=3,GO:0005509; GO:0005634; GO:0030132; GO:0048488; GO:0098793,synaptic vesicle endocytosis [GO:0048488],clathrin coat of coated pit [GO:0030132]; nucleus [GO:0005634]; presynapse [GO:0098793],calcium ion binding [GO:0005509],GO:0005634; GO:0016192; GO:0043226,nucleus; vesicle-mediated transport; organelle
OG_07346,0.6272003504196791,OG_07346,FUN_033753-T1,Peve_00004935,Pocillopora_meandrina_HIv1___RNAseq.g28751.t1,three_way,71.35733333333333,FUN_033753-T1,Q8MPM1,,,,,51.9,362.0,3.4e-99,363.2,sp|Q8MPM1|GELS2_LUMTE Gelsolin-like protein 2 OS=Lumbricus terrestris OX=6398 GN=gelsolin PE=1 SV=1,,,,,,
OG_02683,0.6269820817790284,OG_02683,FUN_010941-T1,Peve_00005967,Pocillopora_meandrina_HIv1___RNAseq.g21806.t1,three_way,91.54933333333334,FUN_010941-T1,E2QWQ2,NLK_CANLF,,Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase),Canis lupus familiaris (Dog) (Canis familiaris),72.8,390.0,1.6000000000000002e-164,580.5,sp|E2QWQ2|NLK_CANLF Serine/threonine-protein kinase NLK OS=Canis lupus familiaris OX=9615 GN=NLK PE=3 SV=1,GO:0000287; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0007179; GO:0016055; GO:0030178; GO:0031625; GO:0035556; GO:0042169; GO:0050821; GO:0071470; GO:0106310; GO:0140297; GO:1904262; GO:1904894,cellular response to osmotic stress [GO:0071470]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH2 domain binding [GO:0042169]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05454,0.6264002960199843,OG_05454,FUN_024412-T1,Peve_00007146,Pocillopora_meandrina_HIv1___RNAseq.g18635.t1,three_way,68.411,FUN_024412-T1,Q6ZQ58,,,,,38.2,878.0,1.9e-105,385.6,sp|Q6ZQ58|LARP1_MOUSE La-related protein 1 OS=Mus musculus OX=10090 GN=Larp1 PE=1 SV=3,,,,,,
OG_01493,0.625524741746393,OG_01493,FUN_006169-T1,Peve_00021028,Pocillopora_meandrina_HIv1___RNAseq.g20427.t1,three_way,83.96716666666667,FUN_006169-T1,Q80UV9,TAF1_MOUSE,,Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250),Mus musculus (Mouse),45.8,1844.0,0.0,1349.7,sp|Q80UV9|TAF1_MOUSE Transcription initiation factor TFIID subunit 1 OS=Mus musculus OX=10090 GN=Taf1 PE=1 SV=2,GO:0003677; GO:0004402; GO:0004674; GO:0005524; GO:0005634; GO:0005669; GO:0016251; GO:0017025; GO:0042789; GO:0045120; GO:0051123; GO:0060261; GO:0071339; GO:0106310; GO:1990841,mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123],MLL1 complex [GO:0071339]; nucleus [GO:0005634]; pronucleus [GO:0045120]; transcription factor TFIID complex [GO:0005669],ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025],GO:0003677; GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0043226; GO:0065003; GO:0140096; GO:0140223,"DNA binding; catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; general transcription initiation factor activity"
OG_02562,0.6243045195266451,OG_02562,FUN_010661-T1,Peve_00031438,Pocillopora_meandrina_HIv1___RNAseq.g21311.t1,three_way,73.56683333333334,FUN_010661-T1,O43491,E41L2_HUMAN,,Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G),Homo sapiens (Human),49.4,336.0,2.6e-87,325.1,sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1,GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778,actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778],cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198],GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,structural molecule activity; nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_04102,0.6238047750367677,OG_04102,FUN_016453-T1,Peve_00040136,Pocillopora_meandrina_HIv1___RNAseq.g97.t1,three_way,59.23416666666667,FUN_016453-T1,Q0VF49,,,,,25.1,355.0,6.7e-07,58.5,sp|Q0VF49|K2012_HUMAN Uncharacterized protein KIAA2012 OS=Homo sapiens OX=9606 GN=KIAA2012 PE=1 SV=2,,,,,,
OG_00102,0.6222015824175052,OG_00102,FUN_000488-T1,Peve_00038241,Pocillopora_meandrina_HIv1___RNAseq.g2338.t1,three_way,92.94666666666666,FUN_000488-T1,Q5E9E6,,,,,80.0,215.0,6.099999999999999e-96,351.7,sp|Q5E9E6|RL10A_BOVIN Large ribosomal subunit protein uL1 OS=Bos taurus OX=9913 GN=RPL10A PE=2 SV=3,,,,,,
OG_08990,0.6215253182167202,OG_08990,FUN_038512-T1,Peve_00041679,Pocillopora_meandrina_HIv1___RNAseq.20620_t,three_way,87.99716666666667,FUN_038512-T1,Q6P1M3,L2GL2_HUMAN,,LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2),Homo sapiens (Human),41.5,959.0,1.6e-203,711.4,sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0043231; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716,branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_02929,0.621518643268912,OG_02929,FUN_012028-T1,Peve_00030379,Pocillopora_meandrina_HIv1___RNAseq.g24047.t2,three_way,77.09433333333334,FUN_012028-T1,Q14192,FHL2_HUMAN,,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),Homo sapiens (Human),42.1,273.0,1.7000000000000002e-74,282.0,sp|Q14192|FHL2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885,atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018],bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_09436,0.6211038587833767,OG_09436,FUN_041408-T1,Peve_00017539,Pocillopora_meandrina_HIv1___RNAseq.g15729.t1,three_way,62.90833333333333,,,,,,,,,,,,,,,,,
OG_05639,0.6209965331223221,OG_05639,FUN_025343-T1,Peve_00027051,Pocillopora_meandrina_HIv1___RNAseq.g13379.t1,three_way,83.50133333333333,FUN_025343-T1,P13732,,,,,66.7,93.0,9.900000000000001e-30,130.6,sp|P13732|RL22_TRIGR Large ribosomal subunit protein eL22 OS=Tripneustes gratilla OX=7673 GN=RPL22 PE=2 SV=1,,,,,,
OG_04187,0.6209783096836278,OG_04187,FUN_016708-T1,Peve_00024196,Pocillopora_meandrina_HIv1___RNAseq.g277.t1,three_way,80.69266666666667,FUN_016708-T1,Q1RMM1,,,,,48.7,431.0,1.0999999999999999e-91,338.6,sp|Q1RMM1|ZC3HF_BOVIN Zinc finger CCCH domain-containing protein 15 OS=Bos taurus OX=9913 GN=ZC3H15 PE=2 SV=1,,,,,,
OG_01200,0.6200322685116648,OG_01200,FUN_004864-T1,Peve_00043710,Pocillopora_meandrina_HIv1___RNAseq.g8629.t1,three_way,43.367666666666665,,,,,,,,,,,,,,,,,
OG_08347,0.6194796447747816,OG_08347,FUN_036881-T1,Peve_00006965,Pocillopora_meandrina_HIv1___TS.g13145.t5a,three_way,67.16199999999999,FUN_036881-T1,O94988,,,,,26.8,1111.0,2.2000000000000008e-59,232.6,sp|O94988|FA13A_HUMAN Protein FAM13A OS=Homo sapiens OX=9606 GN=FAM13A PE=1 SV=2,,,,,,
OG_01456,0.6188339371902762,OG_01456,FUN_005914-T1,Peve_00008476,Pocillopora_meandrina_HIv1___RNAseq.g19568.t1,three_way,83.68299999999999,FUN_005914-T1,Q3T199,,,,,93.0,143.0,3.500000000000001e-71,268.9,sp|Q3T199|RS23_BOVIN Small ribosomal subunit protein uS12 OS=Bos taurus OX=9913 GN=RPS23 PE=1 SV=1,,,,,,
OG_02681,0.6184132023812192,OG_02681,FUN_010931-T1,Peve_00005964,Pocillopora_meandrina_HIv1___RNAseq.g20986.t1,three_way,70.11850000000001,FUN_010931-T1,Q9DBE9,SPB1_MOUSE,,pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3),Mus musculus (Mouse),47.7,830.0,1.7e-162,574.7,sp|Q9DBE9|SPB1_MOUSE pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 OS=Mus musculus OX=10090 GN=Ftsj3 PE=1 SV=1,GO:0001510; GO:0005654; GO:0005694; GO:0005730; GO:0008649; GO:0030688; GO:0062105,RNA methylation [GO:0001510],"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]",RNA 2'-O-methyltransferase activity [GO:0062105]; rRNA methyltransferase activity [GO:0008649],GO:0003824; GO:0005654; GO:0005694; GO:0005730; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleoplasm; chromosome; nucleolus; transferase activity; organelle; catalytic activity, acting on RNA"
OG_08773,0.6175669432631054,OG_08773,FUN_038057-T1,Peve_00030106,Pocillopora_meandrina_HIv1___RNAseq.g785.t1,three_way,62.62983333333333,FUN_038057-T1,Q8S8T8,,,,,30.1,153.0,4.1e-09,62.8,sp|Q8S8T8|PCR10_ARATH Protein PLANT CADMIUM RESISTANCE 10 OS=Arabidopsis thaliana OX=3702 GN=PCR10 PE=2 SV=1,,,,,,
OG_04359,0.6172339622473001,OG_04359,FUN_018010-T1,Peve_00000404,Pocillopora_meandrina_HIv1___RNAseq.g25255.t4,three_way,81.14033333333334,FUN_018010-T1,A2CG49,,,,,35.3,3036.0,0.0,1707.6,sp|A2CG49|KALRN_MOUSE Kalirin OS=Mus musculus OX=10090 GN=Kalrn PE=1 SV=1,,,,,,
OG_05287,0.6172224347940429,OG_05287,FUN_023950-T1,Peve_00017994,Pocillopora_meandrina_HIv1___RNAseq.g18524.t1a,three_way,76.55283333333334,FUN_023950-T1,Q92793,CBP_HUMAN,,CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein lactyltransferas CREBBP) (EC 2.3.1.-) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-),Homo sapiens (Human),41.9,2186.0,0.0,1193.7,sp|Q92793|CBP_HUMAN CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3,GO:0000122; GO:0000123; GO:0000785; GO:0001223; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006473; GO:0007165; GO:0007249; GO:0008270; GO:0008589; GO:0016407; GO:0016479; GO:0016604; GO:0018076; GO:0030511; GO:0031490; GO:0031648; GO:0031669; GO:0034644; GO:0042592; GO:0042733; GO:0043426; GO:0043993; GO:0044017; GO:0045893; GO:0045944; GO:0048156; GO:0048511; GO:0061629; GO:0061733; GO:0065003; GO:0120300; GO:0140297; GO:1900034; GO:1900182; GO:1905168,canonical NF-kappaB signal transduction [GO:0007249]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of DNA-templated transcription [GO:0006355]; regulation of smoothened signaling pathway [GO:0008589]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008092; GO:0016740; GO:0043226; GO:0051604; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; organelle; protein maturation; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_00055,0.6171947852100131,OG_00055,FUN_000330-T1,Peve_00033547,Pocillopora_meandrina_HIv1___RNAseq.g29083.t1,three_way,89.4465,FUN_000330-T1,A0A3G2LGI8,,,,,54.5,2571.0,0.0,2154.8,sp|A0A3G2LGI8|TLN_OSCPE Talin OS=Oscarella pearsei OX=1940113 GN=TLN PE=1 SV=1,,,,,,
OG_09567,0.6167060267111314,OG_09567,FUN_041691-T1,Peve_00041081,Pocillopora_meandrina_HIv1___TS.g11766.t1a,three_way,79.19200000000001,FUN_041691-T1,Q9Y0H3,,,,,62.6,139.0,2e-47,189.9,sp|Q9Y0H3|RS19_MYXGL Small ribosomal subunit protein eS19 OS=Myxine glutinosa OX=7769 GN=rps19 PE=2 SV=1,,,,,,
OG_04370,0.6152928566347181,OG_04370,FUN_018029-T1,Peve_00017615,Pocillopora_meandrina_HIv1___RNAseq.g25340.t1,three_way,59.88433333333333,FUN_018029-T1,Q9ULJ8,,,,,25.1,1213.0,1.4999999999999999e-40,170.2,sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2,,,,,,
OG_03999,0.6152459745352633,OG_03999,FUN_016288-T1,Peve_00010631,Pocillopora_meandrina_HIv1___RNAseq.g397.t1,three_way,75.145,FUN_016288-T1,Q9Z315,,,,,40.3,769.0,9.7e-115,416.0,sp|Q9Z315|SNUT1_MOUSE U4/U6.U5 tri-snRNP-associated protein 1 OS=Mus musculus OX=10090 GN=Sart1 PE=1 SV=1,,,,,,
OG_03206,0.6148946481365581,OG_03206,FUN_012698-T1,Peve_00016828,Pocillopora_meandrina_HIv1___RNAseq.g22855.t1,three_way,79.2805,FUN_012698-T1,Q62901,RERE_RAT,,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein),Rattus norvegicus (Rat),46.5,514.0,8.900000000000001e-124,446.4,sp|Q62901|RERE_RAT Arginine-glutamic acid dipeptide repeats protein OS=Rattus norvegicus OX=10116 GN=Rere PE=1 SV=2,GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0008270; GO:0016605; GO:0021549; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813,branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605],chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; chromatin organization; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_06511,0.6146914768040251,OG_06511,FUN_029308-T1,Peve_00038266,Pocillopora_meandrina_HIv1___RNAseq.g12581.t1,three_way,73.26783333333334,FUN_029308-T1,P14314,GLU2B_HUMAN,,Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH),Homo sapiens (Human),42.0,512.0,3.2999999999999996e-53,211.1,sp|P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens OX=9606 GN=PRKCSH PE=1 SV=2,GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0044325; GO:0051219,intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231],calcium ion binding [GO:0005509]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; transmembrane transporter binding [GO:0044325],GO:0005783; GO:0009101; GO:0043226; GO:0048856; GO:1901135,endoplasmic reticulum; glycoprotein biosynthetic process; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_07486,0.6143319898739756,OG_07486,FUN_034012-T1,Peve_00007016,Pocillopora_meandrina_HIv1___TS.g18832.t1,three_way,67.49216666666666,FUN_034012-T1,B1AQJ2,UBP36_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 36 (EC 2.3.2.-) (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),Mus musculus (Mouse),50.0,470.0,3.3e-123,444.5,sp|B1AQJ2|UBP36_MOUSE Ubiquitin carboxyl-terminal hydrolase 36 OS=Mus musculus OX=10090 GN=Usp36 PE=1 SV=1,GO:0003723; GO:0004843; GO:0005730; GO:0005737; GO:0006325; GO:0006508; GO:0007000; GO:0016242; GO:0016579; GO:0016607; GO:0016740; GO:0031647; GO:0050821; GO:0140936; GO:1990380; GO:2000232,chromatin organization [GO:0006325]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730],cysteine-type deubiquitinase activity [GO:0004843]; histone H2B deubiquitinase activity [GO:0140936]; K48-linked deubiquitinase activity [GO:1990380]; RNA binding [GO:0003723]; transferase activity [GO:0016740],GO:0003723; GO:0003824; GO:0005730; GO:0006325; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleolus; chromatin organization; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_04440,0.6139204891673227,OG_04440,FUN_018842-T1,Peve_00035790,Pocillopora_meandrina_HIv1___RNAseq.g9855.t1,three_way,61.89533333333333,FUN_018842-T1,Q5U4Q0,,,,,31.7,221.0,1.2e-12,76.6,sp|Q5U4Q0|WAC_XENTR WW domain-containing adapter protein with coiled-coil OS=Xenopus tropicalis OX=8364 GN=wac PE=2 SV=1,,,,,,
OG_03436,0.612544532372882,OG_03436,FUN_014494-T1,Peve_00024062,Pocillopora_meandrina_HIv1___RNAseq.g22515.t1,three_way,81.14283333333333,FUN_014494-T1,Q2KHP8,,,,,71.8,429.0,2.0000000000000005e-187,656.8,sp|Q2KHP8|TYW1_XENLA S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 OS=Xenopus laevis OX=8355 GN=tyw1 PE=2 SV=1,,,,,,
OG_01186,0.6122379706145045,OG_01186,FUN_004836-T1,Peve_00019420,Pocillopora_meandrina_HIv1___RNAseq.g8611.t1,three_way,80.11233333333334,FUN_004836-T1,Q8WUQ7,CATIN_HUMAN,,Splicing factor Cactin (Renal carcinoma antigen NY-REN-24),Homo sapiens (Human),60.5,580.0,1.1e-156,555.1,sp|Q8WUQ7|CATIN_HUMAN Splicing factor Cactin OS=Homo sapiens OX=9606 GN=CACTIN PE=1 SV=3,GO:0000398; GO:0001933; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0016607; GO:0031665; GO:0032088; GO:0032688; GO:0032717; GO:0032720; GO:0034122; GO:0043124; GO:0045087; GO:0045292; GO:0045824; GO:0060339; GO:0071013; GO:0071222; GO:0071347; GO:0071356,"cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0016071; GO:0043226; GO:0098542,immune system process; RNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle; defense response to other organism
OG_08513,0.611740965445696,OG_08513,FUN_037439-T1,Peve_00014239,Pocillopora_meandrina_HIv1___RNAseq.g10962.t1,three_way,78.76766666666666,FUN_037439-T1,P97393,RHG05_MOUSE,,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),Mus musculus (Mouse),30.1,1790.0,6.2e-194,680.2,sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3,GO:0002053; GO:0005096; GO:0005783; GO:0005829; GO:0005886; GO:0007165; GO:0008361; GO:0010631; GO:0010634; GO:0016477; GO:0030879; GO:0042169,cell migration [GO:0016477]; epithelial cell migration [GO:0010631]; mammary gland development [GO:0030879]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; signal transduction [GO:0007165],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; SH2 domain binding [GO:0042169],GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0048856; GO:0048870; GO:0098772,endoplasmic reticulum; cytosol; plasma membrane; organelle; anatomical structure development; cell motility; molecular function regulator activity
OG_00033,0.6109311660387814,OG_00033,FUN_000239-T1,Peve_00033353,Pocillopora_meandrina_HIv1___RNAseq.g28955.t1,three_way,97.61933333333332,FUN_000239-T1,Q2KHT7,,,,,89.3,84.0,1.7e-38,159.5,sp|Q2KHT7|RS27_BOVIN Small ribosomal subunit protein eS27 OS=Bos taurus OX=9913 GN=RPS27 PE=1 SV=3,,,,,,
OG_01522,0.6103719834824285,OG_01522,FUN_006276-T1,Peve_00031100,Pocillopora_meandrina_HIv1___RNAseq.g20369.t1,three_way,84.9125,FUN_006276-T1,Q8K5C0,GRHL2_MOUSE,,Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3),Mus musculus (Mouse),32.7,620.0,2.6999999999999998e-70,268.1,sp|Q8K5C0|GRHL2_MOUSE Grainyhead-like protein 2 homolog OS=Mus musculus OX=10090 GN=Grhl2 PE=2 SV=1,GO:0001161; GO:0001228; GO:0001701; GO:0001843; GO:0003208; GO:0003382; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006355; GO:0006357; GO:0007155; GO:0007420; GO:0008544; GO:0010468; GO:0016020; GO:0021915; GO:0030216; GO:0030323; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0048568; GO:0048701; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132; GO:0140297,anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323],cell-cell junction [GO:0005911]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007155; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell adhesion; cell differentiation; cell junction organization; organelle; anatomical structure development; transcription regulator activity
OG_09705,0.6095920154497702,OG_09705,FUN_041939-T1,Peve_00023589,Pocillopora_meandrina_HIv1___RNAseq.g15705.t1,three_way,68.18516666666667,FUN_041939-T1,Q15696,U2AFM_HUMAN,,"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)",Homo sapiens (Human),56.4,172.0,6.7e-51,202.6,sp|Q15696|U2AFM_HUMAN U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 OS=Homo sapiens OX=9606 GN=ZRSR2 PE=1 SV=2,GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008270; GO:0008380; GO:0030628; GO:0042802; GO:0089701,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701],identical protein binding [GO:0042802]; pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0016071; GO:0065003,RNA binding; nucleoplasm; mRNA metabolic process; protein-containing complex assembly
OG_09037,0.6093501106186782,OG_09037,FUN_038638-T1,Peve_00013491,Pocillopora_meandrina_HIv1___RNAseq.g26490.t2,three_way,56.39266666666666,FUN_038638-T1,Q8WXD9,,,,,42.0,143.0,2e-27,126.7,sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1,,,,,,
OG_03914,0.6092578494057708,OG_03914,FUN_015998-T1,Peve_00023991,Pocillopora_meandrina_HIv1___RNAseq.g21377.t2,three_way,83.981,FUN_015998-T1,Q00944,,,,,41.0,1143.0,8.4e-229,795.4,sp|Q00944|FAK1_CHICK Focal adhesion kinase 1 OS=Gallus gallus OX=9031 GN=PTK2 PE=1 SV=2,,,,,,
OG_02469,0.6091135167798487,OG_02469,FUN_009671-T1,Peve_00009662,Pocillopora_meandrina_HIv1___RNAseq.g24573.t3,three_way,83.01083333333334,FUN_009671-T1,Q9NQB0,,,,,67.8,143.0,2.4e-48,194.5,sp|Q9NQB0|TF7L2_HUMAN Transcription factor 7-like 2 OS=Homo sapiens OX=9606 GN=TCF7L2 PE=1 SV=2,,,,,,
OG_02050,0.6090698760033163,OG_02050,FUN_008260-T1,Peve_00042074,Pocillopora_meandrina_HIv1___RNAseq.g17965.t1,three_way,81.01316666666668,FUN_008260-T1,P59325,,,,,52.8,390.0,5e-105,382.9,sp|P59325|IF5_MOUSE Eukaryotic translation initiation factor 5 OS=Mus musculus OX=10090 GN=Eif5 PE=1 SV=1,,,,,,
OG_04072,0.6090057321349268,OG_04072,FUN_016393-T1,Peve_00006406,Pocillopora_meandrina_HIv1___RNAseq.g9756.t1,three_way,90.81433333333334,FUN_016393-T1,Q3T087,,,,,81.8,176.0,2.5e-82,306.2,sp|Q3T087|RL11_BOVIN Large ribosomal subunit protein uL5 OS=Bos taurus OX=9913 GN=RPL11 PE=2 SV=3,,,,,,
OG_01730,0.6089256488214077,OG_01730,FUN_007024-T1,Peve_00032896,Pocillopora_meandrina_HIv1___RNAseq.g20020.t1,three_way,90.27,FUN_007024-T1,O49447,ADT3_ARATH,,"ADP,ATP carrier protein 3, mitochondrial (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)",Arabidopsis thaliana (Mouse-ear cress),66.6,308.0,3.2e-110,399.8,"sp|O49447|ADT3_ARATH ADP,ATP carrier protein 3, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=AAC3 PE=1 SV=1",GO:0005471; GO:0005739; GO:0005743; GO:0005886; GO:0009941; GO:0015865; GO:0016020; GO:0140021; GO:1990544,mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; purine nucleotide transport [GO:0015865],chloroplast envelope [GO:0009941]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP:ADP antiporter activity [GO:0005471],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_06857,0.6085950113138471,OG_06857,FUN_031838-T1,Peve_00030279,Pocillopora_meandrina_HIv1___RNAseq.g5598.t1,three_way,67.74966666666667,FUN_031838-T1,Q3UJB0,,,,,70.4,540.0,9.5e-162,572.4,sp|Q3UJB0|SF3B2_MOUSE Splicing factor 3B subunit 2 OS=Mus musculus OX=10090 GN=Sf3b2 PE=2 SV=1,,,,,,
OG_01177,0.6081657523698032,OG_01177,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_09375,0.6069771537025672,OG_09375,FUN_040550-T1,Peve_00015404,Pocillopora_meandrina_HIv1___RNAseq.g6474.t1,three_way,68.12883333333333,FUN_040550-T1,A7RSH7,,,,,47.5,139.0,4.399999999999999e-24,113.2,sp|A7RSH7|EIF3J_NEMVE Eukaryotic translation initiation factor 3 subunit J OS=Nematostella vectensis OX=45351 GN=v1g240395 PE=3 SV=1,,,,,,
OG_02862,0.6068627731704385,OG_02862,FUN_011907-T1,Peve_00014640,Pocillopora_meandrina_HIv1___RNAseq.g23364.t1,three_way,57.48433333333333,,,,,,,,,,,,,,,,,
OG_03425,0.6065540081679204,OG_03425,FUN_014480-T1,Peve_00037298,Pocillopora_meandrina_HIv1___RNAseq.g22815.t1,three_way,78.496,FUN_014480-T1,Q6AZJ9,,,,,63.9,83.0,3e-28,125.9,sp|Q6AZJ9|RS21_XENLA Small ribosomal subunit protein eS21 OS=Xenopus laevis OX=8355 GN=rps21 PE=1 SV=1,,,,,,
OG_09596,0.6065102774484881,OG_09596,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_04206,0.6062536807005197,OG_04206,FUN_016778-T1,Peve_00032302,Pocillopora_meandrina_HIv1___RNAseq.g10030.t1,three_way,69.55216666666666,FUN_016778-T1,Q5TYQ8,,,,,28.0,640.0,5.1e-21,104.4,sp|Q5TYQ8|ZC3HE_DANRE Zinc finger CCCH domain-containing protein 14 OS=Danio rerio OX=7955 GN=zc3h14 PE=2 SV=1,,,,,,
OG_07499,0.6059510765289325,OG_07499,FUN_034036-T1,Peve_00019782,Pocillopora_meandrina_HIv1___RNAseq.g26045.t1b,three_way,76.29766666666667,FUN_034036-T1,Q95L46,,,,,39.6,793.0,4.6999999999999995e-143,510.0,sp|Q95L46|IF4G2_BOVIN Eukaryotic translation initiation factor 4 gamma 2 OS=Bos taurus OX=9913 GN=EIF4G2 PE=2 SV=2,,,,,,
OG_08280,0.605577789315731,OG_08280,FUN_036204-T1,Peve_00038740,Pocillopora_meandrina_HIv1___RNAseq.g27360.t1,three_way,76.42366666666666,FUN_036204-T1,Q08DZ2,PRP4K_BOVIN,,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog),Bos taurus (Bovine),64.4,469.0,1.3e-160,568.5,sp|Q08DZ2|PRP4K_BOVIN Serine/threonine-protein kinase PRP4 homolog OS=Bos taurus OX=9913 GN=PRP4K PE=2 SV=1,GO:0000244; GO:0000387; GO:0000776; GO:0004674; GO:0005524; GO:0005681; GO:0016607; GO:0045292; GO:0090266; GO:0106310,"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244]",kinetochore [GO:0000776]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016071; GO:0016740; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; mRNA metabolic process; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_01465,0.6051449026410197,OG_01465,FUN_006001-T1,Peve_00036061,Pocillopora_meandrina_HIv1___RNAseq.g19928.t1,three_way,87.754,FUN_006001-T1,P38024,,,,,60.3,330.0,1.3e-116,421.0,sp|P38024|PUR6_CHICK Multifunctional protein ADE2 OS=Gallus gallus OX=9031 GN=AIRC PE=2 SV=1,,,,,,
OG_04880,0.60496163935855,OG_04880,FUN_022914-T1,Peve_00001826,Pocillopora_meandrina_HIv1___RNAseq.g3710.t1,three_way,80.40933333333334,FUN_022914-T1,Q63028,ADDA_RAT,,Alpha-adducin (Erythrocyte adducin subunit alpha),Rattus norvegicus (Rat),47.2,375.0,3.7e-87,323.9,sp|Q63028|ADDA_RAT Alpha-adducin OS=Rattus norvegicus OX=10116 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008290; GO:0014069; GO:0016020; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0046983; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393,actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608],GO:0005198; GO:0005634; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nucleus; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_00687,0.6048786603098746,OG_00687,FUN_002358-T1,Peve_00014905,Pocillopora_meandrina_HIv1___RNAseq.g42.t1,three_way,69.67566666666666,FUN_002358-T1,Q19297,,,,,43.6,94.0,8.4e-17,88.2,sp|Q19297|YZ73_CAEEL Uncharacterized monothiol glutaredoxin F10D7.3 OS=Caenorhabditis elegans OX=6239 GN=F10D7.3 PE=3 SV=2,,,,,,
OG_05852,0.6046643200701249,OG_05852,FUN_025925-T1,Peve_00034317,Pocillopora_meandrina_HIv1___RNAseq.g10524.t1,three_way,79.89450000000001,FUN_025925-T1,A6IPG1,,,,,66.2,225.0,7.6e-65,248.4,sp|A6IPG1|EF1B_RAT Elongation factor 1-beta OS=Rattus norvegicus OX=10116 GN=Eef1b2 PE=1 SV=1,,,,,,
OG_06768,0.6040582242202021,OG_06768,FUN_031608-T1,Peve_00012512,Pocillopora_meandrina_HIv1___RNAseq.g5967.t1,three_way,78.76383333333334,FUN_031608-T1,Q92541,RTF1_HUMAN,,RNA polymerase-associated protein RTF1 homolog,Homo sapiens (Human),48.1,349.0,1e-80,302.4,sp|Q92541|RTF1_HUMAN RNA polymerase-associated protein RTF1 homolog OS=Homo sapiens OX=9606 GN=RTF1 PE=1 SV=4,GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006368; GO:0016055; GO:0016593; GO:0019827,blastocyst growth [GO:0001832]; chromatin organization [GO:0006325]; endodermal cell fate commitment [GO:0001711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0043226,DNA binding; RNA binding; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; organelle
OG_00615,0.6036192105112178,OG_00615,FUN_001781-T1,Peve_00011615,Pocillopora_meandrina_HIv1___RNAseq.g2692.t1,three_way,85.85766666666667,FUN_001781-T1,A0A2R8QP51,DPP9_DANRE,,Dipeptidyl peptidase 9 (EC 3.4.14.5),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,852.0,7.8e-219,761.9,sp|A0A2R8QP51|DPP9_DANRE Dipeptidyl peptidase 9 OS=Danio rerio OX=7955 GN=dpp9 PE=3 SV=1,GO:0004177; GO:0005634; GO:0006508; GO:0008236; GO:0008239; GO:0050727,proteolysis [GO:0006508]; regulation of inflammatory response [GO:0050727],nucleus [GO:0005634],aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07674,0.6035957662498278,OG_07674,FUN_034781-T1,Peve_00029730,Pocillopora_meandrina_HIv1___RNAseq.g12276.t1,three_way,58.02466666666667,FUN_034781-T1,Q6DIJ4,UBP10_XENTR,,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),43.1,485.0,6.800000000000001e-100,366.7,sp|Q6DIJ4|UBP10_XENTR Ubiquitin carboxyl-terminal hydrolase 10 OS=Xenopus tropicalis OX=8364 GN=usp10 PE=2 SV=1,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344,"autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; rescue of stalled ribosome [GO:0072344]",cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005768; GO:0006281; GO:0006914; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; DNA repair; autophagy; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_10135,0.6033732509371609,OG_10135,FUN_043520-T1,Peve_00016242,Pocillopora_meandrina_HIv1___RNAseq.g8031.t1,three_way,87.03166666666667,FUN_043520-T1,Q6QLW4,,,,,84.7,85.0,1e-39,163.7,sp|Q6QLW4|CYC_PECGU Cytochrome c OS=Pectinaria gouldii OX=260746 PE=3 SV=1,,,,,,
OG_01560,0.6018036537745817,OG_01560,FUN_006441-T1,Peve_00038428,Pocillopora_meandrina_HIv1___RNAseq.g20299.t1,three_way,62.89866666666667,,,,,,,,,,,,,,,,,
OG_01906,0.6016991584970004,OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),61.6,620.0,3.3e-199,697.6,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01906,0.6016991584970004,OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),40.4,146.0,3.1999999999999997e-29,132.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_03414,0.6016373928843407,OG_03414,FUN_014462-T1,Peve_00023416,Pocillopora_meandrina_HIv1___RNAseq.g22646.t2,three_way,80.2825,FUN_014462-T1,Q9C086,IN80B_HUMAN,,INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog) (hIes2) (PAP-1-associated protein 1) (PAPA-1) (Zinc finger HIT domain-containing protein 4),Homo sapiens (Human),52.8,195.0,3.8e-12,73.9,sp|Q9C086|IN80B_HUMAN INO80 complex subunit B OS=Homo sapiens OX=9606 GN=INO80B PE=1 SV=2,GO:0000723; GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008270; GO:0016604; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],zinc ion binding [GO:0008270],GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226,nucleoplasm; nucleolus; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle
OG_09706,0.6008978694869412,OG_09706,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),68.5,89.0,1.8e-32,143.7,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_09706,0.6008978694869412,OG_09706,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),29.7,138.0,2.2e-06,57.0,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_04964,0.6003781982846748,OG_04964,FUN_023063-T1,Peve_00024670,Pocillopora_meandrina_HIv1___RNAseq.g3882.t1,three_way,80.55416666666666,FUN_023063-T1,Q66L33,,,,,68.8,192.0,2e-75,283.9,sp|Q66L33|MK16A_XENLA Protein MAK16 homolog A OS=Xenopus laevis OX=8355 GN=mak16-a PE=2 SV=1,,,,,,
OG_01742,0.5999846257501205,OG_01742,FUN_007064-T1,Peve_00008212,Pocillopora_meandrina_HIv1___RNAseq.g20107.t1,three_way,83.80433333333333,FUN_007064-T1,Q66HG8,RED_RAT,,Protein Red (Cytokine IK) (IK factor),Rattus norvegicus (Rat),54.1,603.0,1e-108,395.6,sp|Q66HG8|RED_RAT Protein Red OS=Rattus norvegicus OX=10116 GN=Ik PE=1 SV=1,GO:0000228; GO:0000278; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0007094; GO:0034501; GO:0042802; GO:0071005; GO:0097431,"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]",cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005],identical protein binding [GO:0042802],GO:0000228; GO:0000278; GO:0005634; GO:0005654; GO:0005694; GO:0016071; GO:0043226,nuclear chromosome; mitotic cell cycle; nucleus; nucleoplasm; chromosome; mRNA metabolic process; organelle
OG_01128,0.5992263448757301,OG_01128,FUN_004698-T1,Peve_00044677,Pocillopora_meandrina_HIv1___RNAseq.g8778.t1,three_way,56.21066666666667,,,,,,,,,,,,,,,,,
OG_02407,0.5991204969680993,OG_02407,FUN_009056-T1,Peve_00032033,Pocillopora_meandrina_HIv1___RNAseq.g14479.t1,three_way,51.15833333333333,,,,,,,,,,,,,,,,,
OG_10207,0.5989324608483209,OG_10207,FUN_043642-T1,Peve_00041942,Pocillopora_meandrina_HIv1___RNAseq.g7410.t1,three_way,83.61566666666667,,,,,,,,,,,,,,,,,
OG_03143,0.5984287103908869,OG_03143,FUN_012528-T1,Peve_00013908,Pocillopora_meandrina_HIv1___RNAseq.g23974.t1,three_way,64.574,FUN_012528-T1,Q14149,MORC3_HUMAN,,MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3),Homo sapiens (Human),59.4,483.0,9.3e-152,539.3,sp|Q14149|MORC3_HUMAN MORC family CW-type zinc finger protein 3 OS=Homo sapiens OX=9606 GN=MORC3 PE=1 SV=3,GO:0000122; GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006468; GO:0008270; GO:0009791; GO:0016363; GO:0016605; GO:0016887; GO:0018105; GO:0030674; GO:0032688; GO:0035064; GO:0048147; GO:0050821; GO:0051457; GO:0140002; GO:0140374; GO:2000774,antiviral innate immune response [GO:0140374]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular senescence [GO:2000774]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821],chromatin [GO:0000785]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; histone H3K4me3 reader activity [GO:0140002]; methylated histone binding [GO:0035064]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0098542,immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism
OG_09670,0.5975033134790857,OG_09670,FUN_041888-T1,Peve_00033407,Pocillopora_meandrina_HIv1___RNAseq.g15416.t1,three_way,83.91333333333334,FUN_041888-T1,Q3SZ65,,,,,83.1,397.0,6.8999999999999995e-189,661.4,sp|Q3SZ65|IF4A2_BOVIN Eukaryotic initiation factor 4A-II OS=Bos taurus OX=9913 GN=EIF4A2 PE=2 SV=1,,,,,,
OG_06231,0.5974179177078938,OG_06231,FUN_028181-T1,Peve_00001286,Pocillopora_meandrina_HIv1___RNAseq.g16512.t1,three_way,90.78883333333332,FUN_028181-T1,Q5F418,,,,,69.3,987.0,0.0,1213.4,sp|Q5F418|PSMD1_CHICK 26S proteasome non-ATPase regulatory subunit 1 OS=Gallus gallus OX=9031 GN=PSMD1 PE=2 SV=1,,,,,,
OG_02232,0.5973869674582143,OG_02232,FUN_008642-T1,Peve_00031673,Pocillopora_meandrina_HIv1___RNAseq.g9.t1,three_way,77.27466666666666,FUN_008642-T1,Q3ZC89,MAP2_BOVIN,,Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M),Bos taurus (Bovine),79.0,367.0,2.6e-176,619.8,sp|Q3ZC89|MAP2_BOVIN Methionine aminopeptidase 2 OS=Bos taurus OX=9913 GN=METAP2 PE=2 SV=1,GO:0004177; GO:0004239; GO:0005737; GO:0006508; GO:0008235; GO:0046872; GO:0070006,proteolysis [GO:0006508],cytoplasm [GO:0005737],aminopeptidase activity [GO:0004177]; initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00982,0.5971883785689526,OG_00982,FUN_004365-T1,Peve_00008937,Pocillopora_meandrina_HIv1___TS.g7532.t1,three_way,75.77499999999999,FUN_004365-T1,Q6PC91,,,,,64.1,156.0,5.7e-44,178.7,sp|Q6PC91|BT3L4_DANRE Transcription factor BTF3 homolog 4 OS=Danio rerio OX=7955 GN=btf3l4 PE=2 SV=1,,,,,,
OG_04002,0.5971009312306728,OG_04002,FUN_016297-T1,Peve_00002880,Pocillopora_meandrina_HIv1___RNAseq.g9883.t1,three_way,94.22166666666666,FUN_016297-T1,P35224,,,,,57.2,711.0,3.1e-203,709.9,sp|P35224|CTNB_URECA Catenin beta OS=Urechis caupo OX=6431 PE=2 SV=1,,,,,,
OG_07521,0.5968517934981961,OG_07521,FUN_034091-T1,Peve_00037069,Pocillopora_meandrina_HIv1___RNAseq.g26062.t1,three_way,83.5495,FUN_034091-T1,Q9VWG3,,,,,62.3,154.0,1.1e-44,181.0,sp|Q9VWG3|RS10B_DROME Small ribosomal subunit protein eS10B OS=Drosophila melanogaster OX=7227 GN=RpS10b PE=1 SV=2,,,,,,
OG_05508,0.5965870158040929,OG_05508,FUN_024589-T1,Peve_00007645,Pocillopora_meandrina_HIv1___RNAseq.g19110.t1,three_way,77.43599999999999,FUN_024589-T1,Q96EY1,DNJA3_HUMAN,,"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)",Homo sapiens (Human),42.7,424.0,7.7e-85,315.8,"sp|Q96EY1|DNJA3_HUMAN DnaJ homolog subfamily A member 3, mitochondrial OS=Homo sapiens OX=9606 GN=DNAJA3 PE=1 SV=2",GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0008270; GO:0008285; GO:0009408; GO:0009898; GO:0019901; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043231; GO:0044877; GO:0045211; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0090398; GO:0106137; GO:0140297,activation-induced cell death of T cells [GO:0006924]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to type II interferon [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase-mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; type II interferon receptor binding [GO:0005133]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0002376; GO:0005634; GO:0005739; GO:0005829; GO:0006260; GO:0006355; GO:0006457; GO:0007005; GO:0012501; GO:0030154; GO:0034330; GO:0043226; GO:0098772,immune system process; nucleus; mitochondrion; cytosol; DNA replication; regulation of DNA-templated transcription; protein folding; mitochondrion organization; programmed cell death; cell differentiation; cell junction organization; organelle; molecular function regulator activity
OG_06259,0.5962008057255641,OG_06259,FUN_028277-T1,Peve_00018996,Pocillopora_meandrina_HIv1___RNAseq.g15500.t2,three_way,61.196,,,,,,,,,,,,,,,,,
OG_09598,0.5959682031961577,OG_09598,FUN_041745-T1,Peve_00000338,Pocillopora_meandrina_HIv1___RNAseq.g15790.t1,three_way,56.4945,,,,,,,,,,,,,,,,,
OG_08474,0.5955409879818109,OG_08474,FUN_037291-T1,Peve_00032666,Pocillopora_meandrina_HIv1___RNAseq.22530_t,three_way,88.56233333333334,FUN_037291-T1,Q5EAD6,RL15_BOVIN,,Large ribosomal subunit protein eL15 (60S ribosomal protein L15),Bos taurus (Bovine),76.0,204.0,2.1e-90,333.2,sp|Q5EAD6|RL15_BOVIN Large ribosomal subunit protein eL15 OS=Bos taurus OX=9913 GN=RPL15 PE=2 SV=3,GO:0002181; GO:0003723; GO:0003735; GO:0022625,cytoplasmic translation [GO:0002181],cytosolic large ribosomal subunit [GO:0022625],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198,cytoplasmic translation; RNA binding; structural molecule activity
OG_05643,0.5954772272911277,OG_05643,FUN_025361-T1,Peve_00040526,Pocillopora_meandrina_HIv1___RNAseq.14643_t,three_way,74.309,FUN_025361-T1,P10160,,,,,69.3,153.0,2.4e-57,223.0,sp|P10160|IF5A1_RABIT Eukaryotic translation initiation factor 5A-1 OS=Oryctolagus cuniculus OX=9986 GN=EIF5A PE=1 SV=2,,,,,,
OG_04746,0.5953377366940453,OG_04746,FUN_022627-T1,Peve_00012280,Pocillopora_meandrina_HIv1___RNAseq.g4385.t1,three_way,74.43166666666667,FUN_022627-T1,Q13485,SMAD4_HUMAN,,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),Homo sapiens (Human),52.7,220.0,2.4e-51,205.7,sp|Q13485|SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001837; GO:0003148; GO:0003161; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006366; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048665; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0097191; GO:1901203; GO:1902895; GO:1905305,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_09299,0.5951832991968377,OG_09299,FUN_040152-T1,Peve_00038144,Pocillopora_meandrina_HIv1___RNAseq.g8496.t1,three_way,65.6315,FUN_040152-T1,P17702,,,,,49.2,122.0,2.2999999999999997e-24,113.2,sp|P17702|RL28_RAT Large ribosomal subunit protein eL28 OS=Rattus norvegicus OX=10116 GN=Rpl28 PE=1 SV=4,,,,,,
OG_02006,0.5950669684740288,OG_02006,FUN_008121-T1,Peve_00022347,Pocillopora_meandrina_HIv1___RNAseq.g17884.t1,three_way,60.455666666666666,FUN_008121-T1,Q5TCY1,TTBK1_HUMAN,,Tau-tubulin kinase 1 (EC 2.7.11.1) (Brain-derived tau kinase),Homo sapiens (Human),65.9,308.0,9.2e-116,419.9,sp|Q5TCY1|TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens OX=9606 GN=TTBK1 PE=1 SV=2,GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0007165; GO:0007611; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0018108; GO:0021762; GO:0032273; GO:0043025; GO:0048156; GO:0048471; GO:0050321; GO:0061890; GO:0106310; GO:1903980,learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_00060,0.594142999377435,OG_00060,FUN_000352-T1,Peve_00033531,Pocillopora_meandrina_HIv1___RNAseq.g29116.t1,three_way,77.85483333333333,FUN_000352-T1,P18395,,,,,46.0,817.0,5.600000000000001e-180,632.9,sp|P18395|CSDE1_RAT Cold shock domain-containing protein E1 OS=Rattus norvegicus OX=10116 GN=Csde1 PE=2 SV=1,,,,,,
OG_00078,0.5936656327939994,OG_00078,FUN_000403-T1,Peve_00033519,Pocillopora_meandrina_HIv1___RNAseq.g2544.t1,three_way,79.21583333333334,FUN_000403-T1,A0A0G2K2P5,ZO1_RAT,,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),Rattus norvegicus (Rat),28.2,1783.0,6.4e-140,500.7,sp|A0A0G2K2P5|ZO1_RAT Tight junction protein ZO-1 OS=Rattus norvegicus OX=10116 GN=Tjp1 PE=1 SV=1,GO:0001825; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005921; GO:0005923; GO:0007605; GO:0008013; GO:0008284; GO:0009410; GO:0009986; GO:0014704; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0031410; GO:0032496; GO:0032991; GO:0034334; GO:0036305; GO:0043066; GO:0043116; GO:0043296; GO:0044325; GO:0045177; GO:0045216; GO:0045471; GO:0046581; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0070830; GO:0071000; GO:0071253; GO:0071277; GO:0071333; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; bicellular tight junction assembly [GO:0070830]; blastocyst formation [GO:0001825]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; intercalated disc [GO:0014704]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; connexin binding [GO:0071253]; kinase activity [GO:0016301]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0003824; GO:0005634; GO:0005886; GO:0007010; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,circulatory system process; catalytic activity; nucleus; plasma membrane; cytoskeleton organization; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_07226,0.5927863004352981,OG_07226,FUN_032832-T1,Peve_00014560,Pocillopora_meandrina_HIv1___RNAseq.g24969.t3,three_way,68.74916666666667,FUN_032832-T1,Q66I22,,,,,48.1,270.0,3.4e-62,241.5,sp|Q66I22|SRRT_DANRE Serrate RNA effector molecule homolog OS=Danio rerio OX=7955 GN=srrt PE=2 SV=1,,,,,,
OG_07226,0.5927863004352981,OG_07226,FUN_032832-T1,Peve_00014560,Pocillopora_meandrina_HIv1___RNAseq.g24969.t3,three_way,68.74916666666667,FUN_032832-T1,Q66I22,,,,,35.9,78.0,3.8e-05,52.0,sp|Q66I22|SRRT_DANRE Serrate RNA effector molecule homolog OS=Danio rerio OX=7955 GN=srrt PE=2 SV=1,,,,,,
OG_05618,0.5924663398536985,OG_05618,FUN_025308-T1,Peve_00027048,Pocillopora_meandrina_HIv1___RNAseq.g13453.t1,three_way,61.894,,,,,,,,,,,,,,,,,
OG_07050,0.5924011204422059,OG_07050,FUN_032270-T1,Peve_00014263,Pocillopora_meandrina_HIv1___RNAseq.g24972.t1,three_way,76.632,,,,,,,,,,,,,,,,,
OG_03540,0.5920537790541247,OG_03540,FUN_014660-T1,Peve_00032454,Pocillopora_meandrina_HIv1___RNAseq.g22661.t1,three_way,97.681,FUN_014660-T1,Q2YDI3,,,,,92.9,113.0,1.6e-58,226.5,sp|Q2YDI3|YPEL2_BOVIN Protein yippee-like 2 OS=Bos taurus OX=9913 GN=YPEL2 PE=3 SV=1,,,,,,
OG_03654,0.5919649728218894,OG_03654,FUN_014890-T1,Peve_00003524,Pocillopora_meandrina_HIv1___RNAseq.g21063.t1,three_way,80.91116666666667,FUN_014890-T1,Q9BT92,TCHP_HUMAN,,Trichoplein keratin filament-binding protein (Protein TCHP) (Mitochondrial protein with oncostatic activity) (Mitostatin) (Tumor suppressor protein),Homo sapiens (Human),54.1,135.0,7.5e-30,132.5,sp|Q9BT92|TCHP_HUMAN Trichoplein keratin filament-binding protein OS=Homo sapiens OX=9606 GN=TCHP PE=1 SV=1,GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0006915; GO:0030030; GO:0030057; GO:0030308; GO:0031965; GO:0036064; GO:0045095; GO:0045179; GO:1902018,apoptotic process [GO:0006915]; cell projection organization [GO:0030030]; negative regulation of cell growth [GO:0030308]; negative regulation of cilium assembly [GO:1902018],apical cortex [GO:0045179]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],,GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0012501; GO:0043226,mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; programmed cell death; organelle
OG_07564,0.5919412834013268,OG_07564,FUN_034211-T1,Peve_00027535,Pocillopora_meandrina_HIv1___RNAseq.g26168.t1,three_way,46.269333333333336,,,,,,,,,,,,,,,,,
OG_03918,0.5918396546535302,OG_03918,FUN_016014-T1,Peve_00004540,Pocillopora_meandrina_HIv1___RNAseq.g21369.t1,three_way,67.8095,FUN_016014-T1,B2RX88,CSPP1_MOUSE,,Centrosome and spindle pole associated protein 1,Mus musculus (Mouse),29.2,1240.0,2.1e-09,66.6,sp|B2RX88|CSPP1_MOUSE Centrosome and spindle pole associated protein 1 OS=Mus musculus OX=10090 GN=Cspp1 PE=1 SV=2,GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005929; GO:0032467; GO:0034451; GO:0036064; GO:0051781,positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922],,GO:0005654; GO:0005815; GO:0005929; GO:0043226,nucleoplasm; microtubule organizing center; cilium; organelle
OG_08481,0.5918294677162141,OG_08481,FUN_037310-T1,Peve_00011736,Pocillopora_meandrina_HIv1___RNAseq.g10709.t1,three_way,72.46583333333334,FUN_037310-T1,Q08CX1,,,,,28.3,853.0,6.6e-61,237.3,sp|Q08CX1|RASEF_XENTR Ras and EF-hand domain-containing protein OS=Xenopus tropicalis OX=8364 GN=rasef PE=2 SV=1,,,,,,
OG_03990,0.5918271430867539,OG_03990,FUN_016158-T1,Peve_00022563,Pocillopora_meandrina_HIv1___RNAseq.g21233.t1,three_way,67.15366666666667,FUN_016158-T1,G3UYX5,,,,,31.1,775.0,2.5e-103,379.4,sp|G3UYX5|RGS22_MOUSE Regulator of G-protein signaling 22 OS=Mus musculus OX=10090 GN=Rgs22 PE=1 SV=1,,,,,,
OG_06532,0.5916439987640724,OG_06532,FUN_029392-T1,Peve_00044524,Pocillopora_meandrina_HIv1___TS.g2905.t4c,three_way,42.15233333333333,,,,,,,,,,,,,,,,,
OG_00843,0.5911082189353403,OG_00843,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_01532,0.5910336304201419,OG_01532,FUN_006331-T1,Peve_00012580,Pocillopora_meandrina_HIv1___RNAseq.g20347.t1,three_way,69.86616666666667,FUN_006331-T1,Q92545,TM131_HUMAN,,Transmembrane protein 131 (Protein RW1),Homo sapiens (Human),41.2,1098.0,1.3000000000000002e-218,762.3,sp|Q92545|TM131_HUMAN Transmembrane protein 131 OS=Homo sapiens OX=9606 GN=TMEM131 PE=1 SV=3,GO:0005518; GO:0016020; GO:0032964,collagen biosynthetic process [GO:0032964],membrane [GO:0016020],collagen binding [GO:0005518],,
OG_03731,0.5909240212594009,OG_03731,FUN_015024-T1,Peve_00004784,Pocillopora_meandrina_HIv1___RNAseq.g21180.t1,three_way,68.43833333333333,FUN_015024-T1,Q3T0M7,,,,,55.6,180.0,7e-47,188.7,sp|Q3T0M7|RANG_BOVIN Ran-specific GTPase-activating protein OS=Bos taurus OX=9913 GN=RANBP1 PE=2 SV=1,,,,,,
OG_04590,0.5905606726054144,OG_04590,FUN_022265-T1,Peve_00043988,Pocillopora_meandrina_HIv1___RNAseq.g4716.t1,three_way,60.199,FUN_022265-T1,Q9BU76,,,,,46.3,134.0,3.5000000000000004e-28,127.1,sp|Q9BU76|MMTA2_HUMAN Multiple myeloma tumor-associated protein 2 OS=Homo sapiens OX=9606 GN=MMTAG2 PE=1 SV=1,,,,,,
OG_07838,0.5902704375921914,OG_07838,FUN_035169-T1,Peve_00036181,Pocillopora_meandrina_HIv1___RNAseq.g27918.t1,three_way,87.309,FUN_035169-T1,Q9JK84,,,,,54.5,299.0,5.5000000000000004e-80,299.3,sp|Q9JK84|PAR6G_MOUSE Partitioning defective 6 homolog gamma OS=Mus musculus OX=10090 GN=Pard6g PE=2 SV=1,,,,,,
OG_06109,0.5900287934401325,OG_06109,FUN_027814-T1,Peve_00036499,Pocillopora_meandrina_HIv1___RNAseq.g13890.t1,three_way,84.264,FUN_027814-T1,O00571,DDX3X_HUMAN,,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)",Homo sapiens (Human),71.5,425.0,1.6999999999999996e-177,623.6,sp|O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=3,GO:0002753; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010628; GO:0010629; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031252; GO:0031333; GO:0031369; GO:0032481; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035591; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043186; GO:0043273; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070131; GO:0071243; GO:0071470; GO:0071651; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243,cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055],cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; signaling adaptor activity [GO:0035591]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; GTPase activity; extracellular region; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06443,0.5887821207603824,OG_06443,FUN_029154-T1,Peve_00041026,Pocillopora_meandrina_HIv1___RNAseq.g25735.t1,three_way,90.00566666666667,FUN_029154-T1,Q86XH1,,,,,57.3,820.0,1.7000000000000002e-218,760.8,sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1,,,,,,
OG_02611,0.5887389965412041,OG_02611,FUN_010745-T1,Peve_00038409,Pocillopora_meandrina_HIv1___TS.g25690.t1,three_way,79.04633333333334,FUN_010745-T1,O75153,,,,,47.6,1302.0,0.0,1138.6,sp|O75153|CLU_HUMAN Clustered mitochondria protein homolog OS=Homo sapiens OX=9606 GN=CLUH PE=1 SV=2,,,,,,
OG_04491,0.5886447886801541,OG_04491,FUN_021922-T1,Peve_00016338,Pocillopora_meandrina_HIv1___RNAseq.g2917.t1,three_way,68.88416666666666,,,,,,,,,,,,,,,,,
OG_05040,0.5886123622009972,OG_05040,FUN_023224-T1,Peve_00029811,Pocillopora_meandrina_HIv1___RNAseq.g708.t1,three_way,94.295,FUN_023224-T1,Q5ZJK8,,,,,81.7,531.0,3.7e-254,878.6,sp|Q5ZJK8|TCPH_CHICK T-complex protein 1 subunit eta OS=Gallus gallus OX=9031 GN=CCT7 PE=1 SV=1,,,,,,
OG_00438,0.5877141580065873,OG_00438,FUN_001349-T1,Peve_00023406,Pocillopora_meandrina_HIv1___RNAseq.g1876.t1,three_way,83.4015,FUN_001349-T1,Q8IYW2,,,,,31.7,2766.0,0.0,1193.3,sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3,,,,,,
OG_09597,0.5873282877219591,OG_09597,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_04046,0.5867029852760838,OG_04046,FUN_016360-T1,Peve_00004338,Pocillopora_meandrina_HIv1___RNAseq.g9672.t1,three_way,64.9715,FUN_016360-T1,Q9Y6R0,NUMBL_HUMAN,,Numb-like protein (Numb-related protein) (Numb-R),Homo sapiens (Human),58.1,160.0,1e-46,189.5,sp|Q9Y6R0|NUMBL_HUMAN Numb-like protein OS=Homo sapiens OX=9606 GN=NUMBL PE=1 SV=1,GO:0005737; GO:0007399; GO:0007409; GO:0019221; GO:0019538; GO:0021670; GO:0021849; GO:0034332; GO:0050769; GO:0050775; GO:0098978; GO:0150052,adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978],,GO:0034330; GO:0048856,cell junction organization; anatomical structure development
OG_02394,0.586678590650543,OG_02394,FUN_009022-T1,Peve_00044352,Pocillopora_meandrina_HIv1___RNAseq.g3941.t1,three_way,75.0855,FUN_009022-T1,Q1AAU6,ASAP1_RAT,,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",Rattus norvegicus (Rat),38.6,1193.0,7.400000000000001e-201,702.6,"sp|Q1AAU6|ASAP1_RAT Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Asap1 PE=1 SV=2",GO:0000139; GO:0001786; GO:0002102; GO:0005096; GO:0005546; GO:0005547; GO:0008270; GO:0032588; GO:0043197; GO:0060271; GO:0061000; GO:0061512; GO:0098978; GO:0099175; GO:1903527,cilium assembly [GO:0060271]; negative regulation of dendritic spine development [GO:0061000]; positive regulation of membrane tubulation [GO:1903527]; protein localization to cilium [GO:0061512]; regulation of postsynapse organization [GO:0099175],dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; podosome [GO:0002102]; trans-Golgi network membrane [GO:0032588],"GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; zinc ion binding [GO:0008270]",GO:0008289; GO:0043226; GO:0044782; GO:0098772,lipid binding; organelle; cilium organization; molecular function regulator activity
OG_01076,0.5865330854104885,OG_01076,FUN_004562-T1,Peve_00016040,Pocillopora_meandrina_HIv1___RNAseq.g8226.t1,three_way,71.31733333333334,,,,,,,,,,,,,,,,,
OG_02786,0.585867964447471,OG_02786,FUN_011741-T1,Peve_00015648,Pocillopora_meandrina_HIv1___RNAseq.g23891.t1,three_way,43.050666666666665,,,,,,,,,,,,,,,,,
OG_02910,0.5853817811955736,OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,39.1,266.0,5e-53,210.7,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_02910,0.5853817811955736,OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,55.6,36.0,3.2e-07,58.5,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_04315,0.585371425770147,OG_04315,FUN_017915-T1,Peve_00017903,Pocillopora_meandrina_HIv1___RNAseq.g332.t1,three_way,82.63666666666667,FUN_017915-T1,P07814,SYEP_HUMAN,,Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)],Homo sapiens (Human),58.0,1343.0,0.0,1438.3,sp|P07814|SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens OX=9606 GN=EPRS1 PE=1 SV=5,GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006418; GO:0006424; GO:0006433; GO:0008270; GO:0016020; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904,cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005829; GO:0005886; GO:0006399; GO:0006520; GO:0016874; GO:0140098,"RNA binding; catalytic activity; cytosol; plasma membrane; tRNA metabolic process; amino acid metabolic process; ligase activity; catalytic activity, acting on RNA"
OG_01404,0.5853123941512361,OG_01404,FUN_005470-T1,Peve_00002032,Pocillopora_meandrina_HIv1___RNAseq.g6626.t1,three_way,74.86033333333333,FUN_005470-T1,Q07817,B2CL1_HUMAN,,Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X),Homo sapiens (Human),38.9,126.0,2.2e-19,97.1,sp|Q07817|B2CL1_HUMAN Bcl-2-like protein 1 OS=Homo sapiens OX=9606 GN=BCL2L1 PE=1 SV=1,GO:0001541; GO:0001701; GO:0001836; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006897; GO:0007281; GO:0007283; GO:0008584; GO:0008630; GO:0008637; GO:0009566; GO:0010507; GO:0015267; GO:0019901; GO:0030672; GO:0031965; GO:0032465; GO:0032946; GO:0034097; GO:0035234; GO:0040008; GO:0042802; GO:0043065; GO:0043066; GO:0043524; GO:0044565; GO:0046898; GO:0046902; GO:0050673; GO:0051093; GO:0051402; GO:0051434; GO:0051607; GO:0051881; GO:0071230; GO:0071312; GO:0071480; GO:0071839; GO:0090201; GO:0097048; GO:0097136; GO:0097192; GO:0097284; GO:1900118; GO:1901029; GO:1902042; GO:1902230; GO:1902236; GO:1903077; GO:2000242; GO:2000669; GO:2000811; GO:2001240; GO:2001243,apoptotic mitochondrial changes [GO:0008637]; apoptotic process in bone marrow cell [GO:0071839]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to gamma radiation [GO:0071480]; defense response to virus [GO:0051607]; dendritic cell apoptotic process [GO:0097048]; dendritic cell proliferation [GO:0044565]; ectopic germ cell programmed cell death [GO:0035234]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of developmental process [GO:0051093]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of reproductive process [GO:2000242]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mononuclear cell proliferation [GO:0032946]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; spermatogenesis [GO:0007283],Bcl-2 family protein complex [GO:0097136]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; synaptic vesicle membrane [GO:0030672],BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901],GO:0005215; GO:0005739; GO:0005783; GO:0005815; GO:0005829; GO:0007005; GO:0012501; GO:0016192; GO:0022414; GO:0043226; GO:0048856; GO:0061024,transporter activity; mitochondrion; endoplasmic reticulum; microtubule organizing center; cytosol; mitochondrion organization; programmed cell death; vesicle-mediated transport; reproductive process; organelle; anatomical structure development; membrane organization
OG_09257,0.5850741405272697,OG_09257,FUN_040059-T1,Peve_00014920,Pocillopora_meandrina_HIv1___RNAseq.g7726.t1,three_way,86.54366666666667,FUN_040059-T1,Q99LC5,,,,,71.0,328.0,1.4000000000000001e-123,444.1,"sp|Q99LC5|ETFA_MOUSE Electron transfer flavoprotein subunit alpha, mitochondrial OS=Mus musculus OX=10090 GN=Etfa PE=1 SV=2",,,,,,
OG_01584,0.5850108466449588,OG_01584,FUN_006621-T1,Peve_00040867,Pocillopora_meandrina_HIv1___RNAseq.g20504.t1,three_way,51.0425,FUN_006621-T1,Q8WWI1,LMO7_HUMAN,,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),Homo sapiens (Human),43.5,131.0,4.7e-23,112.8,sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005635; GO:0005739; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; mitochondrion; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05425,0.5848292511304762,OG_05425,FUN_024370-T1,Peve_00003575,Pocillopora_meandrina_HIv1___RNAseq.g19085.t1,three_way,79.644,FUN_024370-T1,Q02040,AK17A_HUMAN,,"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)",Homo sapiens (Human),58.5,275.0,1.9e-87,324.7,sp|Q02040|AK17A_HUMAN A-kinase anchor protein 17A OS=Homo sapiens OX=9606 GN=AKAP17A PE=1 SV=2,GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018,B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; signal transduction [GO:0007165],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],protein kinase A binding [GO:0051018]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0043226,immune system process; RNA binding; nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_04478,0.584745189786194,OG_04478,FUN_021108-T1,Peve_00008861,Pocillopora_meandrina_HIv1___RNAseq.g4371.t1,three_way,84.41233333333334,FUN_021108-T1,Q15119,PDK2_HUMAN,,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)",Homo sapiens (Human),50.9,385.0,7.8e-108,392.1,"sp|Q15119|PDK2_HUMAN [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Homo sapiens OX=9606 GN=PDK2 PE=1 SV=2",GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0045254; GO:0050848; GO:0072332,cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of ketone metabolic process [GO:0010565]; regulation of pH [GO:0006885],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; mitochondrion; cytosol; carbohydrate metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05892,0.5843284851382988,OG_05892,FUN_026058-T1,Peve_00022194,Pocillopora_meandrina_HIv1___RNAseq.g10568.t1,three_way,87.0575,FUN_026058-T1,Q9BUQ8,,,,,74.4,575.0,3.3e-256,885.9,sp|Q9BUQ8|DDX23_HUMAN Probable ATP-dependent RNA helicase DDX23 OS=Homo sapiens OX=9606 GN=DDX23 PE=1 SV=3,,,,,,
OG_08265,0.5841064524615978,OG_08265,FUN_036177-T1,Peve_00027216,Pocillopora_meandrina_HIv1___RNAseq.g27511.t1,three_way,55.68066666666667,,,,,,,,,,,,,,,,,
OG_04436,0.584082049581341,OG_04436,FUN_018806-T1,Peve_00035781,Pocillopora_meandrina_HIv1___TS.g23409.t1,three_way,74.02616666666667,FUN_018806-T1,P97411,,,,,37.4,604.0,6.7e-85,316.6,sp|P97411|ICA69_MOUSE Islet cell autoantigen 1 OS=Mus musculus OX=10090 GN=Ica1 PE=1 SV=3,,,,,,
OG_08716,0.583950459587191,OG_08716,FUN_037968-T1,Peve_00012657,Pocillopora_meandrina_HIv1___RNAseq.g26237.t1,three_way,76.11933333333333,FUN_037968-T1,Q16658,FSCN1_HUMAN,,Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55),Homo sapiens (Human),40.2,488.0,2.5e-97,357.5,sp|Q16658|FSCN1_HUMAN Fascin OS=Homo sapiens OX=9606 GN=FSCN1 PE=1 SV=3,GO:0001725; GO:0001726; GO:0002102; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0005902; GO:0005911; GO:0005938; GO:0007043; GO:0007163; GO:0010592; GO:0015629; GO:0016477; GO:0030027; GO:0030035; GO:0030036; GO:0030046; GO:0030175; GO:0030426; GO:0030674; GO:0031253; GO:0032534; GO:0032956; GO:0035089; GO:0044393; GO:0045296; GO:0048870; GO:0051015; GO:0051017; GO:0051491; GO:0070062; GO:0071803; GO:0090091,actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725],actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0034330; GO:0043226; GO:0048870; GO:0060090,RNA binding; cytosol; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_03959,0.5838119119870969,OG_03959,FUN_016104-T1,Peve_00010767,Pocillopora_meandrina_HIv1___RNAseq.g21594.t1,three_way,76.85283333333332,FUN_016104-T1,Q9H3C7,,,,,65.9,355.0,1.6e-133,478.0,sp|Q9H3C7|GGNB2_HUMAN Gametogenetin-binding protein 2 OS=Homo sapiens OX=9606 GN=GGNBP2 PE=1 SV=1,,,,,,
OG_05823,0.5837532581941994,OG_05823,FUN_025840-T1,Peve_00028313,Pocillopora_meandrina_HIv1___RNAseq.g10336.t1,three_way,94.462,FUN_025840-T1,Q5ZLC5,ATPB_CHICK,,"ATP synthase F(1) complex catalytic subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)",Gallus gallus (Chicken),91.4,466.0,4.6e-241,835.1,"sp|Q5ZLC5|ATPB_CHICK ATP synthase F(1) complex catalytic subunit beta, mitochondrial OS=Gallus gallus OX=9031 GN=ATP5F1B PE=1 SV=1",GO:0001525; GO:0005524; GO:0005739; GO:0005743; GO:0015986; GO:0016887; GO:0042776; GO:0045259; GO:0046933,angiogenesis [GO:0001525]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]",GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; transporter activity; mitochondrion; hydrolase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05874,0.5826616617744914,OG_05874,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_03051,0.582439368051273,OG_03051,FUN_012298-T1,Peve_00038614,Pocillopora_meandrina_HIv1___RNAseq.g23768.t1,three_way,61.748,,,,,,,,,,,,,,,,,
OG_06781,0.5821842894036461,OG_06781,FUN_031648-T1,Peve_00043574,Pocillopora_meandrina_HIv1___RNAseq.g5681.t1,three_way,93.75783333333334,FUN_031648-T1,Q6PD03,2A5A_MOUSE,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha),Mus musculus (Mouse),75.4,443.0,6.199999999999999e-189,661.8,sp|Q6PD03|2A5A_MOUSE Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform OS=Mus musculus OX=10090 GN=Ppp2r5a PE=1 SV=1,GO:0000159; GO:0000775; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0007165; GO:0019210; GO:0019900; GO:0030018; GO:0031430; GO:0072542; GO:1903077,negative regulation of protein localization to plasma membrane [GO:1903077]; signal transduction [GO:0007165],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]",kinase binding [GO:0019900]; kinase inhibitor activity [GO:0019210]; protein phosphatase activator activity [GO:0072542],GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; plasma membrane; organelle; molecular function regulator activity
OG_04585,0.5821073054532037,OG_04585,FUN_022251-T1,Peve_00021288,Pocillopora_meandrina_HIv1___RNAseq.g4724.t1,three_way,52.4535,FUN_022251-T1,P35969,,,,,30.3,511.0,3.1999999999999996e-49,198.7,sp|P35969|VGFR1_MOUSE Vascular endothelial growth factor receptor 1 OS=Mus musculus OX=10090 GN=Flt1 PE=1 SV=1,,,,,,
OG_08395,0.580885167459607,OG_08395,FUN_037007-T1,Peve_00032339,Pocillopora_meandrina_HIv1___RNAseq.g26697.t1,three_way,81.91016666666667,,,,,,,,,,,,,,,,,
OG_08165,0.5800982198196426,OG_08165,FUN_035962-T1,Peve_00006624,Pocillopora_meandrina_HIv1___RNAseq.g12329.t1,three_way,87.42883333333333,FUN_035962-T1,Q9GYZ0,,,,,39.5,1065.0,2e-180,634.8,sp|Q9GYZ0|KIF15_STRPU Kinesin-like protein KIF15 OS=Strongylocentrotus purpuratus OX=7668 GN=KIF15 PE=1 SV=1,,,,,,
OG_10035,0.5800030755539171,OG_10035,FUN_043299-T1,Peve_00026362,Pocillopora_meandrina_HIv1___RNAseq.g8894.t1,three_way,72.17666666666666,FUN_043299-T1,Q6P9Q6,FKB15_MOUSE,,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),Mus musculus (Mouse),36.7,619.0,1.2000000000000001e-80,303.5,sp|Q6P9Q6|FKB15_MOUSE FK506-binding protein 15 OS=Mus musculus OX=10090 GN=Fkbp15 PE=1 SV=2,GO:0003779; GO:0005768; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030424; GO:0030426,endocytosis [GO:0006897],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; early endosome [GO:0005769]; endosome [GO:0005768]; growth cone [GO:0030426]; membrane [GO:0016020],actin binding [GO:0003779],GO:0005768; GO:0005856; GO:0008092; GO:0016192; GO:0031410; GO:0043226,endosome; cytoskeleton; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_04816,0.5795496136496958,OG_04816,FUN_022797-T1,Peve_00024723,Pocillopora_meandrina_HIv1___TS.g9662.t2,three_way,93.94933333333334,FUN_022797-T1,P36876,,,,,76.0,441.0,2.8e-204,712.6,sp|P36876|2ABA_RAT Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform OS=Rattus norvegicus OX=10116 GN=Ppp2r2a PE=2 SV=1,,,,,,
OG_06181,0.5779701331728323,OG_06181,FUN_028088-T1,Peve_00031660,Pocillopora_meandrina_HIv1___TS.g11574.t1,three_way,88.21483333333333,FUN_028088-T1,P18907,,,,,76.6,988.0,0.0,1502.3,sp|P18907|AT1A1_HORSE Sodium/potassium-transporting ATPase subunit alpha-1 OS=Equus caballus OX=9796 GN=ATP1A1 PE=3 SV=1,,,,,,
OG_08173,0.5779461150475103,OG_08173,FUN_035981-T1,Peve_00045083,Pocillopora_meandrina_HIv1___RNAseq.g12342.t1,three_way,87.08966666666667,FUN_035981-T1,Q9QYJ0,,,,,57.3,410.0,3.3e-127,456.4,sp|Q9QYJ0|DNJA2_MOUSE DnaJ homolog subfamily A member 2 OS=Mus musculus OX=10090 GN=Dnaja2 PE=1 SV=1,,,,,,
OG_04032,0.5778752899904894,OG_04032,FUN_016340-T1,Peve_00044576,Pocillopora_meandrina_HIv1___RNAseq.g9730.t1,three_way,73.72266666666667,FUN_016340-T1,Q6P7A2,UBE4A_RAT,,Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A),Rattus norvegicus (Rat),39.6,1095.0,2.2e-194,681.0,sp|Q6P7A2|UBE4A_RAT Ubiquitin conjugation factor E4 A OS=Rattus norvegicus OX=10116 GN=Ube4a PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0034450; GO:0036503; GO:0061630,ERAD pathway [GO:0036503]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05423,0.5776275430714171,OG_05423,FUN_024368-T1,Peve_00003573,Pocillopora_meandrina_HIv1___RNAseq.g19083.t1,three_way,88.05250000000001,FUN_024368-T1,Q9Y496,KIF3A_HUMAN,,Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A),Homo sapiens (Human),71.0,648.0,6.800000000000001e-216,751.9,sp|Q9Y496|KIF3A_HUMAN Kinesin-like protein KIF3A OS=Homo sapiens OX=9606 GN=KIF3A PE=1 SV=4,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006996; GO:0008017; GO:0008089; GO:0008574; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0019903; GO:0030507; GO:0031267; GO:0034454; GO:0060271; GO:0070062; GO:0072383; GO:0097542; GO:1902414; GO:1904115,anterograde axonal transport [GO:0008089]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031],axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein phosphatase binding [GO:0019903]; small GTPase binding [GO:0031267]; spectrin binding [GO:0030507],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_05879,0.577495779998387,OG_05879,FUN_026032-T1,Peve_00003809,Pocillopora_meandrina_HIv1___RNAseq.g10470.t1,three_way,63.20466666666667,FUN_026032-T1,P05205,HP1_DROME,,Heterochromatin protein 1 (HP1) (Non-histone chromosomal protein C1A9 antigen),Drosophila melanogaster (Fruit fly),49.7,191.0,4.3e-25,116.3,sp|P05205|HP1_DROME Heterochromatin protein 1 OS=Drosophila melanogaster OX=7227 GN=Su(var)205 PE=1 SV=2,GO:0000182; GO:0000278; GO:0000723; GO:0000775; GO:0000779; GO:0000781; GO:0000791; GO:0000792; GO:0000793; GO:0003682; GO:0003696; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005694; GO:0005700; GO:0005701; GO:0005703; GO:0005721; GO:0006355; GO:0010369; GO:0030544; GO:0030674; GO:0031507; GO:0031508; GO:0035064; GO:0042393; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0051276; GO:0070063; GO:0099122; GO:0141006; GO:0141194; GO:1905632; GO:1905634; GO:1905646,chromosome organization [GO:0051276]; heterochromatin formation [GO:0031507]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-templated transcription [GO:0045892]; pericentric heterochromatin formation [GO:0031508]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to euchromatin [GO:1905632]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization to chromatin [GO:1905634]; siRNA-mediated heterochromatin formation [GO:0141194]; telomere maintenance [GO:0000723]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],"chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696],GO:0000278; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0031047; GO:0032200; GO:0042393; GO:0043226; GO:0060090,mitotic cell cycle; DNA binding; RNA binding; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; regulatory ncRNA-mediated gene silencing; telomere organization; histone binding; organelle; molecular adaptor activity
OG_04511,0.5772428432950156,OG_04511,FUN_022043-T1,Peve_00004576,Pocillopora_meandrina_HIv1___RNAseq.g9277.t1,three_way,83.28766666666667,FUN_022043-T1,Q9BZE4,GTPB4_HUMAN,,GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1),Homo sapiens (Human),58.0,638.0,2.2e-202,706.8,sp|Q9BZE4|GTPB4_HUMAN GTP-binding protein 4 OS=Homo sapiens OX=9606 GN=GTPBP4 PE=1 SV=3,GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0010972; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0042273; GO:0048471; GO:0050821; GO:1990275,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA replication [GO:0008156]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; ribosomal large subunit biogenesis [GO:0042273]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; preribosome binding [GO:1990275]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016787; GO:0030154; GO:0043226,RNA binding; catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; cytosol; hydrolase activity; cell differentiation; organelle
OG_05328,0.5769659986471112,OG_05328,FUN_024026-T1,Peve_00024951,Pocillopora_meandrina_HIv1___RNAseq.g19281.t1,three_way,75.564,FUN_024026-T1,Q5S1U6,,,,,41.0,390.0,1.3e-78,295.0,sp|Q5S1U6|IFRD1_PIG Interferon-related developmental regulator 1 OS=Sus scrofa OX=9823 GN=IFRD1 PE=2 SV=1,,,,,,
OG_02575,0.5767853652676944,OG_02575,FUN_010681-T1,Peve_00044788,Pocillopora_meandrina_HIv1___TS.g26095.t1,three_way,79.83833333333334,,,,,,,,,,,,,,,,,
OG_08859,0.5765387800479076,OG_08859,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_02907,0.5764953509994154,OG_02907,FUN_011984-T1,Peve_00000523,Pocillopora_meandrina_HIv1___TS.g16589.t1,three_way,64.19166666666666,FUN_011984-T1,Q8JHI3,AR13B_DANRE,,ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein scorpion),Danio rerio (Zebrafish) (Brachydanio rerio),53.8,208.0,2.4999999999999997e-62,241.1,sp|Q8JHI3|AR13B_DANRE ADP-ribosylation factor-like protein 13B OS=Danio rerio OX=7955 GN=arl13b PE=1 SV=1,GO:0003924; GO:0005525; GO:0005929; GO:0007224; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0035845; GO:0060170; GO:0060271; GO:0097500; GO:0097730; GO:1905515,cilium assembly [GO:0060271]; formation of radial glial scaffolds [GO:0021943]; interneuron migration from the subpallium to the cortex [GO:0021830]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224],ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005929; GO:0016787; GO:0043226; GO:0044782; GO:0048870,catalytic activity; GTPase activity; cilium; hydrolase activity; organelle; cilium organization; cell motility
OG_06271,0.5764763613300442,OG_06271,FUN_028303-T1,Peve_00027867,Pocillopora_meandrina_HIv1___RNAseq.g15547.t1,three_way,85.15633333333334,FUN_028303-T1,Q32LN4,CFA45_BOVIN,,Cilia- and flagella-associated protein 45,Bos taurus (Bovine),35.3,547.0,1e-17,93.2,sp|Q32LN4|CFA45_BOVIN Cilia- and flagella-associated protein 45 OS=Bos taurus OX=9913 GN=CFAP45 PE=1 SV=2,GO:0005576; GO:0005879; GO:0016208; GO:0030317; GO:0036126; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0160112,cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],9+0 motile cilium [GO:0097728]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126],AMP binding [GO:0016208],GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_05958,0.5761317380265232,OG_05958,FUN_026305-T1,Peve_00025709,Pocillopora_meandrina_HIv1___RNAseq.g3058.t1,three_way,89.43866666666666,FUN_026305-T1,P21613,,,,,58.8,972.0,2.4e-239,830.5,sp|P21613|KINH_DORPE Kinesin heavy chain OS=Doryteuthis pealeii OX=1051067 PE=1 SV=1,,,,,,
OG_03562,0.5759266781304782,OG_03562,FUN_014710-T1,Peve_00004185,Pocillopora_meandrina_HIv1___TS.g27294.t1,three_way,91.096,FUN_014710-T1,Q5SPC5,OTOF_DANRE,,Otoferlin (Fer-1-like protein 2),Danio rerio (Zebrafish) (Brachydanio rerio),49.8,2026.0,0.0,1855.5,sp|Q5SPC5|OTOF_DANRE Otoferlin OS=Danio rerio OX=7955 GN=otof PE=3 SV=1,GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0007009; GO:0007605; GO:0010996; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0036465; GO:0042995; GO:0048787; GO:0050885,neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle recycling [GO:0036465],basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672],AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509],GO:0016192; GO:0050877; GO:0061024; GO:0065003,vesicle-mediated transport; nervous system process; membrane organization; protein-containing complex assembly
OG_04165,0.5752185418073784,OG_04165,FUN_016646-T1,Peve_00042745,Pocillopora_meandrina_HIv1___RNAseq.g199.t1,three_way,51.387166666666666,FUN_016646-T1,P30173,,,,,42.1,378.0,2.2e-80,302.4,sp|P30173|ACT13_SOLTU Actin-101 OS=Solanum tuberosum OX=4113 GN=AC101 PE=3 SV=1,,,,,,
OG_02829,0.5749331687585537,OG_02829,FUN_011844-T1,Peve_00034372,Pocillopora_meandrina_HIv1___RNAseq.g23374.t1,three_way,76.01283333333333,FUN_011844-T1,Q8VHI6,WASF3_MOUSE,,Actin-binding protein WASF3 (Protein WAVE-3) (Wiskott-Aldrich syndrome protein family member 3) (WASP family protein member 3),Mus musculus (Mouse),40.6,502.0,1.2e-40,169.1,sp|Q8VHI6|WASF3_MOUSE Actin-binding protein WASF3 OS=Mus musculus OX=10090 GN=Wasf3 PE=1 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0031643; GO:0097386; GO:0098794; GO:0098885; GO:0098978,actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794],actin binding [GO:0003779],GO:0005856; GO:0007010; GO:0008092; GO:0034330; GO:0043226; GO:0048856,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; cell junction organization; organelle; anatomical structure development
OG_08969,0.5746211303214251,OG_08969,FUN_038474-T1,Peve_00039890,Pocillopora_meandrina_HIv1___RNAseq.g28227.t1,three_way,84.79233333333333,FUN_038474-T1,Q9R0Q6,,,,,53.0,372.0,2.5e-108,393.7,sp|Q9R0Q6|ARC1A_MOUSE Actin-related protein 2/3 complex subunit 1A OS=Mus musculus OX=10090 GN=Arpc1a PE=1 SV=1,,,,,,
OG_03779,0.5742326466995147,OG_03779,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_02327,0.5741058413981188,OG_02327,FUN_008919-T1,Peve_00020782,Pocillopora_meandrina_HIv1___RNAseq.g3998.t1,three_way,71.58416666666666,FUN_008919-T1,Q5R7U7,,,,,42.5,537.0,3.1000000000000004e-104,380.6,sp|Q5R7U7|DCTN4_PONAB Dynactin subunit 4 OS=Pongo abelii OX=9601 GN=DCTN4 PE=2 SV=1,,,,,,
OG_03055,0.5738685188878154,OG_03055,FUN_012302-T1,Peve_00038607,Pocillopora_meandrina_HIv1___RNAseq.g23764.t1,three_way,58.20183333333334,FUN_012302-T1,Q640M1,,,,,32.3,764.0,3.5e-72,274.6,sp|Q640M1|UT14A_MOUSE U3 small nucleolar RNA-associated protein 14 homolog A OS=Mus musculus OX=10090 GN=Utp14a PE=1 SV=1,,,,,,
OG_05204,0.5738414527036955,OG_05204,FUN_023588-T1,Peve_00028963,Pocillopora_meandrina_HIv1___TS.g17411.t1,three_way,68.98,FUN_023588-T1,Q5ZK33,LETM1_CHICK,,Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1),Gallus gallus (Chicken),40.7,644.0,2.9999999999999993e-105,384.4,sp|Q5ZK33|LETM1_CHICK Mitochondrial proton/calcium exchanger protein OS=Gallus gallus OX=9031 GN=LETM1 PE=2 SV=1,GO:0005509; GO:0005739; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007005; GO:0007007; GO:0015369; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093,calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022],GO:0005215; GO:0005739; GO:0007005; GO:0043226; GO:0055085; GO:0061024; GO:0065003,transporter activity; mitochondrion; mitochondrion organization; organelle; transmembrane transport; membrane organization; protein-containing complex assembly
OG_01225,0.5737065221921016,OG_01225,FUN_004907-T1,Peve_00026331,Pocillopora_meandrina_HIv1___RNAseq.g8340.t1,three_way,55.694,FUN_004907-T1,Q9WTY1,,,,,38.0,213.0,7.8e-26,120.2,sp|Q9WTY1|PDCD7_MOUSE Programmed cell death protein 7 OS=Mus musculus OX=10090 GN=Pdcd7 PE=1 SV=1,,,,,,
OG_04571,0.5735766236712333,OG_04571,FUN_022218-T1,Peve_00028321,Pocillopora_meandrina_HIv1___RNAseq.g4733.t1c,three_way,83.12133333333334,FUN_022218-T1,Q6QN10,,,,,66.3,181.0,2.999999999999999e-47,189.9,sp|Q6QN10|NACA_CHILA Nascent polypeptide-associated complex subunit alpha OS=Chinchilla lanigera OX=34839 PE=2 SV=1,,,,,,
OG_09256,0.5733754477822329,OG_09256,FUN_040058-T1,Peve_00018499,Pocillopora_meandrina_HIv1___RNAseq.g7727.t1b,three_way,76.5945,FUN_040058-T1,Q8CFI0,NED4L_MOUSE,,E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (EC 2.3.2.36) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2),Mus musculus (Mouse),47.7,973.0,1.6e-243,844.0,sp|Q8CFI0|NED4L_MOUSE E3 ubiquitin-protein ligase NEDD4-like OS=Mus musculus OX=10090 GN=Nedd4l PE=1 SV=2,GO:0002028; GO:0003085; GO:0005771; GO:0005794; GO:0006511; GO:0006814; GO:0009651; GO:0010765; GO:0010766; GO:0016567; GO:0019871; GO:0030154; GO:0031647; GO:0051649; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252; GO:1902305; GO:2000810,cell differentiation [GO:0030154]; establishment of localization in cell [GO:0051649]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of sodium ion transport [GO:0010765]; protein ubiquitination [GO:0016567]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; regulation protein catabolic process at postsynapse [GO:0140252]; response to salt stress [GO:0009651]; sodium ion transport [GO:0006814]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; postsynapse [GO:0098794],sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02488,0.5733562167672076,OG_02488,FUN_009820-T1,Peve_00042914,Pocillopora_meandrina_HIv1___RNAseq.g24547.t1,three_way,81.36066666666666,FUN_009820-T1,Q6NZ09,,,,,50.5,380.0,2.1e-54,214.5,sp|Q6NZ09|ADRM1_DANRE Proteasomal ubiquitin receptor ADRM1 OS=Danio rerio OX=7955 GN=adrm1b PE=1 SV=1,,,,,,
OG_00520,0.5728998857882347,OG_00520,FUN_001519-T1,Peve_00042520,Pocillopora_meandrina_HIv1___TS.g4541.t1,three_way,73.94266666666667,FUN_001519-T1,Q6QDP7,CR3L2_RAT,,Cyclic AMP-responsive element-binding protein 3-like protein 2 (cAMP-responsive element-binding protein 3-like protein 2) (SCI-related protein Ra69) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2],Rattus norvegicus (Rat),38.3,334.0,6.8e-34,146.7,sp|Q6QDP7|CR3L2_RAT Cyclic AMP-responsive element-binding protein 3-like protein 2 OS=Rattus norvegicus OX=10116 GN=Creb3l2 PE=2 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002062; GO:0005634; GO:0005783; GO:0005789; GO:0006357; GO:0006888; GO:0006986; GO:0010628; GO:0010976; GO:0034976; GO:0035497; GO:0045893; GO:0045944; GO:0051216; GO:0097038,cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038],"cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005783; GO:0006355; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00420,0.5727461949500533,OG_00420,FUN_001325-T1,Peve_00036958,Pocillopora_meandrina_HIv1___RNAseq.g2268.t1,three_way,83.70033333333333,FUN_001325-T1,P81004,,,,,62.9,280.0,5.2e-103,375.6,sp|P81004|VDAC2_XENLA Non-selective voltage-gated ion channel VDAC2 OS=Xenopus laevis OX=8355 GN=vdac2 PE=1 SV=1,,,,,,
OG_07233,0.5726220824504736,OG_07233,FUN_032906-T1,Peve_00014529,Pocillopora_meandrina_HIv1___RNAseq.g24991.t1,three_way,83.96633333333334,FUN_032906-T1,Q14671,,,,,46.1,1272.0,9e-53,210.7,sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3,,,,,,
OG_06270,0.5720432739555398,OG_06270,FUN_028301-T1,Peve_00000714,Pocillopora_meandrina_HIv1___TS.g10572.t1,three_way,51.42816666666666,FUN_028301-T1,D3ZSP7,TTC3_RAT,,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D),Rattus norvegicus (Rat),27.5,741.0,7.4e-62,241.5,sp|D3ZSP7|TTC3_RAT E3 ubiquitin-protein ligase TTC3 OS=Rattus norvegicus OX=10116 GN=Ttc3 PE=3 SV=3,GO:0004842; GO:0005634; GO:0005773; GO:0005794; GO:0006511; GO:0008270; GO:0030517; GO:0045665; GO:0070936,negative regulation of axon extension [GO:0030517]; negative regulation of neuron differentiation [GO:0045665]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; vacuole [GO:0005773],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005773; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vacuole; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05777,0.5713035184169003,OG_05777,FUN_025746-T1,Peve_00008534,Pocillopora_meandrina_HIv1___RNAseq.g10426.t1,three_way,57.30083333333333,FUN_025746-T1,Q6P132,,,,,40.8,152.0,1.9999999999999998e-32,142.9,sp|Q6P132|TXB1B_DANRE Tax1-binding protein 1 homolog B OS=Danio rerio OX=7955 GN=tax1bp1b PE=2 SV=3,,,,,,
OG_08111,0.5711864892317404,OG_08111,FUN_035864-T1,Peve_00042154,Pocillopora_meandrina_HIv1___RNAseq.g11966.t1,three_way,90.75366666666666,FUN_035864-T1,O60231,DHX16_HUMAN,,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),Homo sapiens (Human),62.5,1039.0,0.0,1148.7,sp|O60231|DHX16_HUMAN Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 OS=Homo sapiens OX=9606 GN=DHX16 PE=1 SV=2,GO:0000398; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008380; GO:0016887; GO:0038187; GO:0043130; GO:0060090; GO:0071005; GO:0140374,"antiviral innate immune response [GO:0140374]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; molecular adaptor activity [GO:0060090]; pattern recognition receptor activity [GO:0038187]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ubiquitin binding [GO:0043130],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0060090; GO:0098542; GO:0140098; GO:0140657,"immune system process; RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; molecular transducer activity; molecular adaptor activity; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10221,0.5711429942602055,OG_10221,FUN_043835-T1,Peve_00041794,Pocillopora_meandrina_HIv1___TS.g12323.t1,three_way,54.1065,,,,,,,,,,,,,,,,,
OG_05409,0.5709760005805118,OG_05409,FUN_024343-T1,Peve_00016806,Pocillopora_meandrina_HIv1___RNAseq.g18931.t1,three_way,80.135,FUN_024343-T1,Q6BRB4,,,,,37.3,83.0,3.1e-06,53.9,sp|Q6BRB4|NHP6_DEBHA Non-histone chromosomal protein 6 OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) OX=284592 GN=NHP6 PE=3 SV=1,,,,,,
OG_01954,0.5705313879432714,OG_01954,FUN_008020-T1,Peve_00031302,Pocillopora_meandrina_HIv1___RNAseq.g30341.t1,three_way,85.20216666666667,FUN_008020-T1,P27448,MARK3_HUMAN,,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),Homo sapiens (Human),52.2,826.0,3.2000000000000005e-201,703.4,sp|P27448|MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens OX=9606 GN=MARK3 PE=1 SV=5,GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0048156; GO:0050321; GO:0070062; GO:0106310; GO:1900181,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005829; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05733,0.5702577500994326,OG_05733,FUN_025659-T1,Peve_00042174,Pocillopora_meandrina_HIv1___RNAseq.g23073.t1,three_way,72.82333333333334,,,,,,,,,,,,,,,,,
OG_00179,0.5700913275598937,OG_00179,FUN_000872-T1,Peve_00002057,Pocillopora_meandrina_HIv1___RNAseq.g1815.t1,three_way,56.59033333333333,FUN_000872-T1,Q08288,LYAR_MOUSE,,Cell growth-regulating nucleolar protein (Ly1 antibody-reactive protein) (Protein expressed in male leptotene and zygotene spermatocytes 264) (MLZ-264),Mus musculus (Mouse),40.4,406.0,2.3e-39,164.5,sp|Q08288|LYAR_MOUSE Cell growth-regulating nucleolar protein OS=Mus musculus OX=10090 GN=Lyar PE=1 SV=2,GO:0000122; GO:0001750; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008270; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0048821; GO:0050766; GO:0140297; GO:0140416,erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750],DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription regulator inhibitor activity [GO:0140416]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0048856; GO:0098542; GO:0098772,immune system process; DNA binding; nucleus; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity
OG_01728,0.569786160580283,OG_01728,FUN_007020-T1,Peve_00037180,Pocillopora_meandrina_HIv1___RNAseq.g20542.t1,three_way,63.67233333333333,FUN_007020-T1,Q6ZZY0,,,,,46.9,497.0,1.3e-139,499.6,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_02649,0.5693202154914636,OG_02649,FUN_010831-T1,Peve_00017536,Pocillopora_meandrina_HIv1___RNAseq.g20914.t1,three_way,75.07333333333334,FUN_010831-T1,P09057,DCOR_RAT,,Ornithine decarboxylase (ODC) (EC 4.1.1.17),Rattus norvegicus (Rat),53.1,409.0,6.7e-132,472.2,sp|P09057|DCOR_RAT Ornithine decarboxylase OS=Rattus norvegicus OX=10116 GN=Odc1 PE=1 SV=1,GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471,"cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from arginine, via ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016829; GO:0048856,catalytic activity; cytosol; amino acid metabolic process; lyase activity; anatomical structure development
OG_01276,0.5693139839596221,OG_01276,FUN_005056-T1,Peve_00016747,Pocillopora_meandrina_HIv1___RNAseq.g8303.t1,three_way,56.921,FUN_005056-T1,P42568,AF9_HUMAN,,Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3),Homo sapiens (Human),38.0,92.0,2.1e-09,65.1,sp|P42568|AF9_HUMAN Protein AF-9 OS=Homo sapiens OX=9606 GN=MLLT3 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007379; GO:0008023; GO:0009952; GO:0010467; GO:0042393; GO:0045893; GO:0060090; GO:0060218; GO:0070062; GO:0070577; GO:0090090; GO:0140030; GO:0140044; GO:0140072; GO:0140119; GO:1902275; GO:2000035; GO:2000096,"anterior/posterior pattern specification [GO:0009952]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of chromatin organization [GO:1902275]; regulation of stem cell division [GO:2000035]; segment specification [GO:0007379]",chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; histone H3K9ac reader activity [GO:0140072]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; molecular adaptor activity [GO:0060090],GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0060090,DNA binding; nucleus; nucleoplasm; chromosome; cytosol; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; molecular adaptor activity
OG_01259,0.568391490059038,OG_01259,FUN_005018-T1,Peve_00015875,Pocillopora_meandrina_HIv1___RNAseq.g8677.t1,three_way,82.69383333333333,FUN_005018-T1,Q6GPM1,,,,,45.6,799.0,4e-132,474.2,sp|Q6GPM1|ZFR_XENLA Zinc finger RNA-binding protein OS=Xenopus laevis OX=8355 GN=zfr PE=2 SV=1,,,,,,
OG_08901,0.5683392150279591,OG_08901,FUN_038315-T1,Peve_00035853,Pocillopora_meandrina_HIv1___RNAseq.g1120.t1,three_way,66.31266666666666,FUN_038315-T1,Q8NDV7,,,,,34.4,224.0,3.4e-17,93.2,sp|Q8NDV7|TNR6A_HUMAN Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens OX=9606 GN=TNRC6A PE=1 SV=2,,,,,,
OG_01802,0.567779237219562,OG_01802,FUN_007332-T1,Peve_00043671,Pocillopora_meandrina_HIv1___RNAseq.g30303.t1,three_way,92.95366666666666,FUN_007332-T1,Q2YDE4,,,,,78.9,246.0,5.2e-115,415.2,sp|Q2YDE4|PSA6_BOVIN Proteasome subunit alpha type-6 OS=Bos taurus OX=9913 GN=PSMA6 PE=1 SV=1,,,,,,
OG_02833,0.5677774035012407,OG_02833,FUN_011848-T1,Peve_00034362,Pocillopora_meandrina_HIv1___TS.g16261.t2,three_way,56.089333333333336,,,,,,,,,,,,,,,,,
OG_04775,0.567729035550904,OG_04775,FUN_022679-T1,Peve_00018004,Pocillopora_meandrina_HIv1___RNAseq.g4840.t1,three_way,62.58166666666666,FUN_022679-T1,Q9UKJ3,,,,,46.6,223.0,1.2e-49,199.5,sp|Q9UKJ3|GPTC8_HUMAN G patch domain-containing protein 8 OS=Homo sapiens OX=9606 GN=GPATCH8 PE=1 SV=2,,,,,,
OG_02889,0.5667445312725349,OG_02889,FUN_011944-T1,Peve_00016922,Pocillopora_meandrina_HIv1___RNAseq.g9188.t1,three_way,71.43466666666666,FUN_011944-T1,Q6Q759,SPG17_HUMAN,,Sperm-associated antigen 17 (Projection protein PF6 homolog),Homo sapiens (Human),31.0,2357.0,6.9000000000000005e-174,614.0,sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1,GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953,axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514],,GO:0005576; GO:0005794; GO:0005929; GO:0006886; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782,extracellular region; Golgi apparatus; cilium; intracellular protein transport; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_01171,0.5665529646076952,OG_01171,FUN_004795-T1,Peve_00010263,Pocillopora_meandrina_HIv1___RNAseq.g8536.t1,three_way,53.3395,FUN_004795-T1,Q56A10,ZN608_MOUSE,,Zinc finger protein 608,Mus musculus (Mouse),41.6,219.0,6.9e-29,132.1,sp|Q56A10|ZN608_MOUSE Zinc finger protein 608 OS=Mus musculus OX=10090 GN=Znf608 PE=1 SV=1,GO:0000122; GO:0008270; GO:0033085,negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122],,zinc ion binding [GO:0008270],GO:0006355,regulation of DNA-templated transcription
OG_03644,0.5662211872848727,OG_03644,FUN_014875-T1,Peve_00012982,Pocillopora_meandrina_HIv1___RNAseq.g21044.t1,three_way,69.73266666666667,,,,,,,,,,,,,,,,,
OG_09084,0.5661056532274771,OG_09084,FUN_038831-T1,Peve_00028780,Pocillopora_meandrina_HIv1___RNAseq.g28634.t1,three_way,67.26416666666667,FUN_038831-T1,F8VPZ5,ERCC6_MOUSE,,DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB),Mus musculus (Mouse),51.2,1068.0,1.6000000000000004e-277,957.6,sp|F8VPZ5|ERCC6_MOUSE DNA excision repair protein ERCC-6 OS=Mus musculus OX=10090 GN=Ercc6 PE=1 SV=1,GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006974; GO:0006979; GO:0007254; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032786; GO:0034243; GO:0035264; GO:0042262; GO:0045494; GO:0045943; GO:0045944; GO:0045945; GO:0060261; GO:0090734; GO:0097680; GO:0110016; GO:0140463; GO:0140658; GO:0140664; GO:1905168; GO:2001033,"base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription elongation by RNA polymerase I [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]",B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein tyrosine kinase activator activity [GO:0030296]",GO:0003677; GO:0003824; GO:0005634; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0060090; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; cell differentiation; organelle; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_09463,0.5659807739465585,OG_09463,FUN_041486-T1,Peve_00004078,Pocillopora_meandrina_HIv1___RNAseq.g15672.t2,three_way,56.60683333333333,FUN_041486-T1,D3ZZL9,,,,,35.3,388.0,1.7e-30,137.9,sp|D3ZZL9|GCC2_RAT GRIP and coiled-coil domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Gcc2 PE=1 SV=1,,,,,,
OG_10063,0.5658949432237266,OG_10063,FUN_043363-T1,Peve_00016658,Pocillopora_meandrina_HIv1___RNAseq.g8970.t1,three_way,82.36583333333333,FUN_043363-T1,Q8C4Y3,NELFB_MOUSE,,Negative elongation factor B (NELF-B) (Cofactor of BRCA1),Mus musculus (Mouse),45.5,587.0,1.2e-135,485.0,sp|Q8C4Y3|NELFB_MOUSE Negative elongation factor B OS=Mus musculus OX=10090 GN=Nelfb PE=1 SV=2,GO:0003723; GO:0005741; GO:0005829; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737,cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; stem cell differentiation [GO:0048863],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021],RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0006355; GO:0030154,RNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation
OG_03722,0.5658004175916844,OG_03722,FUN_015007-T1,Peve_00034683,Pocillopora_meandrina_HIv1___RNAseq.g21247.t1,three_way,90.045,FUN_015007-T1,A6NIH7,U119B_HUMAN,,Protein unc-119 homolog B,Homo sapiens (Human),68.4,193.0,2.3000000000000002e-74,280.0,sp|A6NIH7|U119B_HUMAN Protein unc-119 homolog B OS=Homo sapiens OX=9606 GN=UNC119B PE=1 SV=1,GO:0005829; GO:0005929; GO:0007399; GO:0008289; GO:0035869; GO:0042953; GO:0060271,cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytosol; cilium; lipid binding; organelle; cilium organization; anatomical structure development
OG_02267,0.5652989875557461,OG_02267,FUN_008716-T1,Peve_00034975,Pocillopora_meandrina_HIv1___RNAseq.g74.t1,three_way,91.29516666666667,FUN_008716-T1,P16036,,,,,73.7,354.0,1.1e-145,517.7,sp|P16036|S25A3_RAT Solute carrier family 25 member 3 OS=Rattus norvegicus OX=10116 GN=Slc25a3 PE=1 SV=1,,,,,,
OG_02650,0.5651918072211647,OG_02650,FUN_010832-T1,Peve_00017537,Pocillopora_meandrina_HIv1___RNAseq.g20916.t1,three_way,73.97983333333333,FUN_010832-T1,Q13118,KLF10_HUMAN,,Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1),Homo sapiens (Human),62.6,179.0,2.5e-12,74.7,sp|Q13118|KLF10_HUMAN Krueppel-like factor 10 OS=Homo sapiens OX=9606 GN=KLF10 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008270; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:1990837,bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019],chromatin [GO:0000785]; nucleus [GO:0005634],"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0023052; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; signaling; organelle; anatomical structure development; transcription regulator activity
OG_03032,0.5651871821976304,OG_03032,FUN_012266-T1,Peve_00036382,Pocillopora_meandrina_HIv1___RNAseq.g23541.t2,three_way,83.19966666666666,FUN_012266-T1,Q921C3,BRWD1_MOUSE,,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),Mus musculus (Mouse),45.5,1509.0,1.3e-305,1051.2,sp|Q921C3|BRWD1_MOUSE Bromodomain and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Brwd1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005930; GO:0006357; GO:0007010; GO:0008360; GO:0031514,cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357],axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0006355; GO:0007010; GO:0043226,nucleus; nucleoplasm; nucleolus; cytosol; cilium; regulation of DNA-templated transcription; cytoskeleton organization; organelle
OG_09739,0.5650076729924928,OG_09739,FUN_042001-T1,Peve_00016464,Pocillopora_meandrina_HIv1___RNAseq.g15220.t1,three_way,91.06033333333332,FUN_042001-T1,Q9P013,CWC15_HUMAN,,Spliceosome-associated protein CWC15 homolog,Homo sapiens (Human),73.8,229.0,3.2e-52,206.5,sp|Q9P013|CWC15_HUMAN Spliceosome-associated protein CWC15 homolog OS=Homo sapiens OX=9606 GN=CWC15 PE=1 SV=2,GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005739; GO:0016607; GO:0045292; GO:0071007; GO:0071013,"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mitochondrion; mRNA metabolic process; organelle
OG_06904,0.5647155555292971,OG_06904,FUN_031950-T1,Peve_00031823,Pocillopora_meandrina_HIv1___RNAseq.g6062.t1,three_way,97.722,FUN_031950-T1,P48601,,,,,94.3,334.0,2e-178,626.3,sp|P48601|PRS4_DROME 26S proteasome regulatory subunit 4 OS=Drosophila melanogaster OX=7227 GN=Rpt2 PE=1 SV=2,,,,,,
OG_02882,0.5645852792071018,OG_02882,FUN_011932-T1,Peve_00039643,Pocillopora_meandrina_HIv1___RNAseq.g23333.t1,three_way,85.123,FUN_011932-T1,Q8AVQ6,,,,,57.1,231.0,5.8e-66,252.3,sp|Q8AVQ6|SYF2_XENLA Pre-mRNA-splicing factor syf2 OS=Xenopus laevis OX=8355 GN=syf2 PE=2 SV=1,,,,,,
OG_03467,0.5643267083387652,OG_03467,FUN_014552-T1,Peve_00009117,Pocillopora_meandrina_HIv1___RNAseq.g22698.t1,three_way,65.17083333333333,FUN_014552-T1,Q9Y4C8,,,,,44.6,998.0,6.599999999999999e-198,692.6,sp|Q9Y4C8|RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3,,,,,,
OG_02190,0.5640773259730032,OG_02190,FUN_008544-T1,Peve_00013775,Pocillopora_meandrina_HIv1___RNAseq.g6331.t2,three_way,81.17266666666667,FUN_008544-T1,Q99MD6,TRXR3_MOUSE,,Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2),Mus musculus (Mouse),60.5,588.0,1.7000000000000002e-209,730.3,sp|Q99MD6|TRXR3_MOUSE Thioredoxin reductase 3 OS=Mus musculus OX=10090 GN=Txnrd3 PE=1 SV=3,GO:0001825; GO:0004791; GO:0005634; GO:0005783; GO:0006749; GO:0007283; GO:0030154; GO:0045454; GO:0050660,blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],flavin adenine dinucleotide binding [GO:0050660]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005783; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_08361,0.564028298693254,OG_08361,FUN_036910-T1,Peve_00018417,Pocillopora_meandrina_HIv1___RNAseq.g10815.t1,three_way,60.812666666666665,,,,,,,,,,,,,,,,,
OG_10031,0.5635359343340651,OG_10031,FUN_043286-T1,Peve_00007448,Pocillopora_meandrina_HIv1___RNAseq.g8869.t1,three_way,90.06933333333333,FUN_043286-T1,Q5ZKN1,CDK9_CHICK,,Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9),Gallus gallus (Chicken),71.5,375.0,2.3e-151,536.6,sp|Q5ZKN1|CDK9_CHICK Cyclin-dependent kinase 9 OS=Gallus gallus OX=9031 GN=CDK9 PE=2 SV=1,GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0008353; GO:0032968; GO:0045944; GO:0070691; GO:0106310; GO:0120187,positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634]; P-TEFb complex [GO:0070691],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02682,0.5630769906987181,OG_02682,FUN_010940-T1,Peve_00005965,Pocillopora_meandrina_HIv1___RNAseq.g20987.t1,three_way,71.95466666666667,FUN_010940-T1,Q6P1V4,,,,,58.3,841.0,1.9e-226,787.3,sp|Q6P1V4|EIF3C_XENTR Eukaryotic translation initiation factor 3 subunit C OS=Xenopus tropicalis OX=8364 GN=eif3c PE=2 SV=1,,,,,,
OG_05413,0.5630016616029059,OG_05413,FUN_024350-T1,Peve_00021948,Pocillopora_meandrina_HIv1___RNAseq.g18672.t1,three_way,54.338166666666666,FUN_024350-T1,Q01804,OTUD4_HUMAN,,OTU domain-containing protein 4 (EC 3.4.19.12) (HIV-1-induced protein HIN-1),Homo sapiens (Human),46.7,285.0,7.4e-66,254.2,sp|Q01804|OTUD4_HUMAN OTU domain-containing protein 4 OS=Homo sapiens OX=9606 GN=OTUD4 PE=1 SV=4,GO:0003723; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006307; GO:0006508; GO:0034122; GO:0035871; GO:0060090; GO:0061578; GO:0070536; GO:0071108; GO:0140374; GO:1903093; GO:2000660,antiviral innate immune response [GO:0140374]; DNA alkylation repair [GO:0006307]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of protein K48-linked deubiquitination [GO:1903093],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; RNA binding; catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_09806,0.5629357711214388,OG_09806,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_04560,0.5628294950949009,OG_04560,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_03309,0.5627390221518254,OG_03309,FUN_013385-T1,Peve_00015992,Pocillopora_meandrina_HIv1___RNAseq.g22980.t2,three_way,65.83083333333333,FUN_013385-T1,Q24180,DEAF1_DROME,,Deformed epidermal autoregulatory factor 1 (Protein DEAF-1),Drosophila melanogaster (Fruit fly),45.2,84.0,2.6e-16,87.8,sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1,GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776,embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; polytene chromosome [GO:0005700],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005694; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; chromosome; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04123,0.5623110486097566,OG_04123,FUN_016504-T1,Peve_00016812,Pocillopora_meandrina_HIv1___RNAseq.g9720.t1,three_way,88.1275,FUN_016504-T1,Q9Y2X3,NOP58_HUMAN,,Nucleolar protein 58 (Nucleolar protein 5),Homo sapiens (Human),71.5,445.0,1.6e-174,614.0,sp|Q9Y2X3|NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens OX=9606 GN=NOP58 PE=1 SV=1,GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0048254; GO:0051117; GO:0070761,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254],box C/D methylation guide snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732],ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0043226,RNA binding; nucleoplasm; nucleolus; cytosol; organelle
OG_06772,0.5621058205414736,OG_06772,FUN_031637-T1,Peve_00032681,Pocillopora_meandrina_HIv1___RNAseq.g5689.t1,three_way,76.88733333333333,FUN_031637-T1,Q5HZE0,S2529_RAT,,Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29),Rattus norvegicus (Rat),52.4,288.0,1.7e-80,300.8,sp|Q5HZE0|S2529_RAT Mitochondrial basic amino acids transporter OS=Rattus norvegicus OX=10116 GN=Slc25a29 PE=2 SV=1,GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0015174; GO:0015227; GO:0015822; GO:0089709; GO:1903401; GO:1903826; GO:1990575,L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity L-arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_04454,0.5619761944973816,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,0.5619761944973816,OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_02891,0.5619748744905857,OG_02891,FUN_011946-T1,Peve_00016920,Pocillopora_meandrina_HIv1___RNAseq.g9190.t1,three_way,81.93116666666667,FUN_011946-T1,O75937,DNJC8_HUMAN,,DnaJ homolog subfamily C member 8 (Splicing protein spf31),Homo sapiens (Human),46.0,163.0,6.8e-34,145.6,sp|O75937|DNJC8_HUMAN DnaJ homolog subfamily C member 8 OS=Homo sapiens OX=9606 GN=DNAJC8 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005829; GO:0030544; GO:0045171,,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],Hsp70 protein binding [GO:0030544],GO:0005634; GO:0005654; GO:0005829; GO:0043226,nucleus; nucleoplasm; cytosol; organelle
OG_03251,0.5619356075829467,OG_03251,FUN_012973-T1,Peve_00026801,Pocillopora_meandrina_HIv1___RNAseq.g12974.t1,three_way,78.81466666666667,FUN_012973-T1,B1AJZ9,FHAD1_HUMAN,,Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1),Homo sapiens (Human),25.4,1528.0,7.0000000000000006e-34,148.3,sp|B1AJZ9|FHAD1_HUMAN Forkhead-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHAD1 PE=1 SV=2,GO:0036126,,sperm flagellum [GO:0036126],,GO:0005929; GO:0043226,cilium; organelle
OG_08153,0.5616853980691581,OG_08153,FUN_035930-T1,Peve_00036624,Pocillopora_meandrina_HIv1___RNAseq.g12067.t1,three_way,73.38733333333333,FUN_035930-T1,Q6EDY6,CARL1_MOUSE,,"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)",Mus musculus (Mouse),37.8,1029.0,9.8e-173,609.8,sp|Q6EDY6|CARL1_MOUSE F-actin-uncapping protein LRRC16A OS=Mus musculus OX=10090 GN=Carmil1 PE=1 SV=2,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:1900026; GO:1902745; GO:2000813,actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886],protein-containing complex binding [GO:0044877],GO:0005634; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0007163; GO:0016192; GO:0031410; GO:0043226; GO:0048870,nucleus; endosome; cytosol; cytoskeleton; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; cytoplasmic vesicle; organelle; cell motility
OG_07643,0.5612862577630943,OG_07643,FUN_034422-T1,Peve_00038700,Pocillopora_meandrina_HIv1___RNAseq.g28563.t1,three_way,91.19266666666668,FUN_034422-T1,Q6DEU9,CTR9_XENTR,,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),77.7,896.0,0.0,1350.1,sp|Q6DEU9|CTR9_XENTR RNA polymerase-associated protein CTR9 homolog OS=Xenopus tropicalis OX=8364 GN=ctr9 PE=2 SV=1,GO:0000122; GO:0000791; GO:0001711; GO:0006368; GO:0016593; GO:0016607; GO:0019827; GO:0045638,endodermal cell fate commitment [GO:0001711]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368],Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nuclear speck [GO:0016607],,GO:0006355; GO:0043226,regulation of DNA-templated transcription; organelle
OG_05936,0.5604194369242321,OG_05936,FUN_026166-T1,Peve_00008132,Pocillopora_meandrina_HIv1___RNAseq.g3195.t1,three_way,97.83466666666666,FUN_026166-T1,P62194,,,,,91.0,400.0,1.9e-205,716.5,sp|P62194|PRS8_BOVIN 26S proteasome regulatory subunit 8 OS=Bos taurus OX=9913 GN=PSMC5 PE=2 SV=1,,,,,,
OG_06743,0.5602831568404684,OG_06743,FUN_031549-T1,Peve_00022771,Pocillopora_meandrina_HIv1___RNAseq.g5142.t1,three_way,79.50266666666667,FUN_031549-T1,Q5F480,ITPK1_CHICK,,"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)",Gallus gallus (Chicken),42.8,320.0,4.6e-77,289.7,sp|Q5F480|ITPK1_CHICK Inositol-tetrakisphosphate 1-kinase OS=Gallus gallus OX=9031 GN=ITPK1 PE=2 SV=1,GO:0000287; GO:0000825; GO:0005524; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052835; GO:0070266,inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266],,"ATP binding [GO:0005524]; inositol-1,3,4,5-tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol-3,4,5,6-tetrakisphosphate 1-kinase activity [GO:0047325]; inositol-3,4,6-trisphosphate 1-kinase activity [GO:0052835]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]",GO:0003824; GO:0012501; GO:0016740; GO:0016853,catalytic activity; programmed cell death; transferase activity; isomerase activity
OG_03508,0.5596078986227137,OG_03508,FUN_014618-T1,Peve_00002400,Pocillopora_meandrina_HIv1___RNAseq.g22773.t1,three_way,83.10666666666667,FUN_014618-T1,O88637,,,,,60.2,379.0,4.7e-131,469.2,sp|O88637|PCY2_RAT Ethanolamine-phosphate cytidylyltransferase OS=Rattus norvegicus OX=10116 GN=Pcyt2 PE=1 SV=1,,,,,,
OG_00721,0.5593928309460652,OG_00721,FUN_002661-T1,Peve_00043790,Pocillopora_meandrina_HIv1___RNAseq.g14882.t1a,three_way,78.43133333333333,FUN_002661-T1,Q00709,,,,,40.5,116.0,4.1e-20,99.8,sp|Q00709|BCL2_CHICK Apoptosis regulator Bcl-2 OS=Gallus gallus OX=9031 GN=BCL2 PE=2 SV=1,,,,,,
OG_06818,0.5593182757888753,OG_06818,FUN_031724-T1,Peve_00000894,Pocillopora_meandrina_HIv1___TS.g24210.t1,three_way,56.0895,FUN_031724-T1,Q9P219,DAPLE_HUMAN,,Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues) (hDaple) (Hook-related protein 2) (HkRP2),Homo sapiens (Human),35.4,432.0,7.8e-60,235.3,sp|Q9P219|DAPLE_HUMAN Protein Daple OS=Homo sapiens OX=9606 GN=CCDC88C PE=1 SV=3,GO:0001578; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005576; GO:0005737; GO:0005813; GO:0007026; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043296; GO:0044782; GO:0046330; GO:0046983; GO:0051959; GO:0060071; GO:0090090; GO:0120197; GO:1902691,"apical constriction [GO:0003383]; cilium organization [GO:0044782]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule bundle formation [GO:0001578]; mucociliary clearance [GO:0120197]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of JNK cascade [GO:0046330]; protein destabilization [GO:0031648]; respiratory basal cell differentiation [GO:1902691]; small GTPase-mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",apical junction complex [GO:0043296]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular region [GO:0005576],dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983],GO:0003016; GO:0005576; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0030154; GO:0044782; GO:0098772,respiratory system process; extracellular region; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; cell differentiation; cilium organization; molecular function regulator activity
OG_04096,0.5589030087308083,OG_04096,FUN_016436-T1,Peve_00002886,Pocillopora_meandrina_HIv1___TS.g23399.t2,three_way,66.57249999999999,FUN_016436-T1,P05455,LA_HUMAN,,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),Homo sapiens (Human),46.4,196.0,2.2e-38,160.6,sp|P05455|LA_HUMAN Lupus La protein OS=Homo sapiens OX=9606 GN=SSB PE=1 SV=2,GO:0000049; GO:0000781; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0010494; GO:0042780; GO:0045727; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904,histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; positive regulation of translation [GO:0045727]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]",mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005829; GO:0006399; GO:0006913; GO:0016071; GO:0043226,RNA binding; nucleus; cytosol; tRNA metabolic process; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_09358,0.5586121158896403,OG_09358,FUN_040444-T1,Peve_00004018,Pocillopora_meandrina_HIv1___RNAseq.g6519.t1,three_way,96.19533333333334,FUN_040444-T1,P80021,,,,,82.6,552.0,6.3e-254,877.9,"sp|P80021|ATPA_PIG ATP synthase F(1) complex subunit alpha, mitochondrial OS=Sus scrofa OX=9823 GN=ATP5F1A PE=1 SV=2",,,,,,
OG_04273,0.5582663432276646,OG_04273,FUN_017832-T1,Peve_00009486,Pocillopora_meandrina_HIv1___RNAseq.g9637.t3,three_way,63.501,FUN_017832-T1,Q28EW0,TM87A_XENTR,,Transmembrane protein 87A (Elkin1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),53.1,388.0,5.7e-112,406.8,sp|Q28EW0|TM87A_XENTR Transmembrane protein 87A OS=Xenopus tropicalis OX=8364 GN=tmem87a PE=2 SV=1,GO:0000139; GO:0005886; GO:0032580; GO:0050976; GO:0071260,cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_08661,0.5582389389067961,OG_08661,FUN_037877-T1,Peve_00027466,Pocillopora_meandrina_HIv1___TS.g13174.t1,three_way,47.705333333333336,FUN_037877-T1,P86733,,,,,41.8,110.0,7.4e-27,125.6,sp|P86733|KCP_HALAI BPTI/Kunitz domain-containing protein (Fragment) OS=Haliotis asinina OX=109174 PE=1 SV=1,,,,,,
OG_01166,0.5580624453075137,OG_01166,FUN_004786-T1,Peve_00037743,Pocillopora_meandrina_HIv1___RNAseq.g8520.t1,three_way,93.30766666666666,FUN_004786-T1,Q8C4X2,,,,,80.6,330.0,1.9e-155,550.1,sp|Q8C4X2|KC1G3_MOUSE Casein kinase I isoform gamma-3 OS=Mus musculus OX=10090 GN=Csnk1g3 PE=1 SV=2,,,,,,
OG_04983,0.5580017839207414,OG_04983,FUN_023110-T1,Peve_00000494,Pocillopora_meandrina_HIv1___RNAseq.g1701.t2,three_way,63.913,FUN_023110-T1,Q8IUR6,,,,,61.0,59.0,2e-11,71.6,sp|Q8IUR6|CRERF_HUMAN CREB3 regulatory factor OS=Homo sapiens OX=9606 GN=CREBRF PE=1 SV=2,,,,,,
OG_04145,0.5575308935513867,OG_04145,FUN_016607-T1,Peve_00010246,Pocillopora_meandrina_HIv1___RNAseq.g9625.t1,three_way,82.545,FUN_016607-T1,Q6AYD3,PA2G4_RAT,,Proliferation-associated protein 2G4,Rattus norvegicus (Rat),62.8,288.0,7.3e-106,385.2,sp|Q6AYD3|PA2G4_RAT Proliferation-associated protein 2G4 OS=Rattus norvegicus OX=10116 GN=Pa2g4 PE=1 SV=1,GO:0003676; GO:0003714; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892; GO:1990904,negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005634; GO:0005730; GO:0006355; GO:0043226; GO:0060090; GO:0140110,RNA binding; nucleus; nucleolus; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_01751,0.5571314177615073,OG_01751,FUN_007085-T1,Peve_00019888,Pocillopora_meandrina_HIv1___RNAseq.g20076.t1,three_way,70.81283333333333,FUN_007085-T1,Q5E9X4,LRC59_BOVIN,,"Leucine-rich repeat-containing protein 59 [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]",Bos taurus (Bovine),70.4,159.0,3.4e-14,80.5,sp|Q5E9X4|LRC59_BOVIN Leucine-rich repeat-containing protein 59 OS=Bos taurus OX=9913 GN=LRRC59 PE=2 SV=1,GO:0005635; GO:0005789; GO:0042645,,endoplasmic reticulum membrane [GO:0005789]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635],,GO:0005635; GO:0043226,nuclear envelope; organelle
OG_06217,0.5571013040895205,OG_06217,FUN_028158-T1,Peve_00024808,Pocillopora_meandrina_HIv1___RNAseq.g16501.t1,three_way,79.09966666666666,FUN_028158-T1,Q9Y5P8,,,,,48.1,459.0,2.1e-120,434.1,sp|Q9Y5P8|P2R3B_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta OS=Homo sapiens OX=9606 GN=PPP2R3B PE=1 SV=2,,,,,,
OG_06301,0.5570569883040943,OG_06301,FUN_028506-T1,Peve_00029711,Pocillopora_meandrina_HIv1___RNAseq.g15898.t1,three_way,64.91666666666667,,,,,,,,,,,,,,,,,
OG_03470,0.5567086008894732,OG_03470,FUN_014556-T1,Peve_00035993,Pocillopora_meandrina_HIv1___RNAseq.g22695.t1,three_way,72.46883333333334,FUN_014556-T1,E1BLT8,ZDHC5_BOVIN,,Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5),Bos taurus (Bovine),52.3,243.0,9.599999999999999e-70,265.4,sp|E1BLT8|ZDHC5_BOVIN Palmitoyltransferase ZDHHC5 OS=Bos taurus OX=9913 GN=ZDHHC5 PE=3 SV=1,GO:0005654; GO:0005886; GO:0006869; GO:0016409; GO:0019706; GO:0030425; GO:0045087; GO:0045335; GO:0062208; GO:0072659; GO:0098794; GO:0098978; GO:0140639; GO:1900227; GO:1903078; GO:1905171,innate immune response [GO:0045087]; lipid transport [GO:0006869]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to plasma membrane [GO:0072659],dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0002376; GO:0003824; GO:0005654; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0072659; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleoplasm; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; defense response to other organism; catalytic activity, acting on a protein"
OG_06961,0.5566672540074078,OG_06961,FUN_032091-T1,Peve_00012819,Pocillopora_meandrina_HIv1___RNAseq.g5277.t1,three_way,71.29066666666667,FUN_032091-T1,Q00IB7,,,,,40.9,952.0,1.5e-190,668.7,sp|Q00IB7|PKHH1_DANRE Pleckstrin homology domain-containing family H member 1 OS=Danio rerio OX=7955 GN=plekhh1 PE=2 SV=1,,,,,,
OG_03948,0.5564190668452279,OG_03948,FUN_016087-T1,Peve_00010774,Pocillopora_meandrina_HIv1___RNAseq.g21606.t1,three_way,69.82266666666666,FUN_016087-T1,Q92667,AKAP1_HUMAN,,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",Homo sapiens (Human),36.7,316.0,8.2e-45,183.0,"sp|Q92667|AKAP1_HUMAN A-kinase anchor protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=AKAP1 PE=1 SV=1",GO:0003723; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0016020; GO:0034237; GO:0140374,antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005739; GO:0005829; GO:0012501; GO:0043226; GO:0098542,immune system process; RNA binding; mitochondrion; cytosol; programmed cell death; organelle; defense response to other organism
OG_04207,0.5562483421089044,OG_04207,FUN_016779-T1,Peve_00032301,Pocillopora_meandrina_HIv1___RNAseq.g10031.t1,three_way,80.821,FUN_016779-T1,Q8BTW9,PAK4_MOUSE,,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),Mus musculus (Mouse),45.4,597.0,1.4e-119,431.4,sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus OX=10090 GN=Pak4 PE=1 SV=1,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0045766; GO:0060996; GO:0106310; GO:2000352,apoptotic process [GO:0006915]; dendritic spine development [GO:0060996]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766],cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0012501; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; programmed cell death; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_05252,0.5561872095644,OG_05252,FUN_023700-T1,Peve_00017416,Pocillopora_meandrina_HIv1___RNAseq.g17595.t2b,three_way,81.831,FUN_023700-T1,O14776,TCRG1_HUMAN,,Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150),Homo sapiens (Human),60.9,274.0,1.7000000000000001e-65,251.1,sp|O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1 PE=1 SV=2,GO:0000122; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063,mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation factor activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390],GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0140110,RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_06953,0.5561011331547271,OG_06953,FUN_032067-T1,Peve_00024741,Pocillopora_meandrina_HIv1___RNAseq.g6039.t1,three_way,74.31583333333334,FUN_032067-T1,Q8N128,,,,,48.1,52.0,4e-10,67.0,sp|Q8N128|F177A_HUMAN Protein FAM177A1 OS=Homo sapiens OX=9606 GN=FAM177A1 PE=1 SV=1,,,,,,
OG_03575,0.5557404711116454,OG_03575,FUN_014729-T1,Peve_00009500,Pocillopora_meandrina_HIv1___RNAseq.g22490.t1,three_way,91.43733333333331,,,,,,,,,,,,,,,,,
OG_03886,0.5553601611138705,OG_03886,FUN_015434-T1,Peve_00033645,Pocillopora_meandrina_HIv1___RNAseq.g22219.t1,three_way,88.301,FUN_015434-T1,P53448,,,,,75.0,356.0,4.3999999999999996e-147,522.3,sp|P53448|ALDOC_CARAU Fructose-bisphosphate aldolase C OS=Carassius auratus OX=7957 GN=aldoc PE=2 SV=2,,,,,,
OG_01956,0.5553001318195157,OG_01956,FUN_008023-T1,Peve_00011345,Pocillopora_meandrina_HIv1___RNAseq.g30348.t1,three_way,75.81166666666667,FUN_008023-T1,Q4R8N7,,,,,50.2,518.0,2.2e-115,417.5,sp|Q4R8N7|STIP1_MACFA Stress-induced-phosphoprotein 1 OS=Macaca fascicularis OX=9541 GN=STIP1 PE=2 SV=1,,,,,,
OG_02243,0.5552901768416122,OG_02243,FUN_008660-T1,Peve_00002968,Pocillopora_meandrina_HIv1___RNAseq.g14873.t1,three_way,90.71133333333331,FUN_008660-T1,H9BW96,,,,,88.4,207.0,3.8e-101,369.0,sp|H9BW96|RAB7_EPICO Ras-related protein rab7 OS=Epinephelus coioides OX=94232 GN=rab7 PE=1 SV=1,,,,,,
OG_04026,0.5550050080375554,OG_04026,FUN_016333-T1,Peve_00044546,Pocillopora_meandrina_HIv1___TS.g23374.t1,three_way,71.42983333333333,FUN_016333-T1,P35869,AHR_HUMAN,,Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76),Homo sapiens (Human),40.4,381.0,7.4e-62,240.4,sp|P35869|AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens OX=9606 GN=AHR PE=1 SV=2,GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001094; GO:0001223; GO:0001568; GO:0002819; GO:0002841; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006805; GO:0006915; GO:0009410; GO:0009636; GO:0010468; GO:0017025; GO:0030888; GO:0032922; GO:0032991; GO:0034751; GO:0034752; GO:0034753; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837,"apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]",aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic aryl hydrocarbon receptor complex [GO:0034752]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_10169,0.5549357918208601,OG_10169,FUN_043572-T1,Peve_00017257,Pocillopora_meandrina_HIv1___RNAseq.g8027.t1,three_way,71.741,FUN_043572-T1,Q91YU8,,,,,53.6,302.0,3.1e-84,313.9,sp|Q91YU8|SSF1_MOUSE Suppressor of SWI4 1 homolog OS=Mus musculus OX=10090 GN=Ppan PE=1 SV=2,,,,,,
OG_01399,0.5542434579421958,OG_01399,FUN_005387-T1,Peve_00044223,Pocillopora_meandrina_HIv1___RNAseq.g6614.t1,three_way,86.572,FUN_005387-T1,Q32LQ4,,,,,68.3,262.0,1.9e-105,384.0,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_01391,0.5536782953650987,OG_01391,FUN_005366-T1,Peve_00041492,Pocillopora_meandrina_HIv1___RNAseq.g6638.t1,three_way,90.41666666666669,FUN_005366-T1,Q9CR47,,,,,71.3,174.0,1.5999999999999999e-62,240.7,sp|Q9CR47|NSA2_MOUSE Ribosome biogenesis protein NSA2 homolog OS=Mus musculus OX=10090 GN=Nsa2 PE=2 SV=1,,,,,,
OG_07416,0.5533561440330141,OG_07416,FUN_033874-T1,Peve_00043316,Pocillopora_meandrina_HIv1___RNAseq.g28405.t1,three_way,78.36116666666666,,,,,,,,,,,,,,,,,
OG_02983,0.5532589250647445,OG_02983,FUN_012153-T1,Peve_00040788,Pocillopora_meandrina_HIv1___RNAseq.g23437.t1,three_way,74.26066666666667,FUN_012153-T1,Q5EA89,,,,,36.4,308.0,8e-20,99.4,sp|Q5EA89|FA76A_BOVIN Protein FAM76A OS=Bos taurus OX=9913 GN=FAM76A PE=2 SV=1,,,,,,
OG_07938,0.553223563112195,OG_07938,FUN_035444-T1,Peve_00002174,Pocillopora_meandrina_HIv1___RNAseq.g27111.t1,three_way,85.51933333333334,FUN_035444-T1,Q8BZZ3,WWP1_MOUSE,,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase WWP1) (WW domain-containing protein 1),Mus musculus (Mouse),57.0,910.0,8.499999999999999e-234,811.6,sp|Q8BZZ3|WWP1_MOUSE NEDD4-like E3 ubiquitin-protein ligase WWP1 OS=Mus musculus OX=10090 GN=Wwp1 PE=1 SV=2,GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0016567; GO:0030217; GO:0030324; GO:0043161; GO:0045892; GO:0061630; GO:0070161,lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217],anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03909,0.5531164557452128,OG_03909,FUN_015985-T1,Peve_00024008,Pocillopora_meandrina_HIv1___RNAseq.g21401.t1,three_way,57.967666666666666,,,,,,,,,,,,,,,,,
OG_05798,0.5530672669125221,OG_05798,FUN_025782-T1,Peve_00009656,Pocillopora_meandrina_HIv1___RNAseq.g10389.t1,three_way,90.97166666666666,FUN_025782-T1,Q9U505,,,,,57.1,168.0,8.099999999999997e-35,148.3,"sp|Q9U505|AT5G_MANSE ATP synthase lipid-binding protein, mitochondrial OS=Manduca sexta OX=7130 PE=2 SV=1",,,,,,
OG_00582,0.5529200849875793,OG_00582,FUN_001655-T1,Peve_00038364,Pocillopora_meandrina_HIv1___RNAseq.g29406.t1,three_way,93.90866666666666,FUN_001655-T1,P53621,COPA_HUMAN,,Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin],Homo sapiens (Human),75.2,1228.0,0.0,1507.7,sp|P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=2,GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133],hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198],GO:0003723; GO:0005198; GO:0005615; GO:0005829; GO:0006886; GO:0016192; GO:0022600; GO:0031410; GO:0043226; GO:0048018; GO:0098772,RNA binding; structural molecule activity; extracellular space; cytosol; intracellular protein transport; vesicle-mediated transport; digestive system process; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_07076,0.5528243588097037,OG_07076,FUN_032313-T1,Peve_00002570,Pocillopora_meandrina_HIv1___RNAseq.g24766.t1,three_way,78.20966666666666,FUN_032313-T1,Q99729,ROAA_HUMAN,,Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (APOBEC1-binding protein 1) (ABBP-1),Homo sapiens (Human),46.6,193.0,2.3999999999999998e-43,177.6,sp|Q99729|ROAA_HUMAN Heterogeneous nuclear ribonucleoprotein A/B OS=Homo sapiens OX=9606 GN=HNRNPAB PE=1 SV=2,GO:0000785; GO:0001837; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0010468; GO:0016556; GO:0030425; GO:0044877; GO:0045293; GO:0045893; GO:0071230; GO:0071598; GO:0090575; GO:0141166; GO:1904580; GO:1990837; GO:1990904; GO:2000623,"cellular response to amino acid stimulus [GO:0071230]; chromosomal 5-methylcytosine DNA demethylation pathway [GO:0141166]; epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mRNA editing complex [GO:0045293]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575],mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0030154; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; organelle
OG_09247,0.5527552165756948,OG_09247,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00082,0.5521220839274854,OG_00082,FUN_000411-T1,Peve_00010961,Pocillopora_meandrina_HIv1___RNAseq.g2317.t1,three_way,32.01166666666666,,,,,,,,,,,,,,,,,
OG_04906,0.5519698034671555,OG_04906,FUN_022955-T1,Peve_00001405,Pocillopora_meandrina_HIv1___RNAseq.17404_t,three_way,60.97516666666667,FUN_022955-T1,Q8CGI1,,,,,56.6,76.0,3.5e-19,99.0,sp|Q8CGI1|F193A_MOUSE Protein FAM193A OS=Mus musculus OX=10090 GN=Fam193a PE=1 SV=2,,,,,,
OG_01009,0.5514213815218398,OG_01009,FUN_004436-T1,Peve_00033216,Pocillopora_meandrina_HIv1___RNAseq.g11488.t1,three_way,71.79266666666666,FUN_004436-T1,Q9H3R0,,,,,38.8,1037.0,4.0999999999999996e-191,669.8,sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2,,,,,,
OG_05797,0.5512959840918265,OG_05797,FUN_025780-T1,Peve_00009651,Pocillopora_meandrina_HIv1___RNAseq.g10358.t1,three_way,87.72200000000001,FUN_025780-T1,P18687,,,,,71.6,556.0,2.2e-220,766.5,"sp|P18687|CH60_CRIGR 60 kDa heat shock protein, mitochondrial OS=Cricetulus griseus OX=10029 GN=HSPD1 PE=2 SV=1",,,,,,
OG_08202,0.5510403266373357,OG_08202,FUN_036047-T1,Peve_00029867,Pocillopora_meandrina_HIv1___RNAseq.g27387.t1,three_way,71.29666666666667,FUN_036047-T1,Q2HJ57,,,,,48.2,137.0,3.2999999999999997e-29,129.4,sp|Q2HJ57|COTL1_BOVIN Coactosin-like protein OS=Bos taurus OX=9913 GN=COTL1 PE=2 SV=3,,,,,,
OG_08727,0.5509744961953607,OG_08727,FUN_037982-T1,Peve_00018338,Pocillopora_meandrina_HIv1___RNAseq.g26193.t1,three_way,71.84733333333332,,,,,,,,,,,,,,,,,
OG_04033,0.5509586502077713,OG_04033,FUN_016341-T1,Peve_00044577,Pocillopora_meandrina_HIv1___RNAseq.g9731.t1,three_way,85.63799999999999,FUN_016341-T1,Q5ZKX6,UBE2F_CHICK,,NEDD8-conjugating enzyme UBE2F (EC 2.3.2.34) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F),Gallus gallus (Chicken),60.9,184.0,1.2e-62,241.1,sp|Q5ZKX6|UBE2F_CHICK NEDD8-conjugating enzyme UBE2F OS=Gallus gallus OX=9031 GN=UBE2F PE=2 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654; GO:0061663,protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09397,0.5508727950246884,OG_09397,FUN_040695-T1,Peve_00029579,Pocillopora_meandrina_HIv1___RNAseq.g9092.t1,three_way,83.89,FUN_040695-T1,Q5RF04,,,,,63.8,160.0,1.5999999999999996e-53,210.3,sp|Q5RF04|RLP24_PONAB Probable ribosome biogenesis protein RLP24 OS=Pongo abelii OX=9601 GN=RSL24D1 PE=2 SV=1,,,,,,
OG_08542,0.550775628084272,OG_08542,FUN_037495-T1,Peve_00028567,Pocillopora_meandrina_HIv1___TS.g22722.t1,three_way,69.01516666666667,FUN_037495-T1,Q60431,CASP3_MESAU,,Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],Mesocricetus auratus (Golden hamster),44.7,255.0,1.6e-54,214.9,sp|Q60431|CASP3_MESAU Caspase-3 OS=Mesocricetus auratus OX=10036 GN=CASP3 PE=2 SV=1,GO:0004175; GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0030182; GO:0030216; GO:0030218; GO:0031264; GO:0031647; GO:0043525; GO:1902004,apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytoplasm [GO:0005737]; death-inducing signaling complex [GO:0031264],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175],GO:0003824; GO:0012501; GO:0016787; GO:0030154; GO:0140096,"catalytic activity; programmed cell death; hydrolase activity; cell differentiation; catalytic activity, acting on a protein"
OG_01366,0.5506450697134352,OG_01366,FUN_005313-T1,Peve_00003312,Pocillopora_meandrina_HIv1___RNAseq.g8174.t1,three_way,94.14516666666668,FUN_005313-T1,Q04727,TLE4_HUMAN,,Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4),Homo sapiens (Human),84.8,356.0,3.9e-180,632.1,sp|Q04727|TLE4_HUMAN Transducin-like enhancer protein 4 OS=Homo sapiens OX=9606 GN=TLE4 PE=1 SV=3,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055],beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_08648,0.5502411292201013,OG_08648,FUN_037843-T1,Peve_00025123,Pocillopora_meandrina_HIv1___RNAseq.g1437.t1,three_way,91.50183333333334,FUN_037843-T1,P56701,,,,,72.5,861.0,0.0,1194.9,sp|P56701|PSMD2_BOVIN 26S proteasome non-ATPase regulatory subunit 2 OS=Bos taurus OX=9913 GN=PSMD2 PE=1 SV=2,,,,,,
OG_02309,0.5501678401565789,OG_02309,FUN_008889-T1,Peve_00020945,Pocillopora_meandrina_HIv1___RNAseq.g4003.t1,three_way,51.47683333333334,FUN_008889-T1,D3Z8E6,CAMP1_RAT,,Calmodulin-regulated spectrin-associated protein 1,Rattus norvegicus (Rat),43.7,142.0,7.000000000000001e-32,142.1,sp|D3Z8E6|CAMP1_RAT Calmodulin-regulated spectrin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Camsap1 PE=1 SV=2,GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0036449; GO:0051011,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule minus-end [GO:0036449],calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507],GO:0007010; GO:0008092,cytoskeleton organization; cytoskeletal protein binding
OG_02850,0.5497388155214616,OG_02850,FUN_011882-T1,Peve_00018836,Pocillopora_meandrina_HIv1___RNAseq.g23402.t1,three_way,89.64316666666666,FUN_011882-T1,O14602,,,,,84.8,145.0,2.7e-50,199.5,"sp|O14602|IF1AY_HUMAN Eukaryotic translation initiation factor 1A, Y-chromosomal OS=Homo sapiens OX=9606 GN=EIF1AY PE=1 SV=4",,,,,,
OG_09500,0.5487350112844718,OG_09500,FUN_041544-T1,Peve_00021436,Pocillopora_meandrina_HIv1___RNAseq.g15993.t1,three_way,85.34433333333334,FUN_041544-T1,Q9Z2W1,STK25_MOUSE,,Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1),Mus musculus (Mouse),63.5,417.0,2.7e-143,510.0,sp|Q9Z2W1|STK25_MOUSE Serine/threonine-protein kinase 25 OS=Mus musculus OX=10090 GN=Stk25 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005794; GO:0007163; GO:0007409; GO:0032874; GO:0036481; GO:0042803; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0090168; GO:0090443; GO:0106310,axonogenesis [GO:0007409]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874],FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005794; GO:0007163; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; establishment or maintenance of cell polarity; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02948,0.5484234841090618,OG_02948,FUN_012066-T1,Peve_00004089,Pocillopora_meandrina_HIv1___RNAseq.g23637.t1,three_way,63.71233333333333,FUN_012066-T1,Q7Z020,,,,,25.4,562.0,7.2e-37,157.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_07641,0.5481859592803192,OG_07641,FUN_034420-T1,Peve_00021291,Pocillopora_meandrina_HIv1___RNAseq.g28575.t1,three_way,76.00066666666666,FUN_034420-T1,Q32LP4,S4A10_BOVIN,,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Bos taurus (Bovine),48.4,1093.0,1.6000000000000002e-273,944.1,sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1,GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982,bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_00300,0.547748922878438,OG_00300,FUN_001098-T1,Peve_00003181,Pocillopora_meandrina_HIv1___RNAseq.g29379.t1a,three_way,85.81566666666667,FUN_001098-T1,Q5E964,,,,,55.2,375.0,4.9000000000000005e-117,422.5,sp|Q5E964|PSD13_BOVIN 26S proteasome non-ATPase regulatory subunit 13 OS=Bos taurus OX=9913 GN=PSMD13 PE=2 SV=1,,,,,,
OG_08540,0.5473233842029858,OG_08540,FUN_037491-T1,Peve_00028570,Pocillopora_meandrina_HIv1___RNAseq.g1307.t1,three_way,88.51766666666667,FUN_037491-T1,P31153,METK2_HUMAN,,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),Homo sapiens (Human),79.0,381.0,3.6e-177,622.5,sp|P31153|METK2_HUMAN S-adenosylmethionine synthase isoform type-2 OS=Homo sapiens OX=9606 GN=MAT2A PE=1 SV=1,GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0036094; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0061431; GO:1904263; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to methionine [GO:0061431]; one-carbon metabolic process [GO:0006730]; positive regulation of TORC1 signaling [GO:1904263]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556],cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; small molecule binding [GO:0036094],GO:0003824; GO:0005829; GO:0006790; GO:0016740; GO:0065003,catalytic activity; cytosol; sulfur compound metabolic process; transferase activity; protein-containing complex assembly
OG_00025,0.5472353360372082,OG_00025,FUN_000226-T1,Peve_00012014,Pocillopora_meandrina_HIv1___RNAseq.g28941.t1,three_way,60.776,FUN_000226-T1,Q6P4K1,,,,,55.3,94.0,2.3e-23,112.1,sp|Q6P4K1|HDGR2_XENTR Hepatoma-derived growth factor-related protein 2 OS=Xenopus tropicalis OX=8364 GN=hdgfl2 PE=2 SV=1,,,,,,
OG_00025,0.5472353360372082,OG_00025,FUN_000226-T1,Peve_00012014,Pocillopora_meandrina_HIv1___RNAseq.g28941.t1,three_way,60.776,FUN_000226-T1,Q6P4K1,,,,,36.7,79.0,2.4e-09,65.5,sp|Q6P4K1|HDGR2_XENTR Hepatoma-derived growth factor-related protein 2 OS=Xenopus tropicalis OX=8364 GN=hdgfl2 PE=2 SV=1,,,,,,
OG_03801,0.5467669696067453,OG_03801,FUN_015184-T1,Peve_00023889,Pocillopora_meandrina_HIv1___RNAseq.g22343.t1,three_way,40.410833333333336,FUN_015184-T1,P34331,PLK1_CAEEL,,Serine/threonine-protein kinase plk-1 (EC 2.7.11.21) (Polo-like kinase 1),Caenorhabditis elegans,29.1,292.0,1.2e-19,100.1,sp|P34331|PLK1_CAEEL Serine/threonine-protein kinase plk-1 OS=Caenorhabditis elegans OX=6239 GN=plk-1 PE=1 SV=4,GO:0000776; GO:0000793; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0007077; GO:0007098; GO:0007147; GO:0030496; GO:0040038; GO:0045132; GO:0051233; GO:0051726; GO:0106310; GO:0110039,centrosome cycle [GO:0007098]; female meiosis II [GO:0007147]; meiotic chromosome segregation [GO:0045132]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; regulation of cell cycle [GO:0051726],centrosome [GO:0005813]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005634; GO:0005694; GO:0005815; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0061024; GO:0140013; GO:0140096,"cytokinesis; catalytic activity; nucleus; chromosome; microtubule organizing center; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; membrane organization; meiotic nuclear division; catalytic activity, acting on a protein"
OG_03659,0.54669857549446,OG_03659,FUN_014896-T1,Peve_00003546,Pocillopora_meandrina_HIv1___RNAseq.g21104.t1,three_way,65.60683333333333,FUN_014896-T1,Q69ZX6,MOR2A_MOUSE,,ATPase MORC2A (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1),Mus musculus (Mouse),41.3,920.0,5.7999999999999996e-151,536.6,sp|Q69ZX6|MOR2A_MOUSE ATPase MORC2A OS=Mus musculus OX=10090 GN=Morc2a PE=1 SV=2,GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042393; GO:0042803; GO:0140719; GO:0141005,chromatin remodeling [GO:0006338]; constitutive heterochromatin formation [GO:0140719]; DNA damage response [GO:0006974]; transposable element silencing by heterochromatin formation [GO:0141005],cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0016787; GO:0042393; GO:0043226,catalytic activity; nucleus; cytosol; chromatin organization; hydrolase activity; histone binding; organelle
OG_05054,0.5466196011339549,OG_05054,FUN_023250-T1,Peve_00019253,Pocillopora_meandrina_HIv1___RNAseq.g17400.t1,three_way,95.03433333333334,FUN_023250-T1,Q9GR88,,,,,85.8,431.0,4.2e-216,751.9,sp|Q9GR88|ERF1_POLMI Eukaryotic peptide chain release factor subunit 1 OS=Polyandrocarpa misakiensis OX=7723 GN=ERF1 PE=2 SV=1,,,,,,
OG_05998,0.5462173610251887,OG_05998,FUN_026487-T1,Peve_00037220,Pocillopora_meandrina_HIv1___RNAseq.g4189.t1,three_way,92.38083333333331,FUN_026487-T1,P24844,MYL9_HUMAN,,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",Homo sapiens (Human),73.8,172.0,7.299999999999998e-68,258.1,sp|P24844|MYL9_HUMAN Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4,GO:0001725; GO:0005200; GO:0005509; GO:0005737; GO:0005829; GO:0005859; GO:0005938; GO:0006937; GO:0008307; GO:0016460; GO:0030016; GO:0030018; GO:0030239; GO:0032036; GO:0043149; GO:0070527,myofibril assembly [GO:0030239]; platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937]; stress fiber assembly [GO:0043149],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0005829; GO:0007010; GO:0007155; GO:0008092; GO:0043226,structural molecule activity; cytosol; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle
OG_07108,0.5461839148115194,OG_07108,FUN_032378-T1,Peve_00041776,Pocillopora_meandrina_HIv1___RNAseq.7604_t,three_way,89.479,FUN_032378-T1,Q5R7J8,TP4A1_PONAB,,Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),64.7,167.0,1.4000000000000001e-59,230.7,sp|Q5R7J8|TP4A1_PONAB Protein tyrosine phosphatase type IVA 1 OS=Pongo abelii OX=9601 GN=PTP4A1 PE=2 SV=1,GO:0004725; GO:0005634; GO:0005769; GO:0005783; GO:0005819; GO:0005886,,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819],protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005768; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_09600,0.5457110887852924,OG_09600,FUN_041750-T1,Peve_00042716,Pocillopora_meandrina_HIv1___RNAseq.g15091.t1,three_way,84.30533333333332,FUN_041750-T1,Q5ZJH9,DKC1_CHICK,,H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (Dyskerin),Gallus gallus (Chicken),71.6,437.0,1.2e-177,624.4,sp|Q5ZJH9|DKC1_CHICK H/ACA ribonucleoprotein complex subunit DKC1 OS=Gallus gallus OX=9031 GN=DKC1 PE=2 SV=1,GO:0000455; GO:0000495; GO:0003723; GO:0005654; GO:0005697; GO:0007004; GO:0009982; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:1990481,box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004],box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005654; GO:0016071; GO:0016073; GO:0016853; GO:0032200; GO:0043226,RNA binding; catalytic activity; nucleoplasm; mRNA metabolic process; snRNA metabolic process; isomerase activity; telomere organization; organelle
OG_04711,0.5455448936357778,OG_04711,FUN_022518-T1,Peve_00030465,Pocillopora_meandrina_HIv1___TS.g21661.t1,three_way,66.89816666666665,FUN_022518-T1,Q99996,AKAP9_HUMAN,,A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao),Homo sapiens (Human),36.4,291.0,1.9e-34,152.1,sp|Q99996|AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens OX=9606 GN=AKAP9 PE=1 SV=4,GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007268; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0034237; GO:0034705; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0098909; GO:0098978; GO:0099104; GO:0099147; GO:1903358,cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165],centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076],DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325],GO:0003677; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0023052; GO:0043226; GO:0060090; GO:0098772,DNA binding; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; signaling; organelle; molecular adaptor activity; molecular function regulator activity
OG_09327,0.5454367843269683,OG_09327,FUN_040244-T1,Peve_00018569,Pocillopora_meandrina_HIv1___RNAseq.g7779.t1,three_way,90.07933333333334,FUN_040244-T1,P00637,,,,,64.3,328.0,5.4e-123,442.2,"sp|P00637|F16P1_RABIT Fructose-1,6-bisphosphatase 1 OS=Oryctolagus cuniculus OX=9986 GN=FBP1 PE=1 SV=4",,,,,,
OG_01378,0.5453665457105652,OG_01378,FUN_005335-T1,Peve_00035219,Pocillopora_meandrina_HIv1___RNAseq.g8197.t1,three_way,80.54866666666666,FUN_005335-T1,Q9Z1N9,,,,,49.1,1628.0,0.0,1434.9,sp|Q9Z1N9|UN13B_MOUSE Protein unc-13 homolog B OS=Mus musculus OX=10090 GN=Unc13b PE=1 SV=2,,,,,,
OG_03035,0.5452355339390955,OG_03035,FUN_012273-T1,Peve_00023570,Pocillopora_meandrina_HIv1___RNAseq.g23877.t1,three_way,69.00583333333333,FUN_012273-T1,Q8WUA2,,,,,69.7,373.0,1.7e-149,530.8,sp|Q8WUA2|PPIL4_HUMAN Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1,,,,,,
OG_02248,0.5446039356902654,OG_02248,FUN_008665-T1,Peve_00044711,Pocillopora_meandrina_HIv1___RNAseq.g64.t1,three_way,73.61466666666666,FUN_008665-T1,Q6RHR9,,,,,33.7,1372.0,3.9e-185,650.6,"sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1",,,,,,
OG_04588,0.5444699599620726,OG_04588,FUN_022260-T1,Peve_00043990,Pocillopora_meandrina_HIv1___RNAseq.g4718.t1,three_way,93.872,FUN_022260-T1,P61209,,,,,95.0,179.0,3.3e-95,349.0,sp|P61209|ARF1_DROME ADP-ribosylation factor 1 OS=Drosophila melanogaster OX=7227 GN=Arf1 PE=1 SV=2,,,,,,
OG_06255,0.5442986688559681,OG_06255,FUN_028269-T1,Peve_00013158,Pocillopora_meandrina_HIv1___TS.g10539.t1b,three_way,69.86733333333333,,,,,,,,,,,,,,,,,
OG_09855,0.5441082887299008,OG_09855,FUN_042848-T1,Peve_00023277,Pocillopora_meandrina_HIv1___RNAseq.g7251.t2,three_way,92.89133333333334,FUN_042848-T1,Q9Z1N5,,,,,85.5,429.0,4.2000000000000003e-213,741.9,sp|Q9Z1N5|DX39B_MOUSE Spliceosome RNA helicase Ddx39b OS=Mus musculus OX=10090 GN=Ddx39b PE=1 SV=1,,,,,,
OG_02972,0.543958652419521,OG_02972,FUN_012136-T1,Peve_00035460,Pocillopora_meandrina_HIv1___RNAseq.g23778.t1,three_way,82.50333333333333,FUN_012136-T1,Q5XFX0,,,,,41.0,200.0,5.1e-33,142.5,sp|Q5XFX0|TAGL2_RAT Transgelin-2 OS=Rattus norvegicus OX=10116 GN=Tagln2 PE=1 SV=1,,,,,,
OG_05133,0.5439096431828914,OG_05133,FUN_023402-T1,Peve_00038654,Pocillopora_meandrina_HIv1___RNAseq.g17559.t1,three_way,90.449,FUN_023402-T1,Q3ZCH0,HSPA9_BOVIN,,"Stress-70 protein, mitochondrial (EC 3.6.4.10) (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)",Bos taurus (Bovine),78.8,660.0,3.6e-295,1015.4,"sp|Q3ZCH0|HSPA9_BOVIN Stress-70 protein, mitochondrial OS=Bos taurus OX=9913 GN=HSPA9 PE=2 SV=1",GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006611; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0036444; GO:0042026; GO:0042645; GO:0043065; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0140662; GO:1902037; GO:1903707,calcium import into the mitochondrion [GO:0036444]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; positive regulation of apoptotic process [GO:0043065]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003824; GO:0005730; GO:0005739; GO:0006457; GO:0006886; GO:0006913; GO:0016787; GO:0030154; GO:0043226; GO:0044183; GO:0055085; GO:0140657,catalytic activity; nucleolus; mitochondrion; protein folding; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; cell differentiation; organelle; protein folding chaperone; transmembrane transport; ATP-dependent activity
OG_02828,0.5436647148948891,OG_02828,FUN_011843-T1,Peve_00034373,Pocillopora_meandrina_HIv1___RNAseq.g23373.t1,three_way,84.43299999999999,FUN_011843-T1,Q9SEE4,,,,,41.8,297.0,9.3e-61,235.3,sp|Q9SEE4|PIRL_SOLLC Pirin-like protein OS=Solanum lycopersicum OX=4081 PE=2 SV=1,,,,,,
OG_08755,0.5433835595130353,OG_08755,FUN_038024-T1,Peve_00018113,Pocillopora_meandrina_HIv1___TS.g19285.t1,three_way,85.45183333333334,FUN_038024-T1,P55884,EIF3B_HUMAN,,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),Homo sapiens (Human),62.8,646.0,3e-256,885.9,sp|P55884|EIF3B_HUMAN Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=3,GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0010494; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525,formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]",molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369],GO:0003723; GO:0005829; GO:0043226; GO:0060090; GO:0065003,RNA binding; cytosol; organelle; molecular adaptor activity; protein-containing complex assembly
OG_00543,0.5433651945691131,OG_00543,FUN_001577-T1,Peve_00010785,Pocillopora_meandrina_HIv1___RNAseq.g2029.t1,three_way,69.47,FUN_001577-T1,Q6A039,,,,,55.0,453.0,3.1e-134,480.7,sp|Q6A039|TBC12_MOUSE TBC1 domain family member 12 OS=Mus musculus OX=10090 GN=Tbc1d12 PE=1 SV=2,,,,,,
OG_07984,0.5432896942454364,OG_07984,FUN_035609-T1,Peve_00025646,Pocillopora_meandrina_HIv1___RNAseq.g28046.t1a,three_way,55.686166666666665,FUN_035609-T1,Q9JI13,SAS10_MOUSE,,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Crl-1) (Disrupter of silencing SAS10) (UTP3 homolog),Mus musculus (Mouse),33.1,360.0,9.1e-37,156.4,sp|Q9JI13|SAS10_MOUSE Something about silencing protein 10 OS=Mus musculus OX=10090 GN=Utp3 PE=1 SV=1,GO:0005634; GO:0005730; GO:0006325; GO:0007420; GO:0032040; GO:0042274,brain development [GO:0007420]; chromatin organization [GO:0006325]; ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],,GO:0005634; GO:0005730; GO:0006325; GO:0043226; GO:0048856,nucleus; nucleolus; chromatin organization; organelle; anatomical structure development
OG_00936,0.5432394921922504,OG_00936,FUN_004285-T1,Peve_00018587,Pocillopora_meandrina_HIv1___TS.g7877.t1,three_way,51.23383333333334,FUN_004285-T1,Q15811,,,,,38.4,86.0,2.3e-07,60.1,sp|Q15811|ITSN1_HUMAN Intersectin-1 OS=Homo sapiens OX=9606 GN=ITSN1 PE=1 SV=3,,,,,,
OG_06207,0.5431397650972223,OG_06207,FUN_028143-T1,Peve_00037720,Pocillopora_meandrina_HIv1___TS.g11444.t1,three_way,74.73266666666667,FUN_028143-T1,Q5SZT7,NKAPL_MOUSE,,NKAP-like protein,Mus musculus (Mouse),72.4,123.0,4.9e-41,169.9,sp|Q5SZT7|NKAPL_MOUSE NKAP-like protein OS=Mus musculus OX=10090 GN=Nkapl PE=1 SV=1,GO:0003682; GO:0005634; GO:0007283; GO:0030154,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0022414; GO:0030154; GO:0043226,nucleus; reproductive process; cell differentiation; organelle
OG_03800,0.543105283130734,OG_03800,FUN_015183-T1,Peve_00023878,Pocillopora_meandrina_HIv1___RNAseq.g22309.t1,three_way,61.66833333333334,FUN_015183-T1,Q86US8,EST1A_HUMAN,,Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a),Homo sapiens (Human),34.5,918.0,1.2999999999999999e-129,466.1,sp|Q86US8|EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens OX=9606 GN=SMG6 PE=1 SV=2,GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006406; GO:0032204; GO:0032210; GO:0035303; GO:0036064; GO:0042162; GO:0043021; GO:0046872; GO:0070034; GO:0070182; GO:1904354,"mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]","chromosome, telomeric region [GO:0000781]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; telomerase holoenzyme complex [GO:0005697]",DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0005815; GO:0005829; GO:0005886; GO:0006913; GO:0016071; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; nucleolus; microtubule organizing center; cytosol; plasma membrane; nucleocytoplasmic transport; mRNA metabolic process; organelle; catalytic activity, acting on RNA"
OG_03163,0.5428948287119799,OG_03163,FUN_012561-T1,Peve_00016373,Pocillopora_meandrina_HIv1___RNAseq.g23582.t1,three_way,69.20983333333334,FUN_012561-T1,Q92834,RPGR_HUMAN,,X-linked retinitis pigmentosa GTPase regulator,Homo sapiens (Human),44.0,448.0,1.1e-68,263.1,sp|Q92834|RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens OX=9606 GN=RPGR PE=1 SV=2,GO:0001750; GO:0003723; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0006511; GO:0006886; GO:0007601; GO:0010508; GO:0016567; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0060271; GO:0061630; GO:0097499,cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; positive regulation of autophagy [GO:0010508]; protein localization to non-motile cilium [GO:0097499]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630],GO:0003723; GO:0003824; GO:0005794; GO:0005815; GO:0005929; GO:0006886; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0098772; GO:0140096,"RNA binding; catalytic activity; Golgi apparatus; microtubule organizing center; cilium; intracellular protein transport; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; nervous system process; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00618,0.542844553571649,OG_00618,FUN_001784-T1,Peve_00011611,Pocillopora_meandrina_HIv1___RNAseq.g2640.t1a,three_way,76.89133333333334,FUN_001784-T1,Q91ZR4,NEK8_MOUSE,,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8),Mus musculus (Mouse),40.8,650.0,1.2e-118,429.9,sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310,animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02932,0.5427110257718,OG_02932,FUN_012033-T1,Peve_00037665,Pocillopora_meandrina_HIv1___RNAseq.g24057.t1,three_way,77.83616666666667,FUN_012033-T1,Q5ZIN1,NUDC_CHICK,,Nuclear migration protein nudC (Nuclear distribution protein C homolog),Gallus gallus (Chicken),62.9,329.0,2.6e-77,290.4,sp|Q5ZIN1|NUDC_CHICK Nuclear migration protein nudC OS=Gallus gallus OX=9031 GN=NUDC PE=2 SV=1,GO:0005737; GO:0005874; GO:0006457; GO:0007052; GO:0007080; GO:0030496; GO:0051082; GO:0051301; GO:0072686,cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; protein folding [GO:0006457],cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686],unfolded protein binding [GO:0051082],GO:0006457; GO:0007010; GO:0043226,protein folding; cytoskeleton organization; organelle
OG_09988,0.5426209873268056,OG_09988,FUN_043182-T1,Peve_00043027,Pocillopora_meandrina_HIv1___RNAseq.g6806.t1,three_way,59.36083333333333,FUN_043182-T1,Q9Z136,,,,,38.8,361.0,3.4e-62,241.9,sp|Q9Z136|TSC1_RAT Hamartin OS=Rattus norvegicus OX=10116 GN=Tsc1 PE=1 SV=1,,,,,,
OG_09472,0.5424669280408986,OG_09472,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_08909,0.5423530003246737,OG_08909,FUN_038340-T1,Peve_00000096,Pocillopora_meandrina_HIv1___RNAseq.g1108.t1,three_way,79.30233333333334,FUN_038340-T1,Q17770,,,,,56.6,431.0,9.2e-145,515.0,sp|Q17770|PDI2_CAEEL Protein disulfide-isomerase 2 OS=Caenorhabditis elegans OX=6239 GN=pdi-2 PE=1 SV=1,,,,,,
OG_07630,0.5422503814546045,OG_07630,FUN_034382-T1,Peve_00027165,Pocillopora_meandrina_HIv1___RNAseq.g26151.t3,three_way,63.092,FUN_034382-T1,Q15723,ELF2_HUMAN,,ETS-related transcription factor Elf-2 (E74-like factor 2) (New ETS-related factor),Homo sapiens (Human),61.7,94.0,5.3e-27,123.6,sp|Q15723|ELF2_HUMAN ETS-related transcription factor Elf-2 OS=Homo sapiens OX=9606 GN=ELF2 PE=1 SV=2,GO:0000785; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016604; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:1990837,cell differentiation [GO:0030154]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_03849,0.5419553995815466,OG_03849,FUN_015340-T1,Peve_00011273,Pocillopora_meandrina_HIv1___RNAseq.g21716.t1,three_way,56.37466666666666,FUN_015340-T1,Q6NTW1,,,,,36.2,343.0,6.6e-45,183.3,sp|Q6NTW1|BSC1B_XENLA BSD domain-containing protein 1-B OS=Xenopus laevis OX=8355 GN=bsdc1-b PE=2 SV=1,,,,,,
OG_06046,0.5417746659249001,OG_06046,FUN_026714-T1,Peve_00018519,Pocillopora_meandrina_HIv1___RNAseq.g9373.t1,three_way,56.48,FUN_026714-T1,Q96EW2,,,,,42.0,138.0,4.4e-20,99.4,sp|Q96EW2|HBAP1_HUMAN HSPB1-associated protein 1 OS=Homo sapiens OX=9606 GN=HSPBAP1 PE=1 SV=1,,,,,,
OG_03668,0.5414163251877256,OG_03668,FUN_014908-T1,Peve_00003535,Pocillopora_meandrina_HIv1___RNAseq.g21073.t1,three_way,82.90766666666666,FUN_014908-T1,P62253,UB2G1_HUMAN,,"Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed]",Homo sapiens (Human),76.2,164.0,5.2e-74,278.5,sp|P62253|UB2G1_HUMAN Ubiquitin-conjugating enzyme E2 G1 OS=Homo sapiens OX=9606 GN=UBE2G1 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0031625; GO:0043161; GO:0061631; GO:0070062; GO:0070534; GO:0070936,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; extracellular exosome [GO:0070062],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_07498,0.5410513652502404,OG_07498,FUN_034034-T1,Peve_00019783,Pocillopora_meandrina_HIv1___RNAseq.g26094.t1,three_way,69.25983333333333,FUN_034034-T1,Q6P859,,,,,47.1,187.0,9.3e-41,168.7,sp|Q6P859|GPTC4_XENTR G patch domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=gpatch4 PE=2 SV=1,,,,,,
OG_06202,0.5406276694187758,OG_06202,FUN_028138-T1,Peve_00042833,Pocillopora_meandrina_HIv1___RNAseq.g15552.t1,three_way,60.35533333333333,FUN_028138-T1,Q6DRI7,DDX51_DANRE,,ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51),Danio rerio (Zebrafish) (Brachydanio rerio),46.6,528.0,1.1000000000000001e-125,452.2,sp|Q6DRI7|DDX51_DANRE ATP-dependent RNA helicase DDX51 OS=Danio rerio OX=7955 GN=ddx51 PE=2 SV=1,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016887,rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleolus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01731,0.5404259792948114,OG_01731,FUN_007026-T1,Peve_00037182,Pocillopora_meandrina_HIv1___RNAseq.g20544.t1,three_way,86.548,FUN_007026-T1,Q9GMB8,,,,,66.1,516.0,2.1999999999999997e-192,673.3,"sp|Q9GMB8|SYSC_BOVIN Serine--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=SARS1 PE=2 SV=3",,,,,,
OG_02357,0.5402008185179711,OG_02357,FUN_008960-T1,Peve_00021628,Pocillopora_meandrina_HIv1___RNAseq.g4043.t1,three_way,50.3,,,,,,,,,,,,,,,,,
OG_01647,0.5400067030775445,OG_01647,FUN_006799-T1,Peve_00019091,Pocillopora_meandrina_HIv1___RNAseq.g20493.t1,three_way,63.5435,FUN_006799-T1,O08623,SQSTM_RAT,,Sequestosome-1 (Protein kinase C-zeta-interacting protein) (PKC-zeta-interacting protein) (Ubiquitin-binding protein p62),Rattus norvegicus (Rat),22.9,462.0,1.0999999999999998e-24,115.9,sp|O08623|SQSTM_RAT Sequestosome-1 OS=Rattus norvegicus OX=10116 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0005080; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0033554; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0045202; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140313; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; cellular response to stress [GO:0033554]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; inclusion body [GO:0016234]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; synapse [GO:0045202],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; molecular sequestering activity [GO:0140313]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; molecular sequestering activity
OG_00042,0.5399598290958113,OG_00042,FUN_000265-T1,Peve_00027789,Pocillopora_meandrina_HIv1___RNAseq.g28979.t1,three_way,91.153,FUN_000265-T1,P84023,SMAD3_CHICK,,Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3),Gallus gallus (Chicken),74.9,430.0,5.4e-189,661.8,sp|P84023|SMAD3_CHICK Mothers against decapentaplegic homolog 3 OS=Gallus gallus OX=9031 GN=SMAD3 PE=2 SV=1,GO:0000978; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0009653; GO:0030154; GO:0032924; GO:0045944; GO:0046872; GO:0060395; GO:0070411; GO:0071141; GO:0071144,activin receptor signaling pathway [GO:0032924]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_09951,0.5399248981119584,OG_09951,FUN_043118-T1,Peve_00026295,Pocillopora_meandrina_HIv1___RNAseq.g7887.t1,three_way,78.261,FUN_043118-T1,P08081,CLCA_RAT,,Clathrin light chain A (Lca),Rattus norvegicus (Rat),34.8,221.0,5.9e-23,109.0,sp|P08081|CLCA_RAT Clathrin light chain A OS=Rattus norvegicus OX=10116 GN=Clta PE=1 SV=1,GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0006897; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0048488; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978,cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488],clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672],clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198],GO:0005198; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0065003,structural molecule activity; lysosome; endosome; vacuole; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_03805,0.5396269161977866,OG_03805,FUN_015192-T1,Peve_00013032,Pocillopora_meandrina_HIv1___RNAseq.g22303.t1,three_way,69.30916666666666,FUN_015192-T1,Q8WY54,PPM1E_HUMAN,,Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA),Homo sapiens (Human),52.3,367.0,7.700000000000001e-98,359.0,sp|Q8WY54|PPM1E_HUMAN Protein phosphatase 1E OS=Homo sapiens OX=9606 GN=PPM1E PE=1 SV=3,GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006469; GO:0007165; GO:0032991; GO:0035970; GO:0046872; GO:0051496; GO:0071222; GO:0071466,cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05177,0.5393126773516228,OG_05177,FUN_023507-T1,Peve_00005822,Pocillopora_meandrina_HIv1___RNAseq.g568.t1,three_way,58.58383333333333,,,,,,,,,,,,,,,,,
OG_08920,0.5390201593798175,OG_08920,FUN_038376-T1,Peve_00000077,Pocillopora_meandrina_HIv1___RNAseq.g1090.t1,three_way,74.45483333333334,FUN_038376-T1,F1LQX4,RHG44_RAT,,Rho GTPase-activating protein 44 (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2),Rattus norvegicus (Rat),43.8,486.0,3.8e-108,393.7,sp|F1LQX4|RHG44_RAT Rho GTPase-activating protein 44 OS=Rattus norvegicus OX=10116 GN=Arhgap44 PE=1 SV=2,GO:0005096; GO:0005543; GO:0005886; GO:0006887; GO:0007165; GO:0014069; GO:0030425; GO:0031256; GO:0031267; GO:0032956; GO:0035021; GO:0043087; GO:0043197; GO:0048786; GO:0050804; GO:0051490; GO:0055037; GO:0061001; GO:0098793; GO:0098794; GO:0098978; GO:0099010; GO:0099152,"exocytosis [GO:0006887]; modification of postsynaptic structure [GO:0099010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]",dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037],GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0098772,endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; molecular function regulator activity
OG_09888,0.5388108735233864,OG_09888,FUN_042963-T1,Peve_00039045,Pocillopora_meandrina_HIv1___RNAseq.4783_t,three_way,65.88283333333334,FUN_042963-T1,Q4VGL6,RC3H1_MOUSE,,Roquin-1 (Roquin) (EC 2.3.2.27) (Protein Sanroque) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1),Mus musculus (Mouse),60.2,523.0,1.3e-165,585.5,sp|Q4VGL6|RC3H1_MOUSE Roquin-1 OS=Mus musculus OX=10090 GN=Rc3h1 PE=1 SV=1,GO:0000184; GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003725; GO:0003729; GO:0003730; GO:0004842; GO:0005737; GO:0008270; GO:0010468; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0071347; GO:1900151; GO:1901224; GO:1905762; GO:2000320; GO:2000628,"3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932],CCR4-NOT complex binding [GO:1905762]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; RNA binding; catalytic activity; mRNA metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01630,0.5380029139603625,OG_01630,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_09324,0.5366679204464434,OG_09324,FUN_040241-T1,Peve_00018573,Pocillopora_meandrina_HIv1___RNAseq.g7782.t1,three_way,95.93533333333332,FUN_040241-T1,Q7ZVZ7,,,,,75.6,287.0,3.9e-138,492.3,sp|Q7ZVZ7|AB17C_DANRE Alpha/beta hydrolase domain-containing protein 17C OS=Danio rerio OX=7955 GN=abhd17c PE=2 SV=1,,,,,,
OG_02809,0.5365964526219902,OG_02809,FUN_011782-T1,Peve_00041236,Pocillopora_meandrina_HIv1___RNAseq.g23305.t1,three_way,58.14066666666667,FUN_011782-T1,Q8R149,,,,,48.5,204.0,3.2e-45,184.5,sp|Q8R149|BUD13_MOUSE BUD13 homolog OS=Mus musculus OX=10090 GN=Bud13 PE=1 SV=1,,,,,,
OG_07730,0.5364804822203377,OG_07730,FUN_034891-T1,Peve_00037339,Pocillopora_meandrina_HIv1___TS.g15151.t2,three_way,94.67133333333334,FUN_034891-T1,Q13951,,,,,57.1,170.0,1.1e-48,194.5,sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2,,,,,,
OG_02729,0.5363341568925853,OG_02729,FUN_011256-T1,Peve_00006851,Pocillopora_meandrina_HIv1___RNAseq.g22321.t1,three_way,72.50033333333333,FUN_011256-T1,Q9R1S4,XBP1_RAT,,"X-box-binding protein 1 (Hepatocarcinogenesis-related transcription factor) (HTF) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]",Rattus norvegicus (Rat),64.4,90.0,3.4e-15,83.6,sp|Q9R1S4|XBP1_RAT X-box-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Xbp1 PE=2 SV=1,GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001525; GO:0001889; GO:0001935; GO:0002071; GO:0002639; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006355; GO:0006366; GO:0006511; GO:0007517; GO:0007584; GO:0008284; GO:0009410; GO:0010506; GO:0030335; GO:0030968; GO:0031017; GO:0031490; GO:0031648; GO:0034976; GO:0035356; GO:0035470; GO:0035924; GO:0042149; GO:0042632; GO:0042802; GO:0043066; GO:0043565; GO:0044389; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045766; GO:0045944; GO:0046982; GO:0051602; GO:0055089; GO:0055092; GO:0060096; GO:0060612; GO:0060691; GO:0070059; GO:0071222; GO:0071230; GO:0071236; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:0090575; GO:0098793; GO:1900100; GO:1902236; GO:1903489; GO:1990418; GO:1990830; GO:1990837; GO:2000347,"adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid homeostasis [GO:0055089]; glandular epithelial cell maturation [GO:0002071]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; response to electrical stimulus [GO:0051602]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; serotonin secretion, neurotransmission [GO:0060096]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; presynapse [GO:0098793]; RNA polymerase II transcription regulator complex [GO:0090575],"chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin-like protein ligase binding [GO:0044389]",GO:0003677; GO:0005634; GO:0005783; GO:0006351; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; DNA-templated transcription; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_00153,0.5357129703166911,OG_00153,FUN_000607-T1,Peve_00041268,Pocillopora_meandrina_HIv1___RNAseq.g2497.t1,three_way,77.315,FUN_000607-T1,Q16543,,,,,63.4,372.0,2.3e-90,334.0,sp|Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1,,,,,,
OG_07072,0.5356636889660527,OG_07072,FUN_032308-T1,Peve_00001539,Pocillopora_meandrina_HIv1___RNAseq.g24763.t1,three_way,65.20216666666667,FUN_032308-T1,Q3B8Q1,DDX21_RAT,,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),Rattus norvegicus (Rat),49.4,579.0,2.1999999999999998e-147,524.2,sp|Q3B8Q1|DDX21_RAT Nucleolar RNA helicase 2 OS=Rattus norvegicus OX=10116 GN=Ddx21 PE=2 SV=1,GO:0002735; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006364; GO:0006366; GO:0009615; GO:0016887; GO:0019843; GO:0030515; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045945; GO:0051607; GO:0062176; GO:0097322; GO:0110016,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop processing [GO:0062176]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366],B-WICH complex [GO:0110016]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515],GO:0002376; GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0098542; GO:0140098; GO:0140657,"immune system process; RNA binding; catalytic activity; nucleoplasm; nucleolus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06606,0.5353284368148884,OG_06606,FUN_029754-T1,Peve_00019513,Pocillopora_meandrina_HIv1___RNAseq.g17315.t1,three_way,73.25083333333333,FUN_029754-T1,D3ZYR1,FCHO2_RAT,,F-BAR domain only protein 2,Rattus norvegicus (Rat),35.2,1026.0,1.2e-117,426.0,sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1,GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793,clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]",GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0065003; GO:0072659,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; protein-containing complex assembly; protein localization to plasma membrane
OG_06445,0.5351996137552367,OG_06445,FUN_029156-T1,Peve_00041032,Pocillopora_meandrina_HIv1___RNAseq.g25738.t1,three_way,72.0625,FUN_029156-T1,Q6DEZ2,,,,,32.0,977.0,4.3e-129,464.2,sp|Q6DEZ2|F120A_XENTR Constitutive coactivator of PPAR-gamma-like protein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fam120a PE=2 SV=1,,,,,,
OG_09269,0.535126047801181,OG_09269,FUN_040075-T1,Peve_00021003,Pocillopora_meandrina_HIv1___RNAseq.g7690.t1,three_way,38.61383333333333,,,,,,,,,,,,,,,,,
OG_06014,0.5350785105454161,OG_06014,FUN_026541-T1,Peve_00020321,Pocillopora_meandrina_HIv1___RNAseq.g4240.t1,three_way,62.72516666666667,FUN_026541-T1,P55197,AF10_HUMAN,,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),Homo sapiens (Human),78.8,184.0,1.1999999999999999e-90,336.3,sp|P55197|AF10_HUMAN Protein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031491; GO:0032991; GO:0042393; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; histone binding; organelle
OG_06014,0.5350785105454161,OG_06014,FUN_026541-T1,Peve_00020321,Pocillopora_meandrina_HIv1___RNAseq.g4240.t1,three_way,62.72516666666667,FUN_026541-T1,P55197,AF10_HUMAN,,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),Homo sapiens (Human),46.3,67.0,7.8e-10,67.8,sp|P55197|AF10_HUMAN Protein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031491; GO:0032991; GO:0042393; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; histone binding; organelle
OG_02395,0.5348299438074395,OG_02395,FUN_009023-T1,Peve_00044350,Pocillopora_meandrina_HIv1___RNAseq.g3942.t1,three_way,93.496,FUN_009023-T1,Q92519,TRIB2_HUMAN,,Tribbles homolog 2 (TRB-2),Homo sapiens (Human),54.1,338.0,2.2000000000000001e-100,367.1,sp|Q92519|TRIB2_HUMAN Tribbles homolog 2 OS=Homo sapiens OX=9606 GN=TRIB2 PE=1 SV=1,GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629,negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106],GO:0005634; GO:0005856; GO:0043226; GO:0098772,nucleus; cytoskeleton; organelle; molecular function regulator activity
OG_05785,0.5345520886500312,OG_05785,FUN_025760-T1,Peve_00041463,Pocillopora_meandrina_HIv1___RNAseq.g10421.t1,three_way,74.163,FUN_025760-T1,Q566I1,,,,,31.3,518.0,1.4e-47,193.0,sp|Q566I1|IN80D_XENLA INO80 complex subunit D OS=Xenopus laevis OX=8355 GN=ino80d PE=2 SV=1,,,,,,
OG_00194,0.5336539524273957,OG_00194,FUN_000900-T1,Peve_00009738,Pocillopora_meandrina_HIv1___RNAseq.g29451.t1,three_way,81.18366666666667,FUN_000900-T1,Q5R787,,,,,37.9,533.0,2.6e-76,287.7,sp|Q5R787|ARFG3_PONAB ADP-ribosylation factor GTPase-activating protein 3 OS=Pongo abelii OX=9601 GN=ARFGAP3 PE=2 SV=1,,,,,,
OG_08538,0.5335904170726574,OG_08538,FUN_037488-T1,Peve_00020417,Pocillopora_meandrina_HIv1___TS.g22716.t1,three_way,79.14133333333334,FUN_037488-T1,Q08BI9,MCU_DANRE,,"Calcium uniporter protein, mitochondrial",Danio rerio (Zebrafish) (Brachydanio rerio),55.8,283.0,5.2e-86,319.3,"sp|Q08BI9|MCU_DANRE Calcium uniporter protein, mitochondrial OS=Danio rerio OX=7955 GN=mcu PE=1 SV=1",GO:0005262; GO:0005743; GO:0006851; GO:0007015; GO:0008016; GO:0015292; GO:0019722; GO:0032024; GO:0034704; GO:0036444; GO:0042593; GO:0042802; GO:0043009; GO:0046872; GO:0051259; GO:0051560; GO:0051561; GO:0051649; GO:0060027; GO:1990246,actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; establishment of localization in cell [GO:0051649]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016],calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246],calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; uniporter activity [GO:0015292],GO:0005215; GO:0048856; GO:0055085; GO:0065003,transporter activity; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_03513,0.5334255064959591,OG_03513,FUN_014624-T1,Peve_00002411,Pocillopora_meandrina_HIv1___RNAseq.g22781.t1,three_way,98.58133333333332,FUN_014624-T1,P48727,,,,,90.4,332.0,5e-182,638.3,sp|P48727|GLC7B_CAEEL Serine/threonine-protein phosphatase PP1-beta OS=Caenorhabditis elegans OX=6239 GN=gsp-2 PE=1 SV=1,,,,,,
OG_02378,0.5333644999363729,OG_02378,FUN_008989-T1,Peve_00001693,Pocillopora_meandrina_HIv1___RNAseq.g3898.t1,three_way,97.019,FUN_008989-T1,Q9Y3B4,SF3B6_HUMAN,,"Splicing factor 3B subunit 6 (Pre-mRNA branch site protein p14) (SF3b 14 kDa subunit) (SF3B14a) (Spliceosome-associated protein, 14-kDa) (Splicing factor 3b, subunit 6, 14kDa)",Homo sapiens (Human),78.7,122.0,3.7e-53,208.8,sp|Q9Y3B4|SF3B6_HUMAN Splicing factor 3B subunit 6 OS=Homo sapiens OX=9606 GN=SF3B6 PE=1 SV=1,GO:0000398; GO:0001825; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:1903241,"blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_07285,0.5332091462795165,OG_07285,FUN_033611-T1,Peve_00007851,Pocillopora_meandrina_HIv1___TS.g24988.t1b,three_way,76.69316666666667,FUN_033611-T1,Q80TP3,UBR5_MOUSE,,"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog)",Mus musculus (Mouse),42.4,2918.0,0.0,1864.0,sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2,GO:0003723; GO:0005634; GO:0005737; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0043130; GO:0045879; GO:0048471; GO:0050847; GO:0061630; GO:0071596; GO:0071629; GO:0071630; GO:0140861; GO:0141198,cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of gene expression [GO:0010628]; progesterone receptor signaling pathway [GO:0050847]; protein branched polyubiquitination [GO:0141198]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03862,0.533102718160899,OG_03862,FUN_015365-T1,Peve_00000208,Pocillopora_meandrina_HIv1___RNAseq.g21709.t1,three_way,84.68366666666667,FUN_015365-T1,P91119,PDE5_CAEEL,,"Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17)",Caenorhabditis elegans,44.3,774.0,3.4e-175,617.1,"sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3",GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0019933; GO:0032528; GO:0042542; GO:0046872; GO:0047555,cAMP-mediated signaling [GO:0019933]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],,"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_03708,0.533092387764979,OG_03708,FUN_014981-T1,Peve_00039942,Pocillopora_meandrina_HIv1___TS.g25894.t1,three_way,81.89766666666667,FUN_014981-T1,Q8CCN5,BCAS3_MOUSE,,BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3 homolog) (K20D4) (Protein rudhira),Mus musculus (Mouse),47.1,768.0,1.1e-178,628.6,sp|Q8CCN5|BCAS3_MOUSE BCAS3 microtubule associated cell migration factor OS=Mus musculus OX=10090 GN=Bcas3 PE=1 SV=2,GO:0000407; GO:0000791; GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0006914; GO:0007267; GO:0010595; GO:0031252; GO:0032956; GO:0035091; GO:0043085; GO:0045111; GO:0045944; GO:0048487; GO:0071391; GO:0071944,angiogenesis [GO:0001525]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956],cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407],beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; phosphatidylinositol binding [GO:0035091],GO:0005634; GO:0005856; GO:0006355; GO:0006914; GO:0008092; GO:0008289; GO:0023052; GO:0043226,nucleus; cytoskeleton; regulation of DNA-templated transcription; autophagy; cytoskeletal protein binding; lipid binding; signaling; organelle
OG_05484,0.532973943530727,OG_05484,FUN_024481-T1,Peve_00016898,Pocillopora_meandrina_HIv1___RNAseq.g19066.t2,three_way,65.00099999999999,FUN_024481-T1,Q92870,APBB2_HUMAN,,Amyloid beta precursor protein binding family B member 2 (Amyloid-beta (A4) precursor protein-binding family B member 2) (Protein Fe65-like 1),Homo sapiens (Human),36.6,331.0,3.8e-55,218.8,sp|Q92870|APBB2_HUMAN Amyloid beta precursor protein binding family B member 2 OS=Homo sapiens OX=9606 GN=APBB2 PE=1 SV=3,GO:0000122; GO:0001540; GO:0001764; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0006355; GO:0006939; GO:0007411; GO:0016020; GO:0030027; GO:0030198; GO:0030426; GO:0035556; GO:0036438; GO:0043065; GO:0043066; GO:0045202; GO:0045944; GO:0050808; GO:0060090; GO:1901988,axon guidance [GO:0007411]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808],cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202],amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090],GO:0003012; GO:0005634; GO:0005768; GO:0005783; GO:0005794; GO:0006355; GO:0030198; GO:0031410; GO:0034330; GO:0043226; GO:0048870; GO:0060090,muscle system process; nucleus; endosome; endoplasmic reticulum; Golgi apparatus; regulation of DNA-templated transcription; extracellular matrix organization; cytoplasmic vesicle; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_00211,0.5327621119030551,OG_00211,FUN_000930-T1,Peve_00009721,Pocillopora_meandrina_HIv1___RNAseq.g29463.t1,three_way,75.37,FUN_000930-T1,A0LJ16,,,,,43.9,269.0,7.6e-61,235.7,sp|A0LJ16|PHNXL_SYNFM Phosphonoacetaldehyde hydrolase-like protein OS=Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB) OX=335543 GN=phnX2 PE=3 SV=1,,,,,,
OG_03455,0.5324971715340835,OG_03455,FUN_014530-T1,Peve_00044383,Pocillopora_meandrina_HIv1___RNAseq.g22614.t1,three_way,89.24866666666667,FUN_014530-T1,P52301,,,,,86.3,211.0,6.7e-106,384.8,sp|P52301|RAN_XENLA GTP-binding nuclear protein Ran OS=Xenopus laevis OX=8355 GN=ran PE=1 SV=2,,,,,,
OG_02167,0.5324631609955431,OG_02167,FUN_008516-T1,Peve_00042439,Pocillopora_meandrina_HIv1___RNAseq.g14800.t1,three_way,88.02866666666667,FUN_008516-T1,P35435,,,,,60.6,279.0,8.8e-85,315.1,"sp|P35435|ATPG_RAT ATP synthase F(1) complex subunit gamma, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5f1c PE=1 SV=2",,,,,,
OG_09605,0.5321898024147845,OG_09605,FUN_041759-T1,Peve_00041567,Pocillopora_meandrina_HIv1___RNAseq.g15102.t1,three_way,88.23033333333333,FUN_041759-T1,Q7XMK8,,,,,72.9,402.0,1.1e-173,610.9,sp|Q7XMK8|RH6_ORYSJ DEAD-box ATP-dependent RNA helicase 6 OS=Oryza sativa subsp. japonica OX=39947 GN=Os04g0533000 PE=2 SV=1,,,,,,
OG_06417,0.5321561954297056,OG_06417,FUN_029104-T1,Peve_00038072,Pocillopora_meandrina_HIv1___TS.g8929.t1,three_way,65.834,FUN_029104-T1,P41970,ELK3_HUMAN,,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),Homo sapiens (Human),60.0,85.0,1.5000000000000002e-22,107.8,sp|P41970|ELK3_HUMAN ETS domain-containing protein Elk-3 OS=Homo sapiens OX=9606 GN=ELK3 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0030154; GO:0042060; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; cell differentiation; wound healing; organelle; transcription regulator activity
OG_00512,0.5320772663670441,OG_00512,FUN_001504-T1,Peve_00012115,Pocillopora_meandrina_HIv1___RNAseq.g1890.t1,three_way,97.17433333333334,FUN_001504-T1,A5PJW8,RPB2_BOVIN,,DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48),Bos taurus (Bovine),87.3,1174.0,0.0,2134.4,sp|A5PJW8|RPB2_BOVIN DNA-directed RNA polymerase II subunit RPB2 OS=Bos taurus OX=9913 GN=POLR2B PE=1 SV=1,GO:0000781; GO:0003677; GO:0003682; GO:0003899; GO:0003968; GO:0005665; GO:0005739; GO:0006366; GO:0008270; GO:0016787; GO:0032549; GO:0071667,transcription by RNA polymerase II [GO:0006366],"chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; RNA polymerase II, core complex [GO:0005665]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; ribonucleoside binding [GO:0032549]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005739; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; catalytic activity; mitochondrion; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_08829,0.5320022549259903,OG_08829,FUN_038166-T1,Peve_00025794,Pocillopora_meandrina_HIv1___RNAseq.g1069.t1,three_way,75.97183333333332,FUN_038166-T1,P85037,FOXK1_HUMAN,,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),Homo sapiens (Human),48.9,499.0,9.7e-110,399.1,sp|P85037|FOXK1_HUMAN Forkhead box protein K1 OS=Homo sapiens OX=9606 GN=FOXK1 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007517; GO:0010507; GO:0010906; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837,canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; intracellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005975; GO:0006091; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140110; GO:1901135,DNA binding; nucleus; nucleoplasm; carbohydrate metabolic process; generation of precursor metabolites and energy; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; transcription regulator activity; carbohydrate derivative metabolic process
OG_01322,0.5317808851755705,OG_01322,FUN_005189-T1,Peve_00017153,Pocillopora_meandrina_HIv1___TS.g19845.t2b,three_way,59.13133333333333,FUN_005189-T1,Q6PD21,SHB_MOUSE,,SH2 domain-containing adapter protein B,Mus musculus (Mouse),57.5,106.0,1.9e-31,138.7,sp|Q6PD21|SHB_MOUSE SH2 domain-containing adapter protein B OS=Mus musculus OX=10090 GN=Shb PE=1 SV=2,GO:0001525; GO:0001568; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0030097; GO:0030159; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0048514; GO:0050852; GO:0071425; GO:1900194,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852],cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],phosphotyrosine residue binding [GO:0001784]; signaling receptor complex adaptor activity [GO:0030159],GO:0002376; GO:0005654; GO:0005829; GO:0005886; GO:0012501; GO:0043226; GO:0048856; GO:0060090,immune system process; nucleoplasm; cytosol; plasma membrane; programmed cell death; organelle; anatomical structure development; molecular adaptor activity
OG_05783,0.5315583699403533,OG_05783,FUN_025757-T1,Peve_00029936,Pocillopora_meandrina_HIv1___RNAseq.g10418.t1,three_way,73.75783333333334,FUN_025757-T1,Q5R4D6,LEO1_PONAB,,RNA polymerase-associated protein LEO1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),67.6,256.0,2.5000000000000002e-89,330.9,sp|Q5R4D6|LEO1_PONAB RNA polymerase-associated protein LEO1 OS=Pongo abelii OX=9601 GN=LEO1 PE=2 SV=1,GO:0001711; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0031124; GO:0032968; GO:0045638; GO:1990269,endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593],RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269],GO:0006355; GO:0016071,regulation of DNA-templated transcription; mRNA metabolic process
OG_02547,0.5315396977947549,OG_02547,FUN_010634-T1,Peve_00009631,Pocillopora_meandrina_HIv1___RNAseq.g21306.t1,three_way,52.05883333333333,,,,,,,,,,,,,,,,,
OG_04881,0.531481761733509,OG_04881,FUN_022915-T1,Peve_00001787,Pocillopora_meandrina_HIv1___RNAseq.g3711.t1,three_way,84.37066666666666,FUN_022915-T1,P55036,PSMD4_HUMAN,,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein),Homo sapiens (Human),60.6,383.0,1.1e-98,361.7,sp|P55036|PSMD4_HUMAN 26S proteasome non-ATPase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMD4 PE=1 SV=1,GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161; GO:0060090,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226; GO:0060090,RNA binding; nucleus; nucleoplasm; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_01784,0.531370323376271,OG_01784,FUN_007160-T1,Peve_00028234,Pocillopora_meandrina_HIv1___RNAseq.g19727.t1,three_way,78.381,FUN_007160-T1,Q9JMD3,STA10_MOUSE,,START domain-containing protein 10 (StARD10) (PCTP-like protein) (PCTP-L) (Serologically defined colon cancer antigen 28 homolog) (StAR-related lipid transfer protein 10),Mus musculus (Mouse),43.5,237.0,4.3e-54,213.0,sp|Q9JMD3|STA10_MOUSE START domain-containing protein 10 OS=Mus musculus OX=10090 GN=Stard10 PE=1 SV=1,GO:0005829; GO:0005902; GO:0006869; GO:0008289; GO:0016020; GO:0031514; GO:0032782; GO:0035360; GO:0046581,bile acid secretion [GO:0032782]; lipid transport [GO:0006869]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360],cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226,cytosol; cilium; lipid binding; organelle
OG_03624,0.5313670837924216,OG_03624,FUN_014812-T1,Peve_00022208,Pocillopora_meandrina_HIv1___RNAseq.g22403.t1,three_way,61.155,,,,,,,,,,,,,,,,,
OG_03837,0.5311708199740697,OG_03837,FUN_015294-T1,Peve_00022864,Pocillopora_meandrina_HIv1___RNAseq.g22110.t1,three_way,50.94466666666667,FUN_015294-T1,Q5EBL4,RIPL1_HUMAN,,RILP-like protein 1 (Rab-interacting lysosomal-like protein 1),Homo sapiens (Human),34.1,217.0,6.2e-22,107.1,sp|Q5EBL4|RIPL1_HUMAN RILP-like protein 1 OS=Homo sapiens OX=9606 GN=RILPL1 PE=1 SV=1,GO:0003382; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0007263; GO:0031267; GO:0036064; GO:0046983; GO:0051959; GO:0060271; GO:1903445,cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; nitric oxide mediated signal transduction [GO:0007263]; protein transport from ciliary membrane to plasma membrane [GO:1903445],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0043226; GO:0044782; GO:0061024; GO:0072659,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; cilium; intracellular protein transport; organelle; cilium organization; membrane organization; protein localization to plasma membrane
OG_10007,0.5309834639310698,OG_10007,FUN_043242-T1,Peve_00001436,Pocillopora_meandrina_HIv1___RNAseq.g6708.t1,three_way,59.496500000000005,FUN_043242-T1,Q6YHK3,CD109_HUMAN,,CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109),Homo sapiens (Human),25.8,1416.0,2.8e-104,382.1,sp|Q6YHK3|CD109_HUMAN CD109 antigen OS=Homo sapiens OX=9606 GN=CD109 PE=1 SV=2,GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647,hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089],cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; side of membrane [GO:0098552],serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0048856; GO:0098772,extracellular region; extracellular space; cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_09866,0.5308913145478419,OG_09866,FUN_042875-T1,Peve_00040165,Pocillopora_meandrina_HIv1___RNAseq.g7231.t1,three_way,78.882,FUN_042875-T1,Q9Y6K8,,,,,36.4,563.0,2e-101,372.1,sp|Q9Y6K8|KAD5_HUMAN Adenylate kinase isoenzyme 5 OS=Homo sapiens OX=9606 GN=AK5 PE=1 SV=2,,,,,,
OG_02112,0.5308866829500712,OG_02112,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_04270,0.5305750967060859,OG_04270,FUN_017828-T1,Peve_00032669,Pocillopora_meandrina_HIv1___RNAseq.g9643.t1,three_way,84.98966666666666,FUN_017828-T1,P52162,,,,,65.5,139.0,1.8e-38,160.6,sp|P52162|MAX_CHICK Protein max OS=Gallus gallus OX=9031 GN=MAX PE=3 SV=1,,,,,,
OG_05599,0.5304111285838806,OG_05599,FUN_025140-T1,Peve_00020870,Pocillopora_meandrina_HIv1___RNAseq.g19432.t1,three_way,82.82633333333334,FUN_025140-T1,Q14135,,,,,29.6,287.0,6.5e-11,69.3,sp|Q14135|VGLL4_HUMAN Transcription cofactor vestigial-like protein 4 OS=Homo sapiens OX=9606 GN=VGLL4 PE=1 SV=5,,,,,,
OG_05802,0.5302395277518024,OG_05802,FUN_025792-T1,Peve_00021008,Pocillopora_meandrina_HIv1___RNAseq.g10401.t1,three_way,63.68466666666667,FUN_025792-T1,P68254,1433T_MOUSE,,14-3-3 protein theta (14-3-3 protein tau),Mus musculus (Mouse),62.0,237.0,1.1e-72,274.6,sp|P68254|1433T_MOUSE 14-3-3 protein theta OS=Mus musculus OX=10090 GN=Ywhaq PE=1 SV=1,GO:0005634; GO:0005829; GO:0006605; GO:0007165; GO:0007264; GO:0019904; GO:0032991; GO:0034766; GO:0042802; GO:0044325; GO:0045202; GO:0045892; GO:0071889,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monoatomic ion transmembrane transport [GO:0034766]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; synapse [GO:0045202],14-3-3 protein binding [GO:0071889]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325],GO:0005634; GO:0005829; GO:0006355; GO:0043226,nucleus; cytosol; regulation of DNA-templated transcription; organelle
OG_03336,0.5297444312114075,OG_03336,FUN_013557-T1,Peve_00038567,Pocillopora_meandrina_HIv1___RNAseq.g22961.t1,three_way,93.49333333333334,FUN_013557-T1,Q62074,KPCI_MOUSE,,Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (nPKC-iota),Mus musculus (Mouse),69.2,591.0,1.4999999999999999e-245,850.1,sp|Q62074|KPCI_MOUSE Protein kinase C iota type OS=Mus musculus OX=10090 GN=Prkci PE=1 SV=3,GO:0000139; GO:0004672; GO:0004674; GO:0004699; GO:0005524; GO:0005543; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005903; GO:0005923; GO:0005929; GO:0007015; GO:0008270; GO:0010976; GO:0015630; GO:0016324; GO:0016477; GO:0031252; GO:0032869; GO:0034351; GO:0035089; GO:0042462; GO:0043220; GO:0043524; GO:0045171; GO:0045177; GO:0045197; GO:0045216; GO:0046326; GO:0048194; GO:0051092; GO:0060252; GO:0070555; GO:0098685; GO:0098978; GO:0099072; GO:0106310; GO:0120157; GO:1903078; GO:2000353,actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to insulin stimulus [GO:0032869]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220],"ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005634; GO:0005768; GO:0005829; GO:0005856; GO:0005929; GO:0006355; GO:0007163; GO:0008289; GO:0016740; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; nucleus; endosome; cytosol; cytoskeleton; cilium; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; lipid binding; transferase activity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_09400,0.5296932050941591,OG_09400,FUN_040714-T1,Peve_00002273,Pocillopora_meandrina_HIv1___RNAseq.g6550.t1,three_way,90.7025,FUN_040714-T1,A1L3F4,,,,,49.5,552.0,8.6e-96,352.4,sp|A1L3F4|MEX3B_XENLA RNA-binding protein MEX3B OS=Xenopus laevis OX=8355 GN=mex3b PE=2 SV=1,,,,,,
OG_01129,0.5296354709910692,OG_01129,FUN_004699-T1,Peve_00044676,Pocillopora_meandrina_HIv1___RNAseq.g8779.t2,three_way,49.28933333333333,,,,,,,,,,,,,,,,,
OG_00296,0.5296054761540997,OG_00296,FUN_001087-T1,Peve_00003172,Pocillopora_meandrina_HIv1___RNAseq.g29386.t1,three_way,70.96266666666666,,,,,,,,,,,,,,,,,
OG_06313,0.529592776229634,OG_06313,FUN_028553-T1,Peve_00000750,Pocillopora_meandrina_HIv1___TS.g15553.t2,three_way,74.64583333333333,FUN_028553-T1,A2AT37,RENT2_MOUSE,,Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog) (Upf2),Mus musculus (Mouse),48.4,1041.0,5e-267,922.5,sp|A2AT37|RENT2_MOUSE Regulator of nonsense transcripts 2 OS=Mus musculus OX=10090 GN=Upf2 PE=1 SV=1,GO:0000184; GO:0001889; GO:0003723; GO:0005737; GO:0005829; GO:0006986; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471,"animal organ regeneration [GO:0031100]; liver development [GO:0001889]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to unfolded protein [GO:0006986]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; perinuclear region of cytoplasm [GO:0048471],RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005829; GO:0016071; GO:0043226; GO:0048856,DNA binding; RNA binding; cytosol; mRNA metabolic process; organelle; anatomical structure development
OG_04968,0.5295537341278411,OG_04968,FUN_023073-T1,Peve_00014063,Pocillopora_meandrina_HIv1___RNAseq.g1646.t2,three_way,77.28333333333333,FUN_023073-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),42.4,2171.0,0.0,1587.8,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_05008,0.5295346124230135,OG_05008,FUN_023159-T1,Peve_00018798,Pocillopora_meandrina_HIv1___RNAseq.g640.t1,three_way,86.96466666666667,FUN_023159-T1,O00909,ARF1_DICDI,,ADP-ribosylation factor 1 (EC 3.6.5.2),Dictyostelium discoideum (Social amoeba),82.2,180.0,4.5e-84,312.0,sp|O00909|ARF1_DICDI ADP-ribosylation factor 1 OS=Dictyostelium discoideum OX=44689 GN=arfA PE=1 SV=3,GO:0000281; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0045335; GO:0048471; GO:0051489; GO:0140220,intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; regulation of filopodium assembly [GO:0051489]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; pathogen-containing vacuole [GO:0140220]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0000910; GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226,cytokinesis; catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_04664,0.5295143321995752,OG_04664,FUN_022412-T1,Peve_00037635,Pocillopora_meandrina_HIv1___RNAseq.18822_t,three_way,91.77833333333334,FUN_022412-T1,Q15382,,,,,70.5,156.0,5.100000000000001e-59,228.8,sp|Q15382|RHEB_HUMAN GTP-binding protein Rheb OS=Homo sapiens OX=9606 GN=RHEB PE=1 SV=1,,,,,,
OG_01087,0.5295051347576831,OG_01087,FUN_004580-T1,Peve_00016266,Pocillopora_meandrina_HIv1___RNAseq.g6606.t1,three_way,55.715,FUN_004580-T1,Q6NXI6,RPRD2_MOUSE,,Regulation of nuclear pre-mRNA domain-containing protein 2,Mus musculus (Mouse),33.6,387.0,5.4e-46,188.3,sp|Q6NXI6|RPRD2_MOUSE Regulation of nuclear pre-mRNA domain-containing protein 2 OS=Mus musculus OX=10090 GN=Rprd2 PE=1 SV=1,GO:0097550; GO:0099122,,transcription preinitiation complex [GO:0097550],RNA polymerase II C-terminal domain binding [GO:0099122],,
OG_07091,0.5292431288425898,OG_07091,FUN_032348-T1,Peve_00012753,Pocillopora_meandrina_HIv1___TS.g25052.t1,three_way,72.73100000000001,FUN_032348-T1,Q9PT60,,,,,44.5,263.0,4.7e-52,207.2,sp|Q9PT60|RBP1A_XENLA RalA-binding protein 1-A OS=Xenopus laevis OX=8355 GN=ralbp1-a PE=1 SV=3,,,,,,
OG_01123,0.528959990873947,OG_01123,FUN_004691-T1,Peve_00019711,Pocillopora_meandrina_HIv1___TS.g20478.t1,three_way,79.91966666666667,FUN_004691-T1,Q9Y2I6,NINL_HUMAN,,Ninein-like protein,Homo sapiens (Human),30.6,517.0,7.2999999999999975e-47,191.8,sp|Q9Y2I6|NINL_HUMAN Ninein-like protein OS=Homo sapiens OX=9606 GN=NINL PE=1 SV=2,GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0034454,microtubule anchoring at centrosome [GO:0034454],centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874],calcium ion binding [GO:0005509],GO:0005815; GO:0005829; GO:0007010,microtubule organizing center; cytosol; cytoskeleton organization
OG_07749,0.5281955118886035,OG_07749,FUN_034938-T1,Peve_00036685,Pocillopora_meandrina_HIv1___RNAseq.g27832.t1,three_way,69.10716666666667,FUN_034938-T1,Q7Z614,SNX20_HUMAN,,Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1),Homo sapiens (Human),35.0,246.0,3.5000000000000005e-22,107.1,sp|Q7Z614|SNX20_HUMAN Sorting nexin-20 OS=Homo sapiens OX=9606 GN=SNX20 PE=1 SV=1,GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981,protein transport [GO:0015031],early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005654; GO:0005886; GO:0008289,nucleoplasm; plasma membrane; lipid binding
OG_01290,0.5279803552541426,OG_01290,FUN_005113-T1,Peve_00007463,Pocillopora_meandrina_HIv1___RNAseq.g8268.t1,three_way,72.56616666666666,FUN_005113-T1,O15945,ARNT_DROME,,Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango),Drosophila melanogaster (Fruit fly),57.4,378.0,5.4e-115,416.8,sp|O15945|ARNT_DROME Aryl hydrocarbon receptor nuclear translocator homolog OS=Drosophila melanogaster OX=7227 GN=tgo PE=1 SV=3,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575,appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_06608,0.5277244881824192,OG_06608,FUN_029758-T1,Peve_00019497,Pocillopora_meandrina_HIv1___TS.g3083.t1,three_way,75.64366666666666,FUN_029758-T1,O75694,NU155_HUMAN,,Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155),Homo sapiens (Human),46.4,1399.0,0.0,1191.4,sp|O75694|NU155_HUMAN Nuclear pore complex protein Nup155 OS=Homo sapiens OX=9606 GN=NUP155 PE=1 SV=1,GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0017056; GO:0031965; GO:0035196; GO:0036228; GO:0044611; GO:0086014,atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006886; GO:0006913; GO:0061024,structural molecule activity; nuclear envelope; cytosol; intracellular protein transport; nucleocytoplasmic transport; membrane organization
OG_09830,0.5276645728540127,OG_09830,FUN_042807-T1,Peve_00003076,Pocillopora_meandrina_HIv1___RNAseq.g7424.t1,three_way,78.86633333333333,FUN_042807-T1,P41240,CSK_HUMAN,,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),Homo sapiens (Human),56.1,442.0,8.4e-143,508.4,sp|P41240|CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens OX=9606 GN=CSK PE=1 SV=1,GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0034236; GO:0034332; GO:0035556; GO:0042802; GO:0042997; GO:0045779; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0050860; GO:0050868; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375; GO:1990782,adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; oligodendrocyte differentiation [GO:0048709]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; transferase activity; cell differentiation; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_06972,0.5276588682625896,OG_06972,FUN_032106-T1,Peve_00030222,Pocillopora_meandrina_HIv1___RNAseq.g5395.t1,three_way,94.85066666666668,FUN_032106-T1,P53451,,,,,75.0,539.0,3.9000000000000003e-224,778.9,sp|P53451|TCPD_TAKRU T-complex protein 1 subunit delta OS=Takifugu rubripes OX=31033 GN=cct4 PE=2 SV=1,,,,,,
OG_09217,0.527637665904409,OG_09217,FUN_039937-T1,Peve_00007733,Pocillopora_meandrina_HIv1___RNAseq.g15743.t1,three_way,79.05833333333334,FUN_039937-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,451.0,1.1e-66,255.8,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_00708,0.5275674858962993,OG_00708,FUN_002469-T1,Peve_00034012,Pocillopora_meandrina_HIv1___TS.g4051.t1,three_way,74.81733333333334,FUN_002469-T1,Q7TMY8,HUWE1_MOUSE,,"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (E3Histone) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",Mus musculus (Mouse),41.0,4757.0,0.0,2664.4,sp|Q7TMY8|HUWE1_MOUSE E3 ubiquitin-protein ligase HUWE1 OS=Mus musculus OX=10090 GN=Huwe1 PE=1 SV=5,GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006284; GO:0006513; GO:0030154; GO:0031398; GO:0032922; GO:0035359; GO:0043123; GO:0043161; GO:0061630; GO:0070936; GO:0140852; GO:0141198,base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; transferase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_00487,0.5274283988382925,OG_00487,FUN_001453-T1,Peve_00018442,Pocillopora_meandrina_HIv1___RNAseq.g1954.t1,three_way,80.51,FUN_001453-T1,Q9UBR2,CATZ_HUMAN,,Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X),Homo sapiens (Human),61.6,297.0,1.4000000000000005e-111,404.1,sp|Q9UBR2|CATZ_HUMAN Cathepsin Z OS=Homo sapiens OX=9606 GN=CTSZ PE=1 SV=1,GO:0002003; GO:0004180; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0005886; GO:0005938; GO:0006508; GO:0008234; GO:0009986; GO:0010757; GO:0016807; GO:0030134; GO:0030426; GO:0031410; GO:0033116; GO:0035580; GO:0043231; GO:0051603; GO:0060441; GO:0062023; GO:0070062; GO:1904813,angiotensin maturation [GO:0002003]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580],carboxypeptidase activity [GO:0004180]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234],GO:0003824; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; lysosome; vacuole; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09811,0.5274170944584079,OG_09811,FUN_042633-T1,Peve_00030033,Pocillopora_meandrina_HIv1___RNAseq.19516_t,three_way,82.042,FUN_042633-T1,P08651,NFIC_HUMAN,,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),Homo sapiens (Human),48.2,390.0,3.2e-79,297.7,sp|P08651|NFIC_HUMAN Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0006366; GO:0042475; GO:0045944; GO:1990837,DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA replication; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07897,0.5273835182276843,OG_07897,FUN_035276-T1,Peve_00044995,Pocillopora_meandrina_HIv1___RNAseq.g27859.t1,three_way,66.694,,,,,,,,,,,,,,,,,
OG_02454,0.5272485470163504,OG_02454,FUN_009532-T1,Peve_00009560,Pocillopora_meandrina_HIv1___RNAseq.g24493.t1,three_way,88.02533333333334,FUN_009532-T1,Q148N0,,,,,64.9,976.0,0.0,1304.7,sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1,,,,,,
OG_02014,0.5271881031793579,OG_02014,FUN_008187-T1,Peve_00010858,Pocillopora_meandrina_HIv1___RNAseq.g29995.t1,three_way,91.01733333333334,FUN_008187-T1,O75582,KS6A5_HUMAN,,Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL),Homo sapiens (Human),63.9,723.0,1.5e-266,920.2,sp|O75582|KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens OX=9606 GN=RPS6KA5 PE=1 SV=1,GO:0000287; GO:0001818; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007411; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0044024; GO:0045892; GO:0045944; GO:0051092; GO:0070498; GO:0099175; GO:0106310,axon guidance [GO:0007411]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0006954; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; inflammatory response; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04827,0.5270864260419382,OG_04827,FUN_022821-T1,Peve_00016085,Pocillopora_meandrina_HIv1___RNAseq.g3443.t1,three_way,74.968,FUN_022821-T1,B3S3D5,,,,,72.1,104.0,1.5e-34,148.3,sp|B3S3D5|DDRGK_TRIAD DDRGK domain-containing protein 1 OS=Trichoplax adhaerens OX=10228 GN=TRIADDRAFT_58679 PE=3 SV=1,,,,,,
OG_01034,0.5270762727625857,OG_01034,FUN_004469-T1,Peve_00007167,Pocillopora_meandrina_HIv1___RNAseq.g4952.t1,three_way,86.357,FUN_004469-T1,P14211,CALR_MOUSE,,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),Mus musculus (Mouse),77.3,198.0,5.6e-85,315.5,sp|P14211|CALR_MOUSE Calreticulin OS=Mus musculus OX=10090 GN=Calr PE=1 SV=1,GO:0000122; GO:0001669; GO:0001849; GO:0002502; GO:0003729; GO:0005049; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0005840; GO:0006611; GO:0007283; GO:0008284; GO:0009410; GO:0009897; GO:0010595; GO:0010628; GO:0016020; GO:0017148; GO:0030246; GO:0030866; GO:0031625; GO:0032355; GO:0033018; GO:0033144; GO:0033574; GO:0034504; GO:0040020; GO:0042277; GO:0042562; GO:0042824; GO:0044183; GO:0044194; GO:0044322; GO:0045335; GO:0045665; GO:0045787; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0055007; GO:0060473; GO:0071257; GO:0071285; GO:0090398; GO:0098586; GO:0098794; GO:0098978; GO:0140313; GO:1900026; GO:1901164; GO:1901224; GO:1901652; GO:1903416; GO:1904614; GO:2000510,cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynapse [GO:0098794]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003723; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005840; GO:0006355; GO:0006886; GO:0006913; GO:0007010; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044183; GO:0065003; GO:0140104; GO:0140313,RNA binding; extracellular region; extracellular space; nuclear envelope; mitochondrion; lysosome; vacuole; endoplasmic reticulum; cytosol; ribosome; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; protein folding chaperone; protein-containing complex assembly; molecular carrier activity; molecular sequestering activity
OG_00642,0.5270394776923892,OG_00642,FUN_001883-T1,Peve_00030486,Pocillopora_meandrina_HIv1___RNAseq.g2592.t1,three_way,67.79133333333333,FUN_001883-T1,P55814,,,,,55.6,90.0,3.9e-23,109.8,sp|P55814|OAZ1_XENLA Ornithine decarboxylase antizyme 1 OS=Xenopus laevis OX=8355 GN=oaz1 PE=2 SV=2,,,,,,
OG_00439,0.5269600189173924,OG_00439,FUN_001350-T1,Peve_00023405,Pocillopora_meandrina_HIv1___RNAseq.g1875.t1,three_way,48.55,FUN_001350-T1,Q8BM75,ARI5B_MOUSE,,AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (Developmentally and sexually retarded with transient immune abnormalities protein) (Desrt) (MRF1-like) (Modulator recognition factor protein 2) (MRF-2),Mus musculus (Mouse),24.0,758.0,3.2999999999999998e-43,179.1,sp|Q8BM75|ARI5B_MOUSE AT-rich interactive domain-containing protein 5B OS=Mus musculus OX=10090 GN=Arid5b PE=1 SV=3,GO:0000122; GO:0000976; GO:0001822; GO:0003713; GO:0005634; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830,adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705],nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_03386,0.5268118752324307,OG_03386,FUN_013641-T1,Peve_00019982,Pocillopora_meandrina_HIv1___RNAseq.g13568.t1,three_way,45.04066666666667,,,,,,,,,,,,,,,,,
OG_00661,0.5267706501938814,OG_00661,FUN_001954-T1,Peve_00024484,Pocillopora_meandrina_HIv1___RNAseq.g29228.t1,three_way,86.64866666666667,FUN_001954-T1,Q6FIF0,ZFAN6_HUMAN,,AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3),Homo sapiens (Human),38.9,208.0,1.9e-29,130.6,sp|Q6FIF0|ZFAN6_HUMAN AN1-type zinc finger protein 6 OS=Homo sapiens OX=9606 GN=ZFAND6 PE=1 SV=2,GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0015031; GO:0031593; GO:0043066; GO:0043122; GO:0071356,apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; protein transport [GO:0015031]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829],DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270],GO:0003677; GO:0005829; GO:0012501,DNA binding; cytosol; programmed cell death
OG_07195,0.5267272747060826,OG_07195,FUN_032699-T1,Peve_00006288,Pocillopora_meandrina_HIv1___RNAseq.g29941.t1,three_way,87.00933333333333,FUN_032699-T1,Q8CJG0,AGO2_MOUSE,,Protein argonaute-2 (Argonaute2) (mAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Piwi/argonaute family protein meIF2C2) (Protein slicer),Mus musculus (Mouse),68.1,846.0,0.0,1192.9,sp|Q8CJG0|AGO2_MOUSE Protein argonaute-2 OS=Mus musculus OX=10090 GN=Ago2 PE=1 SV=3,GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0009791; GO:0010467; GO:0010586; GO:0010628; GO:0016442; GO:0030154; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0033962; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035925; GO:0043489; GO:0045727; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090128; GO:0090624; GO:0090625; GO:0098794; GO:0098808; GO:0098978; GO:1900153; GO:1901165; GO:1990904,"cell differentiation [GO:0030154]; gene expression [GO:0010467]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of translational initiation [GO:0045947]; P-body assembly [GO:0033962]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of synapse maturation [GO:0090128]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RISC complex assembly [GO:0070922]; RNA stabilization [GO:0043489]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578],"core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0031047; GO:0043226; GO:0065003; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_01574,0.5265581761681354,OG_01574,FUN_006578-T1,Peve_00018194,Pocillopora_meandrina_HIv1___RNAseq.g20266.t1,three_way,88.35233333333333,FUN_006578-T1,P49139,,,,,62.1,346.0,1.4000000000000001e-126,454.1,sp|P49139|MAPK2_RABIT MAP kinase-activated protein kinase 2 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=MAPKAPK2 PE=1 SV=2,,,,,,
OG_06869,0.5262318790959305,OG_06869,FUN_031869-T1,Peve_00010191,Pocillopora_meandrina_HIv1___RNAseq.g5647.t1,three_way,60.89966666666667,,,,,,,,,,,,,,,,,
OG_04043,0.5260977246169732,OG_04043,FUN_016352-T1,Peve_00004333,Pocillopora_meandrina_HIv1___RNAseq.g9675.t1,three_way,65.38916666666667,FUN_016352-T1,Q8CI75,DI3L2_MOUSE,,DIS3-like exonuclease 2 (EC 3.1.13.-),Mus musculus (Mouse),48.3,818.0,3.1e-212,740.7,sp|Q8CI75|DI3L2_MOUSE DIS3-like exonuclease 2 OS=Mus musculus OX=10090 GN=Dis3l2 PE=1 SV=1,GO:0000175; GO:0000278; GO:0000287; GO:0000932; GO:0000956; GO:0004540; GO:0005737; GO:0005829; GO:0008266; GO:0008285; GO:0010587; GO:0019827; GO:0051301; GO:0051306; GO:1990074,cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process [GO:0000956]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827],cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932],3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; RNA nuclease activity [GO:0004540],GO:0000278; GO:0003723; GO:0003824; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"mitotic cell cycle; RNA binding; catalytic activity; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_02253,0.5260716464337253,OG_02253,FUN_008699-T1,Peve_00035972,Pocillopora_meandrina_HIv1___RNAseq.g6277.t1,three_way,57.66416666666667,FUN_008699-T1,Q9ESV0,,,,,40.4,639.0,1.6e-122,441.8,sp|Q9ESV0|DDX24_MOUSE ATP-dependent RNA helicase DDX24 OS=Mus musculus OX=10090 GN=Ddx24 PE=1 SV=2,,,,,,
OG_09391,0.5260208307105947,OG_09391,FUN_040687-T1,Peve_00042976,Pocillopora_meandrina_HIv1___RNAseq.g6440.t2,three_way,44.80716666666667,FUN_040687-T1,Q8AVX1,,,,,26.1,299.0,2.6e-09,64.7,sp|Q8AVX1|GKP1B_XENLA G kinase-anchoring protein 1-B OS=Xenopus laevis OX=8355 GN=gkap1-b PE=2 SV=1,,,,,,
OG_07655,0.5259922945618394,OG_07655,FUN_034489-T1,Peve_00043240,Pocillopora_meandrina_HIv1___RNAseq.g28566.t1,three_way,65.82883333333334,FUN_034489-T1,Q9Y3B9,,,,,36.4,214.0,3.8e-22,106.7,sp|Q9Y3B9|RRP15_HUMAN RRP15-like protein OS=Homo sapiens OX=9606 GN=RRP15 PE=1 SV=2,,,,,,
OG_00529,0.5259647319346338,OG_00529,FUN_001534-T1,Peve_00014191,Pocillopora_meandrina_HIv1___RNAseq.12922_t,three_way,52.932500000000005,FUN_001534-T1,O13024,,,,,52.7,110.0,1.1e-20,104.0,sp|O13024|INCEA_XENLA Inner centromere protein A OS=Xenopus laevis OX=8355 GN=incenp-a PE=1 SV=1,,,,,,
OG_07662,0.525829593435478,OG_07662,FUN_034715-T1,Peve_00014894,Pocillopora_meandrina_HIv1___RNAseq.g28726.t1,three_way,68.227,FUN_034715-T1,P31399,,,,,34.0,144.0,3.6e-21,102.8,"sp|P31399|ATP5H_RAT ATP synthase peripheral stalk subunit d, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5pd PE=1 SV=3",,,,,,
OG_00402,0.5257758627981386,OG_00402,FUN_001289-T1,Peve_00037015,Pocillopora_meandrina_HIv1___TS.g4708.t1a,three_way,81.49916666666667,FUN_001289-T1,Q9ULJ6,,,,,45.5,1166.0,3.5e-155,550.8,sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3,,,,,,
OG_03938,0.5251939366261918,OG_03938,FUN_016055-T1,Peve_00011789,Pocillopora_meandrina_HIv1___RNAseq.g21631.t1,three_way,71.45683333333334,FUN_016055-T1,Q8IYT8,ULK2_HUMAN,,Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2),Homo sapiens (Human),34.9,1096.0,7e-132,473.4,sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens OX=9606 GN=ULK2 PE=1 SV=3,GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007165; GO:0007411; GO:0008104; GO:0010506; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310; GO:0160038,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axon guidance [GO:0007411]; collateral sprouting [GO:0048668]; mitophagy [GO:0000423]; negative regulation of collateral sprouting [GO:0048671]; piecemeal microautophagy of the nucleus [GO:0034727]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]; somatic sensory system development [GO:0160038],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06197,0.5251883338367235,OG_06197,FUN_028122-T1,Peve_00004261,Pocillopora_meandrina_HIv1___RNAseq.g15557.t2,three_way,43.58133333333333,FUN_028122-T1,P36335,,,,,26.3,598.0,1.3e-35,152.9,sp|P36335|NCA12_XENLA Neural cell adhesion molecule 1-B OS=Xenopus laevis OX=8355 GN=ncam1-b PE=2 SV=1,,,,,,
OG_03940,0.524891968294999,OG_03940,FUN_016075-T1,Peve_00021919,Pocillopora_meandrina_HIv1___RNAseq.g21617.t1,three_way,62.84066666666667,FUN_016075-T1,Q43470,,,,,64.7,238.0,7.3e-72,271.9,sp|Q43470|1433B_HORVU 14-3-3-like protein B OS=Hordeum vulgare OX=4513 PE=2 SV=1,,,,,,
OG_08653,0.5248083115626605,OG_08653,FUN_037849-T1,Peve_00002752,Pocillopora_meandrina_HIv1___RNAseq.g1438.t1,three_way,68.4055,,,,,,,,,,,,,,,,,
OG_02541,0.5246914685457652,OG_02541,FUN_010624-T1,Peve_00004472,Pocillopora_meandrina_HIv1___TS.g26046.t2,three_way,68.38433333333333,FUN_010624-T1,Q6NSQ7,,,,,44.8,415.0,2.5000000000000003e-78,294.3,sp|Q6NSQ7|LTV1_MOUSE Protein LTV1 homolog OS=Mus musculus OX=10090 GN=Ltv1 PE=1 SV=2,,,,,,
OG_03845,0.5244792043742185,OG_03845,FUN_015318-T1,Peve_00023982,Pocillopora_meandrina_HIv1___RNAseq.g21728.t1,three_way,82.93366666666667,FUN_015318-T1,Q5QNI2,,,,,31.0,532.0,4.7999999999999997e-54,213.8,sp|Q5QNI2|NCL1_ORYSJ Sodium/calcium exchanger NCL1 OS=Oryza sativa subsp. japonica OX=39947 GN=NCL1 PE=2 SV=1,,,,,,
OG_00646,0.5244641243887445,OG_00646,FUN_001899-T1,Peve_00018640,Pocillopora_meandrina_HIv1___RNAseq.g2574.t1,three_way,74.81766666666667,,,,,,,,,,,,,,,,,
OG_08459,0.524447966591372,OG_08459,FUN_037228-T1,Peve_00044304,Pocillopora_meandrina_HIv1___TS.g13535.t1,three_way,54.508833333333335,,,,,,,,,,,,,,,,,
OG_06500,0.5244478280278712,OG_06500,FUN_029291-T1,Peve_00036559,Pocillopora_meandrina_HIv1___RNAseq.g11686.t1,three_way,61.11266666666666,FUN_029291-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),44.3,300.0,2.0999999999999997e-68,263.1,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_07039,0.5244365451983849,OG_07039,FUN_032235-T1,Peve_00043486,Pocillopora_meandrina_HIv1___RNAseq.g24841.t1,three_way,59.83833333333334,,,,,,,,,,,,,,,,,
OG_06475,0.5244058532402833,OG_06475,FUN_029242-T1,Peve_00013752,Pocillopora_meandrina_HIv1___RNAseq.g25409.t1,three_way,68.66733333333333,,,,,,,,,,,,,,,,,
OG_05327,0.5243503312653048,OG_05327,FUN_024025-T1,Peve_00023796,Pocillopora_meandrina_HIv1___RNAseq.g19282.t1,three_way,89.24733333333333,FUN_024025-T1,Q6AZW1,,,,,66.2,74.0,9.6e-20,98.2,sp|Q6AZW1|KISHB_DANRE Protein kish-B OS=Danio rerio OX=7955 GN=tmem167b PE=3 SV=1,,,,,,
OG_09835,0.5243489268741521,OG_09835,FUN_042814-T1,Peve_00021878,Pocillopora_meandrina_HIv1___RNAseq.g7429.t1,three_way,82.54266666666666,FUN_042814-T1,E9Q634,MYO1E_MOUSE,,Unconventional myosin-Ie (Unconventional myosin 1E),Mus musculus (Mouse),66.0,1113.0,0.0,1439.5,sp|E9Q634|MYO1E_MOUSE Unconventional myosin-Ie OS=Mus musculus OX=10090 GN=Myo1e PE=1 SV=1,GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005903; GO:0005912; GO:0006897; GO:0016459; GO:0016887; GO:0030097; GO:0032836; GO:0035091; GO:0035166; GO:0045334; GO:0048008; GO:0051015; GO:0072015,endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091],GO:0003014; GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856,renal system process; cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development
OG_10081,0.5235664484948659,OG_10081,FUN_043392-T1,Peve_00024262,Pocillopora_meandrina_HIv1___RNAseq.g9003.t1,three_way,69.4955,FUN_043392-T1,Q32P51,RA1L2_HUMAN,,Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2),Homo sapiens (Human),40.3,186.0,4.3e-31,137.1,sp|Q32P51|RA1L2_HUMAN Heterogeneous nuclear ribonucleoprotein A1-like 2 OS=Homo sapiens OX=9606 GN=HNRNPA1L2 PE=1 SV=2,GO:0000398; GO:0003723; GO:0005737; GO:0051028; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737],RNA binding [GO:0003723],GO:0003723; GO:0016071,RNA binding; mRNA metabolic process
OG_09107,0.5227000900302863,OG_09107,FUN_038934-T1,Peve_00043964,Pocillopora_meandrina_HIv1___RNAseq.g1039.t1,three_way,93.333,FUN_038934-T1,Q5ZLL1,KC1E_CHICK,,Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1),Gallus gallus (Chicken),76.2,420.0,1.2e-178,627.5,sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus OX=9031 GN=CSNK1E PE=2 SV=2,GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006897; GO:0007165; GO:0032436; GO:0048511; GO:0090263; GO:0106310,endocytosis [GO:0006897]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; rhythmic process [GO:0048511]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016192; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vesicle-mediated transport; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04592,0.5226321784142886,OG_04592,FUN_022267-T1,Peve_00043987,Pocillopora_meandrina_HIv1___RNAseq.g4714.t2,three_way,76.18966666666667,FUN_022267-T1,Q63357,MYO1D_RAT,,Unconventional myosin-Id (Myosin heavy chain myr 4),Rattus norvegicus (Rat),52.1,637.0,3e-186,653.3,sp|Q63357|MYO1D_RAT Unconventional myosin-Id OS=Rattus norvegicus OX=10116 GN=Myo1d PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030048; GO:0030424; GO:0030673; GO:0030900; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0044853; GO:0048306; GO:0051015; GO:0061502; GO:0097440,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; early endosome to recycling endosome transport [GO:0061502]; endocytosis [GO:0006897]; forebrain development [GO:0030900]; protein transport [GO:0015031],actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904],GO:0003774; GO:0003824; GO:0005768; GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_06174,0.5224738123277034,OG_06174,FUN_028030-T1,Peve_00044201,Pocillopora_meandrina_HIv1___RNAseq.g13933.t1,three_way,44.60566666666666,,,,,,,,,,,,,,,,,
OG_01039,0.5221503306370301,OG_01039,FUN_004474-T1,Peve_00007173,Pocillopora_meandrina_HIv1___RNAseq.g4947.t1,three_way,57.66016666666667,FUN_004474-T1,Q7TN02,MED26_MOUSE,,Mediator of RNA polymerase II transcription subunit 26 (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26),Mus musculus (Mouse),62.8,78.0,3.2e-18,94.4,sp|Q7TN02|MED26_MOUSE Mediator of RNA polymerase II transcription subunit 26 OS=Mus musculus OX=10090 GN=Med26 PE=1 SV=1,GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_02074,0.522133687095899,OG_02074,FUN_008290-T1,Peve_00018505,Pocillopora_meandrina_HIv1___RNAseq.g18018.t1,three_way,70.76516666666666,FUN_008290-T1,Q5PRF9,SMAG2_HUMAN,,Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B),Homo sapiens (Human),32.0,719.0,1.7e-72,275.4,sp|Q5PRF9|SMAG2_HUMAN Protein Smaug homolog 2 OS=Homo sapiens OX=9606 GN=SAMD4B PE=1 SV=1,GO:0000289; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0030371,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289],cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0045182,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; translation regulator activity
OG_04244,0.5221075268446383,OG_04244,FUN_017766-T1,Peve_00035953,Pocillopora_meandrina_HIv1___RNAseq.g462.t1,three_way,86.78283333333333,FUN_017766-T1,P19517,,,,,56.8,405.0,1.8e-114,414.5,sp|P19517|CACB1_RABIT Voltage-dependent L-type calcium channel subunit beta-1 OS=Oryctolagus cuniculus OX=9986 GN=CACNB1 PE=1 SV=1,,,,,,
OG_01038,0.5220811601243586,OG_01038,FUN_004473-T1,Peve_00007172,Pocillopora_meandrina_HIv1___RNAseq.g4948.t1,three_way,45.68216666666667,FUN_004473-T1,P98081,DAB_DROME,,Protein disabled,Drosophila melanogaster (Fruit fly),41.4,157.0,2.5e-28,129.4,sp|P98081|DAB_DROME Protein disabled OS=Drosophila melanogaster OX=7227 GN=Dab PE=1 SV=2,GO:0005118; GO:0005829; GO:0006898; GO:0007349; GO:0007391; GO:0008045; GO:0016319; GO:0017124; GO:0030424; GO:0035591; GO:0042051; GO:0045874; GO:0048488; GO:0072583; GO:0098793,cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; positive regulation of sevenless signaling pathway [GO:0045874]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488],axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793],sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591],GO:0005829; GO:0016192; GO:0048856; GO:0060090,cytosol; vesicle-mediated transport; anatomical structure development; molecular adaptor activity
OG_06852,0.5220365937664102,OG_06852,FUN_031801-T1,Peve_00019325,Pocillopora_meandrina_HIv1___RNAseq.g5575.t1,three_way,84.17933333333333,FUN_031801-T1,Q4V8V1,,,,,45.0,271.0,2.2e-57,224.6,sp|Q4V8V1|BM1LA_DANRE Breast cancer metastasis-suppressor 1-like protein-A OS=Danio rerio OX=7955 GN=brms1la PE=2 SV=1,,,,,,
OG_00154,0.5220256792661567,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),47.8,912.0,6.499999999999998e-229,796.2,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_00154,0.5220256792661567,OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),37.4,286.0,1.3e-27,127.5,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_00388,0.5219833298184324,OG_00388,FUN_001241-T1,Peve_00022814,Pocillopora_meandrina_HIv1___TS.g4819.t1,three_way,90.189,FUN_001241-T1,Q5BJ41,CNOT6_XENLA,,CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase),Xenopus laevis (African clawed frog),59.0,558.0,8e-140,498.8,sp|Q5BJ41|CNOT6_XENLA CCR4-NOT transcription complex subunit 6 OS=Xenopus laevis OX=8355 GN=cnot6 PE=1 SV=1,GO:0000175; GO:0000289; GO:0003713; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0035279; GO:0046872; GO:0070966,"miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]",CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_05276,0.521817925906778,OG_05276,FUN_023934-T1,Peve_00017662,Pocillopora_meandrina_HIv1___RNAseq.g18854.t1,three_way,58.2855,,,,,,,,,,,,,,,,,
OG_00431,0.521771026247095,OG_00431,FUN_001341-T1,Peve_00036939,Pocillopora_meandrina_HIv1___RNAseq.g2290.t1,three_way,95.667,FUN_001341-T1,P25867,UBCD1_DROME,,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),Drosophila melanogaster (Fruit fly),95.2,147.0,5.000000000000001e-81,301.6,sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1,GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"mitotic cell cycle; immune system process; catalytic activity; nucleus; cytosol; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_02465,0.5217147155189219,OG_02465,FUN_009656-T1,Peve_00003553,Pocillopora_meandrina_HIv1___RNAseq.g24581.t1,three_way,62.471,FUN_009656-T1,P31946,1433B_HUMAN,,"14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]",Homo sapiens (Human),64.4,250.0,2.1e-74,280.4,sp|P31946|1433B_HUMAN 14-3-3 protein beta/alpha OS=Homo sapiens OX=9606 GN=YWHAB PE=1 SV=3,GO:0004860; GO:0004864; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0005925; GO:0006605; GO:0007165; GO:0008104; GO:0016020; GO:0017053; GO:0019899; GO:0019904; GO:0042308; GO:0042470; GO:0042802; GO:0042826; GO:0044877; GO:0045296; GO:0045744; GO:0045892; GO:0045944; GO:0048471; GO:0050815; GO:0051219; GO:0070062; GO:0140311,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein import into nucleus [GO:0042308]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription repressor complex [GO:0017053]; vacuolar membrane [GO:0005774],cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877],GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772; GO:0140313,nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sequestering activity
OG_05005,0.5216736602720258,OG_05005,FUN_023153-T1,Peve_00014158,Pocillopora_meandrina_HIv1___RNAseq.g17694.t1,three_way,72.7995,FUN_023153-T1,Q9Y2H2,SAC2_HUMAN,,Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2),Homo sapiens (Human),48.1,774.0,2e-204,714.5,sp|Q9Y2H2|SAC2_HUMAN Phosphatidylinositide phosphatase SAC2 OS=Homo sapiens OX=9606 GN=INPP5F PE=1 SV=3,GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043491; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135,adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135],axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037],inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803],GO:0003012; GO:0003824; GO:0005768; GO:0006629; GO:0016192; GO:0016787; GO:0031410; GO:0043226,muscle system process; catalytic activity; endosome; lipid metabolic process; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_05790,0.5216641775837719,OG_05790,FUN_025768-T1,Peve_00021329,Pocillopora_meandrina_HIv1___RNAseq.g10371.t1,three_way,68.259,FUN_025768-T1,Q6GL69,,,,,49.5,192.0,2.9e-44,180.3,sp|Q6GL69|MK67I_XENTR MKI67 FHA domain-interacting nucleolar phosphoprotein-like OS=Xenopus tropicalis OX=8364 GN=nifk PE=2 SV=1,,,,,,
OG_06065,0.5213455586228672,OG_06065,FUN_026899-T1,Peve_00021656,Pocillopora_meandrina_HIv1___RNAseq.g9422.t1,three_way,59.486,FUN_026899-T1,Q5C9Z4,NOM1_HUMAN,,Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog),Homo sapiens (Human),48.6,664.0,3.3e-126,454.1,sp|Q5C9Z4|NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NOM1 PE=1 SV=1,GO:0003723; GO:0005730; GO:0042274; GO:0048820,hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730],RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0043226,RNA binding; nucleolus; organelle
OG_01150,0.5212891113611442,OG_01150,FUN_004749-T1,Peve_00007765,Pocillopora_meandrina_HIv1___RNAseq.g8815.t3,three_way,45.58733333333333,FUN_004749-T1,P27447,,,,,37.6,93.0,4.9e-07,57.8,sp|P27447|YES_XIPHE Tyrosine-protein kinase Yes OS=Xiphophorus hellerii OX=8084 GN=yes PE=2 SV=3,,,,,,
OG_02805,0.5209397116788049,OG_02805,FUN_011776-T1,Peve_00006118,Pocillopora_meandrina_HIv1___RNAseq.g23292.t1,three_way,81.48183333333333,FUN_011776-T1,Q01196,RUNX1_HUMAN,,Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit),Homo sapiens (Human),48.8,320.0,7.1e-71,269.6,sp|Q01196|RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens OX=9606 GN=RUNX1 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001503; GO:0002062; GO:0002573; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0006357; GO:0010755; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0032743; GO:0032967; GO:0042803; GO:0043231; GO:0043371; GO:0043378; GO:0045595; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0060043; GO:0061026; GO:0071425; GO:0140297; GO:1903055; GO:1905203,"cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_03952,0.5208364732718394,OG_03952,FUN_016091-T1,Peve_00013366,Pocillopora_meandrina_HIv1___RNAseq.g21574.t1,three_way,91.33766666666666,FUN_016091-T1,P63085,MK01_MOUSE,,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),Mus musculus (Mouse),85.7,349.0,1.0999999999999996e-177,624.0,sp|P63085|MK01_MOUSE Mitogen-activated protein kinase 1 OS=Mus musculus OX=10090 GN=Mapk1 PE=1 SV=3,GO:0000165; GO:0001784; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006351; GO:0006915; GO:0006974; GO:0007173; GO:0007507; GO:0008286; GO:0008353; GO:0009887; GO:0010759; GO:0014032; GO:0014044; GO:0016301; GO:0018105; GO:0018107; GO:0019858; GO:0019902; GO:0030278; GO:0030521; GO:0030641; GO:0030878; GO:0031143; GO:0031647; GO:0031663; GO:0032206; GO:0032496; GO:0032872; GO:0033598; GO:0034198; GO:0035094; GO:0036064; GO:0038133; GO:0042473; GO:0042552; GO:0042802; GO:0043330; GO:0045542; GO:0045596; GO:0048009; GO:0048538; GO:0050847; GO:0050852; GO:0050853; GO:0051090; GO:0051403; GO:0051493; GO:0060020; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0061514; GO:0070371; GO:0070849; GO:0071356; GO:0072584; GO:0072686; GO:0090170; GO:0106310; GO:0120041; GO:2000641,androgen receptor signaling pathway [GO:0030521]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cellular response to amino acid starvation [GO:0034198]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; DNA damage response [GO:0006974]; DNA-templated transcription [GO:0006351]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-34-mediated signaling pathway [GO:0061514]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; myelination [GO:0042552]; negative regulation of cell differentiation [GO:0045596]; neural crest cell development [GO:0014032]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of telomere maintenance [GO:0032206]; progesterone receptor signaling pathway [GO:0050847]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; Schwann cell development [GO:0014044]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440],caveola [GO:0005901]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005768; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0012501; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; mitochondrion; endosome; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein"
OG_09839,0.5207636569074694,OG_09839,FUN_042820-T1,Peve_00019572,Pocillopora_meandrina_HIv1___RNAseq.g7438.t1,three_way,89.72666666666667,FUN_042820-T1,P40424,PBX1_HUMAN,,Pre-B-cell leukemia transcription factor 1 (Homeobox protein PBX1) (Homeobox protein PRL),Homo sapiens (Human),69.0,407.0,9.8e-132,471.9,sp|P40424|PBX1_HUMAN Pre-B-cell leukemia transcription factor 1 OS=Homo sapiens OX=9606 GN=PBX1 PE=1 SV=1,GO:0000086; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001222; GO:0001228; GO:0001654; GO:0001655; GO:0001658; GO:0001779; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006694; GO:0007420; GO:0007548; GO:0009887; GO:0009952; GO:0009954; GO:0010971; GO:0030278; GO:0030325; GO:0030326; GO:0035162; GO:0043433; GO:0045665; GO:0045944; GO:0048536; GO:0048538; GO:0048568; GO:0048666; GO:0048706; GO:0072089; GO:0090575; GO:0140297; GO:1990837; GO:2000648,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; G2/M transition of mitotic cell cycle [GO:0000086]; natural killer cell differentiation [GO:0001779]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006629; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; lipid metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05712,0.5207192553657156,OG_05712,FUN_025596-T1,Peve_00037559,Pocillopora_meandrina_HIv1___RNAseq.g23150.t1,three_way,86.92,FUN_025596-T1,Q6NS26,,,,,65.8,549.0,1.3000000000000002e-214,747.3,sp|Q6NS26|CDKAL_XENLA Threonylcarbamoyladenosine tRNA methylthiotransferase OS=Xenopus laevis OX=8355 GN=cdkal1 PE=2 SV=1,,,,,,
OG_00644,0.520711189478304,OG_00644,FUN_001889-T1,Peve_00030492,Pocillopora_meandrina_HIv1___RNAseq.g2578.t2,three_way,70.65033333333334,,,,,,,,,,,,,,,,,
OG_04712,0.520501844458129,OG_04712,FUN_022519-T1,Peve_00026444,Pocillopora_meandrina_HIv1___RNAseq.g4252.t1,three_way,93.754,FUN_022519-T1,F6XBL2,,,,,71.0,414.0,4.3000000000000005e-162,572.4,sp|F6XBL2|PSD11_XENTR 26S proteasome non-ATPase regulatory subunit 11 OS=Xenopus tropicalis OX=8364 GN=psmd11 PE=3 SV=2,,,,,,
OG_08078,0.5203537106952303,OG_08078,FUN_035802-T1,Peve_00017705,Pocillopora_meandrina_HIv1___RNAseq.g11918.t1,three_way,55.39816666666666,,,,,,,,,,,,,,,,,
OG_05523,0.5202447003676954,OG_05523,FUN_024629-T1,Peve_00012710,Pocillopora_meandrina_HIv1___RNAseq.g18959.t1,three_way,61.03916666666667,,,,,,,,,,,,,,,,,
OG_09702,0.5200531311059996,OG_09702,FUN_041933-T1,Peve_00023581,Pocillopora_meandrina_HIv1___RNAseq.g15700.t1,three_way,61.377,FUN_041933-T1,P52594,AGFG1_HUMAN,,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),Homo sapiens (Human),57.9,183.0,3.4e-54,214.9,sp|P52594|AGFG1_HUMAN Arf-GAP domain and FG repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=AGFG1 PE=1 SV=2,GO:0001675; GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005737; GO:0005829; GO:0006406; GO:0007289; GO:0008270; GO:0031410; GO:0042995; GO:0043025; GO:0043231; GO:0045109,acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nuclear pore [GO:0005643],DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005829; GO:0006913; GO:0007010; GO:0022414; GO:0031410; GO:0043226; GO:0098772,DNA binding; RNA binding; cytosol; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_02675,0.5199912727897832,OG_02675,FUN_010920-T1,Peve_00025754,Pocillopora_meandrina_HIv1___RNAseq.g21799.t1,three_way,91.52566666666668,FUN_010920-T1,P63009,,,,,72.2,956.0,0.0,1317.0,sp|P63009|AP2B1_BOVIN AP-2 complex subunit beta OS=Bos taurus OX=9913 GN=AP2B1 PE=1 SV=2,,,,,,
OG_09777,0.5199389674041056,OG_09777,FUN_042107-T1,Peve_00009513,Pocillopora_meandrina_HIv1___RNAseq.g21779.t1,three_way,95.49616666666668,FUN_042107-T1,Q6GQ52,,,,,67.9,84.0,1.4000000000000001e-28,126.7,sp|Q6GQ52|TI10B_XENLA Mitochondrial import inner membrane translocase subunit Tim10-B OS=Xenopus laevis OX=8355 GN=timm10-b PE=3 SV=1,,,,,,
OG_03810,0.5199363566874933,OG_03810,FUN_015219-T1,Peve_00023888,Pocillopora_meandrina_HIv1___RNAseq.g22336.t1,three_way,80.74166666666666,FUN_015219-T1,Q6GM71,LRWD1_XENLA,,Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein),Xenopus laevis (African clawed frog),26.8,728.0,4.2e-63,244.2,sp|Q6GM71|LRWD1_XENLA Leucine-rich repeat and WD repeat-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrwd1 PE=2 SV=1,GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005737; GO:0005813; GO:0006260; GO:0006325; GO:0008327; GO:0061628; GO:0071169,chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]",chromatin binding [GO:0003682]; histone H3K27me3 reader activity [GO:0061628]; methyl-CpG binding [GO:0008327],GO:0003677; GO:0005634; GO:0005815; GO:0006260; GO:0006325; GO:0043226; GO:0060090,DNA binding; nucleus; microtubule organizing center; DNA replication; chromatin organization; organelle; molecular adaptor activity
OG_02124,0.5198277816366018,OG_02124,FUN_008418-T1,Peve_00009794,Pocillopora_meandrina_HIv1___RNAseq.g18045.t1,three_way,95.60633333333334,FUN_008418-T1,P53488,,,,,89.1,359.0,1.2e-192,673.7,sp|P53488|ARP2_CHICK Actin-related protein 2 OS=Gallus gallus OX=9031 GN=ACTR2 PE=2 SV=1,,,,,,
OG_00196,0.5197391116504381,OG_00196,FUN_000908-T1,Peve_00010044,Pocillopora_meandrina_HIv1___RNAseq.g29495.t1,three_way,77.85966666666667,FUN_000908-T1,Q8QG61,,,,,64.7,499.0,3.3e-210,732.6,sp|Q8QG61|CRY1_CHICK Cryptochrome-1 OS=Gallus gallus OX=9031 GN=CRY1 PE=2 SV=1,,,,,,
OG_06268,0.5196625609748874,OG_06268,FUN_028299-T1,Peve_00000718,Pocillopora_meandrina_HIv1___RNAseq.g15542.t2,three_way,70.94366666666667,,,,,,,,,,,,,,,,,
OG_09158,0.5192842675822368,OG_09158,FUN_039817-T1,Peve_00039024,Pocillopora_meandrina_HIv1___RNAseq.g7505.t1,three_way,89.61566666666667,FUN_039817-T1,Q9Z1Q9,,,,,66.3,991.0,0.0,1398.6,sp|Q9Z1Q9|SYVC_MOUSE Valine--tRNA ligase OS=Mus musculus OX=10090 GN=Vars1 PE=1 SV=1,,,,,,
OG_04526,0.5191440493589871,OG_04526,FUN_022067-T1,Peve_00012095,Pocillopora_meandrina_HIv1___RNAseq.g4618.t1,three_way,80.96883333333334,FUN_022067-T1,Q86X95,CIR1_HUMAN,,Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor) (Recepin),Homo sapiens (Human),54.5,134.0,2.9000000000000002e-30,134.0,sp|Q86X95|CIR1_HUMAN Corepressor interacting with RBPJ 1 OS=Homo sapiens OX=9606 GN=CIR1 PE=1 SV=1,GO:0000122; GO:0001701; GO:0003714; GO:0005634; GO:0005737; GO:0005813; GO:0006397; GO:0008380; GO:0016607; GO:0019901; GO:0032991; GO:0042826; GO:0044877; GO:0045892,in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; RNA splicing [GO:0008380],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005815; GO:0006355; GO:0016071; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; microtubule organizing center; regulation of DNA-templated transcription; mRNA metabolic process; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_05743,0.5190546143619491,OG_05743,FUN_025670-T1,Peve_00042194,Pocillopora_meandrina_HIv1___TS.g15944.t1,three_way,81.551,FUN_025670-T1,O09012,PEX5_MOUSE,,Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (PXR1P) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1),Mus musculus (Mouse),47.9,645.0,2.2e-117,424.5,sp|O09012|PEX5_MOUSE Peroxisomal targeting signal 1 receptor OS=Mus musculus OX=10090 GN=Pex5 PE=1 SV=2,GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005739; GO:0005777; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006629; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0016020; GO:0016558; GO:0016560; GO:0016562; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0034614; GO:0040018; GO:0044721; GO:0045046; GO:0048468; GO:0050905; GO:0140597,"cell development [GO:0048468]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome membrane targeting sequence binding [GO:0033328]; peroxisome targeting sequence binding [GO:0000268]; protein carrier chaperone [GO:0140597]; small GTPase binding [GO:0031267],GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0006629; GO:0006886; GO:0006914; GO:0007005; GO:0007031; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0061024; GO:0140104,mitochondrion; peroxisome; Golgi apparatus; cytosol; lipid metabolic process; intracellular protein transport; autophagy; mitochondrion organization; peroxisome organization; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; membrane organization; molecular carrier activity
OG_00199,0.5190113595082285,OG_00199,FUN_000912-T1,Peve_00010054,Pocillopora_meandrina_HIv1___RNAseq.g29489.t1,three_way,68.19866666666667,FUN_000912-T1,Q8BSF5,,,,,22.8,479.0,1.7e-26,122.9,sp|Q8BSF5|KLH38_MOUSE Kelch-like protein 38 OS=Mus musculus OX=10090 GN=Klhl38 PE=2 SV=1,,,,,,
OG_05922,0.5189877583222954,OG_05922,FUN_026145-T1,Peve_00014871,Pocillopora_meandrina_HIv1___RNAseq.g3240.t1,three_way,90.387,FUN_026145-T1,Q2KJA2,,,,,72.2,540.0,1.6999999999999999e-233,810.1,sp|Q2KJA2|ABCF2_BOVIN ATP-binding cassette sub-family F member 2 OS=Bos taurus OX=9913 GN=ABCF2 PE=2 SV=1,,,,,,
OG_00225,0.5187324372175129,OG_00225,FUN_000960-T1,Peve_00021379,Pocillopora_meandrina_HIv1___RNAseq.13437_t,three_way,86.795,FUN_000960-T1,P28271,ACOHC_MOUSE,,Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1),Mus musculus (Mouse),71.1,869.0,0.0,1303.1,sp|P28271|ACOHC_MOUSE Cytoplasmic aconitate hydratase OS=Mus musculus OX=10090 GN=Aco1 PE=1 SV=3,GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0046872; GO:0050892; GO:0051538; GO:0051539,citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]",GO:0003723; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006091; GO:0016829; GO:0022600; GO:0043226; GO:0055086,RNA binding; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; cytosol; generation of precursor metabolites and energy; lyase activity; digestive system process; organelle; nucleobase-containing small molecule metabolic process
OG_02111,0.5186986938169547,OG_02111,FUN_008396-T1,Peve_00043608,Pocillopora_meandrina_HIv1___RNAseq.g6175.t1,three_way,71.88550000000001,FUN_008396-T1,Q9EQC5,SCYL1_MOUSE,,N-terminal kinase-like protein (105 kDa kinase-like protein) (Mitosis-associated kinase-like protein NTKL) (SCY1-like protein 1),Mus musculus (Mouse),51.4,675.0,2.1e-182,641.0,sp|Q9EQC5|SCYL1_MOUSE N-terminal kinase-like protein OS=Mus musculus OX=10090 GN=Scyl1 PE=1 SV=1,GO:0004672; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005813; GO:0005829; GO:0006890; GO:0006954; GO:0008104; GO:0021522; GO:0030126; GO:0048666,"inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]",centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; protein kinase activity [GO:0004672],GO:0003824; GO:0005794; GO:0005815; GO:0005829; GO:0006954; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; microtubule organizing center; cytosol; inflammatory response; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00161,0.5186805808750318,OG_00161,FUN_000618-T1,Peve_00043948,Pocillopora_meandrina_HIv1___TS.g4276.t2,three_way,66.084,FUN_000618-T1,Q6DRN3,NOC3L_DANRE,,Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein),Danio rerio (Zebrafish) (Brachydanio rerio),39.2,694.0,9.7e-120,432.6,sp|Q6DRN3|NOC3L_DANRE Nucleolar complex protein 3 homolog OS=Danio rerio OX=7955 GN=noc3l PE=2 SV=1,GO:0003682; GO:0005634; GO:0005730; GO:0006270; GO:0007517; GO:0019216,DNA replication initiation [GO:0006270]; muscle organ development [GO:0007517]; regulation of lipid metabolic process [GO:0019216],nucleolus [GO:0005730]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005730; GO:0043226; GO:0048856,nucleus; nucleolus; organelle; anatomical structure development
OG_08187,0.5185358887911964,OG_08187,FUN_036027-T1,Peve_00011108,Pocillopora_meandrina_HIv1___RNAseq.g27237.t1,three_way,96.29633333333334,FUN_036027-T1,P60519,,,,,75.9,116.0,3.2e-46,185.7,sp|P60519|GBRL2_BOVIN Gamma-aminobutyric acid receptor-associated protein-like 2 OS=Bos taurus OX=9913 GN=GABARAPL2 PE=1 SV=1,,,,,,
OG_04350,0.5184175839990328,OG_04350,FUN_017986-T1,Peve_00004549,Pocillopora_meandrina_HIv1___RNAseq.g25273.t2,three_way,67.53116666666666,FUN_017986-T1,Q9GZT9,,,,,54.3,208.0,4.6e-62,240.0,sp|Q9GZT9|EGLN1_HUMAN Egl nine homolog 1 OS=Homo sapiens OX=9606 GN=EGLN1 PE=1 SV=1,,,,,,
OG_00931,0.5182471896205166,OG_00931,FUN_004276-T1,Peve_00008947,Pocillopora_meandrina_HIv1___TS.g18429.t1,three_way,69.30033333333334,FUN_004276-T1,Q9I8J6,,,,,41.7,168.0,5.7e-26,119.8,sp|Q9I8J6|EBP2_XENLA Probable rRNA-processing protein EBP2 OS=Xenopus laevis OX=8355 GN=ebna1bp2 PE=2 SV=1,,,,,,
OG_02328,0.5181521013991606,OG_02328,FUN_008921-T1,Peve_00006943,Pocillopora_meandrina_HIv1___TS.g30078.t1,three_way,78.52199999999999,FUN_008921-T1,F1PCT7,,,,,39.1,591.0,6.2e-114,412.9,sp|F1PCT7|RPN2_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 OS=Canis lupus familiaris OX=9615 GN=RPN2 PE=1 SV=3,,,,,,
OG_01413,0.5181476710231072,OG_01413,FUN_005700-T1,Peve_00008485,Pocillopora_meandrina_HIv1___RNAseq.g19563.t1,three_way,75.503,FUN_005700-T1,Q9Z2V9,,,,,40.4,213.0,5.4e-36,152.9,sp|Q9Z2V9|CCNI_MOUSE Cyclin-I OS=Mus musculus OX=10090 GN=Ccni PE=2 SV=4,,,,,,
OG_04293,0.5179914459093392,OG_04293,FUN_017859-T1,Peve_00014752,Pocillopora_meandrina_HIv1___RNAseq.g9574.t2,three_way,59.749500000000005,FUN_017859-T1,Q04205,,,,,47.0,285.0,3.1e-68,261.9,sp|Q04205|TENS1_CHICK Tensin-1 OS=Gallus gallus OX=9031 GN=TNS1 PE=1 SV=3,,,,,,
OG_01374,0.5179774546254337,OG_01374,FUN_005330-T1,Peve_00003301,Pocillopora_meandrina_HIv1___TS.g19931.t1,three_way,58.007000000000005,FUN_005330-T1,A6QPM3,PRDM6_BOVIN,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6),Bos taurus (Bovine),32.9,313.0,3e-37,157.9,sp|A6QPM3|PRDM6_BOVIN Putative histone-lysine N-methyltransferase PRDM6 OS=Bos taurus OX=9913 GN=PRDM6 PE=2 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0010468; GO:0022008; GO:0032259; GO:0042802; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_08249,0.5176627696622016,OG_08249,FUN_036158-T1,Peve_00039218,Pocillopora_meandrina_HIv1___RNAseq.g27493.t1,three_way,85.587,FUN_036158-T1,Q5PQY6,,,,,58.8,838.0,6.9e-268,924.9,"sp|Q5PQY6|LONP2_DANRE Lon protease homolog 2, peroxisomal OS=Danio rerio OX=7955 GN=lonp2 PE=2 SV=1",,,,,,
OG_00213,0.5176292111474242,OG_00213,FUN_000932-T1,Peve_00009724,Pocillopora_meandrina_HIv1___RNAseq.g29460.t1,three_way,85.761,FUN_000932-T1,P00516,,,,,65.8,619.0,1.3e-240,833.9,sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus OX=9913 GN=PRKG1 PE=1 SV=2,,,,,,
OG_04893,0.5176128911977416,OG_04893,FUN_022937-T1,Peve_00026752,Pocillopora_meandrina_HIv1___RNAseq.g3737.t1,three_way,87.12,FUN_022937-T1,P67827,KC1A_BOVIN,,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),Bos taurus (Bovine),87.7,277.0,5.1000000000000005e-145,515.4,sp|P67827|KC1A_BOVIN Casein kinase I isoform alpha OS=Bos taurus OX=9913 GN=CSNK1A1 PE=1 SV=1,GO:0000139; GO:0000776; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007165; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1900226,cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03842,0.5175543781740438,OG_03842,FUN_015304-T1,Peve_00004797,Pocillopora_meandrina_HIv1___RNAseq.g22098.t1,three_way,76.9795,FUN_015304-T1,Q174D3,,,,,51.8,114.0,2.2e-23,110.9,sp|Q174D3|MED19_AEDAE Mediator of RNA polymerase II transcription subunit 19 OS=Aedes aegypti OX=7159 GN=MED19 PE=3 SV=1,,,,,,
OG_03503,0.5174858710835479,OG_03503,FUN_014613-T1,Peve_00001900,Pocillopora_meandrina_HIv1___RNAseq.g22759.t1,three_way,82.95233333333333,FUN_014613-T1,Q92616,GCN1_HUMAN,,Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1),Homo sapiens (Human),50.3,2683.0,0.0,2509.9,sp|Q92616|GCN1_HUMAN Stalled ribosome sensor GCN1 OS=Homo sapiens OX=9606 GN=GCN1 PE=1 SV=7,GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0006417; GO:0008135; GO:0016020; GO:0019887; GO:0022626; GO:0034198; GO:0043539; GO:0045296; GO:0055106; GO:0060090; GO:0072344; GO:0140469; GO:0160127; GO:0170011,cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; ribosome [GO:0005840],"cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activator activity [GO:0043539]; RNA binding [GO:0003723]; stalled ribosome sensor activity [GO:0170011]; translation factor activity, RNA binding [GO:0008135]; ubiquitin-protein transferase regulator activity [GO:0055106]",GO:0003723; GO:0005829; GO:0005840; GO:0043226; GO:0060090; GO:0098772; GO:0140299,RNA binding; cytosol; ribosome; organelle; molecular adaptor activity; molecular function regulator activity; molecular sensor activity
OG_08933,0.5168859723535277,OG_08933,FUN_038395-T1,Peve_00000045,Pocillopora_meandrina_HIv1___RNAseq.g28267.t1,three_way,81.313,FUN_038395-T1,Q96DY2,,,,,34.0,429.0,5e-53,210.3,sp|Q96DY2|DRC10_HUMAN Dynein regulatory complex protein 10 OS=Homo sapiens OX=9606 GN=IQCD PE=1 SV=2,,,,,,
OG_09086,0.5160027196778745,OG_09086,FUN_038833-T1,Peve_00028686,Pocillopora_meandrina_HIv1___RNAseq.21094_t,three_way,62.954166666666666,FUN_038833-T1,O15169,AXIN1_HUMAN,,Axin-1 (Axis inhibition protein 1) (hAxin),Homo sapiens (Human),27.2,904.0,3.3e-52,208.4,sp|O15169|AXIN1_HUMAN Axin-1 OS=Homo sapiens OX=9606 GN=AXIN1 PE=1 SV=2,GO:0000209; GO:0001701; GO:0002039; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0010629; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060,apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605],beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0006325; GO:0006355; GO:0006913; GO:0007010; GO:0012501; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0065003; GO:0098772,nucleus; nucleolus; cytosol; cytoskeleton; plasma membrane; chromatin organization; regulation of DNA-templated transcription; nucleocytoplasmic transport; cytoskeleton organization; programmed cell death; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity
OG_01698,0.5159874491517963,OG_01698,FUN_006941-T1,Peve_00042016,Pocillopora_meandrina_HIv1___RNAseq.g20150.t1,three_way,80.58666666666667,FUN_006941-T1,Q32N90,,,,,36.0,566.0,4.4000000000000003e-100,367.9,sp|Q32N90|MBTD1_XENLA MBT domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=mbtd1 PE=2 SV=1,,,,,,
OG_08415,0.515896441730527,OG_08415,FUN_037071-T1,Peve_00004736,Pocillopora_meandrina_HIv1___RNAseq.g26783.t1,three_way,86.73233333333333,FUN_037071-T1,Q99973,TEP1_HUMAN,,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),Homo sapiens (Human),26.9,577.0,1.6999999999999998e-43,179.9,sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2,GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904,telomere maintenance via recombination [GO:0000722],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0006310; GO:0016740; GO:0032200; GO:0140097,"RNA binding; catalytic activity; DNA recombination; transferase activity; telomere organization; catalytic activity, acting on DNA"
OG_03209,0.515512072554927,OG_03209,FUN_012701-T1,Peve_00016835,Pocillopora_meandrina_HIv1___RNAseq.g12828.t1,three_way,66.00966666666667,,,,,,,,,,,,,,,,,
OG_06773,0.5154469231640652,OG_06773,FUN_031638-T1,Peve_00032680,Pocillopora_meandrina_HIv1___TS.g24410.t3a,three_way,91.53766666666668,FUN_031638-T1,P25490,TYY1_HUMAN,,Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1),Homo sapiens (Human),88.5,113.0,4.1e-58,226.5,sp|P25490|TYY1_HUMAN Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2,GO:0000122; GO:0000400; GO:0000723; GO:0000724; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005677; GO:0006275; GO:0006282; GO:0006338; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010628; GO:0010629; GO:0016363; GO:0030183; GO:0031011; GO:0031519; GO:0032688; GO:0033044; GO:0034644; GO:0034696; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0046332; GO:0048593; GO:0051726; GO:0060382; GO:0061052; GO:0071347; GO:0071707; GO:0140297; GO:1902894; GO:1904507; GO:1990837,anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723],chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0140110,immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; telomere organization; organelle; transcription regulator activity
OG_08264,0.5154279291463242,OG_08264,FUN_036176-T1,Peve_00027215,Pocillopora_meandrina_HIv1___RNAseq.g27510.t1,three_way,89.82000000000001,FUN_036176-T1,P28075,,,,,76.9,229.0,1.1e-97,357.8,sp|P28075|PSB5_RAT Proteasome subunit beta type-5 OS=Rattus norvegicus OX=10116 GN=Psmb5 PE=1 SV=3,,,,,,
OG_02668,0.5153859268424704,OG_02668,FUN_010887-T1,Peve_00035839,Pocillopora_meandrina_HIv1___RNAseq.g21002.t1,three_way,87.91066666666666,FUN_010887-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),67.4,307.0,5e-129,463.0,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_07673,0.5152251437802005,OG_07673,FUN_034780-T1,Peve_00029729,Pocillopora_meandrina_HIv1___RNAseq.g12275.t1,three_way,82.57533333333333,FUN_034780-T1,Q9Y4W6,AFG32_HUMAN,,Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein),Homo sapiens (Human),68.9,637.0,6.099999999999999e-247,855.1,sp|Q9Y4W6|AFG32_HUMAN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0030163; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0051604; GO:0055001; GO:0060013; GO:0072753; GO:0110097; GO:0141164,axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0055085; GO:0061024; GO:0140096; GO:0140657,"catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; cell junction organization; organelle; anatomical structure development; protein maturation; transmembrane transport; membrane organization; catalytic activity, acting on a protein; ATP-dependent activity"
OG_01811,0.5149139695260521,OG_01811,FUN_007646-T1,Peve_00034271,Pocillopora_meandrina_HIv1___RNAseq.g5811.t1,three_way,71.30533333333334,FUN_007646-T1,Q92994,,,,,44.1,551.0,3.1e-91,337.4,sp|Q92994|TF3B_HUMAN Transcription factor IIIB 90 kDa subunit OS=Homo sapiens OX=9606 GN=BRF1 PE=1 SV=1,,,,,,
OG_07719,0.5147651291545804,OG_07719,FUN_034874-T1,Peve_00005761,Pocillopora_meandrina_HIv1___RNAseq.g27163.t1,three_way,71.02033333333334,FUN_034874-T1,P00172,,,,,52.7,131.0,2.2000000000000002e-30,133.3,sp|P00172|CYB5_PIG Cytochrome b5 OS=Sus scrofa OX=9823 GN=CYB5A PE=1 SV=3,,,,,,
OG_08356,0.5147302324133819,OG_08356,FUN_036900-T1,Peve_00018370,Pocillopora_meandrina_HIv1___RNAseq.g10779.t1,three_way,79.11716666666666,FUN_036900-T1,Q99PW8,KIF17_MOUSE,,Kinesin-like protein KIF17 (MmKIF17),Mus musculus (Mouse),42.7,1061.0,2.3e-197,690.6,sp|Q99PW8|KIF17_MOUSE Kinesin-like protein KIF17 OS=Mus musculus OX=10090 GN=Kif17 PE=1 SV=1,GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0015031; GO:0015630; GO:0016192; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0098794; GO:0098971; GO:1990075,anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007018; GO:0008092; GO:0016192; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; organelle; ATP-dependent activity
OG_05530,0.5146626955211794,OG_05530,FUN_024677-T1,Peve_00012721,Pocillopora_meandrina_HIv1___RNAseq.g18952.t1,three_way,50.53216666666667,FUN_024677-T1,Q6ZVD7,STOX1_HUMAN,,Storkhead-box protein 1 (Winged-helix domain-containing protein),Homo sapiens (Human),39.2,158.0,6.199999999999999e-24,114.4,sp|Q6ZVD7|STOX1_HUMAN Storkhead-box protein 1 OS=Homo sapiens OX=9606 GN=STOX1 PE=1 SV=2,GO:0000977; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0006357; GO:0010468; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904031; GO:1904120,cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription by RNA polymerase II [GO:0006357],cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977],GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05234,0.5145356599965211,OG_05234,FUN_023649-T1,Peve_00027829,Pocillopora_meandrina_HIv1___RNAseq.g19794.t1,three_way,56.414,FUN_023649-T1,O96790,,,,,33.2,277.0,5.8e-27,123.2,sp|O96790|DPGN_DIPMA Serine protease inhibitor dipetalogastin (Fragment) OS=Dipetalogaster maximus OX=72496 PE=1 SV=2,,,,,,
OG_09672,0.5144861358495194,OG_09672,FUN_041890-T1,Peve_00033394,Pocillopora_meandrina_HIv1___RNAseq.g15420.t1,three_way,92.026,FUN_041890-T1,P38117,ETFB_HUMAN,,Electron transfer flavoprotein subunit beta (Beta-ETF),Homo sapiens (Human),68.8,253.0,1.4e-94,347.4,sp|P38117|ETFB_HUMAN Electron transfer flavoprotein subunit beta OS=Homo sapiens OX=9606 GN=ETFB PE=1 SV=3,GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251,amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904],electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],electron transfer activity [GO:0009055],GO:0005739; GO:0006091; GO:0006520; GO:0006629; GO:0043226,mitochondrion; generation of precursor metabolites and energy; amino acid metabolic process; lipid metabolic process; organelle
OG_08369,0.5142248020633833,OG_08369,FUN_036922-T1,Peve_00018419,Pocillopora_meandrina_HIv1___RNAseq.g10827.t3,three_way,57.46,,,,,,,,,,,,,,,,,
OG_01294,0.5141063261514829,OG_01294,FUN_005118-T1,Peve_00026683,Pocillopora_meandrina_HIv1___RNAseq.g8264.t1,three_way,92.74866666666668,FUN_005118-T1,Q9VQ93,GOLP3_DROME,,Golgi phosphoprotein 3 homolog sauron (Protein rotini),Drosophila melanogaster (Fruit fly),72.3,267.0,1.4000000000000005e-111,404.1,sp|Q9VQ93|GOLP3_DROME Golgi phosphoprotein 3 homolog sauron OS=Drosophila melanogaster OX=7227 GN=sau PE=1 SV=1,GO:0000139; GO:0000281; GO:0000301; GO:0000915; GO:0005794; GO:0005802; GO:0005829; GO:0006890; GO:0007030; GO:0007053; GO:0007110; GO:0007111; GO:0007112; GO:0010314; GO:0031267; GO:0031410; GO:0031985; GO:0032154; GO:0032266; GO:0036089; GO:0043001; GO:0046718; GO:0048194; GO:0051225; GO:0070273; GO:0070300; GO:0090307; GO:0140312; GO:0140450,"actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; protein targeting to Golgi apparatus [GO:0140450]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]; symbiont entry into host cell [GO:0046718]",cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],cargo adaptor activity [GO:0140312]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; small GTPase binding [GO:0031267],GO:0000910; GO:0005794; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0072659,cytokinesis; Golgi apparatus; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane
OG_05231,0.5140732055559675,OG_05231,FUN_023644-T1,Peve_00027824,Pocillopora_meandrina_HIv1___RNAseq.g17819.t1,three_way,74.502,,,,,,,,,,,,,,,,,
OG_04932,0.5138544557719338,OG_04932,FUN_023000-T1,Peve_00024659,Pocillopora_meandrina_HIv1___RNAseq.g3813.t1,three_way,53.00183333333333,FUN_023000-T1,Q90Z00,FGR1A_DANRE,,Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,804.0,7.2e-136,486.5,sp|Q90Z00|FGR1A_DANRE Fibroblast growth factor receptor 1-A OS=Danio rerio OX=7955 GN=fgfr1a PE=1 SV=2,GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043410; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699,anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_09942,0.5138170610714912,OG_09942,FUN_043106-T1,Peve_00014958,Pocillopora_meandrina_HIv1___RNAseq.g7005.t1,three_way,83.65,FUN_043106-T1,Q17GZ9,,,,,39.5,731.0,1.6e-124,448.4,sp|Q17GZ9|ARP5_AEDAE Actin-related protein 5 OS=Aedes aegypti OX=7159 GN=Arp5 PE=3 SV=1,,,,,,
OG_01762,0.5137802388185094,OG_01762,FUN_007117-T1,Peve_00043801,Pocillopora_meandrina_HIv1___RNAseq.g18998.t1,three_way,71.51549999999999,FUN_007117-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),30.2,129.0,4.2e-10,67.0,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_03062,0.513773925266622,OG_03062,FUN_012326-T1,Peve_00023484,Pocillopora_meandrina_HIv1___RNAseq.g23752.t1,three_way,88.28433333333334,FUN_012326-T1,Q64331,MYO6_MOUSE,,Unconventional myosin-VI (Protein twist) (Unconventional myosin-6),Mus musculus (Mouse),58.0,1266.0,0.0,1217.2,sp|Q64331|MYO6_MOUSE Unconventional myosin-VI OS=Mus musculus OX=10090 GN=Myo6 PE=1 SV=2,GO:0003774; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005905; GO:0006605; GO:0006897; GO:0007268; GO:0007416; GO:0007605; GO:0007626; GO:0008104; GO:0012506; GO:0014047; GO:0014069; GO:0015031; GO:0016358; GO:0016459; GO:0030136; GO:0030175; GO:0030424; GO:0032587; GO:0042472; GO:0042491; GO:0043025; GO:0045202; GO:0048167; GO:0048471; GO:0048839; GO:0051015; GO:0071257; GO:0098683; GO:0098685; GO:0098833; GO:0098871; GO:0098884; GO:0098978; GO:0099171,cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; glutamate secretion [GO:0014047]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein localization [GO:0008104]; protein targeting [GO:0006605]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; sensory perception of sound [GO:0007605]; synapse assembly [GO:0007416],axon [GO:0030424]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cochlear hair cell ribbon synapse [GO:0098683]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; presynaptic endocytic zone [GO:0098833]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; vesicle membrane [GO:0012506],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774],GO:0003774; GO:0005634; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,cytoskeletal motor activity; nucleus; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_01208,0.5137474819505997,OG_01208,FUN_004881-T1,Peve_00043727,Pocillopora_meandrina_HIv1___RNAseq.g8658.t1,three_way,72.80466666666666,FUN_004881-T1,Q8IWZ8,SUGP1_HUMAN,,SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4),Homo sapiens (Human),55.6,169.0,3.899999999999999e-46,187.2,sp|Q8IWZ8|SUGP1_HUMAN SURP and G-patch domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SUGP1 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005654; GO:0005681; GO:0006397; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0016071,RNA binding; nucleoplasm; mRNA metabolic process
OG_05657,0.5136816247718664,OG_05657,FUN_025412-T1,Peve_00030580,Pocillopora_meandrina_HIv1___RNAseq.g13312.t1,three_way,88.07566666666666,FUN_025412-T1,Q3MHN0,PSB6_BOVIN,,Proteasome subunit beta type-6 (EC 3.4.25.1),Bos taurus (Bovine),69.7,208.0,1.2999999999999999e-83,310.8,sp|Q3MHN0|PSB6_BOVIN Proteasome subunit beta type-6 OS=Bos taurus OX=9913 GN=PSMB6 PE=1 SV=1,GO:0004175; GO:0004298; GO:0005634; GO:0005829; GO:0005839; GO:0019774; GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]",endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03673,0.5135898141770653,OG_03673,FUN_014924-T1,Peve_00006268,Pocillopora_meandrina_HIv1___RNAseq.g21081.t1,three_way,64.52166666666666,FUN_014924-T1,Q6PAJ1,BCR_MOUSE,,Breakpoint cluster region protein (EC 2.7.11.1),Mus musculus (Mouse),38.2,798.0,1.9999999999999997e-142,508.8,sp|Q6PAJ1|BCR_MOUSE Breakpoint cluster region protein OS=Mus musculus OX=10090 GN=Bcr PE=1 SV=3,GO:0002692; GO:0003014; GO:0004674; GO:0005085; GO:0005096; GO:0005524; GO:0005829; GO:0005886; GO:0006909; GO:0007264; GO:0007420; GO:0014069; GO:0016477; GO:0030036; GO:0030216; GO:0030424; GO:0032496; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043312; GO:0043314; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051649; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0106310; GO:1905517; GO:1905522; GO:2000378,actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; establishment of localization in cell [GO:0051649]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of phagocytosis [GO:0050766]; regulation of cell cycle [GO:0051726]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; response to lipopolysaccharide [GO:0032496]; small GTPase-mediated signal transduction [GO:0007264],axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003013; GO:0003014; GO:0003824; GO:0005829; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0098772; GO:0140096,"immune system process; circulatory system process; renal system process; catalytic activity; cytosol; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09656,0.513421949260681,OG_09656,FUN_041861-T1,Peve_00030447,Pocillopora_meandrina_HIv1___RNAseq.g15124.t1,three_way,98.80966666666669,FUN_041861-T1,P62333,PRS10_HUMAN,,26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42),Homo sapiens (Human),86.2,385.0,1e-189,664.1,sp|P62333|PRS10_HUMAN 26S proteasome regulatory subunit 10B OS=Homo sapiens OX=9606 GN=PSMC6 PE=1 SV=1,GO:0000502; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016234; GO:0016887; GO:0022624; GO:0030674; GO:0031597; GO:0036402; GO:0036503; GO:0042802; GO:0043161; GO:0045899; GO:0070062; GO:0090261; GO:1901800,ERAD pathway [GO:0036503]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0060090; GO:0140657,catalytic activity; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; protein catabolic process; organelle; molecular adaptor activity; ATP-dependent activity
OG_08878,0.5134190946248413,OG_08878,FUN_038277-T1,Peve_00041700,Pocillopora_meandrina_HIv1___TS.g8098.t1,three_way,74.06316666666667,FUN_038277-T1,Q0V8S9,,,,,34.8,135.0,1.4e-13,84.7,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_00403,0.5132781212379806,OG_00403,FUN_001290-T1,Peve_00037014,Pocillopora_meandrina_HIv1___TS.g4708.t1b,three_way,90.79066666666668,FUN_001290-T1,P10860,DHE3_RAT,,"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3) (Memory-related gene 2 protein) (MRG-2)",Rattus norvegicus (Rat),65.2,500.0,6.2e-198,691.8,"sp|P10860|DHE3_RAT Glutamate dehydrogenase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Glud1 PE=1 SV=2",GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0006537; GO:0006538; GO:0006541; GO:0007616; GO:0010044; GO:0019899; GO:0021549; GO:0032024; GO:0042803; GO:0043531; GO:0070403; GO:0070728; GO:0072350,cerebellum development [GO:0021549]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; long-term memory [GO:0007616]; positive regulation of insulin secretion [GO:0032024]; response to aluminum ion [GO:0010044]; tricarboxylic acid metabolic process [GO:0072350],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; L-leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005739; GO:0005783; GO:0006520; GO:0016491; GO:0043226; GO:0048856; GO:0050877,catalytic activity; mitochondrion; endoplasmic reticulum; amino acid metabolic process; oxidoreductase activity; organelle; anatomical structure development; nervous system process
OG_03103,0.5131373703741319,OG_03103,FUN_012390-T1,Peve_00022229,Pocillopora_meandrina_HIv1___RNAseq.g23656.t1,three_way,66.252,,,,,,,,,,,,,,,,,
OG_00092,0.513033375329401,OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),34.1,695.0,4.9e-100,368.2,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00092,0.513033375329401,OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),47.9,71.0,4.6e-13,79.3,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_07171,0.5128174161471516,OG_07171,FUN_032607-T1,Peve_00030641,Pocillopora_meandrina_HIv1___RNAseq.g29785.t1,three_way,97.002,FUN_032607-T1,O00487,PSDE_HUMAN,,26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1),Homo sapiens (Human),89.8,265.0,1e-135,484.2,sp|O00487|PSDE_HUMAN 26S proteasome non-ATPase regulatory subunit 14 OS=Homo sapiens OX=9606 GN=PSMD14 PE=1 SV=1,GO:0000502; GO:0000724; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0008237; GO:0008541; GO:0016579; GO:0022624; GO:0031597; GO:0034774; GO:0043161; GO:0045471; GO:0046872; GO:0061133; GO:0061136; GO:0061578; GO:0070536; GO:0070628; GO:0140492; GO:1904813,double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]",endopeptidase activator activity [GO:0061133]; K63-linked deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628],GO:0003824; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; extracellular region; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06819,0.5127342393920091,OG_06819,FUN_031725-T1,Peve_00040632,Pocillopora_meandrina_HIv1___RNAseq.g5493.t1,three_way,86.41283333333334,FUN_031725-T1,Q6P2K6,P4R3A_MOUSE,,Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1),Mus musculus (Mouse),62.4,675.0,1.2e-239,830.9,sp|Q6P2K6|P4R3A_MOUSE Serine/threonine-protein phosphatase 4 regulatory subunit 3A OS=Mus musculus OX=10090 GN=Ppp4r3a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006094; GO:0016607; GO:0019888; GO:0030289; GO:0045722,gluconeogenesis [GO:0006094]; positive regulation of gluconeogenesis [GO:0045722],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289],protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005815; GO:0005829; GO:0005975; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; carbohydrate metabolic process; organelle; molecular function regulator activity
OG_00489,0.5125708814797256,OG_00489,FUN_001455-T1,Peve_00018433,Pocillopora_meandrina_HIv1___RNAseq.g1953.t1,three_way,74.87066666666666,FUN_001455-T1,O94844,RHBT1_HUMAN,,Rho-related BTB domain-containing protein 1,Homo sapiens (Human),39.0,693.0,1.1999999999999999e-113,412.1,sp|O94844|RHBT1_HUMAN Rho-related BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RHOBTB1 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995,actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264],cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; hydrolase activity; cytoplasmic vesicle; organelle
OG_01685,0.5123738854780625,OG_01685,FUN_006917-T1,Peve_00044394,Pocillopora_meandrina_HIv1___RNAseq.g19806.t1,three_way,80.5865,FUN_006917-T1,E2RQ08,RPN1_CANLF,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1),Canis lupus familiaris (Dog) (Canis familiaris),50.0,580.0,2.0000000000000005e-165,583.9,sp|E2RQ08|RPN1_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Canis lupus familiaris OX=9615 GN=RPN1 PE=1 SV=1,GO:0005791; GO:0005829; GO:0006486; GO:0008250; GO:0018279; GO:0160226; GO:0160227,protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279],cytosol [GO:0005829]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227]; rough endoplasmic reticulum [GO:0005791],,GO:0005783; GO:0005829; GO:0006486; GO:0009101; GO:0043226; GO:1901135,endoplasmic reticulum; cytosol; protein glycosylation; glycoprotein biosynthetic process; organelle; carbohydrate derivative metabolic process
OG_05907,0.5123482926918232,OG_05907,FUN_026096-T1,Peve_00013339,Pocillopora_meandrina_HIv1___RNAseq.g10574.t1b,three_way,84.50033333333333,FUN_026096-T1,P19891,,,,,60.1,564.0,4.6e-196,685.6,sp|P19891|ASNS_CRIGR Asparagine synthetase [glutamine-hydrolyzing] OS=Cricetulus griseus OX=10029 GN=ASNS PE=2 SV=2,,,,,,
OG_10145,0.5123123531686476,OG_10145,FUN_043535-T1,Peve_00016667,Pocillopora_meandrina_HIv1___RNAseq.g8056.t1,three_way,80.87466666666667,FUN_043535-T1,O14733,,,,,44.9,256.0,1.8e-48,194.5,sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP2K7 PE=1 SV=2,,,,,,
OG_03889,0.5118656916315492,OG_03889,FUN_015442-T1,Peve_00024428,Pocillopora_meandrina_HIv1___RNAseq.g22272.t2,three_way,80.65666666666667,FUN_015442-T1,Q7KZ85,SPT6H_HUMAN,,Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),Homo sapiens (Human),55.5,1411.0,0.0,1521.5,sp|Q7KZ85|SPT6H_HUMAN Transcription elongation factor SPT6 OS=Homo sapiens OX=9606 GN=SUPT6H PE=1 SV=2,GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0031491; GO:0034728; GO:0042393; GO:0045191; GO:0051028; GO:0051147; GO:0140673,blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; regulation of isotype switching [GO:0045191]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673],nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023],DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005654; GO:0006325; GO:0016071; GO:0042393,DNA binding; RNA binding; nucleoplasm; chromatin organization; mRNA metabolic process; histone binding
OG_01059,0.5118016129131481,OG_01059,FUN_004514-T1,Peve_00044065,Pocillopora_meandrina_HIv1___RNAseq.g11652.t1,three_way,77.31266666666667,FUN_004514-T1,P54731,FAF1_MOUSE,,FAS-associated factor 1,Mus musculus (Mouse),40.6,672.0,1.3e-112,408.7,sp|P54731|FAF1_MOUSE FAS-associated factor 1 OS=Mus musculus OX=10090 GN=Faf1 PE=1 SV=2,GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0019901; GO:0019904; GO:0030155; GO:0031072; GO:0031625; GO:0034098; GO:0036337; GO:0042176; GO:0043124; GO:0043130; GO:0045732; GO:0045740; GO:0048471; GO:0051059; GO:1902043; GO:1990917,apoptotic process [GO:0006915]; Fas signaling pathway [GO:0036337]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0012501; GO:0043226,nucleus; nuclear envelope; nucleoplasm; cytosol; programmed cell death; organelle
OG_02735,0.5112588134357109,OG_02735,FUN_011273-T1,Peve_00042902,Pocillopora_meandrina_HIv1___RNAseq.g22332.t1,three_way,93.65966666666668,FUN_011273-T1,P80317,TCPZ_MOUSE,,T-complex protein 1 subunit zeta (TCP-1-zeta) (EC 3.6.1.-) (CCT-zeta-1),Mus musculus (Mouse),79.5,531.0,1e-240,833.9,sp|P80317|TCPZ_MOUSE T-complex protein 1 subunit zeta OS=Mus musculus OX=10090 GN=Cct6a PE=1 SV=3,GO:0001669; GO:0002199; GO:0005524; GO:0005832; GO:0007339; GO:0016887; GO:0044297; GO:0051082; GO:0140662,binding of sperm to zona pellucida [GO:0007339],acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; zona pellucida receptor complex [GO:0002199],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082],GO:0003824; GO:0016787; GO:0031410; GO:0043226; GO:0044183; GO:0140657,catalytic activity; hydrolase activity; cytoplasmic vesicle; organelle; protein folding chaperone; ATP-dependent activity
OG_03286,0.5112161977760757,OG_03286,FUN_013326-T1,Peve_00022536,Pocillopora_meandrina_HIv1___RNAseq.g13101.t1,three_way,85.618,FUN_013326-T1,A8JF70,ODA1_CHLRE,,Outer dynein arm protein 1 (Docking complex component 2),Chlamydomonas reinhardtii (Chlamydomonas smithii),32.0,500.0,5.699999999999999e-53,210.3,sp|A8JF70|ODA1_CHLRE Outer dynein arm protein 1 OS=Chlamydomonas reinhardtii OX=3055 GN=ODA1 PE=1 SV=1,GO:0036157; GO:0036158; GO:0060294,cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],outer dynein arm [GO:0036157],,GO:0007018; GO:0065003,microtubule-based movement; protein-containing complex assembly
OG_03334,0.5112062064931169,OG_03334,FUN_013555-T1,Peve_00024216,Pocillopora_meandrina_HIv1___RNAseq.g22959.t1,three_way,90.33133333333332,FUN_013555-T1,Q9YHT2,,,,,83.1,249.0,8.500000000000001e-126,451.4,"sp|Q9YHT2|SDHB_CHICK Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial OS=Gallus gallus OX=9031 GN=SDHB PE=1 SV=1",,,,,,
OG_06673,0.5110415625994961,OG_06673,FUN_031076-T1,Peve_00028143,Pocillopora_meandrina_HIv1___RNAseq.g30318.t1,three_way,70.30116666666667,FUN_031076-T1,Q14919,NC2A_HUMAN,,Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha),Homo sapiens (Human),77.4,93.0,4.2e-34,146.4,sp|Q14919|NC2A_HUMAN Dr1-associated corepressor OS=Homo sapiens OX=9606 GN=DRAP1 PE=1 SV=3,GO:0000122; GO:0001046; GO:0001091; GO:0005634; GO:0006366; GO:0016251; GO:0017025; GO:0017054; GO:0042802; GO:0046982; GO:0090575,negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366],negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],core promoter sequence-specific DNA binding [GO:0001046]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025],GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140223,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_06700,0.510738834846637,OG_06700,FUN_031267-T1,Peve_00036736,Pocillopora_meandrina_HIv1___RNAseq.11406_t,three_way,69.776,FUN_031267-T1,P20072,,,,,40.6,313.0,1.1000000000000001e-60,237.3,sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2,,,,,,
OG_03074,0.5105932105329775,OG_03074,FUN_012346-T1,Peve_00012047,Pocillopora_meandrina_HIv1___RNAseq.g24067.t1,three_way,82.01583333333333,FUN_012346-T1,Q7ZVB1,,,,,81.2,197.0,8.7e-44,178.3,sp|Q7ZVB1|CHM1B_DANRE Charged multivesicular body protein 1b OS=Danio rerio OX=7955 GN=chmp1b PE=2 SV=1,,,,,,
OG_05144,0.5103945248881503,OG_05144,FUN_023420-T1,Peve_00019213,Pocillopora_meandrina_HIv1___RNAseq.g581.t1,three_way,86.11033333333333,FUN_023420-T1,Q5ZIG2,SLU7_CHICK,,Pre-mRNA-splicing factor SLU7,Gallus gallus (Chicken),65.2,543.0,4.0999999999999996e-181,636.0,sp|Q5ZIG2|SLU7_CHICK Pre-mRNA-splicing factor SLU7 OS=Gallus gallus OX=9031 GN=SLU7 PE=2 SV=1,GO:0000398; GO:0005681; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0030628,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270],GO:0003723; GO:0016071; GO:0043226,RNA binding; mRNA metabolic process; organelle
OG_06543,0.5103653360220832,OG_06543,FUN_029412-T1,Peve_00028187,Pocillopora_meandrina_HIv1___TS.g2914.t1,three_way,80.83733333333333,FUN_029412-T1,Q9HBH9,,,,,65.3,242.0,6.9e-94,345.5,sp|Q9HBH9|MKNK2_HUMAN MAP kinase-interacting serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MKNK2 PE=1 SV=3,,,,,,
OG_00685,0.5103315200888114,OG_00685,FUN_002352-T1,Peve_00022332,Pocillopora_meandrina_HIv1___RNAseq.g33.t1,three_way,56.47666666666667,FUN_002352-T1,Q69ZL1,,,,,41.2,658.0,7.2e-121,437.6,"sp|Q69ZL1|FGD6_MOUSE FYVE, RhoGEF and PH domain-containing protein 6 OS=Mus musculus OX=10090 GN=Fgd6 PE=1 SV=2",,,,,,
OG_05736,0.5101971225046974,OG_05736,FUN_025662-T1,Peve_00042169,Pocillopora_meandrina_HIv1___RNAseq.g23063.t1,three_way,85.11566666666667,FUN_025662-T1,P39656,OST48_HUMAN,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit),Homo sapiens (Human),69.1,414.0,8.6e-169,594.7,sp|P39656|OST48_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens OX=9606 GN=DDOST PE=1 SV=4,GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0006487; GO:0008047; GO:0008250; GO:0016020; GO:0018279; GO:0031647; GO:0034097; GO:0035577; GO:0042110; GO:0043231; GO:0160226; GO:0160227,protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110],azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227]; plasma membrane [GO:0005886],enzyme activator activity [GO:0008047],GO:0002376; GO:0005783; GO:0005886; GO:0006486; GO:0009101; GO:0043226; GO:0098772; GO:1901135,immune system process; endoplasmic reticulum; plasma membrane; protein glycosylation; glycoprotein biosynthetic process; organelle; molecular function regulator activity; carbohydrate derivative metabolic process
OG_06683,0.510084960807032,OG_06683,FUN_031186-T1,Peve_00041875,Pocillopora_meandrina_HIv1___RNAseq.g5214.t1,three_way,69.12466666666667,FUN_031186-T1,P25500,,,,,64.8,491.0,5.8e-181,636.0,sp|P25500|PAPOA_BOVIN Poly(A) polymerase alpha OS=Bos taurus OX=9913 GN=PAPOLA PE=1 SV=3,,,,,,
OG_06429,0.5097088584889571,OG_06429,FUN_029122-T1,Peve_00016285,Pocillopora_meandrina_HIv1___RNAseq.g25777.t1,three_way,63.29733333333333,FUN_029122-T1,C5FP68,,,,,30.2,202.0,2.1e-24,116.3,sp|C5FP68|SCONB_ARTOC Probable E3 ubiquitin ligase complex SCF subunit sconB OS=Arthroderma otae (strain ATCC MYA-4605 / CBS 113480) OX=554155 GN=sconB PE=3 SV=1,,,,,,
OG_03521,0.509569457980684,OG_03521,FUN_014636-T1,Peve_00002422,Pocillopora_meandrina_HIv1___RNAseq.g22791.t1,three_way,71.30749999999999,FUN_014636-T1,Q8N309,,,,,37.9,348.0,9.999999999999999e-54,213.0,sp|Q8N309|LRC43_HUMAN Leucine-rich repeat-containing protein 43 OS=Homo sapiens OX=9606 GN=LRRC43 PE=1 SV=2,,,,,,
OG_08962,0.5092922694615007,OG_08962,FUN_038456-T1,Peve_00020975,Pocillopora_meandrina_HIv1___RNAseq.g28256.t1,three_way,69.28483333333334,FUN_038456-T1,Q5RA17,,,,,43.3,261.0,7.999999999999999e-50,198.7,sp|Q5RA17|RRP7A_PONAB Ribosomal RNA-processing protein 7 homolog A OS=Pongo abelii OX=9601 GN=RRP7A PE=2 SV=1,,,,,,
OG_02284,0.5091671102324276,OG_02284,FUN_008781-T1,Peve_00042606,Pocillopora_meandrina_HIv1___RNAseq.g12693.t1,three_way,80.42633333333333,,,,,,,,,,,,,,,,,
OG_08571,0.5091272763213759,OG_08571,FUN_037573-T1,Peve_00035298,Pocillopora_meandrina_HIv1___RNAseq.g1590.t1,three_way,98.75133333333332,FUN_037573-T1,O42586,,,,,85.2,405.0,2.1000000000000001e-196,686.4,sp|O42586|PR6AB_XENLA 26S proteasome regulatory subunit 6A-B OS=Xenopus laevis OX=8355 GN=psmc3-b PE=2 SV=1,,,,,,
OG_09748,0.5091088769318268,OG_09748,FUN_042017-T1,Peve_00044151,Pocillopora_meandrina_HIv1___RNAseq.g15194.t1,three_way,79.5055,FUN_042017-T1,B5FXE5,FSP1_TAEGU,,Ferroptosis suppressor protein 1 (FSP1) (EC 1.6.5.-) (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death) (AMID) (p53-responsive gene 3 protein),Taeniopygia guttata (Zebra finch) (Poephila guttata),39.4,373.0,2.0999999999999998e-70,267.7,sp|B5FXE5|FSP1_TAEGU Ferroptosis suppressor protein 1 OS=Taeniopygia guttata OX=59729 GN=AIFM2 PE=2 SV=1,GO:0004174; GO:0005634; GO:0005811; GO:0005886; GO:0008637; GO:0016655; GO:0031966; GO:0042373; GO:0043065; GO:0050660,apoptotic mitochondrial changes [GO:0008637]; positive regulation of apoptotic process [GO:0043065]; vitamin K metabolic process [GO:0042373],lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]",GO:0003824; GO:0005634; GO:0005811; GO:0005886; GO:0007005; GO:0016491; GO:0043226,catalytic activity; nucleus; lipid droplet; plasma membrane; mitochondrion organization; oxidoreductase activity; organelle
OG_05146,0.5090778045016501,OG_05146,FUN_023423-T1,Peve_00019215,Pocillopora_meandrina_HIv1___RNAseq.g583.t1,three_way,90.14433333333334,FUN_023423-T1,Q5R416,CTNA2_PONAB,,Catenin alpha-2 (Alpha N-catenin),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),41.2,1200.0,2.9000000000000003e-214,747.3,sp|Q5R416|CTNA2_PONAB Catenin alpha-2 OS=Pongo abelii OX=9601 GN=CTNNA2 PE=2 SV=3,GO:0005198; GO:0005634; GO:0005737; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222,axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0043226; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; organelle; cell motility
OG_03785,0.5090398710589682,OG_03785,FUN_015145-T1,Peve_00001083,Pocillopora_meandrina_HIv1___RNAseq.g21746.t2,three_way,73.53316666666667,FUN_015145-T1,Q640I9,,,,,30.3,1123.0,1.7999999999999998e-141,505.0,sp|Q640I9|KDM2B_XENLA Lysine-specific demethylase 2B OS=Xenopus laevis OX=8355 GN=kdm2b PE=2 SV=1,,,,,,
OG_04364,0.5087884368076601,OG_04364,FUN_018017-T1,Peve_00026632,Pocillopora_meandrina_HIv1___RNAseq.g25291.t1,three_way,96.487,FUN_018017-T1,Q5ZHW4,RAB5B_CHICK,,Ras-related protein Rab-5B (EC 3.6.5.2),Gallus gallus (Chicken),90.2,153.0,3.8e-75,282.3,sp|Q5ZHW4|RAB5B_CHICK Ras-related protein Rab-5B OS=Gallus gallus OX=9031 GN=RAB5B PE=2 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0012505; GO:0019003; GO:0030139; GO:0031901,endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005886; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0098772,catalytic activity; GTPase activity; endosome; plasma membrane; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_05975,0.508654839352723,OG_05975,FUN_026395-T1,Peve_00028957,Pocillopora_meandrina_HIv1___RNAseq.g2940.t1,three_way,69.13300000000001,FUN_026395-T1,A7S1H9,,,,,55.6,90.0,2.5e-21,102.8,"sp|A7S1H9|SDHF3_NEMVE Succinate dehydrogenase assembly factor 3, mitochondrial OS=Nematostella vectensis OX=45351 GN=acn9 PE=3 SV=1",,,,,,
OG_07803,0.5086372458843599,OG_07803,FUN_035039-T1,Peve_00044750,Pocillopora_meandrina_HIv1___TS.g15093.t1,three_way,84.09616666666668,FUN_035039-T1,Q96GQ7,,,,,59.6,287.0,5.999999999999999e-84,312.4,sp|Q96GQ7|DDX27_HUMAN Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=3,,,,,,
OG_01597,0.5086263858177402,OG_01597,FUN_006639-T1,Peve_00033034,Pocillopora_meandrina_HIv1___RNAseq.g20239.t1,three_way,79.87783333333333,FUN_006639-T1,P53992,SC24C_HUMAN,,Protein transport protein Sec24C (SEC24-related protein C),Homo sapiens (Human),58.8,770.0,3.3e-276,953.0,sp|P53992|SC24C_HUMAN Protein transport protein Sec24C OS=Homo sapiens OX=9606 GN=SEC24C PE=1 SV=3,GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0070971; GO:0090110,COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507],SNARE binding [GO:0000149]; zinc ion binding [GO:0008270],GO:0005829; GO:0006886; GO:0016192; GO:0048856,cytosol; intracellular protein transport; vesicle-mediated transport; anatomical structure development
OG_08051,0.5085752917219964,OG_08051,FUN_035742-T1,Peve_00026223,Pocillopora_meandrina_HIv1___RNAseq.g11866.t1,three_way,82.196,FUN_035742-T1,Q9W1Y1,,,,,43.8,130.0,5.1e-26,119.0,sp|Q9W1Y1|EMC89_DROME ER membrane protein complex subunit 8/9 homolog OS=Drosophila melanogaster OX=7227 GN=EMC8-9 PE=1 SV=1,,,,,,
OG_01464,0.5083080315740498,OG_01464,FUN_006000-T1,Peve_00036040,Pocillopora_meandrina_HIv1___RNAseq.3462_t,three_way,85.708,FUN_006000-T1,Q8CIH9,PUR1_MOUSE,,Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT),Mus musculus (Mouse),60.8,533.0,4.7e-179,629.0,sp|Q8CIH9|PUR1_MOUSE Amidophosphoribosyltransferase OS=Mus musculus OX=10090 GN=Ppat PE=1 SV=1,GO:0004044; GO:0006177; GO:0006189; GO:0009113; GO:0044208; GO:0046872; GO:0051539; GO:0097294,'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113],,"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]",GO:0003824; GO:0016740; GO:0055086; GO:1901135,catalytic activity; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00571,0.5082102172728316,OG_00571,FUN_001630-T1,Peve_00009934,Pocillopora_meandrina_HIv1___RNAseq.g2163.t1,three_way,60.408,FUN_001630-T1,Q7KM13,,,,,40.7,167.0,8.1e-17,90.1,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_02627,0.5081363858747979,OG_02627,FUN_010779-T1,Peve_00004487,Pocillopora_meandrina_HIv1___TS.g25955.t1,three_way,91.82266666666666,FUN_010779-T1,Q9D1P2,KAT8_MOUSE,,"Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Males-absent on the first protein homolog) (mMof) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-)",Mus musculus (Mouse),76.1,397.0,6.4e-180,631.7,sp|Q9D1P2|KAT8_MOUSE Histone acetyltransferase KAT8 OS=Mus musculus OX=10090 GN=Kat8 PE=1 SV=1,GO:0000123; GO:0000776; GO:0003713; GO:0005634; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010506; GO:0010719; GO:0016363; GO:0016407; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0035166; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:1902726; GO:1903108; GO:1990841,dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; mitochondrion; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07670,0.5080780683742252,OG_07670,FUN_034727-T1,Peve_00033249,Pocillopora_meandrina_HIv1___RNAseq.g28714.t1,three_way,89.599,FUN_034727-T1,Q93009,UBP7_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7),Homo sapiens (Human),59.7,1090.0,0.0,1328.5,sp|Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=2,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006283; GO:0006307; GO:0006508; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0042752; GO:0044027; GO:0045721; GO:0048511; GO:0050821; GO:0051090; GO:0070203; GO:0075342; GO:0101005; GO:1901796; GO:1904262; GO:1904353; GO:1905279; GO:1990380,"DNA alkylation repair [GO:0006307]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of TORC1 signaling [GO:1904262]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of establishment of protein localization to telomere [GO:0070203]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; symbiont-mediated disruption of host cell PML body [GO:0075342]; transcription-coupled nucleotide-excision repair [GO:0006283]",chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07280,0.5074319735283801,OG_07280,FUN_033223-T1,Peve_00021001,Pocillopora_meandrina_HIv1___RNAseq.g29776.t1,three_way,67.0795,,,,,,,,,,,,,,,,,
OG_04605,0.5071275958508441,OG_04605,FUN_022295-T1,Peve_00003689,Pocillopora_meandrina_HIv1___RNAseq.g4689.t1,three_way,77.32466666666667,FUN_022295-T1,Q6P5U8,,,,,35.1,535.0,8e-40,166.8,sp|Q6P5U8|CC148_MOUSE Coiled-coil domain-containing protein 148 OS=Mus musculus OX=10090 GN=Ccdc148 PE=2 SV=1,,,,,,
OG_09039,0.5070410099812335,OG_09039,FUN_038685-T1,Peve_00013482,Pocillopora_meandrina_HIv1___TS.g19231.t1,three_way,85.41833333333334,FUN_038685-T1,Q96QU8,,,,,53.9,1170.0,0.0,1206.0,sp|Q96QU8|XPO6_HUMAN Exportin-6 OS=Homo sapiens OX=9606 GN=XPO6 PE=1 SV=1,,,,,,
OG_03558,0.5070184553614336,OG_03558,FUN_014704-T1,Peve_00021212,Pocillopora_meandrina_HIv1___RNAseq.g22535.t1,three_way,50.87083333333333,,,,,,,,,,,,,,,,,
OG_03547,0.5069861652573104,OG_03547,FUN_014674-T1,Peve_00014503,Pocillopora_meandrina_HIv1___RNAseq.g22585.t1,three_way,70.135,FUN_014674-T1,Q9JKV2,CILK1_MOUSE,,Serine/threonine-protein kinase ICK (EC 2.7.11.1) (Intestinal cell kinase) (mICK) (MAK-related kinase) (MRK),Mus musculus (Mouse),80.5,287.0,3.8e-139,496.5,sp|Q9JKV2|CILK1_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus OX=10090 GN=Cilk1 PE=1 SV=2,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005929; GO:0006468; GO:0007165; GO:0035556; GO:0035720; GO:0035721; GO:0036064; GO:0042073; GO:0060271; GO:0097542; GO:0097546; GO:0106310,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; cilium; microtubule-based movement; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_00255,0.5069670413657019,OG_00255,FUN_001019-T1,Peve_00041047,Pocillopora_meandrina_HIv1___RNAseq.g29550.t1,three_way,74.728,FUN_001019-T1,E1C1R4,,,,,44.2,1361.0,1.6999999999999999e-301,1036.9,sp|E1C1R4|UBP47_CHICK Ubiquitin carboxyl-terminal hydrolase 47 OS=Gallus gallus OX=9031 GN=USP47 PE=3 SV=1,,,,,,
OG_03066,0.5067642405981756,OG_03066,FUN_012333-T1,Peve_00028481,Pocillopora_meandrina_HIv1___RNAseq.g23758.t1,three_way,69.9595,FUN_012333-T1,O43524,,,,,35.0,546.0,2e-50,201.8,sp|O43524|FOXO3_HUMAN Forkhead box protein O3 OS=Homo sapiens OX=9606 GN=FOXO3 PE=1 SV=1,,,,,,
OG_08929,0.5064578750262496,OG_08929,FUN_038387-T1,Peve_00000060,Pocillopora_meandrina_HIv1___RNAseq.g28287.t1,three_way,63.87316666666666,FUN_038387-T1,P55202,,,,,36.6,940.0,3e-137,491.1,sp|P55202|ANPRB_ANGJA Atrial natriuretic peptide receptor 2 OS=Anguilla japonica OX=7937 GN=npr2 PE=2 SV=1,,,,,,
OG_05035,0.5064493911985549,OG_05035,FUN_023216-T1,Peve_00029820,Pocillopora_meandrina_HIv1___RNAseq.g691.t1,three_way,77.107,FUN_023216-T1,Q90XN9,,,,,68.3,126.0,2e-36,154.1,sp|Q90XN9|HMX3B_ORYLA Homeobox protein HMX3-B OS=Oryzias latipes OX=8090 GN=hmx3b PE=2 SV=1,,,,,,
OG_04406,0.5061832680679095,OG_04406,FUN_018424-T1,Peve_00031688,Pocillopora_meandrina_HIv1___RNAseq.g10173.t1,three_way,88.72733333333333,FUN_018424-T1,P24156,,,,,76.4,271.0,1.7e-111,403.7,sp|P24156|PHB1_DROME Prohibitin 1 OS=Drosophila melanogaster OX=7227 GN=Phb1 PE=2 SV=2,,,,,,
OG_08483,0.5060783557869892,OG_08483,FUN_037317-T1,Peve_00009173,Pocillopora_meandrina_HIv1___RNAseq.g24177.t1,three_way,64.93,FUN_037317-T1,O73888,,,,,38.0,216.0,6.1e-27,122.5,sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3,,,,,,
OG_09910,0.5060289598127631,OG_09910,FUN_043008-T1,Peve_00017770,Pocillopora_meandrina_HIv1___RNAseq.g7032.t1,three_way,89.62533333333333,FUN_043008-T1,Q9JKK1,STX6_MOUSE,,Syntaxin-6,Mus musculus (Mouse),50.4,232.0,1.3e-55,218.0,sp|Q9JKK1|STX6_MOUSE Syntaxin-6 OS=Mus musculus OX=10090 GN=Stx6 PE=1 SV=1,GO:0000139; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0016020; GO:0019905; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048471; GO:0055037; GO:0055038,"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]",cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905],GO:0005654; GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; endosome; Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization
OG_08988,0.5059262723663958,OG_08988,FUN_038508-T1,Peve_00041683,Pocillopora_meandrina_HIv1___RNAseq.g28175.t1,three_way,84.98566666666667,FUN_038508-T1,P10644,KAP0_HUMAN,,cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1),Homo sapiens (Human),70.1,374.0,1.1e-140,501.1,sp|P10644|KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR1A PE=1 SV=1,GO:0001707; GO:0004862; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005952; GO:0006357; GO:0007189; GO:0008603; GO:0010629; GO:0016020; GO:0019904; GO:0030552; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032991; GO:0034236; GO:0035556; GO:0044853; GO:0045214; GO:0046007; GO:0060038; GO:0071377; GO:0097546; GO:0098978; GO:0120212; GO:0141162,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cardiac muscle cell proliferation [GO:0060038]; cellular response to glucagon stimulus [GO:0071377]; intracellular signal transduction [GO:0035556]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of gene expression [GO:0010629]; positive regulation of insulin secretion [GO:0032024]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuromuscular junction [GO:0031594]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sperm head-tail coupling apparatus [GO:0120212],cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625],GO:0005768; GO:0005815; GO:0005829; GO:0006355; GO:0007010; GO:0031410; GO:0043226; GO:0098772,endosome; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_07863,0.5057629319587792,OG_07863,FUN_035220-T1,Peve_00035885,Pocillopora_meandrina_HIv1___RNAseq.g27612.t1,three_way,83.25133333333333,FUN_035220-T1,D3YXS5,,,,,37.8,932.0,1.3e-153,545.4,sp|D3YXS5|KIF28_MOUSE Kinesin-like protein KIF28 OS=Mus musculus OX=10090 GN=Kif28 PE=3 SV=1,,,,,,
OG_04357,0.5056515326588483,OG_04357,FUN_018007-T1,Peve_00015729,Pocillopora_meandrina_HIv1___RNAseq.g25257.t1,three_way,73.35633333333334,FUN_018007-T1,E7FCP8,NAGS_DANRE,,"N-acetylglutamate synthase, mitochondrial (EC 2.3.1.1) [Cleaved into: N-acetylglutamate synthase, mature form (NAGS-M); N-acetylglutamate synthase, conserved domain form (NAGS-C)]",Danio rerio (Zebrafish) (Brachydanio rerio),41.3,453.0,7.5e-89,329.3,"sp|E7FCP8|NAGS_DANRE N-acetylglutamate synthase, mitochondrial OS=Danio rerio OX=7955 GN=nags PE=1 SV=1",GO:0000050; GO:0004042; GO:0005759; GO:0006526; GO:0006536; GO:0034618,glutamate metabolic process [GO:0006536]; L-arginine biosynthetic process [GO:0006526]; urea cycle [GO:0000050],mitochondrial matrix [GO:0005759],arginine binding [GO:0034618]; L-glutamate N-acetyltransferase activity [GO:0004042],GO:0003824; GO:0006520; GO:0016740; GO:0071941,catalytic activity; amino acid metabolic process; transferase activity; nitrogen cycle metabolic process
OG_01711,0.5054587542255977,OG_01711,FUN_006985-T1,Peve_00045265,Pocillopora_meandrina_HIv1___RNAseq.g20222.t1,three_way,77.84,FUN_006985-T1,Q05086,UBE3A_HUMAN,,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54),Homo sapiens (Human),53.1,755.0,9.8e-221,768.1,sp|Q05086|UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens OX=9606 GN=UBE3A PE=1 SV=4,GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0008021; GO:0008270; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042752; GO:0043161; GO:0045944; GO:0048167; GO:0048511; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061630; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:2000058,androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021],transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016192; GO:0016740; GO:0022414; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; vesicle-mediated transport; transferase activity; reproductive process; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_06654,0.5053736882021097,OG_06654,FUN_030679-T1,Peve_00028159,Pocillopora_meandrina_HIv1___RNAseq.g30326.t1,three_way,92.19966666666669,FUN_030679-T1,Q7TN83,SYT16_MOUSE,,Synaptotagmin-16 (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein),Mus musculus (Mouse),44.2,303.0,5.6e-64,246.5,sp|Q7TN83|SYT16_MOUSE Synaptotagmin-16 OS=Mus musculus OX=10090 GN=Syt16 PE=1 SV=1,GO:0005543; GO:0016020; GO:0042802,,membrane [GO:0016020],identical protein binding [GO:0042802]; phospholipid binding [GO:0005543],GO:0008289,lipid binding
OG_02698,0.5053066501186073,OG_02698,FUN_010966-T1,Peve_00007917,Pocillopora_meandrina_HIv1___RNAseq.g21968.t1,three_way,49.817166666666665,,,,,,,,,,,,,,,,,
OG_04289,0.5052490779183352,OG_04289,FUN_017852-T1,Peve_00019989,Pocillopora_meandrina_HIv1___RNAseq.g9580.t1,three_way,97.72366666666667,FUN_017852-T1,O73817,,,,,79.5,205.0,1.4e-94,347.1,sp|O73817|PSB3_ONCMY Proteasome subunit beta type-3 OS=Oncorhynchus mykiss OX=8022 GN=psmb3 PE=2 SV=1,,,,,,
OG_06201,0.5052428212095355,OG_06201,FUN_028135-T1,Peve_00004259,Pocillopora_meandrina_HIv1___RNAseq.g15553.t1,three_way,87.28,FUN_028135-T1,P53619,COPD_BOVIN,,Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP),Bos taurus (Bovine),59.6,512.0,5.2e-170,599.0,sp|P53619|COPD_BOVIN Coatomer subunit delta OS=Bos taurus OX=9913 GN=ARCN1 PE=1 SV=1,GO:0000139; GO:0005783; GO:0006888; GO:0006890; GO:0006891; GO:0008344; GO:0015031; GO:0021691; GO:0030126; GO:0043473; GO:0051645,"adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intra-Golgi vesicle-mediated transport [GO:0006891]; pigmentation [GO:0043473]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139],,GO:0005783; GO:0016192; GO:0043226,endoplasmic reticulum; vesicle-mediated transport; organelle
OG_04246,0.504920295614337,OG_04246,FUN_017768-T1,Peve_00008289,Pocillopora_meandrina_HIv1___RNAseq.g461.t1,three_way,94.55683333333332,FUN_017768-T1,P51665,PSMD7_HUMAN,,26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40),Homo sapiens (Human),79.5,273.0,5.9999999999999985e-127,455.3,sp|P51665|PSMD7_HUMAN 26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMD7 PE=1 SV=2,GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774],protein homodimerization activity [GO:0042803],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,extracellular region; nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_04236,0.5048917387269445,OG_04236,FUN_017757-T1,Peve_00033745,Pocillopora_meandrina_HIv1___RNAseq.g426.t1,three_way,66.6565,FUN_017757-T1,Q5SS90,,,,,34.7,245.0,5.6e-26,119.8,sp|Q5SS90|CG057_MOUSE Uncharacterized protein C7orf57 homolog OS=Mus musculus OX=10090 GN=Gm11992 PE=1 SV=1,,,,,,
OG_09544,0.504863816681183,OG_09544,FUN_041639-T1,Peve_00007388,Pocillopora_meandrina_HIv1___RNAseq.g14209.t1,three_way,52.72933333333334,,,,,,,,,,,,,,,,,
OG_03291,0.5048181624578596,OG_03291,FUN_013350-T1,Peve_00041996,Pocillopora_meandrina_HIv1___TS.g2168.t1a,three_way,66.735,FUN_013350-T1,Q8CBF3,EPHB1_MOUSE,,Ephrin type-B receptor 1 (EC 2.7.10.1),Mus musculus (Mouse),38.3,975.0,3.2e-176,620.5,sp|Q8CBF3|EPHB1_MOUSE Ephrin type-B receptor 1 OS=Mus musculus OX=10090 GN=Ephb1 PE=1 SV=1,GO:0001525; GO:0001771; GO:0005005; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007411; GO:0008046; GO:0014719; GO:0016020; GO:0021545; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070372; GO:0098978; GO:1902723; GO:1902725,angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; cranial nerve development [GO:0021545]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein-containing complex binding [GO:0044877]; transmembrane-ephrin receptor activity [GO:0005005],GO:0003824; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007163; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endoplasmic reticulum; cytosol; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; transferase activity; cell differentiation; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_00892,0.5047387858032027,OG_00892,FUN_004207-T1,Peve_00011047,Pocillopora_meandrina_HIv1___RNAseq.g11217.t1,three_way,88.71266666666666,FUN_004207-T1,Q28GD4,,,,,45.9,362.0,7.100000000000001e-73,275.8,sp|Q28GD4|ELAV2_XENTR ELAV-like protein 2 OS=Xenopus tropicalis OX=8364 GN=elavl2 PE=2 SV=2,,,,,,
OG_04027,0.5045574906240963,OG_04027,FUN_016334-T1,Peve_00044548,Pocillopora_meandrina_HIv1___RNAseq.g9843.t1,three_way,85.18666666666667,FUN_016334-T1,P60467,,,,,59.6,89.0,2.3e-18,93.2,sp|P60467|SC61B_CANLF Protein transport protein Sec61 subunit beta OS=Canis lupus familiaris OX=9615 GN=SEC61B PE=1 SV=2,,,,,,
OG_10111,0.5043376764991137,OG_10111,FUN_043481-T1,Peve_00021726,Pocillopora_meandrina_HIv1___RNAseq.g7917.t1,three_way,78.01516666666667,FUN_043481-T1,Q6GLQ4,,,,,30.6,710.0,2.3999999999999998e-39,165.6,sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1,,,,,,
OG_01124,0.5043192504537929,OG_01124,FUN_004693-T1,Peve_00003276,Pocillopora_meandrina_HIv1___RNAseq.g8747.t1,three_way,73.396,,,,,,,,,,,,,,,,,
OG_08324,0.5041984964736085,OG_08324,FUN_036753-T1,Peve_00001060,Pocillopora_meandrina_HIv1___RNAseq.g12113.t1,three_way,78.39483333333332,FUN_036753-T1,Q2V2M9,FHOD3_HUMAN,,FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2),Homo sapiens (Human),42.2,1460.0,2.6000000000000004e-214,747.7,sp|Q2V2M9|FHOD3_HUMAN FH1/FH2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FHOD3 PE=1 SV=2,GO:0005737; GO:0005856; GO:0030018; GO:0030866; GO:0045214; GO:0051015; GO:0055003,cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; sarcomere organization [GO:0045214],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018],actin filament binding [GO:0051015],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_09833,0.5039684356217691,OG_09833,FUN_042810-T1,Peve_00028055,Pocillopora_meandrina_HIv1___RNAseq.g7427.t1,three_way,89.57733333333333,FUN_042810-T1,Q9R1P4,PSA1_MOUSE,,Proteasome subunit alpha type-1 (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain) (Proteasome subunit alpha-6) (alpha-6),Mus musculus (Mouse),76.5,243.0,6.3e-109,395.2,sp|Q9R1P4|PSA1_MOUSE Proteasome subunit alpha type-1 OS=Mus musculus OX=10090 GN=Psma1 PE=1 SV=1,GO:0000502; GO:0001530; GO:0002376; GO:0002862; GO:0005654; GO:0005813; GO:0005829; GO:0005839; GO:0006511; GO:0019773,immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; ubiquitin-dependent protein catabolic process [GO:0006511],"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]",lipopolysaccharide binding [GO:0001530],GO:0002376; GO:0005654; GO:0005815; GO:0005829; GO:0008289,immune system process; nucleoplasm; microtubule organizing center; cytosol; lipid binding
OG_01815,0.5039125718489327,OG_01815,FUN_007678-T1,Peve_00013716,Pocillopora_meandrina_HIv1___RNAseq.g5864.t1,three_way,73.167,FUN_007678-T1,O95433,,,,,47.3,347.0,9.9e-88,325.1,sp|O95433|AHSA1_HUMAN Activator of 90 kDa heat shock protein ATPase homolog 1 OS=Homo sapiens OX=9606 GN=AHSA1 PE=1 SV=1,,,,,,
OG_03196,0.5038237319702074,OG_03196,FUN_012675-T1,Peve_00025241,Pocillopora_meandrina_HIv1___RNAseq.g22881.t1,three_way,86.62966666666667,FUN_012675-T1,Q9UNL2,,,,,60.6,180.0,9.9e-55,214.5,sp|Q9UNL2|SSRG_HUMAN Translocon-associated protein subunit gamma OS=Homo sapiens OX=9606 GN=SSR3 PE=1 SV=1,,,,,,
OG_03476,0.5037442902939995,OG_03476,FUN_014567-T1,Peve_00009686,Pocillopora_meandrina_HIv1___RNAseq.g22708.t1,three_way,95.495,FUN_014567-T1,O44437,,,,,81.4,118.0,1.0999999999999999e-47,190.7,sp|O44437|SMD3_DROME Small nuclear ribonucleoprotein Sm D3 OS=Drosophila melanogaster OX=7227 GN=SmD3 PE=1 SV=1,,,,,,
OG_02839,0.5037347998334323,OG_02839,FUN_011863-T1,Peve_00006756,Pocillopora_meandrina_HIv1___RNAseq.g23387.t1,three_way,83.105,FUN_011863-T1,Q24439,,,,,45.1,206.0,5.8e-44,179.1,"sp|Q24439|ATPO_DROME ATP synthase subunit O, mitochondrial OS=Drosophila melanogaster OX=7227 GN=ATPsynO PE=2 SV=2",,,,,,
OG_09990,0.5036269929245607,OG_09990,FUN_043192-T1,Peve_00039864,Pocillopora_meandrina_HIv1___RNAseq.g6808.t1,three_way,67.83833333333334,FUN_043192-T1,Q12904,AIMP1_HUMAN,,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)],Homo sapiens (Human),49.2,315.0,8.1e-58,225.7,sp|Q12904|AIMP1_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens OX=9606 GN=AIMP1 PE=1 SV=2,GO:0000049; GO:0001525; GO:0001937; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006412; GO:0006915; GO:0006954; GO:0007267; GO:0009986; GO:0016020; GO:0017101; GO:0042803; GO:0050900; GO:0051020; GO:0051607; GO:0070094,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634],cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049],GO:0002376; GO:0003723; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0012501; GO:0023052; GO:0043226; GO:0048018; GO:0048870; GO:0098772,immune system process; RNA binding; extracellular space; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; inflammatory response; programmed cell death; signaling; organelle; receptor ligand activity; cell motility; molecular function regulator activity
OG_04261,0.5036101875080011,OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,54.0,767.0,3.7e-223,777.3,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_04261,0.5036101875080011,OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,38.5,78.0,0.002,47.4,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_05047,0.5035725667441523,OG_05047,FUN_023236-T1,Peve_00029852,Pocillopora_meandrina_HIv1___TS.g16967.t1,three_way,66.868,FUN_023236-T1,Q8AW42,,,,,44.2,353.0,1.7e-70,268.1,sp|Q8AW42|S39AD_DANRE Zinc transporter ZIP13 OS=Danio rerio OX=7955 GN=slc39a13 PE=2 SV=1,,,,,,
OG_08501,0.5035434920829434,OG_08501,FUN_037385-T1,Peve_00014721,Pocillopora_meandrina_HIv1___RNAseq.g26899.t1,three_way,86.40616666666666,FUN_037385-T1,Q8K4Z5,,,,,62.7,762.0,3.3e-170,600.1,sp|Q8K4Z5|SF3A1_MOUSE Splicing factor 3A subunit 1 OS=Mus musculus OX=10090 GN=Sf3a1 PE=1 SV=1,,,,,,
OG_01664,0.5033749861682952,OG_01664,FUN_006847-T1,Peve_00023782,Pocillopora_meandrina_HIv1___TS.g29850.t1,three_way,69.21333333333334,FUN_006847-T1,Q32LC7,G3BP1_BOVIN,,Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA/RNA helicase G3BP),Bos taurus (Bovine),34.1,446.0,6.8e-48,193.4,sp|Q32LC7|G3BP1_BOVIN Ras GTPase-activating protein-binding protein 1 OS=Bos taurus OX=9913 GN=G3BP1 PE=2 SV=1,GO:0003677; GO:0003678; GO:0003724; GO:0003729; GO:0004519; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0016887; GO:0033677; GO:0034063; GO:0043024; GO:0043204; GO:0045087; GO:0140693,innate immune response [GO:0045087]; stress granule assembly [GO:0034063],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/RNA helicase activity [GO:0033677]; endonuclease activity [GO:0004519]; molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; ribosomal small subunit binding [GO:0043024]; RNA helicase activity [GO:0003724],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060090; GO:0098542; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; cytosol; hydrolase activity; isomerase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02806,0.503309099896842,OG_02806,FUN_011777-T1,Peve_00006119,Pocillopora_meandrina_HIv1___RNAseq.g23293.t1,three_way,79.81966666666666,FUN_011777-T1,O75486,,,,,41.0,339.0,1.9e-50,201.4,sp|O75486|SUPT3_HUMAN Transcription initiation protein SPT3 homolog OS=Homo sapiens OX=9606 GN=SUPT3H PE=1 SV=3,,,,,,
OG_09136,0.5031690853311807,OG_09136,FUN_039774-T1,Peve_00030564,Pocillopora_meandrina_HIv1___RNAseq.g7453.t1,three_way,59.15083333333333,FUN_039774-T1,Q810V0,,,,,40.6,702.0,1.4999999999999998e-68,262.3,sp|Q810V0|MPP10_MOUSE U3 small nucleolar ribonucleoprotein protein MPP10 OS=Mus musculus OX=10090 GN=Mphosph10 PE=1 SV=2,,,,,,
OG_00605,0.5030509650371712,OG_00605,FUN_001766-T1,Peve_00023732,Pocillopora_meandrina_HIv1___RNAseq.g2675.t1,three_way,76.47133333333333,,,,,,,,,,,,,,,,,
OG_07305,0.5030448566735413,OG_07305,FUN_033691-T1,Peve_00010865,Pocillopora_meandrina_HIv1___RNAseq.g25877.t1,three_way,90.88,FUN_033691-T1,A7SMR1,EIF3D_NEMVE,,Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7),Nematostella vectensis (Starlet sea anemone),76.6,475.0,2.6000000000000004e-211,736.1,sp|A7SMR1|EIF3D_NEMVE Eukaryotic translation initiation factor 3 subunit D OS=Nematostella vectensis OX=45351 GN=v1g235689 PE=3 SV=1,GO:0001732; GO:0002191; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0098808,cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852],mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_09462,0.5029226371795513,OG_09462,FUN_041481-T1,Peve_00015167,Pocillopora_meandrina_HIv1___RNAseq.g15673.t1,three_way,81.04583333333333,FUN_041481-T1,Q6NVN0,SOX2_XENTR,,Transcription factor Sox-2 (SRY (sex determining region Y)-box 2),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.8,271.0,2.8e-42,174.1,sp|Q6NVN0|SOX2_XENTR Transcription factor Sox-2 OS=Xenopus tropicalis OX=8364 GN=sox2 PE=2 SV=1,GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0008283; GO:0021522; GO:0021538; GO:0021982; GO:0031101; GO:0043565; GO:0045893; GO:0045944; GO:0048592; GO:0060119; GO:0071599; GO:1905040; GO:1905812,cell population proliferation [GO:0008283]; epithalamus development [GO:0021538]; eye morphogenesis [GO:0048592]; fin regeneration [GO:0031101]; inner ear receptor cell development [GO:0060119]; nervous system development [GO:0007399]; otic placode development [GO:1905040]; otic vesicle development [GO:0071599]; pineal gland development [GO:0021982]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of motor neuron axon guidance [GO:1905812]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00491,0.5028728334619397,OG_00491,FUN_001461-T1,Peve_00027130,Pocillopora_meandrina_HIv1___TS.g4468.t1,three_way,90.859,FUN_001461-T1,Q8BTQ0,PCGF3_MOUSE,,Polycomb group RING finger protein 3 (RING finger protein 3A),Mus musculus (Mouse),57.9,242.0,6.200000000000001e-73,275.4,sp|Q8BTQ0|PCGF3_MOUSE Polycomb group RING finger protein 3 OS=Mus musculus OX=10090 GN=PcgF3 PE=1 SV=1,GO:0005654; GO:0008270; GO:0031519; GO:0060816; GO:0140862,random inactivation of X chromosome [GO:0060816],nucleoplasm [GO:0005654]; PcG protein complex [GO:0031519],histone H2AK119 ubiquitin ligase activity [GO:0140862]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006325; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; chromatin organization; transferase activity; catalytic activity, acting on a protein"
OG_08396,0.5028515823718596,OG_08396,FUN_037010-T1,Peve_00032338,Pocillopora_meandrina_HIv1___RNAseq.g26698.t1,three_way,85.58966666666667,FUN_037010-T1,Q8N2G6,,,,,56.0,234.0,5.3e-63,242.7,sp|Q8N2G6|ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ZCCHC24 PE=1 SV=1,,,,,,
OG_05341,0.5028510137992844,OG_05341,FUN_024067-T1,Peve_00000150,Pocillopora_meandrina_HIv1___RNAseq.g19254.t1,three_way,69.05799999999999,FUN_024067-T1,Q54RA4,,,,,34.9,352.0,9.9e-50,198.7,sp|Q54RA4|Y3291_DICDI Probable iron/ascorbate oxidoreductase DDB_G0283291 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0283291 PE=3 SV=1,,,,,,
OG_06193,0.5027973066338982,OG_06193,FUN_028115-T1,Peve_00030850,Pocillopora_meandrina_HIv1___RNAseq.g15564.t1,three_way,78.04,FUN_028115-T1,A1A4P5,,,,,54.7,137.0,1.4e-32,141.0,sp|A1A4P5|PFD2_BOVIN Prefoldin subunit 2 OS=Bos taurus OX=9913 GN=PFDN2 PE=2 SV=1,,,,,,
OG_08055,0.5027689751151444,OG_08055,FUN_035750-T1,Peve_00044196,Pocillopora_meandrina_HIv1___RNAseq.g11876.t1,three_way,69.98333333333333,FUN_035750-T1,Q9BQ70,TCF25_HUMAN,,Ribosome quality control complex subunit TCF25 (Nuclear localized protein 1) (Transcription factor 25) (TCF-25),Homo sapiens (Human),47.6,527.0,3.4e-132,473.8,sp|Q9BQ70|TCF25_HUMAN Ribosome quality control complex subunit TCF25 OS=Homo sapiens OX=9606 GN=TCF25 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005829; GO:0061945; GO:0072344; GO:1990112,regulation of protein K48-linked ubiquitination [GO:0061945]; rescue of stalled ribosome [GO:0072344],cytosol [GO:0005829]; nucleus [GO:0005634]; RQC complex [GO:1990112],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005829; GO:0043226,DNA binding; nucleus; cytosol; organelle
OG_08594,0.5026644908287943,OG_08594,FUN_037709-T1,Peve_00027437,Pocillopora_meandrina_HIv1___RNAseq.g1402.t1,three_way,58.09033333333333,FUN_037709-T1,E7F1U2,DNMBP_DANRE,,Dynamin-binding protein (Scaffold protein Tuba),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,728.0,7.8e-103,377.5,sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1,GO:0001822; GO:0005085; GO:0005737; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005794; GO:0005856; GO:0043226; GO:0044782; GO:0048856; GO:0098772,Golgi apparatus; cytoskeleton; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_10052,0.502397416755485,OG_10052,FUN_043326-T1,Peve_00043041,Pocillopora_meandrina_HIv1___RNAseq.g8953.t1,three_way,56.76033333333333,FUN_043326-T1,D3ZAZ5,BCAR3_RAT,,"Breast cancer anti-estrogen resistance protein 3 homolog (BCAR3 adapter protein, NSP family member) (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) (p130Cas-binding protein AND-34)",Rattus norvegicus (Rat),23.4,785.0,4.2e-25,118.2,sp|D3ZAZ5|BCAR3_RAT Breast cancer anti-estrogen resistance protein 3 homolog OS=Rattus norvegicus OX=10116 GN=Bcar3 PE=1 SV=1,GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007173; GO:0007264; GO:0008284; GO:0008286; GO:0016020; GO:0019900; GO:0043410; GO:0043547; GO:0086100,endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784],GO:0098772,molecular function regulator activity
OG_09440,0.502372453826431,OG_09440,FUN_041426-T1,Peve_00008987,Pocillopora_meandrina_HIv1___RNAseq.g15735.t2,three_way,80.48633333333333,FUN_041426-T1,P97360,ETV6_MOUSE,,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),Mus musculus (Mouse),44.6,65.0,1.7e-11,70.9,sp|P97360|ETV6_MOUSE Transcription factor ETV6 OS=Mus musculus OX=10090 GN=Etv6 PE=1 SV=1,GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005730; GO:0005829; GO:0006355; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152,cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296],cytosol [GO:0005829]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005730; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleolus; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; transcription regulator activity
OG_06431,0.5023492977694035,OG_06431,FUN_029125-T1,Peve_00024870,Pocillopora_meandrina_HIv1___RNAseq.g25775.t1,three_way,64.52616666666667,FUN_029125-T1,A4IHD2,,,,,50.8,846.0,7.7e-237,822.4,sp|A4IHD2|ARIP4_XENTR Helicase ARIP4 OS=Xenopus tropicalis OX=8364 GN=rad54l2 PE=2 SV=1,,,,,,
OG_05344,0.5019730745258828,OG_05344,FUN_024075-T1,Peve_00000135,Pocillopora_meandrina_HIv1___TS.g28590.t2,three_way,90.34133333333334,FUN_024075-T1,Q3T0T7,SAR1B_BOVIN,,Small COPII coat GTPase SAR1B (EC 3.6.5.2),Bos taurus (Bovine),71.3,195.0,4.5e-82,305.8,sp|Q3T0T7|SAR1B_BOVIN Small COPII coat GTPase SAR1B OS=Bos taurus OX=9913 GN=SAR1B PE=2 SV=1,GO:0003400; GO:0003924; GO:0003925; GO:0005525; GO:0005765; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032368; GO:0032580; GO:0042953; GO:0046872; GO:0048208; GO:0055088; GO:0061024; GO:0070971; GO:0090110; GO:0140353; GO:0140785; GO:1904262; GO:1990253,cellular response to leucine starvation [GO:1990253]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lipid export from cell [GO:0140353]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; membrane organization [GO:0061024]; negative regulation of TORC1 signaling [GO:1904262]; regulation of COPII vesicle coating [GO:0003400]; regulation of lipid transport [GO:0032368]; vesicle organization [GO:0016050],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765],amino acid sensor activity [GO:0140785]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0003824; GO:0003924; GO:0005829; GO:0006886; GO:0016192; GO:0016787; GO:0061024; GO:0065003; GO:0098772; GO:0140299,catalytic activity; GTPase activity; cytosol; intracellular protein transport; vesicle-mediated transport; hydrolase activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_05806,0.5018439137627702,OG_05806,FUN_025802-T1,Peve_00017927,Pocillopora_meandrina_HIv1___RNAseq.g10356.t1,three_way,86.251,FUN_025802-T1,Q7ZVY5,,,,,65.5,469.0,2.6000000000000003e-184,646.4,"sp|Q7ZVY5|CISY_DANRE Citrate synthase, mitochondrial OS=Danio rerio OX=7955 GN=cs PE=2 SV=1",,,,,,
OG_04220,0.5014913402526696,OG_04220,FUN_016979-T1,Peve_00025290,Pocillopora_meandrina_HIv1___RNAseq.g9902.t2,three_way,75.31333333333333,FUN_016979-T1,G3UYX5,,,,,20.5,1227.0,1.4e-16,90.5,sp|G3UYX5|RGS22_MOUSE Regulator of G-protein signaling 22 OS=Mus musculus OX=10090 GN=Rgs22 PE=1 SV=1,,,,,,
OG_05622,0.5014671744634375,OG_05622,FUN_025315-T1,Peve_00027083,Pocillopora_meandrina_HIv1___RNAseq.g13448.t1,three_way,79.72466666666666,FUN_025315-T1,P30038,AL4A1_HUMAN,,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)",Homo sapiens (Human),55.4,552.0,1.2e-183,644.4,"sp|P30038|AL4A1_HUMAN Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH4A1 PE=1 SV=3",GO:0003842; GO:0004029; GO:0005739; GO:0005759; GO:0005829; GO:0006560; GO:0006562; GO:0009055; GO:0010133; GO:0019470; GO:0042802,4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_05688,0.50129389226402,OG_05688,FUN_025539-T1,Peve_00013053,Pocillopora_meandrina_HIv1___RNAseq.g13801.t1,three_way,63.6775,FUN_025539-T1,O75381,PEX14_HUMAN,,Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14),Homo sapiens (Human),31.0,261.0,1.1e-16,89.4,sp|O75381|PEX14_HUMAN Peroxisomal membrane protein PEX14 OS=Homo sapiens OX=9606 GN=PEX14 PE=1 SV=1,GO:0001650; GO:0003714; GO:0005102; GO:0005634; GO:0005777; GO:0005778; GO:0005829; GO:0007031; GO:0008017; GO:0008320; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0030674; GO:0032091; GO:0032991; GO:0034453; GO:0034614; GO:0036250; GO:0042802; GO:0043433; GO:0044721; GO:0045892; GO:0048487; GO:0065003; GO:1990429,"cellular response to reactive oxygen species [GO:0034614]; microtubule anchoring [GO:0034453]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein binding [GO:0032091]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein-containing complex assembly [GO:0065003]",cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein transmembrane transporter activity [GO:0008320]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714],GO:0005215; GO:0005634; GO:0005777; GO:0005829; GO:0006355; GO:0006886; GO:0007010; GO:0007018; GO:0007031; GO:0008092; GO:0043226; GO:0055085; GO:0060090; GO:0065003; GO:0140110,transporter activity; nucleus; peroxisome; cytosol; regulation of DNA-templated transcription; intracellular protein transport; cytoskeleton organization; microtubule-based movement; peroxisome organization; cytoskeletal protein binding; organelle; transmembrane transport; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_04887,0.5012587417289699,OG_04887,FUN_022928-T1,Peve_00004269,Pocillopora_meandrina_HIv1___RNAseq.g3731.t1,three_way,63.60333333333333,FUN_022928-T1,Q6NZC7,S23IP_MOUSE,,SEC23-interacting protein,Mus musculus (Mouse),46.8,763.0,2.5e-179,630.9,sp|Q6NZC7|S23IP_MOUSE SEC23-interacting protein OS=Mus musculus OX=10090 GN=Sec23ip PE=1 SV=2,GO:0001675; GO:0005801; GO:0007286; GO:0007338; GO:0012507; GO:0046872; GO:0048471; GO:0070971; GO:0097038,acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatid development [GO:0007286],cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471],metal ion binding [GO:0046872],GO:0022414; GO:0043226; GO:0048856,reproductive process; organelle; anatomical structure development
OG_02564,0.5011868233665453,OG_02564,FUN_010663-T1,Peve_00031442,Pocillopora_meandrina_HIv1___RNAseq.g21359.t1,three_way,44.581500000000005,FUN_010663-T1,Q99MV1,TDRD1_MOUSE,,Tudor domain-containing protein 1,Mus musculus (Mouse),28.6,814.0,2.1e-72,277.7,sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_09471,0.5010908570379434,OG_09471,FUN_041497-T1,Peve_00017073,Pocillopora_meandrina_HIv1___RNAseq.g15661.t1,three_way,80.51666666666667,FUN_041497-T1,P62046,,,,,32.5,711.0,2.7e-36,155.2,sp|P62046|LRCH1_MOUSE Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrch1 PE=1 SV=2,,,,,,
OG_00358,0.5009125491204438,OG_00358,FUN_001190-T1,Peve_00014645,Pocillopora_meandrina_HIv1___TS.g6722.t2,three_way,77.6545,FUN_001190-T1,Q7SYD5,SC31A_DANRE,,Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A),Danio rerio (Zebrafish) (Brachydanio rerio),41.3,1314.0,9.899999999999999e-226,785.4,sp|Q7SYD5|SC31A_DANRE Protein transport protein Sec31A OS=Danio rerio OX=7955 GN=sec31a PE=2 SV=1,GO:0001889; GO:0005198; GO:0005789; GO:0007029; GO:0015031; GO:0030127; GO:0030134; GO:0055123; GO:0070971; GO:0090110,COPII-coated vesicle cargo loading [GO:0090110]; digestive system development [GO:0055123]; endoplasmic reticulum organization [GO:0007029]; liver development [GO:0001889]; protein transport [GO:0015031],COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789],structural molecule activity [GO:0005198],GO:0005198; GO:0031410; GO:0043226; GO:0048856,structural molecule activity; cytoplasmic vesicle; organelle; anatomical structure development
OG_04922,0.5008952147512914,OG_04922,FUN_022980-T1,Peve_00043402,Pocillopora_meandrina_HIv1___RNAseq.g3752.t1,three_way,86.49766666666666,FUN_022980-T1,O00567,NOP56_HUMAN,,Nucleolar protein 56 (Nucleolar protein 5A),Homo sapiens (Human),69.4,431.0,3.2000000000000003e-170,599.7,sp|O00567|NOP56_HUMAN Nucleolar protein 56 OS=Homo sapiens OX=9606 GN=NOP56 PE=1 SV=4,GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0045296; GO:0070761; GO:1990226,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],box C/D methylation guide snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732],cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515],GO:0003723; GO:0005654; GO:0005730; GO:0043226,RNA binding; nucleoplasm; nucleolus; organelle
OG_02379,0.5008530526641537,OG_02379,FUN_008991-T1,Peve_00023810,Pocillopora_meandrina_HIv1___RNAseq.g3896.t1,three_way,96.42866666666669,FUN_008991-T1,Q2KJI2,STT3A_BOVIN,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18),Bos taurus (Bovine),85.0,695.0,0.0,1212.6,sp|Q2KJI2|STT3A_BOVIN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A OS=Bos taurus OX=9913 GN=STT3A PE=2 SV=1,GO:0004579; GO:0008250; GO:0018279; GO:0043686; GO:0043687; GO:0046872,co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279],oligosaccharyltransferase complex [GO:0008250],dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872],GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_08401,0.5008517766271324,OG_08401,FUN_037052-T1,Peve_00032336,Pocillopora_meandrina_HIv1___RNAseq.g26789.t1,three_way,75.614,FUN_037052-T1,Q8TBG4,AT2L1_HUMAN,,Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1),Homo sapiens (Human),60.5,435.0,2.200000000000001e-149,530.4,sp|Q8TBG4|AT2L1_HUMAN Ethanolamine-phosphate phospho-lyase OS=Homo sapiens OX=9606 GN=ETNPPL PE=1 SV=1,GO:0005759; GO:0006649; GO:0008483; GO:0016020; GO:0030170; GO:0032094; GO:0050459; GO:0055088; GO:0071385; GO:1905372,cellular response to glucocorticoid stimulus [GO:0071385]; ceramide phosphoethanolamine catabolic process [GO:1905372]; lipid homeostasis [GO:0055088]; phospholipid transfer to membrane [GO:0006649]; response to food [GO:0032094],membrane [GO:0016020]; mitochondrial matrix [GO:0005759],ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],GO:0003824; GO:0006629; GO:0016740; GO:0016829,catalytic activity; lipid metabolic process; transferase activity; lyase activity
OG_01238,0.5003568856650967,OG_01238,FUN_004924-T1,Peve_00034321,Pocillopora_meandrina_HIv1___RNAseq.g8362.t1,three_way,53.07116666666667,FUN_004924-T1,Q92733,PRCC_HUMAN,,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),Homo sapiens (Human),42.9,156.0,6.3e-20,100.5,sp|Q92733|PRCC_HUMAN Proline-rich protein PRCC OS=Homo sapiens OX=9606 GN=PRCC PE=1 SV=1,GO:0005634; GO:0005654; GO:0016607; GO:0051726,regulation of cell cycle [GO:0051726],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0043226,nucleus; nucleoplasm; organelle
OG_01240,0.5003120054781283,OG_01240,FUN_004926-T1,Peve_00034769,Pocillopora_meandrina_HIv1___RNAseq.g8365.t1,three_way,75.525,,,,,,,,,,,,,,,,,
OG_07372,0.5002469548877615,OG_07372,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,43.9,214.0,1.7e-40,169.9,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07372,0.5002469548877615,OG_07372,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,30.4,171.0,0.00058,48.5,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_06858,0.5002027511669684,OG_06858,FUN_031848-T1,Peve_00030290,Pocillopora_meandrina_HIv1___RNAseq.g5607.t1,three_way,63.642,FUN_031848-T1,A6QNR1,,,,,44.3,219.0,1.2e-29,131.7,sp|A6QNR1|RRP36_BOVIN Ribosomal RNA processing protein 36 homolog OS=Bos taurus OX=9913 GN=RRP36 PE=2 SV=1,,,,,,
OG_01248,0.5000768157046356,OG_01248,FUN_004947-T1,Peve_00043267,Pocillopora_meandrina_HIv1___RNAseq.g8394.t1,three_way,76.3205,FUN_004947-T1,Q9BY12,SCAPE_HUMAN,,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),Homo sapiens (Human),41.5,1440.0,9.2e-140,500.0,sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2,GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917,antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0005654; GO:0005783; GO:0005829; GO:0022414; GO:0043226; GO:0048856,nucleoplasm; endoplasmic reticulum; cytosol; reproductive process; organelle; anatomical structure development
OG_03925,0.5000754031900922,OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),40.7,1012.0,4.0000000000000014e-74,282.7,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_03925,0.5000754031900922,OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),34.5,145.0,1.9e-07,61.2,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_09374,0.4999255582911385,OG_09374,FUN_040549-T1,Peve_00015403,Pocillopora_meandrina_HIv1___RNAseq.g6504.t1,three_way,72.52266666666667,FUN_040549-T1,Q2TBV6,CC124_BOVIN,,Coiled-coil domain-containing protein 124,Bos taurus (Bovine),70.7,75.0,3.7e-24,113.2,sp|Q2TBV6|CC124_BOVIN Coiled-coil domain-containing protein 124 OS=Bos taurus OX=9913 GN=CCDC124 PE=2 SV=1,GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0006366; GO:0030496; GO:0051301,cell division [GO:0051301]; transcription by RNA polymerase II [GO:0006366],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634],transcription coactivator activity [GO:0003713],GO:0005634; GO:0005815; GO:0006351; GO:0043226; GO:0060090; GO:0140110,nucleus; microtubule organizing center; DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_03745,0.4999040452065593,OG_03745,FUN_015052-T1,Peve_00001164,Pocillopora_meandrina_HIv1___RNAseq.g21267.t1,three_way,66.9325,FUN_015052-T1,Q6DFQ2,,,,,33.2,340.0,5.7e-31,136.7,sp|Q6DFQ2|NCBP3_XENTR Nuclear cap-binding protein subunit 3 OS=Xenopus tropicalis OX=8364 GN=ncbp3 PE=2 SV=1,,,,,,
OG_05755,0.4997619419317127,OG_05755,FUN_025690-T1,Peve_00005581,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2b,three_way,57.99366666666667,,,,,,,,,,,,,,,,,
OG_10114,0.4996673111547886,OG_10114,FUN_043484-T1,Peve_00021709,Pocillopora_meandrina_HIv1___RNAseq.g7934.t1,three_way,54.963,FUN_043484-T1,Q8R2H1,,,,,25.2,357.0,1.1e-17,92.4,sp|Q8R2H1|IKBL1_RAT NF-kappa-B inhibitor-like protein 1 OS=Rattus norvegicus OX=10116 GN=Nfkbil1 PE=2 SV=2,,,,,,
OG_07729,0.4996456335418365,OG_07729,FUN_034890-T1,Peve_00037340,Pocillopora_meandrina_HIv1___TS.g15152.t1,three_way,81.66833333333334,FUN_034890-T1,O61585,,,,,55.5,714.0,5.000000000000001e-80,300.4,sp|O61585|KTNB1_STRPU Katanin p80 WD40 repeat-containing subunit B1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNB1 PE=1 SV=1,,,,,,
OG_09165,0.4995217873736655,OG_09165,FUN_039827-T1,Peve_00005157,Pocillopora_meandrina_HIv1___RNAseq.g7311.t1,three_way,64.71333333333334,FUN_039827-T1,P00520,,,,,67.9,483.0,8.4e-202,705.7,sp|P00520|ABL1_MOUSE Tyrosine-protein kinase ABL1 OS=Mus musculus OX=10090 GN=Abl1 PE=1 SV=3,,,,,,
OG_02516,0.4994435824900293,OG_02516,FUN_010575-T1,Peve_00032734,Pocillopora_meandrina_HIv1___RNAseq.g21523.t1,three_way,73.19066666666667,FUN_010575-T1,Q9C091,GRB1L_HUMAN,,GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein),Homo sapiens (Human),33.4,1940.0,6.8e-250,866.3,sp|Q9C091|GRB1L_HUMAN GREB1-like protein OS=Homo sapiens OX=9606 GN=GREB1L PE=1 SV=2,GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0061205; GO:0072177,branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065],membrane [GO:0016020],,GO:0022414; GO:0030154; GO:0042254; GO:0048856,reproductive process; cell differentiation; ribosome biogenesis; anatomical structure development
OG_00354,0.4993787908081926,OG_00354,FUN_001184-T1,Peve_00040983,Pocillopora_meandrina_HIv1___RNAseq.g29541.t1,three_way,94.182,FUN_001184-T1,Q5ZIA5,COPB_CHICK,,Coatomer subunit beta (Beta-coat protein) (Beta-COP),Gallus gallus (Chicken),73.1,963.0,0.0,1363.6,sp|Q5ZIA5|COPB_CHICK Coatomer subunit beta OS=Gallus gallus OX=9031 GN=COPB1 PE=2 SV=1,GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0030126,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886],COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139],structural molecule activity [GO:0005198],GO:0005198; GO:0005829; GO:0006886; GO:0016192,structural molecule activity; cytosol; intracellular protein transport; vesicle-mediated transport
OG_02535,0.4993301034136959,OG_02535,FUN_010614-T1,Peve_00013367,Pocillopora_meandrina_HIv1___RNAseq.g21488.t1,three_way,71.218,FUN_010614-T1,A7SWH1,PESC_NEMVE,,Pescadillo homolog,Nematostella vectensis (Starlet sea anemone),65.3,444.0,5.3e-170,599.0,sp|A7SWH1|PESC_NEMVE Pescadillo homolog OS=Nematostella vectensis OX=45351 GN=v1g194255 PE=3 SV=1,GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0030687; GO:0043021; GO:0070545,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]",ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723],GO:0003723; GO:0005654,RNA binding; nucleoplasm
OG_04561,0.4990711717618621,OG_04561,FUN_022200-T1,Peve_00041448,Pocillopora_meandrina_HIv1___TS.g22211.t1,three_way,99.00466666666668,FUN_022200-T1,Q7Z1B8,,,,,84.8,66.0,5.0999999999999975e-25,114.4,sp|Q7Z1B8|S61G1_GRYOR Protein transport protein Sec61 subunit gamma OS=Gryllotalpa orientalis OX=213494 GN=SEC61G PE=3 SV=1,,,,,,
OG_02254,0.4989902611507757,OG_02254,FUN_008700-T1,Peve_00025639,Pocillopora_meandrina_HIv1___RNAseq.g12731.t1,three_way,66.20166666666667,,,,,,,,,,,,,,,,,
OG_06676,0.4989730814172319,OG_06676,FUN_031079-T1,Peve_00028146,Pocillopora_meandrina_HIv1___RNAseq.27627_t,three_way,61.867666666666665,,,,,,,,,,,,,,,,,
OG_02104,0.4987802187277818,OG_02104,FUN_008383-T1,Peve_00005318,Pocillopora_meandrina_HIv1___TS.g24875.t1b,three_way,94.05366666666669,FUN_008383-T1,Q15436,SC23A_HUMAN,,Protein transport protein Sec23A (hSec23A) (SEC23-related protein A),Homo sapiens (Human),74.7,775.0,0.0,1215.3,sp|Q15436|SC23A_HUMAN Protein transport protein Sec23A OS=Homo sapiens OX=9606 GN=SEC23A PE=1 SV=2,GO:0000139; GO:0005096; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012507; GO:0030127; GO:0048471; GO:0070971; GO:0072659; GO:0090110,COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005783; GO:0005829; GO:0006886; GO:0043226; GO:0072659; GO:0098772,endoplasmic reticulum; cytosol; intracellular protein transport; organelle; protein localization to plasma membrane; molecular function regulator activity
OG_06024,0.4987082198931985,OG_06024,FUN_026582-T1,Peve_00006460,Pocillopora_meandrina_HIv1___RNAseq.g4513.t1,three_way,81.87833333333333,FUN_026582-T1,Q8TAQ2,SMRC2_HUMAN,,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),Homo sapiens (Human),51.1,991.0,1.4e-241,837.8,sp|Q8TAQ2|SMRC2_HUMAN SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1,GO:0000776; GO:0000785; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514],histone binding [GO:0042393]; transcription coactivator activity [GO:0003713],GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_05074,0.4986505429571044,OG_05074,FUN_023300-T1,Peve_00041309,Pocillopora_meandrina_HIv1___RNAseq.g17778.t1,three_way,86.52966666666667,FUN_023300-T1,Q3ZCF5,,,,,75.7,276.0,3.2e-128,459.5,"sp|Q3ZCF5|OAT_BOVIN Ornithine aminotransferase, mitochondrial OS=Bos taurus OX=9913 GN=OAT PE=2 SV=1",,,,,,
OG_04965,0.4983496186894925,OG_04965,FUN_023064-T1,Peve_00024668,Pocillopora_meandrina_HIv1___RNAseq.g3883.t1,three_way,87.05566666666667,FUN_023064-T1,P43249,,,,,62.2,566.0,1.8e-203,710.3,sp|P43249|GRK5_BOVIN G protein-coupled receptor kinase 5 OS=Bos taurus OX=9913 GN=GRK5 PE=1 SV=1,,,,,,
OG_05648,0.4982951444251224,OG_05648,FUN_025368-T1,Peve_00040520,Pocillopora_meandrina_HIv1___RNAseq.g13331.t1,three_way,95.874,FUN_025368-T1,Q6PH57,,,,,91.4,339.0,2.9e-140,499.6,sp|Q6PH57|GBB1_DANRE Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1,,,,,,
OG_02279,0.4982295084101634,OG_02279,FUN_008771-T1,Peve_00036717,Pocillopora_meandrina_HIv1___RNAseq.g12703.t1,three_way,83.727,FUN_008771-T1,Q95LL3,,,,,53.3,510.0,1.5e-138,494.6,sp|Q95LL3|TB22B_MACFA TBC1 domain family member 22B OS=Macaca fascicularis OX=9541 GN=TBC1D22B PE=2 SV=1,,,,,,
OG_02945,0.4981329995120313,OG_02945,FUN_012059-T1,Peve_00004100,Pocillopora_meandrina_HIv1___RNAseq.g23640.t1,three_way,57.582,,,,,,,,,,,,,,,,,
OG_00611,0.4979990732074553,OG_00611,FUN_001777-T1,Peve_00035594,Pocillopora_meandrina_HIv1___RNAseq.g2684.t2,three_way,77.261,FUN_001777-T1,Q969G6,RIFK_HUMAN,,Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase),Homo sapiens (Human),63.0,154.0,5.6e-51,202.2,sp|Q969G6|RIFK_HUMAN Riboflavin kinase OS=Homo sapiens OX=9606 GN=RFK PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006771; GO:0006915; GO:0008531; GO:0009231; GO:0009398; GO:0033864; GO:0046872; GO:0072388; GO:0072593,apoptotic process [GO:0006915]; flavin adenine dinucleotide biosynthetic process [GO:0072388]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531],GO:0003824; GO:0005739; GO:0005829; GO:0006766; GO:0012501; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; cytosol; vitamin metabolic process; programmed cell death; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02872,0.4978565389857698,OG_02872,FUN_011922-T1,Peve_00002208,Pocillopora_meandrina_HIv1___TS.g16203.t1,three_way,84.6935,FUN_011922-T1,Q9C102,GLT1_SCHPO,,Glutamate synthase [NADH] (EC 1.4.1.14) (Glutamine-oxoglutarate aminotransferase) (GOGAT),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),51.7,2161.0,0.0,2202.6,sp|Q9C102|GLT1_SCHPO Glutamate synthase [NADH] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=glt1 PE=1 SV=1,GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0016040; GO:0016639; GO:0019676; GO:0050660; GO:0051538; GO:0097054,ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054],cytosol [GO:0005829]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; oxidoreductase activity; organelle
OG_01707,0.497851057204896,OG_01707,FUN_006980-T1,Peve_00035600,Pocillopora_meandrina_HIv1___RNAseq.g20230.t1,three_way,88.05,FUN_006980-T1,Q14141,,,,,67.7,331.0,4.400000000000001e-130,466.1,sp|Q14141|SEPT6_HUMAN Septin-6 OS=Homo sapiens OX=9606 GN=SEPTIN6 PE=1 SV=4,,,,,,
OG_06080,0.4977453009612562,OG_06080,FUN_027065-T1,Peve_00012227,Pocillopora_meandrina_HIv1___RNAseq.g2816.t1,three_way,66.86916666666667,FUN_027065-T1,A2AG06,MEIOC_MOUSE,,Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein),Mus musculus (Mouse),46.5,114.0,4.8e-14,80.9,sp|A2AG06|MEIOC_MOUSE Meiosis-specific coiled-coil domain-containing protein MEIOC OS=Mus musculus OX=10090 GN=Meioc PE=1 SV=1,GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192,"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase chromosome alignment [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]",cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006281; GO:0022414; GO:0043226; GO:0048856; GO:0140013,nucleus; DNA repair; reproductive process; organelle; anatomical structure development; meiotic nuclear division
OG_00273,0.4975684417473157,OG_00273,FUN_001053-T1,Peve_00023870,Pocillopora_meandrina_HIv1___RNAseq.g29644.t1,three_way,85.719,FUN_001053-T1,Q5REU4,,,,,58.1,904.0,2.8e-296,1019.2,sp|Q5REU4|SND1_PONAB Staphylococcal nuclease domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SND1 PE=2 SV=1,,,,,,
OG_04127,0.4973740099036688,OG_04127,FUN_016571-T1,Peve_00042779,Pocillopora_meandrina_HIv1___RNAseq.g9716.t1,three_way,78.609,FUN_016571-T1,Q9D4B2,ODAD4_MOUSE,,Outer dynein arm-docking complex subunit 4 (Tetratricopeptide repeat protein 25) (TPR repeat protein 25),Mus musculus (Mouse),50.6,482.0,3.1e-126,453.8,sp|Q9D4B2|ODAD4_MOUSE Outer dynein arm-docking complex subunit 4 OS=Mus musculus OX=10090 GN=Odad4 PE=1 SV=3,GO:0003341; GO:0005576; GO:0005930; GO:0007420; GO:0007507; GO:0030324; GO:0036158; GO:0060287; GO:0090660; GO:0097728; GO:0097729; GO:0120197; GO:0120228; GO:0120229,brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart development [GO:0007507]; lung development [GO:0030324]; mucociliary clearance [GO:0120197]; outer dynein arm assembly [GO:0036158]; protein localization to motile cilium [GO:0120229],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228],,GO:0003016; GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0048856; GO:0050877; GO:0065003,respiratory system process; extracellular region; cilium; microtubule-based movement; organelle; anatomical structure development; nervous system process; protein-containing complex assembly
OG_00526,0.497369930628078,OG_00526,FUN_001530-T1,Peve_00000625,Pocillopora_meandrina_HIv1___RNAseq.g2045.t2,three_way,82.98033333333333,FUN_001530-T1,Q2KIH7,PH4H_BOVIN,,Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase),Bos taurus (Bovine),64.8,423.0,7.6e-165,581.6,sp|Q2KIH7|PH4H_BOVIN Phenylalanine-4-hydroxylase OS=Bos taurus OX=9913 GN=PAH PE=2 SV=1,GO:0004505; GO:0005506; GO:0006559; GO:0006571,L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571],,iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505],GO:0003824; GO:0006520; GO:0016491,catalytic activity; amino acid metabolic process; oxidoreductase activity
OG_07177,0.4971590853481255,OG_07177,FUN_032628-T1,Peve_00033703,Pocillopora_meandrina_HIv1___RNAseq.g29789.t1,three_way,82.41583333333334,FUN_032628-T1,Q9EQW7,KI13A_MOUSE,,Kinesin-like protein KIF13A,Mus musculus (Mouse),47.9,1454.0,0.0,1170.6,sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1,GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005874; GO:0006886; GO:0008017; GO:0008333; GO:0010008; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383,cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459],centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016853; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; protein localization to plasma membrane; ATP-dependent activity
OG_03635,0.4971517921974239,OG_03635,FUN_014855-T1,Peve_00038800,Pocillopora_meandrina_HIv1___RNAseq.g22371.t1,three_way,96.05733333333332,FUN_014855-T1,Q6P2Q9,PRP8_HUMAN,,Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220),Homo sapiens (Human),92.1,2321.0,0.0,4492.2,sp|Q6P2Q9|PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2,GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157,"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06719,0.4971420819409994,OG_06719,FUN_031470-T1,Peve_00026552,Pocillopora_meandrina_HIv1___RNAseq.g5082.t1,three_way,68.5885,FUN_031470-T1,Q9JLC8,,,,,30.2,4722.0,0.0,1872.1,sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2,,,,,,
OG_04280,0.4969053404465491,OG_04280,FUN_017841-T1,Peve_00016638,Pocillopora_meandrina_HIv1___RNAseq.g9589.t1,three_way,64.23916666666666,,,,,,,,,,,,,,,,,
OG_07943,0.4966531461900588,OG_07943,FUN_035457-T1,Peve_00012137,Pocillopora_meandrina_HIv1___TS.g14393.t2,three_way,86.11866666666667,FUN_035457-T1,Q8BYM7,RSH4A_MOUSE,,Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3),Mus musculus (Mouse),55.7,474.0,5.5e-114,412.9,sp|Q8BYM7|RSH4A_MOUSE Radial spoke head protein 4 homolog A OS=Mus musculus OX=10090 GN=Rsph4a PE=1 SV=2,GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005930; GO:0051649; GO:0060294; GO:0062177; GO:0097729; GO:0120221; GO:0120336; GO:0120337; GO:0120338,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 2 [GO:0120337]; radial spoke head 3 [GO:0120338],,GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0065003,extracellular region; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_06844,0.4966298355072835,OG_06844,FUN_031784-T1,Peve_00010429,Pocillopora_meandrina_HIv1___TS.g24287.t1,three_way,83.68866666666666,FUN_031784-T1,Q9ULT8,HECD1_HUMAN,,E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1),Homo sapiens (Human),52.0,2736.0,0.0,2536.5,sp|Q9ULT8|HECD1_HUMAN E3 ubiquitin-protein ligase HECTD1 OS=Homo sapiens OX=9606 GN=HECTD1 PE=1 SV=4,GO:0003170; GO:0003281; GO:0006511; GO:0016567; GO:0032436; GO:0035904; GO:0046872; GO:0061630,aorta development [GO:0035904]; heart valve development [GO:0003170]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281],,metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_03629,0.4963450687977201,OG_03629,FUN_014846-T1,Peve_00038813,Pocillopora_meandrina_HIv1___RNAseq.g22386.t2,three_way,83.38516666666666,FUN_014846-T1,P97526,NF1_RAT,,Neurofibromin (Neurofibromatosis-related protein NF-1),Rattus norvegicus (Rat),46.1,2783.0,0.0,2161.0,sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1,GO:0000165; GO:0001525; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001935; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006606; GO:0006915; GO:0007154; GO:0007265; GO:0007269; GO:0007405; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008283; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014009; GO:0014010; GO:0014037; GO:0014044; GO:0016477; GO:0016525; GO:0016601; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030316; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033024; GO:0033027; GO:0033028; GO:0033034; GO:0034605; GO:0035021; GO:0036135; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048144; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048708; GO:0048709; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0051402; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070662; GO:0070667; GO:0071549; GO:0071887; GO:0072089; GO:0097192; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1904707; GO:1904738; GO:1904753; GO:1990090; GO:1990874; GO:2000108; GO:2000647; GO:2001241,"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fibroblast proliferation [GO:0048144]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glial cell proliferation [GO:0014009]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; mast cell apoptotic process [GO:0033024]; mast cell proliferation [GO:0070662]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid cell apoptotic process [GO:0033028]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; neurotransmitter secretion [GO:0007269]; observational learning [GO:0098597]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; protein import into nucleus [GO:0006606]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; Schwann cell migration [GO:0036135]; Schwann cell proliferation [GO:0014010]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; vascular associated smooth muscle cell migration [GO:1904738]; vascular associated smooth muscle cell proliferation [GO:1990874]; visual learning [GO:0008542]; wound healing [GO:0042060]",axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991],GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545],GO:0002376; GO:0005634; GO:0005730; GO:0005886; GO:0006886; GO:0006913; GO:0007010; GO:0008092; GO:0008289; GO:0012501; GO:0030154; GO:0030198; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0098772,immune system process; nucleus; nucleolus; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; cytoskeletal protein binding; lipid binding; programmed cell death; cell differentiation; extracellular matrix organization; wound healing; organelle; anatomical structure development; cell motility; nervous system process; molecular function regulator activity
OG_01628,0.4962434810706382,OG_01628,FUN_006742-T1,Peve_00039577,Pocillopora_meandrina_HIv1___RNAseq.g20528.t1,three_way,72.99733333333333,FUN_006742-T1,A6QLE6,ANO4_BOVIN,,Anoctamin-4 (Transmembrane protein 16D),Bos taurus (Bovine),30.5,846.0,3.9999999999999995e-91,337.8,sp|A6QLE6|ANO4_BOVIN Anoctamin-4 OS=Bos taurus OX=9913 GN=ANO4 PE=2 SV=1,GO:0005229; GO:0005886; GO:0006869; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; lipid transport [GO:0006869],plasma membrane [GO:0005886],intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_04459,0.4962360911807486,OG_04459,FUN_019331-T1,Peve_00032903,Pocillopora_meandrina_HIv1___RNAseq.g20800.t1,three_way,84.01033333333334,FUN_019331-T1,O18373,,,,,64.6,305.0,4.3999999999999996e-116,419.1,"sp|O18373|SPS1_DROME Inactive selenide, water dikinase-like protein OS=Drosophila melanogaster OX=7227 GN=Sps1 PE=2 SV=1",,,,,,
OG_06157,0.4957932516565477,OG_06157,FUN_028000-T1,Peve_00023138,Pocillopora_meandrina_HIv1___RNAseq.g14071.t1,three_way,85.642,FUN_028000-T1,Q80W32,DRC9_MOUSE,,Dynein regulatory complex protein 9 (IQ domain-containing protein G),Mus musculus (Mouse),40.1,357.0,2.6999999999999998e-62,240.7,sp|Q80W32|DRC9_MOUSE Dynein regulatory complex protein 9 OS=Mus musculus OX=10090 GN=Iqcg PE=1 SV=1,GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0015629; GO:0030544; GO:0031514; GO:0036126,sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544],GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0048856,cytosol; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; anatomical structure development
OG_04186,0.4957646767005775,OG_04186,FUN_016706-T1,Peve_00034244,Pocillopora_meandrina_HIv1___RNAseq.g282.t2,three_way,70.44399999999999,FUN_016706-T1,Q8VDM6,HNRL1_MOUSE,,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Mus musculus (Mouse),50.9,399.0,8.3e-112,406.4,sp|Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Mus musculus OX=10090 GN=Hnrnpul1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005654; GO:0019899; GO:0045202; GO:1990904,,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],enzyme binding [GO:0019899]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0043226,RNA binding; nucleus; nucleoplasm; organelle
OG_03337,0.4956293044362969,OG_03337,FUN_013559-T1,Peve_00036543,Pocillopora_meandrina_HIv1___RNAseq.g22968.t1,three_way,88.23,FUN_013559-T1,P47756,CAPZB_HUMAN,,F-actin-capping protein subunit beta (CapZ beta),Homo sapiens (Human),80.8,271.0,1.9999999999999999e-128,459.9,sp|P47756|CAPZB_HUMAN F-actin-capping protein subunit beta OS=Homo sapiens OX=9606 GN=CAPZB PE=1 SV=5,GO:0003779; GO:0005829; GO:0005856; GO:0005903; GO:0007010; GO:0008154; GO:0008290; GO:0014069; GO:0015629; GO:0016020; GO:0022604; GO:0030017; GO:0030027; GO:0030032; GO:0030863; GO:0045296; GO:0051016; GO:0070062; GO:0071203; GO:0098685; GO:0098686; GO:0120212,actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; regulation of cell morphogenesis [GO:0022604],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; sarcomere [GO:0030017]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm head-tail coupling apparatus [GO:0120212]; WASH complex [GO:0071203],actin binding [GO:0003779]; cadherin binding [GO:0045296],GO:0005829; GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_00483,0.4956025433522168,OG_00483,FUN_001447-T1,Peve_00019961,Pocillopora_meandrina_HIv1___RNAseq.g1952.t1,three_way,57.163,FUN_001447-T1,Q61824,,,,,37.3,714.0,8.5e-130,466.5,sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2,,,,,,
OG_09362,0.4955076411671228,OG_09362,FUN_040477-T1,Peve_00015410,Pocillopora_meandrina_HIv1___RNAseq.g6522.t1,three_way,73.125,FUN_040477-T1,Q3UHD6,SNX27_MOUSE,,Sorting nexin-27,Mus musculus (Mouse),49.7,503.0,5.2e-142,506.1,sp|Q3UHD6|SNX27_MOUSE Sorting nexin-27 OS=Mus musculus OX=10090 GN=Snx27 PE=1 SV=2,GO:0001772; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0071203; GO:0090128; GO:0098685; GO:0098794; GO:0098837; GO:0098842; GO:0098978; GO:0099072,endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; postsynapse [GO:0098794]; postsynaptic early endosome [GO:0098842]; postsynaptic recycling endosome [GO:0098837]; retromer complex [GO:0030904]; Schaffer collateral - CA1 synapse [GO:0098685]; WASH complex [GO:0071203],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0005768; GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06001,0.4954301221961076,OG_06001,FUN_026490-T1,Peve_00002095,Pocillopora_meandrina_HIv1___RNAseq.g4192.t1,three_way,88.14433333333334,FUN_026490-T1,O57683,,,,,77.7,1266.0,0.0,1677.9,sp|O57683|SF3B1_XENLA Splicing factor 3B subunit 1 OS=Xenopus laevis OX=8355 GN=sf3b1 PE=2 SV=1,,,,,,
OG_06420,0.4954133338267206,OG_06420,FUN_029108-T1,Peve_00017655,Pocillopora_meandrina_HIv1___RNAseq.g25465.t1,three_way,91.391,FUN_029108-T1,Q3SZ71,MPPB_BOVIN,,Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP),Bos taurus (Bovine),69.1,469.0,1.3000000000000006e-186,654.1,sp|Q3SZ71|MPPB_BOVIN Mitochondrial-processing peptidase subunit beta OS=Bos taurus OX=9913 GN=PMPCB PE=2 SV=1,GO:0004222; GO:0005739; GO:0005759; GO:0006627; GO:0046872,protein processing involved in protein targeting to mitochondrion [GO:0006627],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09791,0.4952413955684339,OG_09791,FUN_042593-T1,Peve_00008128,Pocillopora_meandrina_HIv1___RNAseq.g16867.t1,three_way,79.72,FUN_042593-T1,Q80TC6,,,,,50.6,1158.0,2.7e-309,1062.8,sp|Q80TC6|ZSWM5_MOUSE Zinc finger SWIM domain-containing protein 5 OS=Mus musculus OX=10090 GN=Zswim5 PE=2 SV=2,,,,,,
OG_05974,0.4951928992047555,OG_05974,FUN_026394-T1,Peve_00032420,Pocillopora_meandrina_HIv1___RNAseq.g2941.t1,three_way,86.70166666666667,FUN_026394-T1,Q01583,DGK1_DROME,,Diacylglycerol kinase 1 (DAG kinase 1) (DGK 1) (Diglyceride kinase 1) (EC 2.7.1.107),Drosophila melanogaster (Fruit fly),39.6,450.0,3.8e-71,270.4,sp|Q01583|DGK1_DROME Diacylglycerol kinase 1 OS=Drosophila melanogaster OX=7227 GN=Dgk PE=2 SV=5,GO:0004143; GO:0005509; GO:0005524; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0035556; GO:0046339,diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0006629; GO:0016740,catalytic activity; plasma membrane; lipid metabolic process; transferase activity
OG_01080,0.4951889220314175,OG_01080,FUN_004568-T1,Peve_00041493,Pocillopora_meandrina_HIv1___RNAseq.g6639.t1,three_way,81.07966666666665,FUN_004568-T1,Q9JHS4,CLPX_MOUSE,,"ATP-dependent clpX-like chaperone, mitochondrial (EC 3.6.4.10) (ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial) (Caseinolytic mitochondrial matrix peptidase chaperone subunit)",Mus musculus (Mouse),56.7,527.0,5.9e-152,539.3,"sp|Q9JHS4|CLPX_MOUSE ATP-dependent clpX-like chaperone, mitochondrial OS=Mus musculus OX=10090 GN=Clpx PE=1 SV=2",GO:0004176; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662,ATP metabolic process [GO:0046034]; proteolysis involved in protein catabolic process [GO:0051603],cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; ATP-dependent protein folding chaperone [GO:0140662]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0044183; GO:0055086; GO:0098772; GO:0140096; GO:0140657; GO:1901135,"catalytic activity; nucleoplasm; mitochondrion; cytosol; hydrolase activity; organelle; protein folding chaperone; nucleobase-containing small molecule metabolic process; molecular function regulator activity; catalytic activity, acting on a protein; ATP-dependent activity; carbohydrate derivative metabolic process"
OG_01400,0.4951763519132446,OG_01400,FUN_005389-T1,Peve_00042934,Pocillopora_meandrina_HIv1___RNAseq.g7680.t1,three_way,74.071,,,,,,,,,,,,,,,,,
OG_03893,0.4951431116303633,OG_03893,FUN_015448-T1,Peve_00013022,Pocillopora_meandrina_HIv1___RNAseq.g22266.t1,three_way,60.5595,FUN_015448-T1,Q08E13,RNF10_BOVIN,,E3 ubiquitin-protein ligase RNF10 (EC 2.3.2.27) (RING finger protein 10),Bos taurus (Bovine),39.1,791.0,5.5e-107,390.2,sp|Q08E13|RNF10_BOVIN E3 ubiquitin-protein ligase RNF10 OS=Bos taurus OX=9913 GN=RNF10 PE=2 SV=1,GO:0000976; GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0031643; GO:0045944; GO:0061630; GO:1990116,positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein monoubiquitination [GO:0006513]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytoplasm [GO:0005737]; nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05121,0.4950799808934435,OG_05121,FUN_023383-T1,Peve_00015212,Pocillopora_meandrina_HIv1___TS.g17098.t2,three_way,73.90266666666666,FUN_023383-T1,Q26534,,,,,53.8,314.0,1.4e-95,351.7,sp|Q26534|CATL_SCHMA Cathepsin L OS=Schistosoma mansoni OX=6183 GN=CL1 PE=2 SV=1,,,,,,
OG_08410,0.4945098634386459,OG_08410,FUN_037061-T1,Peve_00018395,Pocillopora_meandrina_HIv1___RNAseq.g26778.t1,three_way,63.92483333333333,FUN_037061-T1,Q5U2U2,CRKL_RAT,,Crk-like protein,Rattus norvegicus (Rat),37.5,293.0,5.8e-46,186.0,sp|Q5U2U2|CRKL_RAT Crk-like protein OS=Rattus norvegicus OX=10116 GN=Crkl PE=1 SV=1,GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0002685; GO:0003151; GO:0005654; GO:0005737; GO:0005829; GO:0006629; GO:0007167; GO:0007283; GO:0007338; GO:0007389; GO:0007507; GO:0008284; GO:0008543; GO:0008584; GO:0009887; GO:0009952; GO:0010468; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0043410; GO:0045202; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0060392; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0071774; GO:0086100; GO:0095500; GO:0098698; GO:0098749; GO:0098761; GO:0098890; GO:0160093; GO:1900026; GO:1903977; GO:1904393; GO:1904395; GO:1904888; GO:2000404,acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of gene expression [GO:0010468]; regulation of leukocyte migration [GO:0002685]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; response to fibroblast growth factor [GO:0071774]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; synapse [GO:0045202],identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591],GO:0002376; GO:0005654; GO:0005829; GO:0006629; GO:0007163; GO:0012501; GO:0022414; GO:0048856; GO:0048870; GO:0060090,immune system process; nucleoplasm; cytosol; lipid metabolic process; establishment or maintenance of cell polarity; programmed cell death; reproductive process; anatomical structure development; cell motility; molecular adaptor activity
OG_08892,0.4941438233305236,OG_08892,FUN_038299-T1,Peve_00041738,Pocillopora_meandrina_HIv1___RNAseq.g28301.t1,three_way,89.779,FUN_038299-T1,Q9UPM9,,,,,72.0,182.0,2.4e-79,296.6,sp|Q9UPM9|B9D1_HUMAN B9 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=B9D1 PE=1 SV=1,,,,,,
OG_07594,0.4940883939733858,OG_07594,FUN_034300-T1,Peve_00013958,Pocillopora_meandrina_HIv1___RNAseq.g28501.t1,three_way,80.99333333333334,FUN_034300-T1,Q86WG5,MTMRD_HUMAN,,Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2),Homo sapiens (Human),39.3,2002.0,0.0,1303.1,sp|Q86WG5|MTMRD_HUMAN Myotubularin-related protein 13 OS=Homo sapiens OX=9606 GN=SBF2 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005774; GO:0005829; GO:0006914; GO:0010008; GO:0016020; GO:0019208; GO:0019902; GO:0030424; GO:0035091; GO:0042552; GO:0042802; GO:0048471,autophagy [GO:0006914]; myelination [GO:0042552],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006914; GO:0008289; GO:0098772,cytosol; autophagy; lipid binding; molecular function regulator activity
OG_07738,0.4939871354841136,OG_07738,FUN_034917-T1,Peve_00039135,Pocillopora_meandrina_HIv1___RNAseq.g12141.t1,three_way,71.13166666666666,,,,,,,,,,,,,,,,,
OG_08022,0.4938413768458012,OG_08022,FUN_035677-T1,Peve_00002799,Pocillopora_meandrina_HIv1___RNAseq.g28144.t1,three_way,61.552,FUN_035677-T1,Q96I34,PP16A_HUMAN,,Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3),Homo sapiens (Human),37.7,371.0,1.2e-26,123.2,sp|Q96I34|PP16A_HUMAN Protein phosphatase 1 regulatory subunit 16A OS=Homo sapiens OX=9606 GN=PPP1R16A PE=1 SV=1,GO:0004857; GO:0005737; GO:0005886; GO:0017020,,cytoplasm [GO:0005737]; plasma membrane [GO:0005886],enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_07419,0.4936656919943886,OG_07419,FUN_033880-T1,Peve_00043309,Pocillopora_meandrina_HIv1___RNAseq.g28401.t1,three_way,84.31566666666667,FUN_033880-T1,Q66II8,,,,,67.6,225.0,2.1e-77,290.8,sp|Q66II8|RU17_XENTR U1 small nuclear ribonucleoprotein 70 kDa OS=Xenopus tropicalis OX=8364 GN=snrnp70 PE=2 SV=1,,,,,,
OG_00641,0.4936539956477861,OG_00641,FUN_001882-T1,Peve_00030484,Pocillopora_meandrina_HIv1___TS.g5105.t1,three_way,67.033,,,,,,,,,,,,,,,,,
OG_03505,0.4936308720141419,OG_03505,FUN_014615-T1,Peve_00001904,Pocillopora_meandrina_HIv1___RNAseq.1913_t,three_way,90.09,FUN_014615-T1,Q15370,ELOB_HUMAN,,Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2),Homo sapiens (Human),66.3,104.0,5.9e-34,144.8,sp|Q15370|ELOB_HUMAN Elongin-B OS=Homo sapiens OX=9606 GN=ELOB PE=1 SV=1,GO:0001222; GO:0005654; GO:0005829; GO:0006367; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0032436; GO:0065003; GO:0070449; GO:0140958,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; target-directed miRNA degradation [GO:0140958]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891],transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625],GO:0005654; GO:0005829; GO:0065003,nucleoplasm; cytosol; protein-containing complex assembly
OG_06872,0.4936157201589622,OG_06872,FUN_031875-T1,Peve_00012649,Pocillopora_meandrina_HIv1___RNAseq.g5445.t1a,three_way,81.16000000000001,FUN_031875-T1,Q8BHN3,GANAB_MOUSE,,Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha),Mus musculus (Mouse),53.7,916.0,5.7e-300,1031.6,sp|Q8BHN3|GANAB_MOUSE Neutral alpha-glucosidase AB OS=Mus musculus OX=10090 GN=Ganab PE=1 SV=1,GO:0005783; GO:0005794; GO:0005975; GO:0006491; GO:0015926; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0106407,carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491],endoplasmic reticulum [GO:0005783]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470],"carbohydrate binding [GO:0030246]; Glc2Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0106407]; glucan 1,3-alpha-glucosidase activity [GO:0033919]; glucosidase activity [GO:0015926]",GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0009101; GO:0016787; GO:0031410; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; glycoprotein biosynthetic process; hydrolase activity; cytoplasmic vesicle; organelle; carbohydrate derivative metabolic process
OG_00585,0.4935376338978533,OG_00585,FUN_001658-T1,Peve_00038361,Pocillopora_meandrina_HIv1___RNAseq.g29403.t1,three_way,89.375,FUN_001658-T1,Q5RBE5,,,,,70.9,323.0,2.9e-134,479.6,sp|Q5RBE5|FCL_PONAB GDP-L-fucose synthase OS=Pongo abelii OX=9601 GN=GFUS PE=2 SV=1,,,,,,
OG_03021,0.4935190671198646,OG_03021,FUN_012241-T1,Peve_00018303,Pocillopora_meandrina_HIv1___RNAseq.g23522.t2,three_way,67.49,FUN_012241-T1,O14497,ARI1A_HUMAN,,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",Homo sapiens (Human),36.1,711.0,1.3e-109,400.2,sp|O14497|ARI1A_HUMAN AT-rich interactive domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ARID1A PE=1 SV=3,GO:0000785; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06423,0.4934895231214466,OG_06423,FUN_029112-T1,Peve_00013128,Pocillopora_meandrina_HIv1___RNAseq.g25756.t1,three_way,93.785,FUN_029112-T1,O60830,TI17B_HUMAN,,Mitochondrial import inner membrane translocase subunit Tim17-B,Homo sapiens (Human),66.5,167.0,3.3e-55,216.1,sp|O60830|TI17B_HUMAN Mitochondrial import inner membrane translocase subunit Tim17-B OS=Homo sapiens OX=9606 GN=TIMM17B PE=1 SV=1,GO:0005739; GO:0005743; GO:0005744; GO:0006626; GO:0006886; GO:0008320; GO:0030150,intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744],protein transmembrane transporter activity [GO:0008320],GO:0005215; GO:0005739; GO:0006886; GO:0043226; GO:0055085,transporter activity; mitochondrion; intracellular protein transport; organelle; transmembrane transport
OG_06609,0.4933093406256095,OG_06609,FUN_029759-T1,Peve_00019499,Pocillopora_meandrina_HIv1___RNAseq.g17321.t1,three_way,95.305,FUN_029759-T1,Q9QYK7,RNF11_MOUSE,,RING finger protein 11 (NEDD4 WW domain-binding protein 2) (Sid 1669),Mus musculus (Mouse),62.2,156.0,3.2e-45,182.6,sp|Q9QYK7|RNF11_MOUSE RING finger protein 11 OS=Mus musculus OX=10090 GN=Rnf11 PE=1 SV=1,GO:0000151; GO:0005634; GO:0005769; GO:0006511; GO:0008270; GO:0051865; GO:0055037; GO:0061630,protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],early endosome [GO:0005769]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005768; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05502,0.4931069736338501,OG_05502,FUN_024566-T1,Peve_00009964,Pocillopora_meandrina_HIv1___RNAseq.g19087.t1,three_way,94.32233333333332,FUN_024566-T1,P81436,OGT1_RABIT,,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),Oryctolagus cuniculus (Rabbit),77.1,1013.0,5.3000000000000025e-211,736.1,sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2,GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263,apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0006355; GO:0008289; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; nucleus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid binding; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_07725,0.493049097911334,OG_07725,FUN_034884-T1,Peve_00011623,Pocillopora_meandrina_HIv1___TS.g14516.t1,three_way,73.757,FUN_034884-T1,Q97MV3,,,,,41.7,72.0,3.9e-08,59.3,sp|Q97MV3|MSRA_CLOAB Peptide methionine sulfoxide reductase MsrA OS=Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / IAM 19013 / LMG 5710 / NBRC 13948 / NRRL B-527 / VKM B-1787 / 2291 / W) OX=272562 GN=msrA PE=3 SV=1,,,,,,
OG_08284,0.4930115655442162,OG_08284,FUN_036208-T1,Peve_00038733,Pocillopora_meandrina_HIv1___RNAseq.g27354.t1,three_way,51.08383333333333,FUN_036208-T1,Q5F363,,,,,36.3,658.0,8.7e-114,414.1,sp|Q5F363|JARD2_CHICK Protein Jumonji OS=Gallus gallus OX=9031 GN=JARID2 PE=2 SV=1,,,,,,
OG_04849,0.4930086920008298,OG_04849,FUN_022861-T1,Peve_00025611,Pocillopora_meandrina_HIv1___RNAseq.g3605.t1,three_way,79.88833333333334,FUN_022861-T1,O55003,BNIP3_MOUSE,,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,Mus musculus (Mouse),33.5,188.0,1.5e-15,84.3,sp|O55003|BNIP3_MOUSE BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 OS=Mus musculus OX=10090 GN=Bnip3 PE=1 SV=1,GO:0000423; GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005789; GO:0006915; GO:0009617; GO:0010637; GO:0010659; GO:0010666; GO:0010917; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043069; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0061709; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097193; GO:0097345; GO:0140506; GO:0140507; GO:0140580; GO:1902109; GO:1903599; GO:1990144,apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; mitophagy [GO:0000423]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of programmed cell death [GO:0043069]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane permeability [GO:0046902]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; reticulophagy [GO:0061709],cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; mitochondrion autophagosome adaptor activity [GO:0140580]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0006914; GO:0007005; GO:0012501; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0061024,nucleus; nuclear envelope; nucleoplasm; mitochondrion; autophagy; mitochondrion organization; programmed cell death; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; membrane organization
OG_03265,0.4929146176319119,OG_03265,FUN_013121-T1,Peve_00000437,Pocillopora_meandrina_HIv1___RNAseq.g23034.t1,three_way,98.58766666666668,FUN_013121-T1,Q9GJW7,GBRAP_BOVIN,,Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein),Bos taurus (Bovine),96.6,116.0,7.4000000000000025e-59,227.6,sp|Q9GJW7|GBRAP_BOVIN Gamma-aminobutyric acid receptor-associated protein OS=Bos taurus OX=9913 GN=GABARAP PE=3 SV=2,GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000423; GO:0005764; GO:0005776; GO:0005790; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008429; GO:0008625; GO:0015031; GO:0015629; GO:0031410; GO:0031625; GO:0032436; GO:0035020; GO:0048487; GO:0050811; GO:0097225; GO:0097352; GO:0098696; GO:0098982; GO:1902524,autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; mitophagy [GO:0000423]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein transport [GO:0015031]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rac protein signal transduction [GO:0035020],actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; GABA-ergic synapse [GO:0098982]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225],beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625],GO:0005764; GO:0005773; GO:0005783; GO:0005856; GO:0005886; GO:0006914; GO:0007010; GO:0008092; GO:0008289; GO:0031410; GO:0043226,lysosome; vacuole; endoplasmic reticulum; cytoskeleton; plasma membrane; autophagy; cytoskeleton organization; cytoskeletal protein binding; lipid binding; cytoplasmic vesicle; organelle
OG_08305,0.4926821607671274,OG_08305,FUN_036260-T1,Peve_00012320,Pocillopora_meandrina_HIv1___RNAseq.g27582.t1,three_way,82.303,FUN_036260-T1,Q8WXH2,JPH3_HUMAN,,Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein),Homo sapiens (Human),66.7,57.0,9.9e-20,99.4,sp|Q8WXH2|JPH3_HUMAN Junctophilin-3 OS=Homo sapiens OX=9606 GN=JPH3 PE=1 SV=2,GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0010880; GO:0010882; GO:0014701; GO:0016020; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060402,calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic plasticity [GO:0048167],endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886],,GO:0005886; GO:0050877; GO:0055085,plasma membrane; nervous system process; transmembrane transport
OG_03064,0.4926073131370674,OG_03064,FUN_012330-T1,Peve_00023487,Pocillopora_meandrina_HIv1___RNAseq.g23754.t1,three_way,75.646,FUN_012330-T1,Q9Y6P5,SESN1_HUMAN,,Sestrin-1 (EC 1.11.1.-) (p53-regulated protein PA26),Homo sapiens (Human),47.5,465.0,7.5e-119,429.1,sp|Q9Y6P5|SESN1_HUMAN Sestrin-1 OS=Homo sapiens OX=9606 GN=SESN1 PE=1 SV=2,GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016239; GO:0016684; GO:0030308; GO:0034198; GO:0042149; GO:0051896; GO:0070728; GO:0071233; GO:0072593; GO:0098869; GO:1901031; GO:1904262; GO:1990253,cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"L-leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016491; GO:0043226; GO:0098754,catalytic activity; nucleus; nucleoplasm; cytosol; oxidoreductase activity; organelle; detoxification
OG_09226,0.4925517192511101,OG_09226,FUN_039948-T1,Peve_00039030,Pocillopora_meandrina_HIv1___RNAseq.g7509.t1,three_way,83.78416666666666,FUN_039948-T1,A7SKE9,EIF3G_NEMVE,,Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4),Nematostella vectensis (Starlet sea anemone),63.5,296.0,6.8e-98,358.6,sp|A7SKE9|EIF3G_NEMVE Eukaryotic translation initiation factor 3 subunit G OS=Nematostella vectensis OX=45351 GN=v1g171563 PE=3 SV=1,GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0016282; GO:0033290,formation of cytoplasmic translation initiation complex [GO:0001732],eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852],RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_05207,0.492447762706667,OG_05207,FUN_023591-T1,Peve_00023917,Pocillopora_meandrina_HIv1___RNAseq.g3310.t1,three_way,53.26583333333333,FUN_023591-T1,A7Z035,EPN4_BOVIN,,Clathrin interactor 1 (Epsin-4),Bos taurus (Bovine),38.2,626.0,8.3e-77,289.7,sp|A7Z035|EPN4_BOVIN Clathrin interactor 1 OS=Bos taurus OX=9913 GN=CLINT1 PE=2 SV=1,GO:0005543; GO:0005654; GO:0005768; GO:0005798; GO:0005802; GO:0005886; GO:0006897; GO:0030125; GO:0030276; GO:0048471,endocytosis [GO:0006897],clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],clathrin binding [GO:0030276]; phospholipid binding [GO:0005543],GO:0005654; GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_01605,0.4923638044269552,OG_01605,FUN_006649-T1,Peve_00029032,Pocillopora_meandrina_HIv1___RNAseq.g19952.t1,three_way,81.72066666666667,FUN_006649-T1,Q9W7L4,,,,,61.3,333.0,1.2e-117,424.5,sp|Q9W7L4|LDHB_SCEUN L-lactate dehydrogenase B chain OS=Sceloporus undulatus OX=8520 GN=LDHB PE=2 SV=3,,,,,,
OG_01599,0.4922138406174525,OG_01599,FUN_006642-T1,Peve_00040855,Pocillopora_meandrina_HIv1___TS.g29901.t1b,three_way,61.857,FUN_006642-T1,P60924,DELE1_RAT,,"DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form) (DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form (DELE1(S)) (S-DELE1)]",Rattus norvegicus (Rat),35.4,113.0,3.8e-08,61.2,sp|P60924|DELE1_RAT DAP3-binding cell death enhancer 1 OS=Rattus norvegicus OX=10116 GN=Dele1 PE=2 SV=2,GO:0005739; GO:0005741; GO:0005743; GO:0005829; GO:0006974; GO:0008625; GO:0033554; GO:0043539; GO:0140467; GO:0140468; GO:1901526; GO:1990641,cellular response to stress [GO:0033554]; DNA damage response [GO:0006974]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; positive regulation of mitophagy [GO:1901526]; response to iron ion starvation [GO:1990641],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein serine/threonine kinase activator activity [GO:0043539],GO:0005739; GO:0005829; GO:0043226; GO:0098772,mitochondrion; cytosol; organelle; molecular function regulator activity
OG_06237,0.4918992707260166,OG_06237,FUN_028193-T1,Peve_00000868,Pocillopora_meandrina_HIv1___RNAseq.g16538.t1,three_way,88.00966666666666,FUN_028193-T1,O00303,EIF3F_HUMAN,,Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47),Homo sapiens (Human),53.0,268.0,6.2e-80,298.9,sp|O00303|EIF3F_HUMAN Eukaryotic translation initiation factor 3 subunit F OS=Homo sapiens OX=9606 GN=EIF3F PE=1 SV=1,GO:0001732; GO:0003743; GO:0004843; GO:0005829; GO:0005852; GO:0006413; GO:0006508; GO:0016020; GO:0016282; GO:0031369; GO:0033290; GO:0042802; GO:0045202; GO:0071541; GO:0075522; GO:0140492,formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; proteolysis [GO:0006508]; translational initiation [GO:0006413],"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; synapse [GO:0045202]",cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal-dependent deubiquitinase activity [GO:0140492]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369],GO:0003824; GO:0005829; GO:0016787; GO:0065003; GO:0140096,"catalytic activity; cytosol; hydrolase activity; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_00367,0.4917025850490538,OG_00367,FUN_001208-T1,Peve_00033821,Pocillopora_meandrina_HIv1___RNAseq.g29517.t1,three_way,90.25683333333336,FUN_001208-T1,P55745,,,,,73.9,184.0,3.9e-74,279.3,sp|P55745|RAB21_CANLF Ras-related protein Rab-21 OS=Canis lupus familiaris OX=9615 GN=RAB21 PE=3 SV=3,,,,,,
OG_06219,0.4915411336426913,OG_06219,FUN_028162-T1,Peve_00018136,Pocillopora_meandrina_HIv1___RNAseq.g16500.t1,three_way,57.34316666666667,FUN_028162-T1,Q96T23,RSF1_HUMAN,,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),Homo sapiens (Human),42.2,154.0,6.7e-24,114.0,sp|Q96T23|RSF1_HUMAN Remodeling and spacing factor 1 OS=Homo sapiens OX=9606 GN=RSF1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0008270; GO:0031213; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0050434; GO:0140751,chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213],histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07464,0.491434131469689,OG_07464,FUN_033968-T1,Peve_00015220,Pocillopora_meandrina_HIv1___RNAseq.g28549.t1,three_way,90.424,FUN_033968-T1,Q9Y2H1,ST38L_HUMAN,,Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2),Homo sapiens (Human),71.3,442.0,1.3e-188,660.6,sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens OX=9606 GN=STK38L PE=1 SV=3,GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0010507; GO:0015629; GO:0016020; GO:0035556; GO:0051128; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005829; GO:0005856; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04532,0.4914277153815584,OG_04532,FUN_022076-T1,Peve_00038277,Pocillopora_meandrina_HIv1___RNAseq.g9325.t1,three_way,82.528,FUN_022076-T1,B2GUE2,,,,,35.5,338.0,2.8e-25,117.9,sp|B2GUE2|LRRF2_XENTR Leucine-rich repeat flightless-interacting protein 2 OS=Xenopus tropicalis OX=8364 GN=lrrfip2 PE=2 SV=1,,,,,,
OG_09356,0.4912315850090224,OG_09356,FUN_040442-T1,Peve_00004014,Pocillopora_meandrina_HIv1___RNAseq.g6514.t1,three_way,66.56633333333333,FUN_040442-T1,Q14318,,,,,43.3,319.0,1.5999999999999999e-62,241.9,sp|Q14318|FKBP8_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP8 OS=Homo sapiens OX=9606 GN=FKBP8 PE=1 SV=2,,,,,,
OG_09419,0.4911991605364735,OG_09419,FUN_040971-T1,Peve_00036103,Pocillopora_meandrina_HIv1___RNAseq.g12084.t1,three_way,60.7185,FUN_040971-T1,A2VDZ9,VAPB_BOVIN,,Vesicle-associated membrane protein-associated protein B (VAMP-B) (VAMP-associated protein B) (VAP-B),Bos taurus (Bovine),57.4,162.0,2.7e-48,193.7,sp|A2VDZ9|VAPB_BOVIN Vesicle-associated membrane protein-associated protein B OS=Bos taurus OX=9913 GN=VAPB PE=2 SV=1,GO:0005789; GO:0005886; GO:0006874; GO:0036498; GO:0043495; GO:0061817; GO:0090158,endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; intracellular calcium ion homeostasis [GO:0006874]; IRE1-mediated unfolded protein response [GO:0036498],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],protein-membrane adaptor activity [GO:0043495],GO:0005886; GO:0060090; GO:0061024,plasma membrane; molecular adaptor activity; membrane organization
OG_01993,0.4910451160413152,OG_01993,FUN_008101-T1,Peve_00038876,Pocillopora_meandrina_HIv1___RNAseq.g30155.t1,three_way,89.95933333333333,FUN_008101-T1,Q5R7R9,SNW1_PONAB,,SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),63.8,544.0,5.800000000000001e-178,625.5,sp|Q5R7R9|SNW1_PONAB SNW domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SNW1 PE=2 SV=1,GO:0000122; GO:0000398; GO:0003713; GO:0003714; GO:0005634; GO:0016363; GO:0016922; GO:0030511; GO:0042771; GO:0042809; GO:0042974; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050769; GO:0070562; GO:0071007,"intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]",nuclear matrix [GO:0016363]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007],nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear vitamin D receptor binding [GO:0042809]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0140110,nucleus; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_07565,0.4909416508265699,OG_07565,FUN_034214-T1,Peve_00027532,Pocillopora_meandrina_HIv1___RNAseq.g26163.t1,three_way,52.1425,,,,,,,,,,,,,,,,,
OG_01982,0.4909076871729537,OG_01982,FUN_008090-T1,Peve_00033656,Pocillopora_meandrina_HIv1___RNAseq.g30101.t1,three_way,80.22983333333333,FUN_008090-T1,P58405,STRN3_RAT,,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),Rattus norvegicus (Rat),44.9,824.0,2.0999999999999996e-171,604.4,sp|P58405|STRN3_RAT Striatin-3 OS=Rattus norvegicus OX=10116 GN=Strn3 PE=1 SV=2,GO:0005516; GO:0005654; GO:0005794; GO:0005886; GO:0019901; GO:0030425; GO:0030674; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0035331; GO:0043025; GO:0044877; GO:0045892; GO:0051721; GO:0070016; GO:0090443; GO:0098794,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; response to estradiol [GO:0032355],dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0043226; GO:0060090,nucleoplasm; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_09506,0.4907809703769337,OG_09506,FUN_041551-T1,Peve_00025197,Pocillopora_meandrina_HIv1___RNAseq.g16000.t2,three_way,86.78033333333333,FUN_041551-T1,Q62829,PAK3_RAT,,Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (p21-activated kinase 3) (PAK-3) (p65-PAK),Rattus norvegicus (Rat),65.6,547.0,2.1e-185,650.2,sp|Q62829|PAK3_RAT Serine/threonine-protein kinase PAK 3 OS=Rattus norvegicus OX=10116 GN=Pak3 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0007409; GO:0009267; GO:0010763; GO:0010975; GO:0014069; GO:0016358; GO:0016477; GO:0017124; GO:0030833; GO:0031267; GO:0032956; GO:0035556; GO:0043408; GO:0043525; GO:0046872; GO:0050770; GO:0051020; GO:0060996; GO:0060997; GO:0061003; GO:0098978; GO:0099175; GO:0106310; GO:2000573,axonogenesis [GO:0007409]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; dendrite development [GO:0016358]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175],cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],GO:0003824; GO:0005768; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; endosome; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_09495,0.4907760407999859,OG_09495,FUN_041535-T1,Peve_00039113,Pocillopora_meandrina_HIv1___RNAseq.g15374.t1,three_way,78.69216666666667,FUN_041535-T1,Q5R7X2,,,,,44.6,655.0,4.1e-134,480.7,sp|Q5R7X2|SR140_PONAB U2 snRNP-associated SURP motif-containing protein OS=Pongo abelii OX=9601 GN=U2SURP PE=2 SV=1,,,,,,
OG_06984,0.4907748791962214,OG_06984,FUN_032123-T1,Peve_00040721,Pocillopora_meandrina_HIv1___RNAseq.g5374.t1,three_way,85.32833333333333,FUN_032123-T1,Q8K4B0,MTA1_MOUSE,,Metastasis-associated protein MTA1,Mus musculus (Mouse),52.5,571.0,1e-152,542.3,sp|Q8K4B0|MTA1_MOUSE Metastasis-associated protein MTA1 OS=Mus musculus OX=10090 GN=Mta1 PE=1 SV=1,GO:0000978; GO:0003682; GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005874; GO:0006302; GO:0006338; GO:0008270; GO:0010212; GO:0016581; GO:0032922; GO:0042659; GO:0043153; GO:0043161; GO:0045475; GO:0045814; GO:0045892; GO:0045893; GO:1902499; GO:2000736,"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]",cytoplasm [GO:0005737]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581],chromatin binding [GO:0003682]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005635; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0030163; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nuclear envelope; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; protein catabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_01796,0.4906797579169915,OG_01796,FUN_007181-T1,Peve_00015050,Pocillopora_meandrina_HIv1___RNAseq.g19781.t1,three_way,79.889,FUN_007181-T1,Q80UM3,NAA15_MOUSE,,"N-alpha-acetyltransferase 15, NatA auxiliary subunit (N-terminal acetyltransferase 1) (NMDA receptor-regulated protein 1) (Protein tubedown-1)",Mus musculus (Mouse),59.2,833.0,7.7e-267,921.4,"sp|Q80UM3|NAA15_MOUSE N-alpha-acetyltransferase 15, NatA auxiliary subunit OS=Mus musculus OX=10090 GN=Naa15 PE=1 SV=1",GO:0001525; GO:0005634; GO:0005737; GO:0008080; GO:0030154; GO:0048471,angiogenesis [GO:0001525]; cell differentiation [GO:0030154],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],N-acetyltransferase activity [GO:0008080],GO:0003824; GO:0005634; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; transferase activity; cell differentiation; organelle
OG_09752,0.4905107008545572,OG_09752,FUN_042022-T1,Peve_00044156,Pocillopora_meandrina_HIv1___RNAseq.g15166.t1,three_way,51.5335,,,,,,,,,,,,,,,,,
OG_07127,0.4903448117640104,OG_07127,FUN_032427-T1,Peve_00027370,Pocillopora_meandrina_HIv1___RNAseq.g24120.t1,three_way,71.50633333333333,FUN_032427-T1,Q5U2W5,,,,,53.6,806.0,3e-171,604.0,sp|Q5U2W5|TBL3_RAT Transducin beta-like protein 3 OS=Rattus norvegicus OX=10116 GN=Tbl3 PE=2 SV=1,,,,,,
OG_04939,0.4903301071446579,OG_04939,FUN_023011-T1,Peve_00010014,Pocillopora_meandrina_HIv1___RNAseq.g3825.t1,three_way,91.88166666666667,FUN_023011-T1,Q3ZBL0,RUXG_BOVIN,,Small nuclear ribonucleoprotein G (snRNP-G) (Sm protein G) (Sm-G) (SmG),Bos taurus (Bovine),77.6,49.0,3.7e-16,85.5,sp|Q3ZBL0|RUXG_BOVIN Small nuclear ribonucleoprotein G OS=Bos taurus OX=9913 GN=SNRPG PE=3 SV=1,GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005683; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0034709; GO:0034719; GO:0043186; GO:0046540; GO:0071004; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03491,0.4902557043192281,OG_03491,FUN_014598-T1,Peve_00010088,Pocillopora_meandrina_HIv1___RNAseq.g22739.t1,three_way,60.3855,FUN_014598-T1,Q8VIP2,,,,,36.9,279.0,3.8e-32,142.1,sp|Q8VIP2|MLXPL_RAT Carbohydrate-responsive element-binding protein OS=Rattus norvegicus OX=10116 GN=Mlxipl PE=1 SV=1,,,,,,
OG_08917,0.4901493155254679,OG_08917,FUN_038373-T1,Peve_00000079,Pocillopora_meandrina_HIv1___RNAseq.g1092.t1,three_way,85.541,FUN_038373-T1,Q9UBX3,DIC_HUMAN,,Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10),Homo sapiens (Human),58.7,286.0,3.6999999999999996e-91,336.3,sp|Q9UBX3|DIC_HUMAN Mitochondrial dicarboxylate carrier OS=Homo sapiens OX=9606 GN=SLC25A10 PE=1 SV=2,GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006869; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0035435; GO:0046166; GO:0070221; GO:0071422; GO:0071423; GO:1902358,"dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; monoatomic ion transport [GO:0006811]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transmembrane transport [GO:1902358]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117],GO:0005215; GO:0005634; GO:0005654; GO:0005739; GO:0005975; GO:0006790; GO:0043226; GO:0055085; GO:1901135,transporter activity; nucleus; nucleoplasm; mitochondrion; carbohydrate metabolic process; sulfur compound metabolic process; organelle; transmembrane transport; carbohydrate derivative metabolic process
OG_07345,0.4901147548985927,OG_07345,FUN_033752-T1,Peve_00004934,Pocillopora_meandrina_HIv1___RNAseq.g28752.t1,three_way,78.085,FUN_033752-T1,Q9JI85,NUCB2_RAT,,Nucleobindin-2 (DNA-binding protein NEFA) (Prepronesfatin) [Cleaved into: Nesfatin-1],Rattus norvegicus (Rat),51.0,304.0,4.3e-50,200.3,sp|Q9JI85|NUCB2_RAT Nucleobindin-2 OS=Rattus norvegicus OX=10116 GN=Nucb2 PE=1 SV=1,GO:0001965; GO:0003677; GO:0005085; GO:0005164; GO:0005509; GO:0005615; GO:0005634; GO:0005640; GO:0005737; GO:0005783; GO:0005793; GO:0005797; GO:0007264; GO:0009749; GO:0032099; GO:0042594; GO:0044752; GO:0045599; GO:0046321; GO:0046627; GO:0070093; GO:0141162; GO:1901142; GO:1990680; GO:2000845,insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; tumor necrosis factor receptor binding [GO:0005164],GO:0003677; GO:0005615; GO:0005634; GO:0005783; GO:0043226; GO:0098772,DNA binding; extracellular space; nucleus; endoplasmic reticulum; organelle; molecular function regulator activity
OG_07095,0.4900778321274026,OG_07095,FUN_032353-T1,Peve_00026256,Pocillopora_meandrina_HIv1___RNAseq.g29804.t1,three_way,66.072,FUN_032353-T1,Q8BL06,,,,,55.3,342.0,2.5e-110,401.7,sp|Q8BL06|UBP54_MOUSE Ubiquitin carboxyl-terminal hydrolase 54 OS=Mus musculus OX=10090 GN=Usp54 PE=1 SV=2,,,,,,
OG_02974,0.4899521709759979,OG_02974,FUN_012139-T1,Peve_00001103,Pocillopora_meandrina_HIv1___RNAseq.g23864.t3,three_way,77.9845,FUN_012139-T1,Q8N7X0,ADGB_HUMAN,,Androglobin,Homo sapiens (Human),29.8,1939.0,1.4e-185,652.5,sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3,GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227,proteolysis [GO:0006508]; spermatid development [GO:0007286],sperm annulus [GO:0097227]; sperm midpiece [GO:0097225],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825],GO:0003824; GO:0016787; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; hydrolase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_03924,0.4898583017745407,OG_03924,FUN_016036-T1,Peve_00011811,Pocillopora_meandrina_HIv1___RNAseq.g21652.t1,three_way,47.251000000000005,,,,,,,,,,,,,,,,,
OG_06377,0.489750603381575,OG_06377,FUN_028983-T1,Peve_00034516,Pocillopora_meandrina_HIv1___RNAseq.g25617.t1,three_way,89.974,FUN_028983-T1,Q99JI4,,,,,69.9,389.0,1.1999999999999998e-153,544.3,sp|Q99JI4|PSMD6_MOUSE 26S proteasome non-ATPase regulatory subunit 6 OS=Mus musculus OX=10090 GN=Psmd6 PE=1 SV=1,,,,,,
OG_05875,0.4897413619175076,OG_05875,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_06028,0.4897359353559188,OG_06028,FUN_026589-T1,Peve_00043907,Pocillopora_meandrina_HIv1___TS.g21913.t2,three_way,75.30533333333334,FUN_026589-T1,F8WLE0,,,,,39.4,864.0,1.9e-152,541.6,sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1,,,,,,
OG_01874,0.4894183509667828,OG_01874,FUN_007846-T1,Peve_00014226,Pocillopora_meandrina_HIv1___RNAseq.g20393.t1,three_way,68.34366666666666,FUN_007846-T1,Q9TTR8,,,,,36.1,382.0,1.5e-58,228.4,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_07579,0.4892574432900347,OG_07579,FUN_034260-T1,Peve_00009311,Pocillopora_meandrina_HIv1___RNAseq.g26620.t1,three_way,74.869,FUN_034260-T1,Q9H2X6,HIPK2_HUMAN,,Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1),Homo sapiens (Human),49.5,662.0,4.4e-159,563.9,sp|Q9H2X6|HIPK2_HUMAN Homeodomain-interacting protein kinase 2 OS=Homo sapiens OX=9606 GN=HIPK2 PE=1 SV=2,GO:0000122; GO:0001654; GO:0003016; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007179; GO:0007224; GO:0007628; GO:0008283; GO:0008284; GO:0009952; GO:0010467; GO:0010494; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0030182; GO:0030218; GO:0030330; GO:0030511; GO:0030514; GO:0030578; GO:0030878; GO:0040029; GO:0042771; GO:0043524; GO:0045766; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051402; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0060425; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059,"adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; gene expression [GO:0010467]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; lung morphogenesis [GO:0060425]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of JNK cascade [GO:0046330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; respiratory system process [GO:0003016]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790],GO:0003016; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140096; GO:0140110,"respiratory system process; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_09609,0.4891134876839773,OG_09609,FUN_041767-T1,Peve_00041572,Pocillopora_meandrina_HIv1___RNAseq.g15244.t1,three_way,57.924,FUN_041767-T1,Q6WRH9,,,,,29.6,406.0,5.6000000000000005e-28,128.6,sp|Q6WRH9|IGS10_RAT Immunoglobulin superfamily member 10 OS=Rattus norvegicus OX=10116 GN=Igsf10 PE=1 SV=1,,,,,,
OG_07120,0.4888417325933417,OG_07120,FUN_032405-T1,Peve_00009164,Pocillopora_meandrina_HIv1___RNAseq.g29839.t1,three_way,82.7025,FUN_032405-T1,Q6GNS3,,,,,57.4,509.0,6.3000000000000005e-168,592.0,sp|Q6GNS3|NMD3_XENLA 60S ribosomal export protein NMD3 OS=Xenopus laevis OX=8355 GN=nmd3 PE=2 SV=1,,,,,,
OG_03973,0.4887425406670143,OG_03973,FUN_016127-T1,Peve_00013451,Pocillopora_meandrina_HIv1___RNAseq.g21530.t1,three_way,82.134,FUN_016127-T1,Q5U3N0,,,,,47.0,168.0,1.1e-35,151.4,sp|Q5U3N0|PKHA8_DANRE Pleckstrin homology domain-containing family A member 8 OS=Danio rerio OX=7955 GN=plekha8 PE=2 SV=1,,,,,,
OG_09965,0.4886479545521687,OG_09965,FUN_043146-T1,Peve_00044697,Pocillopora_meandrina_HIv1___RNAseq.g6859.t1,three_way,68.785,FUN_043146-T1,Q9DBQ7,PACE1_MOUSE,,Protein-associating with the carboxyl-terminal domain of ezrin (Ezrin-binding protein PACE-1) (SCY1-like protein 3),Mus musculus (Mouse),38.7,493.0,3.3e-85,317.8,sp|Q9DBQ7|PACE1_MOUSE Protein-associating with the carboxyl-terminal domain of ezrin OS=Mus musculus OX=10090 GN=Scyl3 PE=1 SV=3,GO:0000139; GO:0004672; GO:0005524; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0008104; GO:0021522; GO:0030027; GO:0042802; GO:0048666,inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; spinal cord motor neuron differentiation [GO:0021522],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672],GO:0003824; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; cytosol; inflammatory response; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06622,0.4886229240988532,OG_06622,FUN_029891-T1,Peve_00008454,Pocillopora_meandrina_HIv1___RNAseq.g17343.t1,three_way,56.2075,FUN_029891-T1,O15146,,,,,37.1,318.0,1.7e-61,239.2,"sp|O15146|MUSK_HUMAN Muscle, skeletal receptor tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=MUSK PE=1 SV=1",,,,,,
OG_06780,0.4886183446559999,OG_06780,FUN_031647-T1,Peve_00043573,Pocillopora_meandrina_HIv1___RNAseq.g5682.t1,three_way,73.94383333333333,FUN_031647-T1,A0A1L8G016,,,,,52.6,485.0,1e-89,332.0,sp|A0A1L8G016|DAA11_XENLA Dynein axonemal assembly factor 11 OS=Xenopus laevis OX=8355 GN=dnaaf11 PE=3 SV=1,,,,,,
OG_03618,0.4885132212223162,OG_03618,FUN_014803-T1,Peve_00010343,Pocillopora_meandrina_HIv1___RNAseq.g22413.t1,three_way,74.0495,FUN_014803-T1,Q3UQ28,PXDN_MOUSE,,Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Mus musculus (Mouse),52.2,1478.0,0.0,1216.8,sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005198; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003,catalytic activity; structural molecule activity; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly
OG_04504,0.4882973383645647,OG_04504,FUN_022016-T1,Peve_00042666,Pocillopora_meandrina_HIv1___RNAseq.g3182.t2,three_way,75.399,FUN_022016-T1,P07228,,,,,38.2,808.0,2.6e-144,514.2,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_00849,0.487952090189322,OG_00849,FUN_004100-T1,Peve_00030718,Pocillopora_meandrina_HIv1___RNAseq.g11660.t1,three_way,75.31516666666667,FUN_004100-T1,Q32NH8,PLCD4_XENLA,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4)",Xenopus laevis (African clawed frog),41.4,749.0,1.0000000000000001e-145,518.8,"sp|Q32NH8|PLCD4_XENLA 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 OS=Xenopus laevis OX=8355 GN=plcd4 PE=2 SV=1",GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0005886; GO:0016042; GO:0035556,intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005634; GO:0005783; GO:0005886; GO:0006629; GO:0016787; GO:0043226,catalytic activity; nucleus; endoplasmic reticulum; plasma membrane; lipid metabolic process; hydrolase activity; organelle
OG_05374,0.4879415652778625,OG_05374,FUN_024187-T1,Peve_00013614,Pocillopora_meandrina_HIv1___RNAseq.g18887.t1,three_way,88.22666666666666,FUN_024187-T1,Q921G7,ETFD_MOUSE,,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)",Mus musculus (Mouse),75.3,595.0,1.8999999999999998e-280,966.1,"sp|Q921G7|ETFD_MOUSE Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial OS=Mus musculus OX=10090 GN=Etfdh PE=1 SV=1",GO:0004174; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0033539; GO:0046872; GO:0048039; GO:0051539,fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinone binding [GO:0048039]",GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0006629; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; cytosol; lipid metabolic process; oxidoreductase activity; organelle
OG_02305,0.487923905536153,OG_02305,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,42.3,137.0,2.1e-31,140.2,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_02305,0.487923905536153,OG_02305,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,46.9,128.0,2.5e-29,133.3,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_04857,0.487897135982372,OG_04857,FUN_022871-T1,Peve_00012299,Pocillopora_meandrina_HIv1___RNAseq.g3616.t1,three_way,89.286,FUN_022871-T1,Q90788,NKX25_CHICK,,Homeobox protein Nkx-2.5 (cNKx-2.5) (Homeobox protein NK-2 homolog E),Gallus gallus (Chicken),52.2,159.0,1.2e-33,145.2,sp|Q90788|NKX25_CHICK Homeobox protein Nkx-2.5 OS=Gallus gallus OX=9031 GN=NKX-2.5 PE=2 SV=1,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001947; GO:0003148; GO:0003166; GO:0003168; GO:0003211; GO:0003221; GO:0003222; GO:0003228; GO:0003278; GO:0003285; GO:0003342; GO:0003350; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007512; GO:0010628; GO:0010667; GO:0010765; GO:0010832; GO:0030097; GO:0030154; GO:0030855; GO:0030878; GO:0032991; GO:0032993; GO:0042803; GO:0045666; GO:0045823; GO:0048536; GO:0050673; GO:0050679; GO:0051891; GO:0055005; GO:0055117; GO:0060037; GO:0060038; GO:0060043; GO:0060048; GO:0060261; GO:0060347; GO:0060412; GO:0060413; GO:0060928; GO:0060929; GO:0060971; GO:0061629; GO:0071772; GO:0090090; GO:1903779; GO:1904019; GO:1904036; GO:1990664,adult heart development [GO:0007512]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; bundle of His development [GO:0003166]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; response to BMP [GO:0071772]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytosol [GO:0005829]; Nkx-2.5 complex [GO:1990664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007010; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_03018,0.4878870267824254,OG_03018,FUN_012238-T1,Peve_00020585,Pocillopora_meandrina_HIv1___RNAseq.g23526.t1,three_way,78.7625,FUN_012238-T1,Q8BIQ5,,,,,69.3,215.0,1.0000000000000001e-71,272.7,sp|Q8BIQ5|CSTF2_MOUSE Cleavage stimulation factor subunit 2 OS=Mus musculus OX=10090 GN=Cstf2 PE=1 SV=2,,,,,,
OG_03018,0.4878870267824254,OG_03018,FUN_012238-T1,Peve_00020585,Pocillopora_meandrina_HIv1___RNAseq.g23526.t1,three_way,78.7625,FUN_012238-T1,Q8BIQ5,,,,,73.3,45.0,2.1e-08,62.4,sp|Q8BIQ5|CSTF2_MOUSE Cleavage stimulation factor subunit 2 OS=Mus musculus OX=10090 GN=Cstf2 PE=1 SV=2,,,,,,
OG_06708,0.4878395812584751,OG_06708,FUN_031289-T1,Peve_00026529,Pocillopora_meandrina_HIv1___RNAseq.g5169.t1,three_way,74.811,FUN_031289-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),58.3,599.0,8.2e-179,629.8,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_05338,0.4877907543374268,OG_05338,FUN_024054-T1,Peve_00000164,Pocillopora_meandrina_HIv1___RNAseq.g19258.t1,three_way,82.41566666666667,FUN_024054-T1,Q80T69,RSBN1_MOUSE,,Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1) (Rosbin),Mus musculus (Mouse),56.1,271.0,1.0000000000000001e-81,305.4,sp|Q80T69|RSBN1_MOUSE Lysine-specific demethylase 9 OS=Mus musculus OX=10090 GN=Rsbn1 PE=1 SV=3,GO:0005634; GO:0035575; GO:0046872,,nucleus [GO:0005634],histone H4K20 demethylase activity [GO:0035575]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_07381,0.4877797019164102,OG_07381,FUN_033803-T1,Peve_00009714,Pocillopora_meandrina_HIv1___RNAseq.g26324.t1,three_way,73.78666666666666,FUN_033803-T1,P01108,,,,,27.5,415.0,2.2e-16,88.2,sp|P01108|MYC_MOUSE Myc proto-oncogene protein OS=Mus musculus OX=10090 GN=Myc PE=1 SV=2,,,,,,
OG_08740,0.4877598289954013,OG_08740,FUN_037999-T1,Peve_00021257,Pocillopora_meandrina_HIv1___TS.g19007.t1,three_way,55.495666666666665,FUN_037999-T1,Q09655,,,,,34.5,284.0,1.2e-28,129.0,sp|Q09655|GPAN1_CAEEL G patch domain and ankyrin repeat-containing protein 1 homolog OS=Caenorhabditis elegans OX=6239 GN=ZK1320.7 PE=4 SV=3,,,,,,
OG_03482,0.4877463076443162,OG_03482,FUN_014584-T1,Peve_00001487,Pocillopora_meandrina_HIv1___RNAseq.g22720.t1,three_way,49.659333333333336,FUN_014584-T1,Q1L5Z9,LONF2_HUMAN,,LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192),Homo sapiens (Human),31.0,625.0,2.6999999999999993e-68,261.5,sp|Q1L5Z9|LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 OS=Homo sapiens OX=9606 GN=LONRF2 PE=1 SV=3,GO:0005737; GO:0006515; GO:0008270; GO:0021522; GO:0031175; GO:0043021; GO:0043524; GO:0050905; GO:0051402; GO:0051787; GO:0061630; GO:0061744,motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737],misfolded protein binding [GO:0051787]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0012501; GO:0016740; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; programmed cell death; transferase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_09926,0.4877443228450824,OG_09926,FUN_043040-T1,Peve_00026460,Pocillopora_meandrina_HIv1___RNAseq.g7078.t1,three_way,76.39316666666667,FUN_043040-T1,Q5T8I3,,,,,43.2,359.0,2.5e-57,224.2,sp|Q5T8I3|EEIG2_HUMAN EEIG family member 2 OS=Homo sapiens OX=9606 GN=EEIG2 PE=1 SV=2,,,,,,
OG_05222,0.4876140196210579,OG_05222,FUN_023634-T1,Peve_00027833,Pocillopora_meandrina_HIv1___RNAseq.g17811.t1,three_way,78.49183333333333,FUN_023634-T1,Q98TX3,,,,,45.7,438.0,1.4e-94,348.2,sp|Q98TX3|PDCD4_CHICK Programmed cell death protein 4 OS=Gallus gallus OX=9031 GN=PDCD4 PE=2 SV=1,,,,,,
OG_07340,0.4874647786319386,OG_07340,FUN_033745-T1,Peve_00004929,Pocillopora_meandrina_HIv1___RNAseq.g28757.t1,three_way,54.01,FUN_033745-T1,Q8QGQ6,CLOCK_CHICK,,Circadian locomoter output cycles protein kaput,Gallus gallus (Chicken),37.6,367.0,2.7000000000000002e-58,228.0,sp|Q8QGQ6|CLOCK_CHICK Circadian locomoter output cycles protein kaput OS=Gallus gallus OX=9031 GN=CLOCK PE=1 SV=2,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005829; GO:0006357; GO:0006473; GO:0006974; GO:0032922; GO:0046983; GO:0051775; GO:0070888; GO:1990513,circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; protein acetylation [GO:0006473]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775],CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04689,0.4874059053449517,OG_04689,FUN_022480-T1,Peve_00002919,Pocillopora_meandrina_HIv1___RNAseq.g4299.t1,three_way,73.78766666666667,FUN_022480-T1,Q9UH92,MLX_HUMAN,,Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4),Homo sapiens (Human),61.2,188.0,1.8e-56,220.7,sp|Q9UH92|MLX_HUMAN Max-like protein X OS=Homo sapiens OX=9606 GN=MLX PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:0061629; GO:1990837,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04602,0.487304212927264,OG_04602,FUN_022291-T1,Peve_00003683,Pocillopora_meandrina_HIv1___RNAseq.g4693.t1,three_way,60.70033333333333,,,,,,,,,,,,,,,,,
OG_02722,0.4871680383448347,OG_02722,FUN_011051-T1,Peve_00022611,Pocillopora_meandrina_HIv1___RNAseq.g20976.t1,three_way,89.26266666666666,FUN_011051-T1,Q7T312,,,,,73.6,208.0,1.3e-58,227.6,sp|Q7T312|CCD25_DANRE Coiled-coil domain-containing protein 25 OS=Danio rerio OX=7955 GN=ccdc25 PE=1 SV=1,,,,,,
OG_06846,0.4869530661595538,OG_06846,FUN_031787-T1,Peve_00019324,Pocillopora_meandrina_HIv1___RNAseq.g5568.t1,three_way,65.77866666666667,FUN_031787-T1,A7Z026,,,,,44.6,294.0,6.300000000000001e-65,250.4,sp|A7Z026|PPR37_BOVIN Protein phosphatase 1 regulatory subunit 37 OS=Bos taurus OX=9913 GN=PPP1R37 PE=2 SV=1,,,,,,
OG_05309,0.4869380314816572,OG_05309,FUN_023983-T1,Peve_00020889,Pocillopora_meandrina_HIv1___RNAseq.g19410.t1,three_way,79.52850000000001,FUN_023983-T1,Q5R754,CDKL2_PONAB,,Cyclin-dependent kinase-like 2 (EC 2.7.11.22),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),66.5,328.0,2.6e-132,474.2,sp|Q5R754|CDKL2_PONAB Cyclin-dependent kinase-like 2 OS=Pongo abelii OX=9601 GN=CDKL2 PE=2 SV=1,GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0106310,,cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03594,0.4868910404737802,OG_03594,FUN_014752-T1,Peve_00039159,Pocillopora_meandrina_HIv1___TS.g27211.t1c,three_way,80.13483333333333,FUN_014752-T1,Q04678,,,,,57.2,617.0,2e-173,610.9,sp|Q04678|SSRP1_CHICK FACT complex subunit SSRP1 OS=Gallus gallus OX=9031 GN=SSRP1 PE=2 SV=2,,,,,,
OG_07447,0.4867710409144507,OG_07447,FUN_033939-T1,Peve_00020991,Pocillopora_meandrina_HIv1___RNAseq.g26576.t1,three_way,38.9615,,,,,,,,,,,,,,,,,
OG_08142,0.486462570364181,OG_08142,FUN_035907-T1,Peve_00006737,Pocillopora_meandrina_HIv1___RNAseq.g12031.t1,three_way,87.19116666666667,FUN_035907-T1,Q5RE09,DC1L2_PONAB,,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),51.2,477.0,2.9e-122,440.3,sp|Q5RE09|DC1L2_PONAB Cytoplasmic dynein 1 light intermediate chain 2 OS=Pongo abelii OX=9601 GN=DYNC1LI2 PE=2 SV=1,GO:0000226; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045504,microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874],ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504],GO:0005815; GO:0007010; GO:0007018,microtubule organizing center; cytoskeleton organization; microtubule-based movement
OG_03621,0.4864240896309638,OG_03621,FUN_014808-T1,Peve_00023295,Pocillopora_meandrina_HIv1___RNAseq.g22408.t1,three_way,88.98733333333334,FUN_014808-T1,Q86YT6,MIB1_HUMAN,,E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2),Homo sapiens (Human),73.7,1031.0,0.0,1109.7,sp|Q86YT6|MIB1_HUMAN E3 ubiquitin-protein ligase MIB1 OS=Homo sapiens OX=9606 GN=MIB1 PE=1 SV=1,GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0021953; GO:0031410; GO:0034451; GO:0045665; GO:0045807; GO:0061630; GO:0098978,blood vessel development [GO:0001568]; central nervous system neuron differentiation [GO:0021953]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06785,0.4863083502939949,OG_06785,FUN_031652-T1,Peve_00017753,Pocillopora_meandrina_HIv1___RNAseq.g5676.t1,three_way,63.12333333333333,FUN_031652-T1,Q642T7,,,,,48.6,366.0,1.9e-91,338.2,sp|Q642T7|UTP25_XENTR U3 small nucleolar RNA-associated protein 25 homolog OS=Xenopus tropicalis OX=8364 GN=utp25 PE=2 SV=1,,,,,,
OG_02011,0.4862956215179243,OG_02011,FUN_008183-T1,Peve_00018748,Pocillopora_meandrina_HIv1___RNAseq.g29991.t1,three_way,78.25766666666667,FUN_008183-T1,K4CJJ1,,,,,26.0,481.0,5.5e-26,120.6,"sp|K4CJJ1|NCED2_SOLLC 9-cis-epoxycarotenoid dioxygenase NCED2, chloroplastic OS=Solanum lycopersicum OX=4081 GN=NCED2 PE=2 SV=1",,,,,,
OG_05560,0.4862790311974568,OG_05560,FUN_024778-T1,Peve_00016140,Pocillopora_meandrina_HIv1___RNAseq.g18804.t1,three_way,93.01066666666668,FUN_024778-T1,Q91ZW3,,,,,72.6,999.0,0.0,1404.0,sp|Q91ZW3|SMCA5_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Mus musculus OX=10090 GN=Smarca5 PE=1 SV=1,,,,,,
OG_04593,0.4860472873741721,OG_04593,FUN_022271-T1,Peve_00007683,Pocillopora_meandrina_HIv1___RNAseq.g4712.t1,three_way,56.11566666666666,FUN_022271-T1,Q5F479,,,,,25.6,679.0,7.7e-41,171.4,sp|Q5F479|S11IP_CHICK Serine/threonine-protein kinase 11-interacting protein OS=Gallus gallus OX=9031 GN=STK11IP PE=2 SV=1,,,,,,
OG_08952,0.4859668571913558,OG_08952,FUN_038426-T1,Peve_00000114,Pocillopora_meandrina_HIv1___RNAseq.g1178.t1,three_way,77.04633333333334,FUN_038426-T1,F1R8Z9,FXJ1B_DANRE,,Forkhead box protein J1-B,Danio rerio (Zebrafish) (Brachydanio rerio),45.4,282.0,2.2e-51,204.5,sp|F1R8Z9|FXJ1B_DANRE Forkhead box protein J1-B OS=Danio rerio OX=7955 GN=foxj1b PE=2 SV=1,GO:0000978; GO:0000981; GO:0001947; GO:0003146; GO:0005634; GO:0006357; GO:0007368; GO:0044458; GO:0060088; GO:0060271,auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0044782; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cilium organization; transcription regulator activity
OG_05951,0.4858998689303665,OG_05951,FUN_026211-T1,Peve_00044665,Pocillopora_meandrina_HIv1___RNAseq.g3049.t1,three_way,49.01616666666666,FUN_026211-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),24.8,1256.0,9.1e-63,246.1,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_04353,0.485805534268782,OG_04353,FUN_018000-T1,Peve_00044834,Pocillopora_meandrina_HIv1___RNAseq.29588_t,three_way,55.3835,FUN_018000-T1,Q8IXF0,NPAS3_HUMAN,,Neuronal PAS domain-containing protein 3 (Neuronal PAS3) (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12) (bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6),Homo sapiens (Human),40.8,424.0,9.4e-76,287.0,sp|Q8IXF0|NPAS3_HUMAN Neuronal PAS domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NPAS3 PE=1 SV=1,GO:0000785; GO:0000977; GO:0000981; GO:0005654; GO:0006357; GO:0045893; GO:0046982,positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005654; GO:0006355; GO:0140110,DNA binding; nucleoplasm; regulation of DNA-templated transcription; transcription regulator activity
OG_00237,0.4857919338257326,OG_00237,FUN_000992-T1,Peve_00004455,Pocillopora_meandrina_HIv1___RNAseq.g29194.t1,three_way,92.068,FUN_000992-T1,P82471,GNAQ_RAT,,Guanine nucleotide-binding protein G(q) subunit alpha (EC 3.6.5.-) (Guanine nucleotide-binding protein alpha-q),Rattus norvegicus (Rat),82.2,353.0,8.9e-169,594.3,sp|P82471|GNAQ_RAT Guanine nucleotide-binding protein G(q) subunit alpha OS=Rattus norvegicus OX=10116 GN=Gnaq PE=2 SV=2,GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0003925; GO:0005096; GO:0005525; GO:0005737; GO:0005794; GO:0005834; GO:0005886; GO:0005901; GO:0007186; GO:0007189; GO:0007200; GO:0007206; GO:0007207; GO:0007208; GO:0007215; GO:0007218; GO:0007507; GO:0008217; GO:0009791; GO:0010543; GO:0016020; GO:0016322; GO:0021884; GO:0030234; GO:0030425; GO:0031683; GO:0031965; GO:0032024; GO:0034695; GO:0042711; GO:0042733; GO:0043066; GO:0043267; GO:0044297; GO:0044877; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0050821; GO:0060158; GO:0060828; GO:0086100; GO:0098793; GO:0099524; GO:1904888; GO:1990806,action potential [GO:0001508]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; endothelin receptor signaling pathway [GO:0086100]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; ligand-gated ion channel signaling pathway [GO:1990806]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; neuron remodeling [GO:0016322]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of insulin secretion [GO:0032024]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of blood pressure [GO:0008217]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; regulation of platelet activation [GO:0010543]; response to prostaglandin E [GO:0034695]; skeletal system development [GO:0001501],caveola [GO:0005901]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynapse [GO:0098793],alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; enzyme regulator activity [GO:0030234]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_01029,0.4856872680682662,OG_01029,FUN_004464-T1,Peve_00007170,Pocillopora_meandrina_HIv1___RNAseq.g4957.t1,three_way,65.17666666666668,FUN_004464-T1,P54726,RD23A_MOUSE,,UV excision repair protein RAD23 homolog A (HR23A) (mHR23A),Mus musculus (Mouse),56.6,373.0,1.9e-52,208.0,sp|P54726|RD23A_MOUSE UV excision repair protein RAD23 homolog A OS=Mus musculus OX=10090 GN=Rad23a PE=1 SV=2,GO:0000502; GO:0003684; GO:0005654; GO:0005794; GO:0005829; GO:0006289; GO:0006974; GO:0019900; GO:0031593; GO:0031648; GO:0032436; GO:0043161; GO:0045070; GO:0045787; GO:1990381,DNA damage response [GO:0006974]; nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502],damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin-specific protease binding [GO:1990381],GO:0003677; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0030163; GO:0043226,DNA binding; nucleoplasm; Golgi apparatus; cytosol; DNA repair; protein catabolic process; organelle
OG_01880,0.485672704055793,OG_01880,FUN_007856-T1,Peve_00021797,Pocillopora_meandrina_HIv1___RNAseq.g18293.t1,three_way,48.038,,,,,,,,,,,,,,,,,
OG_08016,0.4856497286490246,OG_08016,FUN_035670-T1,Peve_00002791,Pocillopora_meandrina_HIv1___RNAseq.g28127.t1,three_way,93.71433333333334,FUN_035670-T1,Q9PV94,,,,,77.2,149.0,1.9e-54,214.2,sp|Q9PV94|RSMB_CHICK Small nuclear ribonucleoprotein-associated protein B' OS=Gallus gallus OX=9031 GN=SNRPB PE=2 SV=1,,,,,,
OG_02511,0.485582045421288,OG_02511,FUN_010518-T1,Peve_00003566,Pocillopora_meandrina_HIv1___RNAseq.g12949.t1,three_way,56.06633333333333,FUN_010518-T1,Q5BKC9,NGEF_RAT,,Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor),Rattus norvegicus (Rat),35.8,573.0,2.1e-92,342.4,sp|Q5BKC9|NGEF_RAT Ephexin-1 OS=Rattus norvegicus OX=10116 GN=Ngef PE=1 SV=2,GO:0005085; GO:0005737; GO:0007399; GO:0016020; GO:0030154; GO:0030426; GO:0032956; GO:0043087; GO:0046875; GO:0048013; GO:0061002; GO:0098794; GO:0098978; GO:1905806,cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of synapse pruning [GO:1905806],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; postsynapse [GO:0098794],ephrin receptor binding [GO:0046875]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0030154; GO:0048856; GO:0098772,cell differentiation; anatomical structure development; molecular function regulator activity
OG_09513,0.4854173478599103,OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,27.8,752.0,2.7e-39,166.4,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09513,0.4854173478599103,OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,36.9,187.0,1.8e-19,100.5,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_04380,0.485396017863663,OG_04380,FUN_018046-T1,Peve_00021796,Pocillopora_meandrina_HIv1___RNAseq.g25349.t2,three_way,79.40316666666666,FUN_018046-T1,C3YZ51,,,,,67.8,410.0,3e-144,513.1,sp|C3YZ51|UBA5_BRAFL Ubiquitin-like modifier-activating enzyme 5 OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_113714 PE=3 SV=1,,,,,,
OG_04154,0.4853846050501984,OG_04154,FUN_016621-T1,Peve_00005682,Pocillopora_meandrina_HIv1___RNAseq.g9611.t1,three_way,71.54566666666666,FUN_016621-T1,Q99615,DNJC7_HUMAN,,DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2),Homo sapiens (Human),55.3,414.0,1.4999999999999998e-127,458.0,sp|Q99615|DNJC7_HUMAN DnaJ homolog subfamily C member 7 OS=Homo sapiens OX=9606 GN=DNAJC7 PE=1 SV=2,GO:0001671; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034,chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072],GO:0005654; GO:0005829; GO:0005856; GO:0006457; GO:0043226; GO:0098772,nucleoplasm; cytosol; cytoskeleton; protein folding; organelle; molecular function regulator activity
OG_02418,0.4852265950116818,OG_02418,FUN_009304-T1,Peve_00005826,Pocillopora_meandrina_HIv1___RNAseq.g14445.t1,three_way,85.81966666666666,FUN_009304-T1,B7PRF6,,,,,65.6,180.0,3.7e-70,265.8,sp|B7PRF6|MTND_IXOSC Acireductone dioxygenase OS=Ixodes scapularis OX=6945 GN=IscW_ISCW007295 PE=3 SV=1,,,,,,
OG_02513,0.4852095122278237,OG_02513,FUN_010557-T1,Peve_00032715,Pocillopora_meandrina_HIv1___TS.g26164.t1,three_way,92.39433333333334,FUN_010557-T1,Q2KII4,ELOC_BOVIN,,Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1),Bos taurus (Bovine),88.0,108.0,5.8e-51,201.4,sp|Q2KII4|ELOC_BOVIN Elongin-C OS=Bos taurus OX=9913 GN=ELOC PE=1 SV=1,GO:0006511; GO:0016567; GO:0030674; GO:0031466; GO:0070449,protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449],protein-macromolecule adaptor activity [GO:0030674],GO:0060090,molecular adaptor activity
OG_01387,0.4848795528776035,OG_01387,FUN_005356-T1,Peve_00016032,Pocillopora_meandrina_HIv1___RNAseq.g8215.t1,three_way,63.59766666666667,FUN_005356-T1,Q96I13,ABHD8_HUMAN,,Protein ABHD8 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 8) (Abhydrolase domain-containing protein 8),Homo sapiens (Human),47.5,242.0,2.6e-58,227.6,sp|Q96I13|ABHD8_HUMAN Protein ABHD8 OS=Homo sapiens OX=9606 GN=ABHD8 PE=1 SV=1,GO:0005737; GO:0005739; GO:0006654; GO:0042171; GO:0052689; GO:0055088; GO:0070062; GO:1900226,lipid homeostasis [GO:0055088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; phosphatidic acid biosynthetic process [GO:0006654],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_02463,0.4848655354145845,OG_02463,FUN_009654-T1,Peve_00003555,Pocillopora_meandrina_HIv1___RNAseq.g24583.t1,three_way,69.71183333333333,FUN_009654-T1,A6H8T7,CBPC2_DANRE,,Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) (Testis-expressed protein 25),Danio rerio (Zebrafish) (Brachydanio rerio),48.3,484.0,1.8e-128,462.2,sp|A6H8T7|CBPC2_DANRE Cytosolic carboxypeptidase 2 OS=Danio rerio OX=7955 GN=zte25 PE=2 SV=1,GO:0004181; GO:0005737; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0035610; GO:0036064,protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508],centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06624,0.4848482099588812,OG_06624,FUN_030046-T1,Peve_00008452,Pocillopora_meandrina_HIv1___RNAseq.g17345.t1,three_way,89.0,FUN_030046-T1,Q1JPX3,,,,,66.2,497.0,2.4e-196,686.4,sp|Q1JPX3|SYFA_DANRE Phenylalanine--tRNA ligase alpha subunit OS=Danio rerio OX=7955 GN=farsa PE=2 SV=2,,,,,,
OG_03522,0.4848222144200197,OG_03522,FUN_014637-T1,Peve_00002423,Pocillopora_meandrina_HIv1___RNAseq.g22792.t1,three_way,83.999,FUN_014637-T1,P15651,,,,,74.8,377.0,4.1e-165,582.4,"sp|P15651|ACADS_RAT Short-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acads PE=1 SV=2",,,,,,
OG_09664,0.4848127846944956,OG_09664,FUN_041875-T1,Peve_00040575,Pocillopora_meandrina_HIv1___RNAseq.g15107.t1,three_way,97.13533333333334,FUN_041875-T1,P49841,GSK3B_HUMAN,,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),Homo sapiens (Human),88.7,212.0,1.4000000000000005e-111,403.7,sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens OX=9606 GN=GSK3B PE=1 SV=2,GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0003170; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007005; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010629; GO:0010719; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0019082; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030154; GO:0030336; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031398; GO:0031625; GO:0032007; GO:0032092; GO:0032436; GO:0032886; GO:0034236; GO:0034452; GO:0034976; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043161; GO:0043525; GO:0045597; GO:0045668; GO:0045719; GO:0045724; GO:0045732; GO:0046777; GO:0046825; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060070; GO:0060079; GO:0061629; GO:0070507; GO:0070885; GO:0071109; GO:0071300; GO:0090090; GO:0097110; GO:0097191; GO:0097192; GO:0098793; GO:0098794; GO:0098978; GO:0099171; GO:0106027; GO:0106310; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1902042; GO:1903566; GO:1903940; GO:1904339; GO:1904646; GO:1904781; GO:1990909; GO:2000077; GO:2000466; GO:2000740,canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glycogen metabolic process [GO:0005977]; heart valve development [GO:0003170]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC2 signaling [GO:1903940]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of protein-containing complex assembly [GO:0031334]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; response to endoplasmic reticulum stress [GO:0034976]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Wnt signalosome [GO:1990909],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0007005; GO:0007163; GO:0008092; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0061024; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; mitochondrion organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; membrane organization; catalytic activity, acting on a protein"
OG_07547,0.4847121414374664,OG_07547,FUN_034129-T1,Peve_00006387,Pocillopora_meandrina_HIv1___RNAseq.g25940.t1,three_way,75.964,FUN_034129-T1,O02703,BAX_BOVIN,,Apoptosis regulator BAX,Bos taurus (Bovine),37.1,140.0,9.6e-19,95.1,sp|O02703|BAX_BOVIN Apoptosis regulator BAX OS=Bos taurus OX=9913 GN=BAX PE=2 SV=1,GO:0001783; GO:0001836; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0008053; GO:0008289; GO:0008630; GO:0008637; GO:0009636; GO:0010248; GO:0010917; GO:0015267; GO:0031334; GO:0032091; GO:0032976; GO:0042803; GO:0042981; GO:0043065; GO:0043525; GO:0043653; GO:0046930; GO:0051434; GO:0051881; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:2001244,apoptotic mitochondrial changes [GO:0008637]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein binding [GO:0032091]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to toxic substance [GO:0009636],BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930],BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0007005; GO:0008289; GO:0012501; GO:0043226; GO:0055085,transporter activity; nucleus; mitochondrion; endoplasmic reticulum; cytosol; mitochondrion organization; lipid binding; programmed cell death; organelle; transmembrane transport
OG_00050,0.4847010839561487,OG_00050,FUN_000319-T1,Peve_00033573,Pocillopora_meandrina_HIv1___RNAseq.g29015.t1,three_way,79.55166666666666,FUN_000319-T1,O43396,,,,,57.0,207.0,1.2999999999999999e-61,237.7,sp|O43396|TXNL1_HUMAN Thioredoxin-like protein 1 OS=Homo sapiens OX=9606 GN=TXNL1 PE=1 SV=3,,,,,,
OG_05325,0.4844139096370418,OG_05325,FUN_024017-T1,Peve_00023794,Pocillopora_meandrina_HIv1___RNAseq.g19284.t1,three_way,80.70366666666666,FUN_024017-T1,F6UA42,,,,,57.2,797.0,4.3e-248,859.0,sp|F6UA42|UHRF1_XENTR E3 ubiquitin-protein ligase UHRF1 OS=Xenopus tropicalis OX=8364 GN=uhrf1 PE=3 SV=2,,,,,,
OG_08733,0.4843696154929751,OG_08733,FUN_037990-T1,Peve_00023488,Pocillopora_meandrina_HIv1___RNAseq.g26269.t1,three_way,90.14733333333334,FUN_037990-T1,A5PKG7,,,,,68.2,198.0,5.2e-73,275.4,sp|A5PKG7|KCTD5_BOVIN BTB/POZ domain-containing protein KCTD5 OS=Bos taurus OX=9913 GN=KCTD5 PE=2 SV=1,,,,,,
OG_01040,0.4843193836033294,OG_01040,FUN_004477-T1,Peve_00033228,Pocillopora_meandrina_HIv1___RNAseq.g4945.t1,three_way,66.27733333333333,FUN_004477-T1,Q8BLA8,TRPA1_MOUSE,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Mus musculus (Mouse),27.2,949.0,1.1e-65,253.4,sp|Q8BLA8|TRPA1_MOUSE Transient receptor potential cation channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Trpa1 PE=1 SV=1,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_08103,0.4842728620046319,OG_08103,FUN_035849-T1,Peve_00032507,Pocillopora_meandrina_HIv1___RNAseq.g11952.t1,three_way,79.79733333333333,FUN_035849-T1,Q9VQ29,,,,,62.9,197.0,4.1999999999999996e-70,266.2,"sp|Q9VQ29|UCRI_DROME Cytochrome b-c1 complex subunit Rieske, mitochondrial OS=Drosophila melanogaster OX=7227 GN=RFeSP PE=1 SV=3",,,,,,
OG_00456,0.4841844423768289,OG_00456,FUN_001385-T1,Peve_00019351,Pocillopora_meandrina_HIv1___RNAseq.g2129.t1,three_way,85.12266666666667,FUN_001385-T1,O75398,DEAF1_HUMAN,,Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5),Homo sapiens (Human),43.0,291.0,1.5e-50,202.2,sp|O75398|DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens OX=9606 GN=DEAF1 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0001662; GO:0001843; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0007281; GO:0008270; GO:0008542; GO:0009653; GO:0033599; GO:0045892; GO:0045893; GO:0048706; GO:0090575,anatomical structure morphogenesis [GO:0009653]; behavioral fear response [GO:0001662]; embryonic skeletal system development [GO:0048706]; germ cell development [GO:0007281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542],chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005576; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0050877; GO:0140110,DNA binding; extracellular region; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_01056,0.4841623585145941,OG_01056,FUN_004509-T1,Peve_00012958,Pocillopora_meandrina_HIv1___RNAseq.g11641.t1,three_way,58.72666666666667,,,,,,,,,,,,,,,,,
OG_05265,0.4841326570779949,OG_05265,FUN_023795-T1,Peve_00039445,Pocillopora_meandrina_HIv1___RNAseq.g5766.t1,three_way,90.22266666666668,FUN_023795-T1,Q91VN6,DDX41_MOUSE,,Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41),Mus musculus (Mouse),76.5,548.0,1.1e-243,844.0,sp|Q91VN6|DDX41_MOUSE Probable ATP-dependent RNA helicase DDX41 OS=Mus musculus OX=10090 GN=Ddx41 PE=1 SV=2,GO:0000398; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005783; GO:0005829; GO:0008270; GO:0008283; GO:0016887; GO:0030154; GO:0035458; GO:0045944; GO:0051607; GO:0071013; GO:0140896,"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005783; GO:0005829; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; endoplasmic reticulum; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04577,0.4838624502709416,OG_04577,FUN_022239-T1,Peve_00029745,Pocillopora_meandrina_HIv1___RNAseq.g4755.t1,three_way,65.46666666666667,,,,,,,,,,,,,,,,,
OG_02237,0.4837221552271182,OG_02237,FUN_008649-T1,Peve_00035682,Pocillopora_meandrina_HIv1___RNAseq.g15.t1,three_way,97.37233333333332,FUN_008649-T1,Q32LN1,UBE2H_BOVIN,,Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (Ubiquitin carrier protein H) (Ubiquitin-protein ligase H),Bos taurus (Bovine),73.8,183.0,4.0000000000000004e-72,272.3,sp|Q32LN1|UBE2H_BOVIN Ubiquitin-conjugating enzyme E2 H OS=Bos taurus OX=9913 GN=UBE2H PE=2 SV=1,GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02332,0.483631920287902,OG_02332,FUN_008927-T1,Peve_00036396,Pocillopora_meandrina_HIv1___RNAseq.g4036.t1,three_way,85.159,FUN_008927-T1,Q6P268,PDCL3_DANRE,,Phosducin-like protein 3 (Viral IAP-associated factor 1 homolog),Danio rerio (Zebrafish) (Brachydanio rerio),52.8,248.0,1.9999999999999999e-63,243.8,sp|Q6P268|PDCL3_DANRE Phosducin-like protein 3 OS=Danio rerio OX=7955 GN=pdcl3 PE=2 SV=1,GO:0001525; GO:0005737; GO:0005783; GO:0006457; GO:0006915; GO:0010628; GO:0043184; GO:0044183; GO:0048471,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184],GO:0005783; GO:0006457; GO:0012501; GO:0043226; GO:0044183,endoplasmic reticulum; protein folding; programmed cell death; organelle; protein folding chaperone
OG_08921,0.4833759639806276,OG_08921,FUN_038377-T1,Peve_00000076,Pocillopora_meandrina_HIv1___RNAseq.g1089.t1,three_way,90.58716666666666,FUN_038377-T1,Q7ZXB7,,,,,66.4,125.0,2.1e-40,166.4,sp|Q7ZXB7|LTR2B_XENLA Ragulator complex protein LAMTOR2-B OS=Xenopus laevis OX=8355 GN=lamtor2-b PE=2 SV=1,,,,,,
OG_09207,0.4832838092873131,OG_09207,FUN_039895-T1,Peve_00010157,Pocillopora_meandrina_HIv1___RNAseq.g7346.t1,three_way,66.7045,,,,,,,,,,,,,,,,,
OG_09059,0.4832233585180324,OG_09059,FUN_038742-T1,Peve_00009051,Pocillopora_meandrina_HIv1___RNAseq.g26426.t1,three_way,86.85000000000001,FUN_038742-T1,Q8TB05,,,,,74.4,86.0,2.5e-28,125.9,sp|Q8TB05|UBAD1_HUMAN UBA-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBALD1 PE=1 SV=1,,,,,,
OG_09366,0.4828091230418384,OG_09366,FUN_040490-T1,Peve_00015395,Pocillopora_meandrina_HIv1___RNAseq.g6526.t1,three_way,97.22233333333334,FUN_040490-T1,Q3ZC10,SMD1_BOVIN,,Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (snRNP core protein D1),Bos taurus (Bovine),92.7,82.0,4e-36,152.1,sp|Q3ZC10|SMD1_BOVIN Small nuclear ribonucleoprotein Sm D1 OS=Bos taurus OX=9913 GN=SNRPD1 PE=3 SV=1,GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]",catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_07709,0.4826810137194848,OG_07709,FUN_034854-T1,Peve_00008081,Pocillopora_meandrina_HIv1___RNAseq.g12153.t1,three_way,83.84633333333333,FUN_034854-T1,P08574,CY1_HUMAN,,"Cytochrome c1, heme protein, mitochondrial (EC 7.1.1.8) (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)",Homo sapiens (Human),62.9,213.0,1.2e-76,287.7,"sp|P08574|CY1_HUMAN Cytochrome c1, heme protein, mitochondrial OS=Homo sapiens OX=9606 GN=CYC1 PE=1 SV=3",GO:0005634; GO:0005739; GO:0005743; GO:0006122; GO:0008121; GO:0016020; GO:0020037; GO:0033762; GO:0045275; GO:0045333; GO:0046872,"cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to glucagon [GO:0033762]",membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; respiratory chain complex III [GO:0045275],heme binding [GO:0020037]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121],GO:0005215; GO:0005634; GO:0005739; GO:0006091; GO:0043226,transporter activity; nucleus; mitochondrion; generation of precursor metabolites and energy; organelle
OG_08479,0.4825607775006904,OG_08479,FUN_037306-T1,Peve_00004061,Pocillopora_meandrina_HIv1___RNAseq.g1298.t1,three_way,93.64216666666668,FUN_037306-T1,A5PJN8,,,,,82.2,214.0,7.1e-99,361.7,sp|A5PJN8|SF3A2_BOVIN Splicing factor 3A subunit 2 OS=Bos taurus OX=9913 GN=SF3A2 PE=2 SV=1,,,,,,
OG_08418,0.4821615539994638,OG_08418,FUN_037076-T1,Peve_00004731,Pocillopora_meandrina_HIv1___TS.g13654.t2,three_way,65.30366666666667,FUN_037076-T1,Q6DEW6,,,,,38.3,321.0,3.2e-51,203.8,sp|Q6DEW6|REXO4_XENTR RNA exonuclease 4 OS=Xenopus tropicalis OX=8364 GN=rexo4 PE=2 SV=1,,,,,,
OG_08228,0.482091309882775,OG_08228,FUN_036100-T1,Peve_00032196,Pocillopora_meandrina_HIv1___RNAseq.g27435.t1,three_way,77.412,FUN_036100-T1,Q0P8I7,GMHD_CAMJE,,GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-),Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168),41.3,310.0,2.6e-64,247.3,sp|Q0P8I7|GMHD_CAMJE GDP-D-glycero-alpha-D-manno-heptose dehydrogenase OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) OX=192222 GN=Cj1427c PE=1 SV=1,GO:0003978; GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404,capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289],,GDP binding [GO:0019003]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491]; UDP-glucose 4-epimerase activity [GO:0003978],GO:0003824; GO:0005975; GO:0016491; GO:0016853; GO:0065003,catalytic activity; carbohydrate metabolic process; oxidoreductase activity; isomerase activity; protein-containing complex assembly
OG_02990,0.4820424118170702,OG_02990,FUN_012166-T1,Peve_00008632,Pocillopora_meandrina_HIv1___RNAseq.g23449.t1,three_way,81.14583333333333,FUN_012166-T1,Q9HU55,,,,,37.2,78.0,2.7e-11,71.6,sp|Q9HU55|GLRX_PSEAE Glutaredoxin OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=grx PE=3 SV=1,,,,,,
OG_10174,0.482006319608417,OG_10174,FUN_043583-T1,Peve_00045199,Pocillopora_meandrina_HIv1___RNAseq.g6989.t1,three_way,62.69716666666667,FUN_043583-T1,Q68F67,,,,,45.0,467.0,4.1e-113,410.6,sp|Q68F67|DEN1A_XENLA DENN domain-containing protein 1A OS=Xenopus laevis OX=8355 GN=dennd1a PE=2 SV=1,,,,,,
OG_01257,0.4819982486282648,OG_01257,FUN_004989-T1,Peve_00015880,Pocillopora_meandrina_HIv1___RNAseq.g8684.t1,three_way,92.291,FUN_004989-T1,Q3ZCK9,,,,,73.6,216.0,1.1e-90,334.3,sp|Q3ZCK9|PSA4_BOVIN Proteasome subunit alpha type-4 OS=Bos taurus OX=9913 GN=PSMA4 PE=1 SV=1,,,,,,
OG_04788,0.4818838298713941,OG_04788,FUN_022702-T1,Peve_00018685,Pocillopora_meandrina_HIv1___TS.g22237.t2,three_way,74.7355,FUN_022702-T1,Q3MJK5,CDK12_RAT,,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (Protein kinase for splicing component)",Rattus norvegicus (Rat),77.8,334.0,3.2e-159,564.3,sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus OX=10116 GN=Cdk12 PE=1 SV=1,GO:0002944; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0006397; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019901; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0043484; GO:0045944; GO:0106310; GO:2000737,mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],cyclin K-CDK12 complex [GO:0002944]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05285,0.4818386632663066,OG_05285,FUN_023948-T1,Peve_00016130,Pocillopora_meandrina_HIv1___RNAseq.g18526.t1,three_way,94.61833333333334,FUN_023948-T1,Q176V0,,,,,94.0,83.0,2.8e-37,155.6,sp|Q176V0|UFM1_AEDAE Ubiquitin-fold modifier 1 OS=Aedes aegypti OX=7159 GN=AAEL006251 PE=3 SV=1,,,,,,
OG_04582,0.4817909610477876,OG_04582,FUN_022245-T1,Peve_00037428,Pocillopora_meandrina_HIv1___RNAseq.g4760.t1,three_way,54.247166666666665,FUN_022245-T1,Q96DN6,MBD6_HUMAN,,Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6),Homo sapiens (Human),41.4,99.0,6.5e-16,88.6,sp|Q96DN6|MBD6_HUMAN Methyl-CpG-binding domain protein 6 OS=Homo sapiens OX=9606 GN=MBD6 PE=1 SV=2,GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0010369,,chromocenter [GO:0010369]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005654; GO:0005694; GO:0043226,nucleus; nucleoplasm; chromosome; organelle
OG_07287,0.4816762633867677,OG_07287,FUN_033668-T1,Peve_00006804,Pocillopora_meandrina_HIv1___RNAseq.g28825.t1,three_way,80.98966666666666,FUN_033668-T1,O70579,,,,,61.8,204.0,3.6e-63,243.0,sp|O70579|PM34_MOUSE Peroxisomal membrane protein PMP34 OS=Mus musculus OX=10090 GN=Slc25a17 PE=1 SV=1,,,,,,
OG_00729,0.4815838704703128,OG_00729,FUN_002695-T1,Peve_00009946,Pocillopora_meandrina_HIv1___RNAseq.g20725.t1,three_way,61.78816666666667,FUN_002695-T1,Q90VV1,HES4B_XENLA,,Transcription factor HES-4-B (Hairy and enhancer of split 4-B) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2b),Xenopus laevis (African clawed frog),37.6,194.0,7.2e-20,99.0,sp|Q90VV1|HES4B_XENLA Transcription factor HES-4-B OS=Xenopus laevis OX=8355 GN=hes4-b PE=1 SV=1,GO:0000122; GO:0000978; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0014029; GO:0021501; GO:0033504; GO:0043066; GO:0043565; GO:0045892; GO:0046982; GO:0048642; GO:0050767,floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; prechordal plate formation [GO:0021501]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_09235,0.481579995699868,OG_09235,FUN_039980-T1,Peve_00014321,Pocillopora_meandrina_HIv1___RNAseq.g7547.t1,three_way,79.15883333333333,FUN_039980-T1,Q55G75,,,,,35.5,265.0,6.200000000000001e-44,179.5,sp|Q55G75|Y7786_DICDI PH domain-containing protein DDB_G0267786 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0267786 PE=4 SV=1,,,,,,
OG_01073,0.4815291312799502,OG_01073,FUN_004557-T1,Peve_00016044,Pocillopora_meandrina_HIv1___RNAseq.g8230.t1,three_way,62.48366666666666,FUN_004557-T1,Q8R368,DAAF4_MOUSE,,Dynein axonemal assembly factor 4 (Dyslexia susceptibility 1 candidate gene 1 protein homolog),Mus musculus (Mouse),30.4,316.0,9.3e-29,129.0,sp|Q8R368|DAAF4_MOUSE Dynein axonemal assembly factor 4 OS=Mus musculus OX=10090 GN=Dnaaf4 PE=1 SV=2,GO:0001764; GO:0003341; GO:0003351; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0007611; GO:0030331; GO:0033146; GO:0036158; GO:0036159; GO:0043005; GO:0051649; GO:0061136; GO:0097730; GO:0120293,cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; learning or memory [GO:0007611]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886],nuclear estrogen receptor binding [GO:0030331],GO:0005576; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007018; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0065003,extracellular region; nucleus; microtubule organizing center; cytosol; plasma membrane; cilium; microtubule-based movement; organelle; anatomical structure development; cell motility; nervous system process; protein-containing complex assembly
OG_00130,0.4814613551110049,OG_00130,FUN_000559-T1,Peve_00010241,Pocillopora_meandrina_HIv1___RNAseq.g2460.t1,three_way,74.06333333333333,FUN_000559-T1,Q14247,SRC8_HUMAN,,Src substrate cortactin (Amplaxin) (Oncogene EMS1),Homo sapiens (Human),65.2,66.0,8.9e-19,96.7,sp|Q14247|SRC8_HUMAN Src substrate cortactin OS=Homo sapiens OX=9606 GN=CTTN PE=1 SV=2,GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0007165; GO:0008076; GO:0030027; GO:0030036; GO:0030139; GO:0030426; GO:0030516; GO:0030838; GO:0030863; GO:0043197; GO:0043231; GO:0045296; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098871; GO:0098885; GO:0098978; GO:1901524; GO:1990023; GO:2001237,"actin cytoskeleton organization [GO:0030036]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; regulation of mitophagy [GO:1901524]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]",actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; voltage-gated potassium channel complex [GO:0008076],Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064],GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0048870,endoplasmic reticulum; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; cell motility
OG_02183,0.481448989957654,OG_02183,FUN_008536-T1,Peve_00044627,Pocillopora_meandrina_HIv1___RNAseq.24098_t,three_way,66.34983333333334,,,,,,,,,,,,,,,,,
OG_08790,0.481427270234171,OG_08790,FUN_038086-T1,Peve_00004946,Pocillopora_meandrina_HIv1___RNAseq.g808.t1,three_way,57.21116666666666,,,,,,,,,,,,,,,,,
OG_01618,0.4812391372765436,OG_01618,FUN_006727-T1,Peve_00039555,Pocillopora_meandrina_HIv1___RNAseq.g20013.t1,three_way,71.43566666666666,FUN_006727-T1,Q3UTQ8,CDKL5_MOUSE,,Cyclin-dependent kinase-like 5 (EC 2.7.11.22),Mus musculus (Mouse),44.0,616.0,8.800000000000001e-125,449.5,sp|Q3UTQ8|CDKL5_MOUSE Cyclin-dependent kinase-like 5 OS=Mus musculus OX=10090 GN=Cdkl5 PE=1 SV=1,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0016301; GO:0034504; GO:0036064; GO:0097542; GO:0106310; GO:1902017,protein localization to nucleus [GO:0034504]; regulation of cilium assembly [GO:1902017],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06458,0.4812040652034634,OG_06458,FUN_029187-T1,Peve_00031211,Pocillopora_meandrina_HIv1___RNAseq.g25505.t1,three_way,77.81533333333333,FUN_029187-T1,Q63481,RAB7L_RAT,,Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29),Rattus norvegicus (Rat),52.6,209.0,3e-57,223.4,sp|Q63481|RAB7L_RAT Ras-related protein Rab-7L1 OS=Rattus norvegicus OX=10116 GN=Rab29 PE=1 SV=1,GO:0000139; GO:0001921; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0031965; GO:0031982; GO:0032438; GO:0042110; GO:0042147; GO:0042470; GO:0044788; GO:0048471; GO:0050862; GO:0055037; GO:0060271; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1903441; GO:1905279; GO:1990748,"cell differentiation [GO:0030154]; cellular detoxification [GO:1990748]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; modulation by host of viral process [GO:0044788]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]",cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; vesicle [GO:0031982],dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005739; GO:0005768; GO:0005773; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0008092; GO:0016192; GO:0016787; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0044782; GO:0098754,immune system process; catalytic activity; GTPase activity; nucleoplasm; mitochondrion; endosome; vacuole; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; intracellular protein transport; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; cilium organization; detoxification
OG_10188,0.4811811348796262,OG_10188,FUN_043605-T1,Peve_00040379,Pocillopora_meandrina_HIv1___RNAseq.g6947.t1,three_way,86.577,FUN_043605-T1,Q32L97,,,,,35.8,123.0,8.5e-12,71.6,sp|Q32L97|VAMP4_BOVIN Vesicle-associated membrane protein 4 OS=Bos taurus OX=9913 GN=VAMP4 PE=2 SV=1,,,,,,
OG_05803,0.4811546992700788,OG_05803,FUN_025793-T1,Peve_00021012,Pocillopora_meandrina_HIv1___RNAseq.g10402.t1,three_way,55.269666666666666,FUN_025793-T1,Q6R3M4,POLI_MOUSE,,DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B),Mus musculus (Mouse),40.9,541.0,1.2e-94,349.0,sp|Q6R3M4|POLI_MOUSE DNA polymerase iota OS=Mus musculus OX=10090 GN=Poli PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0019985; GO:0046872; GO:0071494,cellular response to UV-C [GO:0071494]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_07948,0.4810892521223036,OG_07948,FUN_035469-T1,Peve_00012131,Pocillopora_meandrina_HIv1___RNAseq.g27047.t1,three_way,52.6305,FUN_035469-T1,P17706,PTN2_HUMAN,,Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP),Homo sapiens (Human),52.8,307.0,2e-82,308.1,sp|P17706|PTN2_HUMAN Tyrosine-protein phosphatase non-receptor type 2 OS=Homo sapiens OX=9606 GN=PTPN2 PE=1 SV=2,GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0031904; GO:0035335; GO:0038020; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046426; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0070104; GO:0070373; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587,B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor recycling [GO:0038020]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of type II interferon-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome lumen [GO:0031904]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; endoplasmic reticulum; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_00853,0.4810109185155088,OG_00853,FUN_004115-T1,Peve_00008071,Pocillopora_meandrina_HIv1___RNAseq.g11666.t1,three_way,69.32233333333333,FUN_004115-T1,O94632,EGT1_SCHPO,,Ergothioneine biosynthesis protein 1 (Meiotically up-regulated gene 158 protein) [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.21.3.10)],Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),28.3,184.0,1.9e-09,66.2,sp|O94632|EGT1_SCHPO Ergothioneine biosynthesis protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt1 PE=1 SV=4,GO:0004497; GO:0005509; GO:0005634; GO:0005829; GO:0032259; GO:0051321; GO:0052699; GO:0052706; GO:0061686; GO:1903257,ergothioneine biosynthetic process [GO:0052699]; meiotic cell cycle [GO:0051321]; methylation [GO:0032259]; selenoneine biosynthetic process [GO:1903257],cytosol [GO:0005829]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; hercynylcysteine sulfoxide synthase activity [GO:0061686]; L-histidine N(alpha)-methyltransferase activity [GO:0052706]; monooxygenase activity [GO:0004497],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740; GO:0022414; GO:0043226,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity; reproductive process; organelle
OG_05229,0.4809704544458628,OG_05229,FUN_023642-T1,Peve_00027826,Pocillopora_meandrina_HIv1___RNAseq.g17815.t1,three_way,79.919,FUN_023642-T1,P06798,,,,,55.1,107.0,5.1e-20,99.8,sp|P06798|HXA4_MOUSE Homeobox protein Hox-A4 OS=Mus musculus OX=10090 GN=Hoxa4 PE=2 SV=4,,,,,,
OG_01367,0.4809426933461416,OG_01367,FUN_005315-T1,Peve_00003311,Pocillopora_meandrina_HIv1___RNAseq.g8175.t1,three_way,70.18966666666667,FUN_005315-T1,Q9UPR3,SMG5_HUMAN,,Nonsense-mediated mRNA decay factor SMG5 (EST1-like protein B) (LPTS-RP1) (LPTS-interacting protein) (SMG-5 homolog) (hSMG-5),Homo sapiens (Human),31.7,851.0,3.6e-72,274.6,sp|Q9UPR3|SMG5_HUMAN Nonsense-mediated mRNA decay factor SMG5 OS=Homo sapiens OX=9606 GN=SMG5 PE=1 SV=3,GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0031625; GO:0032204; GO:0032210; GO:0035303; GO:0036464; GO:0042162; GO:0042826; GO:0051721; GO:0070034,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0006913; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; cytosol; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_04784,0.4809222783325795,OG_04784,FUN_022696-T1,Peve_00045102,Pocillopora_meandrina_HIv1___TS.g22242.t1,three_way,67.26566666666666,,,,,,,,,,,,,,,,,
OG_05735,0.480919994101547,OG_05735,FUN_025661-T1,Peve_00042170,Pocillopora_meandrina_HIv1___RNAseq.g23064.t1,three_way,97.34233333333331,FUN_025661-T1,Q5ZMP6,,,,,81.8,439.0,1.4000000000000001e-211,736.9,sp|Q5ZMP6|AP2M1_CHICK AP-2 complex subunit mu OS=Gallus gallus OX=9031 GN=AP2M1 PE=2 SV=1,,,,,,
OG_03144,0.4809077911314146,OG_03144,FUN_012530-T1,Peve_00013909,Pocillopora_meandrina_HIv1___TS.g16844.t1b,three_way,95.39133333333334,FUN_012530-T1,P20461,,,,,86.7,458.0,1.3e-228,793.5,sp|P20461|IF2G_PIG Eukaryotic translation initiation factor 2 subunit 3 OS=Sus scrofa OX=9823 GN=EIF2S3 PE=1 SV=2,,,,,,
OG_00372,0.4808932741235713,OG_00372,FUN_001213-T1,Peve_00033813,Pocillopora_meandrina_HIv1___RNAseq.g29512.t1,three_way,79.601,FUN_001213-T1,P20072,,,,,62.2,312.0,2.1999999999999997e-105,384.4,sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2,,,,,,
OG_01603,0.4808135426015421,OG_01603,FUN_006646-T1,Peve_00029030,Pocillopora_meandrina_HIv1___RNAseq.g19948.t1,three_way,55.7015,FUN_006646-T1,Q9BY77,PDIP3_HUMAN,,Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein) (p46) (S6K1 Aly/REF-like target) (SKAR),Homo sapiens (Human),50.7,69.0,2.3e-13,78.2,sp|Q9BY77|PDIP3_HUMAN Polymerase delta-interacting protein 3 OS=Homo sapiens OX=9606 GN=POLDIP3 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016607; GO:0016973; GO:0036464; GO:0044877; GO:0045727,poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006913; GO:0043226,RNA binding; nucleus; nucleoplasm; cytosol; nucleocytoplasmic transport; organelle
OG_10010,0.4807121109241687,OG_10010,FUN_043245-T1,Peve_00001456,Pocillopora_meandrina_HIv1___TS.g20570.t1,three_way,67.59233333333333,FUN_043245-T1,Q60695,,,,,39.4,754.0,3.9e-110,400.6,sp|Q60695|RGL1_MOUSE Ral guanine nucleotide dissociation stimulator-like 1 OS=Mus musculus OX=10090 GN=Rgl1 PE=1 SV=2,,,,,,
OG_10133,0.4806250958502844,OG_10133,FUN_043517-T1,Peve_00017256,Pocillopora_meandrina_HIv1___RNAseq.g8028.t1,three_way,92.006,FUN_043517-T1,O61491,,,,,66.1,419.0,1.6e-84,314.7,sp|O61491|FLOT1_DROME Flotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1,,,,,,
OG_06102,0.4806066216238763,OG_06102,FUN_027803-T1,Peve_00036490,Pocillopora_meandrina_HIv1___RNAseq.g13902.t1,three_way,71.5315,FUN_027803-T1,Q6DFJ3,,,,,34.9,149.0,9.3e-19,94.7,sp|Q6DFJ3|FUD1B_XENLA FUN14 domain-containing protein 1B OS=Xenopus laevis OX=8355 GN=fundc1-b PE=2 SV=1,,,,,,
OG_08321,0.4804579792076354,OG_08321,FUN_036748-T1,Peve_00029513,Pocillopora_meandrina_HIv1___RNAseq.g12118.t1,three_way,83.22666666666667,FUN_036748-T1,Q5ZJ85,PRPF3_CHICK,,U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3),Gallus gallus (Chicken),52.0,696.0,1.8000000000000006e-165,584.3,sp|Q5ZJ85|PRPF3_CHICK U4/U6 small nuclear ribonucleoprotein Prp3 OS=Gallus gallus OX=9031 GN=PRPF3 PE=2 SV=1,GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]",nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540],,GO:0005634; GO:0016071; GO:0043226; GO:0065003,nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_08433,0.4804394120298879,OG_08433,FUN_037167-T1,Peve_00003254,Pocillopora_meandrina_HIv1___RNAseq.g11080.t1,three_way,59.40383333333333,,,,,,,,,,,,,,,,,
OG_04946,0.4804350708938096,OG_04946,FUN_023033-T1,Peve_00008499,Pocillopora_meandrina_HIv1___RNAseq.g3855.t2,three_way,61.9305,FUN_023033-T1,O14924,,,,,29.3,1289.0,6.6e-108,394.4,sp|O14924|RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens OX=9606 GN=RGS12 PE=1 SV=1,,,,,,
OG_08891,0.4803833992533833,OG_08891,FUN_038298-T1,Peve_00041737,Pocillopora_meandrina_HIv1___RNAseq.g28296.t1,three_way,96.35433333333332,FUN_038298-T1,Q6P8E9,,,,,85.9,128.0,2.2e-56,219.5,sp|Q6P8E9|NH2L1_XENTR NHP2-like protein 1 OS=Xenopus tropicalis OX=8364 GN=snu13 PE=2 SV=1,,,,,,
OG_04010,0.4803359075914241,OG_04010,FUN_016311-T1,Peve_00032324,Pocillopora_meandrina_HIv1___RNAseq.g10035.t1,three_way,78.09949999999999,FUN_016311-T1,Q76L87,,,,,37.8,259.0,3.8e-27,124.0,sp|Q76L87|DMTA2_ORYLA Doublesex- and mab-3-related transcription factor A2 OS=Oryzias latipes OX=8090 GN=dmrta2 PE=3 SV=1,,,,,,
OG_04627,0.4802414894500134,OG_04627,FUN_022340-T1,Peve_00028608,Pocillopora_meandrina_HIv1___RNAseq.g4654.t1,three_way,62.08733333333333,FUN_022340-T1,Q63258,ITA7_RAT,,Integrin alpha-7 (H36-alpha7) [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],Rattus norvegicus (Rat),27.7,1149.0,3.1e-87,325.1,sp|Q63258|ITA7_RAT Integrin alpha-7 OS=Rattus norvegicus OX=10116 GN=Itga7 PE=1 SV=2,GO:0005178; GO:0005737; GO:0005927; GO:0007155; GO:0007229; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016477; GO:0031594; GO:0033627; GO:0034113; GO:0034677; GO:0035987; GO:0042383; GO:0043236; GO:0044877; GO:0046872; GO:0048514; GO:0050839; GO:0050900; GO:0098609,blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519],cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integrin alpha7-beta1 complex [GO:0034677]; integrin complex [GO:0008305]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383],cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0002376; GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0048870,immune system process; plasma membrane; cell adhesion; cell differentiation; anatomical structure development; cell motility
OG_00440,0.4801252862042112,OG_00440,FUN_001351-T1,Peve_00023404,Pocillopora_meandrina_HIv1___RNAseq.g1874.t1,three_way,52.506,,,,,,,,,,,,,,,,,
OG_03531,0.4801203088753425,OG_03531,FUN_014646-T1,Peve_00025654,Pocillopora_meandrina_HIv1___RNAseq.g22686.t1,three_way,77.64233333333333,FUN_014646-T1,Q9D1L0,,,,,56.7,60.0,7.4e-11,68.6,sp|Q9D1L0|CHCH2_MOUSE Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 OS=Mus musculus OX=10090 GN=Chchd2 PE=2 SV=1,,,,,,
OG_02016,0.4800868864013263,OG_02016,FUN_008193-T1,Peve_00033874,Pocillopora_meandrina_HIv1___RNAseq.g30167.t1,three_way,91.72483333333334,FUN_008193-T1,O70435,,,,,73.6,254.0,1.6e-103,377.1,sp|O70435|PSA3_MOUSE Proteasome subunit alpha type-3 OS=Mus musculus OX=10090 GN=Psma3 PE=1 SV=3,,,,,,
OG_07639,0.480010707097101,OG_07639,FUN_034399-T1,Peve_00002471,Pocillopora_meandrina_HIv1___RNAseq.g28580.t1,three_way,85.80316666666667,FUN_034399-T1,Q9EPL8,IPO7_MOUSE,,Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7),Mus musculus (Mouse),55.4,1040.0,2.1e-311,1069.7,sp|Q9EPL8|IPO7_MOUSE Importin-7 OS=Mus musculus OX=10090 GN=Ipo7 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0031267; GO:0042393; GO:0045087; GO:0045668; GO:0046332; GO:1900182; GO:1901331,innate immune response [GO:0045087]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267],GO:0002376; GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0042393; GO:0043226; GO:0098542,immune system process; nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; histone binding; organelle; defense response to other organism
OG_00109,0.4797094448995937,OG_00109,FUN_000501-T1,Peve_00043828,Pocillopora_meandrina_HIv1___RNAseq.g2406.t1,three_way,59.06433333333334,FUN_000501-T1,P11616,,,,,23.7,299.0,1.8e-08,61.6,sp|P11616|AA1R_CANLF Adenosine receptor A1 OS=Canis lupus familiaris OX=9615 GN=ADORA1 PE=2 SV=1,,,,,,
OG_10070,0.4796903444600413,OG_10070,FUN_043375-T1,Peve_00004908,Pocillopora_meandrina_HIv1___RNAseq.g8979.t1,three_way,59.082,FUN_043375-T1,Q7T320,,,,,39.1,192.0,1.5e-23,112.1,sp|Q7T320|GORAB_DANRE RAB6-interacting golgin OS=Danio rerio OX=7955 GN=gorab PE=2 SV=1,,,,,,
OG_09052,0.4796191576014428,OG_09052,FUN_038733-T1,Peve_00013932,Pocillopora_meandrina_HIv1___RNAseq.g26435.t1,three_way,77.6025,FUN_038733-T1,O75175,CNOT3_HUMAN,,CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2),Homo sapiens (Human),43.1,826.0,1.5e-134,481.9,sp|O75175|CNOT3_HUMAN CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1,GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006417; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829],CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],,GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0030154; GO:0031047; GO:0043226,nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle
OG_09616,0.4795820538572444,OG_09616,FUN_041776-T1,Peve_00010497,Pocillopora_meandrina_HIv1___RNAseq.g15888.t1,three_way,68.81383333333333,FUN_041776-T1,Q6DRG1,,,,,67.6,142.0,2e-50,201.1,sp|Q6DRG1|RBM42_DANRE RNA-binding protein 42 OS=Danio rerio OX=7955 GN=rbm42 PE=2 SV=2,,,,,,
OG_04558,0.4795340083295619,OG_04558,FUN_022197-T1,Peve_00021103,Pocillopora_meandrina_HIv1___RNAseq.g4796.t1,three_way,90.381,FUN_022197-T1,P15178,,,,,69.7,476.0,1.2e-194,681.0,"sp|P15178|SYDC_RAT Aspartate--tRNA ligase, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dars1 PE=1 SV=1",,,,,,
OG_06920,0.479433201800406,OG_06920,FUN_032004-T1,Peve_00028811,Pocillopora_meandrina_HIv1___TS.g22558.t1,three_way,74.84166666666667,FUN_032004-T1,Q5ZME2,,,,,69.8,331.0,8.9e-126,451.4,"sp|Q5ZME2|MDHC_CHICK Malate dehydrogenase, cytoplasmic OS=Gallus gallus OX=9031 GN=MDH1 PE=2 SV=1",,,,,,
OG_08346,0.479427462180895,OG_08346,FUN_036879-T1,Peve_00006949,Pocillopora_meandrina_HIv1___RNAseq.g10628.t1,three_way,88.30766666666666,FUN_036879-T1,Q27128,PAPSS_URECA,,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],Urechis caupo (Innkeeper worm) (Spoonworm),71.9,597.0,1.0999999999999999e-265,917.1,sp|Q27128|PAPSS_URECA Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase OS=Urechis caupo OX=6431 PE=1 SV=1,GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103],,adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781],GO:0003824; GO:0006790; GO:0016740; GO:0055086; GO:1901135,catalytic activity; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02697,0.4793461931539679,OG_02697,FUN_010962-T1,Peve_00007923,Pocillopora_meandrina_HIv1___TS.g26730.t1,three_way,80.4425,FUN_010962-T1,Q3U319,BRE1B_MOUSE,,E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B),Mus musculus (Mouse),32.2,997.0,1.5e-111,405.6,sp|Q3U319|BRE1B_MOUSE E3 ubiquitin-protein ligase BRE1B OS=Mus musculus OX=10090 GN=Rnf40 PE=1 SV=2,GO:0003730; GO:0004842; GO:0005654; GO:0006325; GO:0008270; GO:0016567; GO:0031625; GO:0033503; GO:0042803; GO:0045944,chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567],HULC complex [GO:0033503]; nucleoplasm [GO:0005654],mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0140096,"RNA binding; catalytic activity; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; catalytic activity, acting on a protein"
OG_06603,0.479313665449701,OG_06603,FUN_029710-T1,Peve_00018724,Pocillopora_meandrina_HIv1___RNAseq.g17312.t1,three_way,68.5275,FUN_029710-T1,Q8N9Q2,SR1IP_HUMAN,,Protein SREK1IP1 (SFRS12-interacting protein 1) (SREK1-interacting protein 1) (Splicing regulatory protein of 18 kDa) (p18SRP),Homo sapiens (Human),75.7,37.0,1.6e-11,70.9,sp|Q8N9Q2|SR1IP_HUMAN Protein SREK1IP1 OS=Homo sapiens OX=9606 GN=SREK1IP1 PE=1 SV=1,GO:0003676; GO:0006397; GO:0008270; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],,nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0016071,mRNA metabolic process
OG_07823,0.4792505755050721,OG_07823,FUN_035093-T1,Peve_00005803,Pocillopora_meandrina_HIv1___RNAseq.g27701.t1,three_way,95.78933333333332,FUN_035093-T1,Q7PD79,,,,,76.3,384.0,1.1e-172,607.4,sp|Q7PD79|GNAS_ANOGA Guanine nucleotide-binding protein G(s) subunit alpha OS=Anopheles gambiae OX=7165 GN=G-s-alpha-60A PE=2 SV=1,,,,,,
OG_06284,0.4790941813031666,OG_06284,FUN_028470-T1,Peve_00036788,Pocillopora_meandrina_HIv1___RNAseq.g16126.t1,three_way,85.66233333333334,FUN_028470-T1,Q17LW0,,,,,59.3,1107.0,1.4e-292,1007.3,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_01705,0.4787789808191462,OG_01705,FUN_006950-T1,Peve_00035084,Pocillopora_meandrina_HIv1___RNAseq.g20153.t1,three_way,71.223,FUN_006950-T1,Q502W6,VWA3B_HUMAN,,von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B),Homo sapiens (Human),35.3,1239.0,4.6e-206,720.7,sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3,GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_03743,0.4786515176904407,OG_03743,FUN_015050-T1,Peve_00001172,Pocillopora_meandrina_HIv1___RNAseq.g21265.t1,three_way,70.01583333333333,FUN_015050-T1,Q8CHW5,,,,,38.3,120.0,7.4e-10,67.4,sp|Q8CHW5|BICL2_MOUSE BICD family-like cargo adapter 2 OS=Mus musculus OX=10090 GN=Bicdl2 PE=1 SV=1,,,,,,
OG_04222,0.4785441957102193,OG_04222,FUN_016983-T1,Peve_00025280,Pocillopora_meandrina_HIv1___RNAseq.g9900.t1,three_way,72.02816666666666,FUN_016983-T1,Q9P203,,,,,37.0,667.0,2.6e-109,397.9,sp|Q9P203|BTBD7_HUMAN BTB/POZ domain-containing protein 7 OS=Homo sapiens OX=9606 GN=BTBD7 PE=1 SV=3,,,,,,
OG_02721,0.4784338973966792,OG_02721,FUN_011049-T1,Peve_00013424,Pocillopora_meandrina_HIv1___TS.g26228.t1,three_way,60.9865,,,,,,,,,,,,,,,,,
OG_02078,0.4783501893146549,OG_02078,FUN_008295-T1,Peve_00012967,Pocillopora_meandrina_HIv1___RNAseq.g18014.t1,three_way,51.149,,,,,,,,,,,,,,,,,
OG_08830,0.4781020516677594,OG_08830,FUN_038167-T1,Peve_00025790,Pocillopora_meandrina_HIv1___RNAseq.g1070.t1,three_way,91.073,FUN_038167-T1,P23098,,,,,73.8,4465.0,0.0,6623.9,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_03571,0.4779719037070499,OG_03571,FUN_014725-T1,Peve_00006848,Pocillopora_meandrina_HIv1___RNAseq.g22496.t1,three_way,80.2465,FUN_014725-T1,Q9WTV0,SEC12_RAT,,Guanine nucleotide-exchange factor SEC12 (Mammalian guanine nucleotide exchange factor Sec12) (mSec12) (Prolactin regulatory element-binding protein),Rattus norvegicus (Rat),33.7,403.0,4.6999999999999995e-49,196.8,sp|Q9WTV0|SEC12_RAT Guanine nucleotide-exchange factor SEC12 OS=Rattus norvegicus OX=10116 GN=Preb PE=1 SV=2,GO:0000978; GO:0003400; GO:0005085; GO:0005634; GO:0005789; GO:0006888; GO:0015031; GO:0045944; GO:0048208; GO:0051020; GO:0070971,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of COPII vesicle coating [GO:0003400],endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0005634; GO:0006355; GO:0016192; GO:0043226; GO:0065003; GO:0098772,DNA binding; nucleus; regulation of DNA-templated transcription; vesicle-mediated transport; organelle; protein-containing complex assembly; molecular function regulator activity
OG_07862,0.4779181612289186,OG_07862,FUN_035217-T1,Peve_00035882,Pocillopora_meandrina_HIv1___TS.g14965.t1,three_way,86.42566666666667,FUN_035217-T1,O43747,,,,,62.9,851.0,9.3e-281,967.6,sp|O43747|AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens OX=9606 GN=AP1G1 PE=1 SV=5,,,,,,
OG_09615,0.477641744994027,OG_09615,FUN_041775-T1,Peve_00014827,Pocillopora_meandrina_HIv1___RNAseq.g15891.t1,three_way,93.94866666666668,FUN_041775-T1,Q8I1F4,,,,,87.3,236.0,1.4000000000000001e-117,424.1,sp|Q8I1F4|FBRL_DROER rRNA 2'-O-methyltransferase fibrillarin OS=Drosophila erecta OX=7220 GN=Fib PE=3 SV=1,,,,,,
OG_05065,0.4776304612331256,OG_05065,FUN_023268-T1,Peve_00018794,Pocillopora_meandrina_HIv1___TS.g17377.t1b,three_way,60.35533333333333,FUN_023268-T1,Q96N46,,,,,35.8,433.0,8.1e-59,230.3,sp|Q96N46|TTC14_HUMAN Tetratricopeptide repeat protein 14 OS=Homo sapiens OX=9606 GN=TTC14 PE=1 SV=1,,,,,,
OG_04954,0.4775869092115198,OG_04954,FUN_023044-T1,Peve_00008510,Pocillopora_meandrina_HIv1___TS.g10041.t2,three_way,72.67383333333333,FUN_023044-T1,Q01085,TIAR_HUMAN,,Nucleolysin TIAR (TIA-1-related protein),Homo sapiens (Human),41.0,373.0,1e-67,258.8,sp|Q01085|TIAR_HUMAN Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1,GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006357; GO:0006915; GO:0006952; GO:0008285; GO:0010494; GO:0035332; GO:0044194; GO:0140517; GO:2000637,apoptotic process [GO:0006915]; defense response [GO:0006952]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of transcription by RNA polymerase II [GO:0006357],cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; nucleoplasm; lysosome; vacuole; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; molecular adaptor activity
OG_08325,0.4775625664285591,OG_08325,FUN_036755-T1,Peve_00027843,Pocillopora_meandrina_HIv1___RNAseq.g27068.t1,three_way,83.454,FUN_036755-T1,Q9CY50,,,,,53.3,197.0,9.4e-56,218.4,sp|Q9CY50|SSRA_MOUSE Translocon-associated protein subunit alpha OS=Mus musculus OX=10090 GN=Ssr1 PE=1 SV=1,,,,,,
OG_00062,0.4775614633283927,OG_00062,FUN_000372-T1,Peve_00033530,Pocillopora_meandrina_HIv1___RNAseq.g29118.t1,three_way,91.26166666666668,FUN_000372-T1,P55258,RAB8A_MOUSE,,Ras-related protein Rab-8A (EC 3.6.5.2) (Oncogene c-mel),Mus musculus (Mouse),79.6,186.0,1.1e-80,300.8,sp|P55258|RAB8A_MOUSE Ras-related protein Rab-8A OS=Mus musculus OX=10090 GN=Rab8a PE=1 SV=2,GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005764; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0010008; GO:0010506; GO:0015629; GO:0019003; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031267; GO:0031489; GO:0032869; GO:0034451; GO:0036064; GO:0043005; GO:0043025; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055037; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098978; GO:0099003; GO:1990782,"autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; regulation of autophagy [GO:0010506]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]",actin cytoskeleton [GO:0015629]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network transport vesicle [GO:0030140],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein tyrosine kinase binding [GO:1990782]; small GTPase binding [GO:0031267],GO:0003824; GO:0003924; GO:0005654; GO:0005730; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0006886; GO:0006914; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0061024; GO:0072659,catalytic activity; GTPase activity; nucleoplasm; nucleolus; lysosome; endosome; vacuole; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; intracellular protein transport; autophagy; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; membrane organization; protein localization to plasma membrane
OG_08763,0.4775243140774991,OG_08763,FUN_038037-T1,Peve_00016939,Pocillopora_meandrina_HIv1___RNAseq.g26547.t1,three_way,82.486,FUN_038037-T1,Q3B8H3,,,,,62.8,164.0,6.6e-56,218.4,"sp|Q3B8H3|TM11B_XENLA Transmembrane protein 11-B, mitochondrial OS=Xenopus laevis OX=8355 GN=tmem11-b PE=2 SV=1",,,,,,
OG_08566,0.4774499428046311,OG_08566,FUN_037567-T1,Peve_00035306,Pocillopora_meandrina_HIv1___RNAseq.g1583.t1,three_way,65.91883333333334,FUN_037567-T1,Q6DDX3,,,,,42.9,77.0,8.7e-12,72.8,sp|Q6DDX3|F19XB_XENLA Protein FAM199X-B OS=Xenopus laevis OX=8355 GN=fam199x-b PE=2 SV=1,,,,,,
OG_07992,0.4773614371917163,OG_07992,FUN_035627-T1,Peve_00029656,Pocillopora_meandrina_HIv1___RNAseq.g28069.t1,three_way,82.09766666666667,FUN_035627-T1,P97762,,,,,67.2,122.0,1.3000000000000001e-48,194.5,sp|P97762|RP9_MOUSE Retinitis pigmentosa 9 protein homolog OS=Mus musculus OX=10090 GN=rp9 PE=1 SV=1,,,,,,
OG_09543,0.477327591464606,OG_09543,FUN_041638-T1,Peve_00040173,Pocillopora_meandrina_HIv1___RNAseq.g14218.t1,three_way,75.633,FUN_041638-T1,Q6P4S6,SIK3_MOUSE,,Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK),Mus musculus (Mouse),44.5,643.0,6.7e-122,440.3,sp|Q6P4S6|SIK3_MOUSE Serine/threonine-protein kinase SIK3 OS=Mus musculus OX=10090 GN=Sik3 PE=1 SV=4,GO:0000287; GO:0001958; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0032880; GO:0035108; GO:0035264; GO:0048705; GO:0060351; GO:0106310; GO:1904263; GO:1904515,cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; limb morphogenesis [GO:0035108]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705],cytoplasm [GO:0005737],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04507,0.477263964884185,OG_04507,FUN_022031-T1,Peve_00036254,Pocillopora_meandrina_HIv1___RNAseq.g3190.t1,three_way,65.41766666666666,FUN_022031-T1,Q86A72,,,,,24.7,178.0,1.5e-07,60.1,sp|Q86A72|Y4781_DICDI Recoverin family protein DDB_G0274781 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0274781 PE=3 SV=1,,,,,,
OG_08050,0.4768107201475063,OG_08050,FUN_035738-T1,Peve_00026220,Pocillopora_meandrina_HIv1___TS.g3202.t2,three_way,93.476,FUN_035738-T1,Q05975,,,,,92.9,212.0,1.9000000000000002e-110,399.8,sp|Q05975|RAB2_LYMST Ras-related protein Rab-2 OS=Lymnaea stagnalis OX=6523 GN=RAB2 PE=2 SV=1,,,,,,
OG_04103,0.4767282110033948,OG_04103,FUN_016454-T1,Peve_00040139,Pocillopora_meandrina_HIv1___RNAseq.g98.t1,three_way,77.08683333333333,FUN_016454-T1,Q6DJM7,CDK14_XENLA,,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14),Xenopus laevis (African clawed frog),56.3,421.0,1.8e-121,437.6,sp|Q6DJM7|CDK14_XENLA Cyclin-dependent kinase 14 OS=Xenopus laevis OX=8355 GN=cdk14 PE=2 SV=1,GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016055; GO:0030332; GO:0051301; GO:0060828; GO:0106310; GO:1901987,cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle phase transition [GO:1901987]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04484,0.476716151116699,OG_04484,FUN_021473-T1,Peve_00002680,Pocillopora_meandrina_HIv1___RNAseq.g2937.t1,three_way,63.3845,FUN_021473-T1,Q3UHB8,,,,,29.0,335.0,3.1e-11,72.0,sp|Q3UHB8|CC177_MOUSE Coiled-coil domain-containing protein 177 OS=Mus musculus OX=10090 GN=Ccdc177 PE=1 SV=1,,,,,,
OG_04345,0.4766822700870044,OG_04345,FUN_017967-T1,Peve_00000394,Pocillopora_meandrina_HIv1___RNAseq.g25247.t1,three_way,83.32000000000001,FUN_017967-T1,Q0IID7,DUS10_BOVIN,,Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48),Bos taurus (Bovine),40.2,323.0,1.2e-64,248.4,sp|Q0IID7|DUS10_BOVIN Dual specificity protein phosphatase 10 OS=Bos taurus OX=9913 GN=DUSP10 PE=2 SV=1,GO:0002819; GO:0004722; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008330; GO:0008432; GO:0010633; GO:0017017; GO:0032496; GO:0032873; GO:0033549; GO:0033550; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0051403; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042,negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; negative regulation of stress-activated MAPK cascade [GO:0032873]; oligodendrocyte differentiation [GO:0048709]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0030154; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; cell differentiation; catalytic activity, acting on a protein"
OG_08010,0.4766668747146891,OG_08010,FUN_035663-T1,Peve_00038557,Pocillopora_meandrina_HIv1___RNAseq.g28119.t3,three_way,87.50766666666667,FUN_035663-T1,O75081,MTG16_HUMAN,,Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein) (hMTG16) (Zinc finger MYND domain-containing protein 4),Homo sapiens (Human),42.8,549.0,6.600000000000001e-80,299.7,sp|O75081|MTG16_HUMAN Protein CBFA2T3 OS=Homo sapiens OX=9606 GN=CBFA2T3 PE=1 SV=2,GO:0000139; GO:0001666; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008270; GO:0008285; GO:0030851; GO:0032436; GO:0045820; GO:0045892; GO:1903715,DNA-templated transcription [GO:0006351]; granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glycolytic process [GO:0045820]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666],Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; nucleolus; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_02061,0.4765734465311101,OG_02061,FUN_008275-T1,Peve_00001958,Pocillopora_meandrina_HIv1___RNAseq.g17983.t1,three_way,79.60266666666666,FUN_008275-T1,Q4JIM4,PSN1_CHICK,,Presenilin-1 (PS-1) (EC 3.4.23.-) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit],Gallus gallus (Chicken),60.3,411.0,9.900000000000001e-123,441.8,sp|Q4JIM4|PSN1_CHICK Presenilin-1 OS=Gallus gallus OX=9031 GN=PSEN1 PE=1 SV=1,GO:0000139; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006509; GO:0006915; GO:0007155; GO:0007219; GO:0016020; GO:0016485; GO:0030424; GO:0034205; GO:0035556; GO:0042325; GO:0042500; GO:0042982; GO:0045202; GO:0055074; GO:0060828; GO:0070765,amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; apoptotic process [GO:0006915]; calcium ion homeostasis [GO:0055074]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of phosphorylation [GO:0042325],axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; synapse [GO:0045202],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]",GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005886; GO:0007155; GO:0012501; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; plasma membrane; cell adhesion; programmed cell death; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_02595,0.4763412082645951,OG_02595,FUN_010716-T1,Peve_00022598,Pocillopora_meandrina_HIv1___RNAseq.g20955.t1,three_way,82.276,FUN_010716-T1,P17713,,,,,64.1,512.0,3.7e-192,672.5,sp|P17713|STK_HYDVU Tyrosine-protein kinase STK OS=Hydra vulgaris OX=6087 GN=STK PE=2 SV=1,,,,,,
OG_00314,0.4762169511209789,OG_00314,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_09721,0.47612084817489,OG_09721,FUN_041967-T1,Peve_00033991,Pocillopora_meandrina_HIv1___RNAseq.g15917.t1,three_way,83.85133333333333,FUN_041967-T1,Q03123,,,,,46.5,260.0,5.2e-54,212.6,sp|Q03123|T2FB_XENLA General transcription factor IIF subunit 2 OS=Xenopus laevis OX=8355 GN=gtf2f2 PE=2 SV=1,,,,,,
OG_08403,0.4760158728488306,OG_08403,FUN_037054-T1,Peve_00042415,Pocillopora_meandrina_HIv1___RNAseq.g26787.t1,three_way,89.36016666666667,FUN_037054-T1,Q3UIK4,MET14_MOUSE,,N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 (Methyltransferase-like protein 14),Mus musculus (Mouse),60.6,436.0,4e-148,526.2,sp|Q3UIK4|MET14_MOUSE N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 OS=Mus musculus OX=10090 GN=Mettl14 PE=1 SV=1,GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0016556; GO:0019827; GO:0021861; GO:0031667; GO:0036396; GO:0042063; GO:0045664; GO:0045727; GO:0048255; GO:0061157; GO:1901533,"forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; regulation of neuron differentiation [GO:0045664]; response to nutrient levels [GO:0031667]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_04801,0.4758670091761813,OG_04801,FUN_022758-T1,Peve_00027945,Pocillopora_meandrina_HIv1___RNAseq.g3153.t1,three_way,64.09166666666667,,,,,,,,,,,,,,,,,
OG_08334,0.4758163368215845,OG_08334,FUN_036829-T1,Peve_00006952,Pocillopora_meandrina_HIv1___TS.g13147.t1,three_way,73.91533333333334,FUN_036829-T1,Q9NYI0,PSD3_HUMAN,,PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3),Homo sapiens (Human),44.6,417.0,3.3999999999999997e-91,337.8,sp|Q9NYI0|PSD3_HUMAN PH and SEC7 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=PSD3 PE=1 SV=2,GO:0005085; GO:0014069; GO:0032012; GO:0032587,regulation of ARF protein signal transduction [GO:0032012],postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0043226; GO:0098772,organelle; molecular function regulator activity
OG_09293,0.4757655194440429,OG_09293,FUN_040138-T1,Peve_00038115,Pocillopora_meandrina_HIv1___RNAseq.g8515.t1,three_way,76.93733333333334,FUN_040138-T1,Q5NVI9,DNJA1_PONAB,,DnaJ homolog subfamily A member 1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),56.7,404.0,5.1e-128,459.1,sp|Q5NVI9|DNJA1_PONAB DnaJ homolog subfamily A member 1 OS=Pongo abelii OX=9601 GN=DNAJA1 PE=2 SV=1,GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0008270; GO:0009408; GO:0016020; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0048471; GO:0051082; GO:0051087; GO:0051223; GO:0070585,negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; Hsp70 protein binding [GO:0030544]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0043226; GO:0098772,nucleus; mitochondrion; endoplasmic reticulum; protein folding; organelle; molecular function regulator activity
OG_02448,0.475753470583105,OG_02448,FUN_009519-T1,Peve_00014186,Pocillopora_meandrina_HIv1___RNAseq.g24501.t1,three_way,81.64666666666666,FUN_009519-T1,Q02874,H2AY_RAT,,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y),Rattus norvegicus (Rat),55.9,381.0,1.7e-101,370.9,sp|Q02874|H2AY_RAT Core histone macro-H2A.1 OS=Rattus norvegicus OX=10116 GN=Macroh2a1 PE=1 SV=5,GO:0000122; GO:0000182; GO:0000228; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0001740; GO:0002082; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006281; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0030527; GO:0031490; GO:0031492; GO:0031507; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0071169; GO:0072570; GO:0090734; GO:0160002; GO:1901837; GO:1902688; GO:1902750; GO:1902882; GO:1903226; GO:1904815; GO:1990841,"DNA repair [GO:0006281]; epigenetic regulation of gene expression [GO:0040029]; establishment of protein localization to chromatin [GO:0071169]; heterochromatin formation [GO:0031507]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of NAD metabolic process [GO:1902688]; regulation of oxidative phosphorylation [GO:0002082]; regulation of response to oxidative stress [GO:1902882]; sex-chromosome dosage compensation [GO:0007549]; transcription initiation-coupled chromatin remodeling [GO:0045815]",Barr body [GO:0001740]; chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734],ADP-D-ribose binding [GO:0072570]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976],GO:0000228; GO:0003677; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0043226; GO:0065003; GO:0098772,nuclear chromosome; DNA binding; structural molecule activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; molecular function regulator activity
OG_02741,0.4756135596866262,OG_02741,FUN_011284-T1,Peve_00033625,Pocillopora_meandrina_HIv1___RNAseq.g22145.t2,three_way,53.47266666666667,FUN_011284-T1,Q5M775,CYTSB_HUMAN,,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),Homo sapiens (Human),46.2,106.0,1.9e-21,106.3,sp|Q5M775|CYTSB_HUMAN Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177,actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824],apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0048856; GO:0050877,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; organelle; anatomical structure development; nervous system process
OG_06737,0.4756021523535,OG_06737,FUN_031524-T1,Peve_00022781,Pocillopora_meandrina_HIv1___RNAseq.g5130.t1,three_way,58.0995,FUN_031524-T1,Q4KLN4,GLE1_RAT,,mRNA export factor GLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1),Rattus norvegicus (Rat),41.9,329.0,2.3e-70,268.5,sp|Q4KLN4|GLE1_RAT mRNA export factor GLE1 OS=Rattus norvegicus OX=10116 GN=Gle1 PE=2 SV=1,GO:0000822; GO:0005543; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0015031; GO:0016973; GO:0031369; GO:0036064; GO:0042802; GO:0044614,poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear pore cytoplasmic filaments [GO:0044614],identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369],GO:0005635; GO:0005815; GO:0006913; GO:0008289; GO:0043226,nuclear envelope; microtubule organizing center; nucleocytoplasmic transport; lipid binding; organelle
OG_07122,0.4755410343361874,OG_07122,FUN_032421-T1,Peve_00009160,Pocillopora_meandrina_HIv1___RNAseq.g29847.t1,three_way,76.65833333333333,FUN_032421-T1,Q6DEY1,,,,,33.8,240.0,8.100000000000001e-28,125.6,sp|Q6DEY1|SPF30_XENTR Survival of motor neuron-related-splicing factor 30 OS=Xenopus tropicalis OX=8364 GN=smndc1 PE=2 SV=1,,,,,,
OG_00570,0.4753554007684943,OG_00570,FUN_001628-T1,Peve_00009929,Pocillopora_meandrina_HIv1___RNAseq.g2165.t1,three_way,85.88366666666667,FUN_001628-T1,P49706,,,,,57.9,290.0,2.8e-88,326.6,sp|P49706|CCND2_CHICK G1/S-specific cyclin-D2 OS=Gallus gallus OX=9031 GN=CCND2 PE=3 SV=1,,,,,,
OG_02338,0.4752983465833187,OG_02338,FUN_008934-T1,Peve_00036402,Pocillopora_meandrina_HIv1___RNAseq.g14257.t1,three_way,76.08966666666667,FUN_008934-T1,A5D7I4,EXT1_BOVIN,,Exostosin-1 (EC 2.4.1.225) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase),Bos taurus (Bovine),50.3,749.0,7.999999999999999e-217,755.0,sp|A5D7I4|EXT1_BOVIN Exostosin-1 OS=Bos taurus OX=9913 GN=EXT1 PE=2 SV=1,GO:0000139; GO:0000271; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0010803; GO:0014033; GO:0015012; GO:0015020; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1902494; GO:1904888; GO:1990823,"antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; polysaccharide biosynthetic process [GO:0000271]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synapse [GO:0045202],acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006790; GO:0006954; GO:0007155; GO:0009101; GO:0016740; GO:0023052; GO:0030154; GO:0030163; GO:0030198; GO:0034330; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:1901135,immune system process; circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; sulfur compound metabolic process; inflammatory response; cell adhesion; glycoprotein biosynthetic process; transferase activity; signaling; cell differentiation; protein catabolic process; extracellular matrix organization; cell junction organization; wound healing; organelle; anatomical structure development; cell motility; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_00058,0.4750979995005561,OG_00058,FUN_000350-T1,Peve_00033537,Pocillopora_meandrina_HIv1___RNAseq.g29114.t1,three_way,92.17333333333332,FUN_000350-T1,P62490,,,,,86.6,216.0,1e-98,360.9,sp|P62490|RB11A_CANLF Ras-related protein Rab-11A OS=Canis lupus familiaris OX=9615 GN=RAB11A PE=2 SV=3,,,,,,
OG_06128,0.4749534027811438,OG_06128,FUN_027932-T1,Peve_00020113,Pocillopora_meandrina_HIv1___RNAseq.g13876.t1,three_way,75.51033333333334,FUN_027932-T1,P49848,TAF6_HUMAN,,Transcription initiation factor TFIID subunit 6 (RNA polymerase II TBP-associated factor subunit E) (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80),Homo sapiens (Human),53.7,456.0,1.8e-142,507.7,sp|P49848|TAF6_HUMAN Transcription initiation factor TFIID subunit 6 OS=Homo sapiens OX=9606 GN=TAF6 PE=1 SV=1,GO:0000124; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006915; GO:0008285; GO:0016251; GO:0017162; GO:0032991; GO:0033276; GO:0042789; GO:0043065; GO:0045786; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:0060261; GO:0071339; GO:2001244,apoptotic process [GO:0006915]; DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276],aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0012501; GO:0016071; GO:0043226; GO:0060090; GO:0065003; GO:0140110; GO:0140223,DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; mRNA metabolic process; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity; general transcription initiation factor activity
OG_07746,0.4749505904448554,OG_07746,FUN_034935-T1,Peve_00018031,Pocillopora_meandrina_HIv1___RNAseq.g27829.t1,three_way,62.48333333333333,FUN_034935-T1,A0A8M2,L14AA_XENLA,,Protein LSM14 homolog A-A (RNA-associated protein 55A-A) (RAP55A-A) (xRAP55) (xRAP55A),Xenopus laevis (African clawed frog),34.3,426.0,8.7e-45,183.0,sp|A0A8M2|L14AA_XENLA Protein LSM14 homolog A-A OS=Xenopus laevis OX=8355 GN=lsm14a-a PE=1 SV=1,GO:0000932; GO:0003723; GO:0003729; GO:0005737; GO:0010494; GO:0017148; GO:0017151; GO:0032991; GO:0033962; GO:0034063; GO:1990904,negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],DEAD/H-box RNA helicase binding [GO:0017151]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0043226,RNA binding; organelle
OG_08880,0.4747348784417223,OG_08880,FUN_038280-T1,Peve_00041710,Pocillopora_meandrina_HIv1___RNAseq.g28313.t1,three_way,72.69066666666667,FUN_038280-T1,Q3TEL6,RN157_MOUSE,,E3 ubiquitin ligase Rnf157 (EC 2.3.2.27) (RING finger protein 157) (RING-type E3 ubiquitin transferase Rnf157),Mus musculus (Mouse),47.4,380.0,1e-91,339.0,sp|Q3TEL6|RN157_MOUSE E3 ubiquitin ligase Rnf157 OS=Mus musculus OX=10090 GN=Rnf157 PE=1 SV=2,GO:0005737; GO:0008270; GO:0016567; GO:0043066; GO:0044297; GO:0061630; GO:1903861,negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite extension [GO:1903861]; protein ubiquitination [GO:0016567],cell body [GO:0044297]; cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_07182,0.4747060627348109,OG_07182,FUN_032637-T1,Peve_00033700,Pocillopora_meandrina_HIv1___RNAseq.g24114.t1,three_way,72.59783333333333,FUN_032637-T1,Q9QYI4,,,,,42.2,384.0,3.8e-69,263.5,sp|Q9QYI4|DJB12_MOUSE DnaJ homolog subfamily B member 12 OS=Mus musculus OX=10090 GN=Dnajb12 PE=1 SV=2,,,,,,
OG_08378,0.4745295845548936,OG_08378,FUN_036955-T1,Peve_00040029,Pocillopora_meandrina_HIv1___RNAseq.g10865.t1,three_way,80.931,FUN_036955-T1,Q9DFS6,IF4EA_DANRE,,Eukaryotic translation initiation factor 4E-1A (eIF4E-1A) (mRNA cap-binding protein),Danio rerio (Zebrafish) (Brachydanio rerio),62.2,196.0,3.3e-73,276.2,sp|Q9DFS6|IF4EA_DANRE Eukaryotic translation initiation factor 4E-1A OS=Danio rerio OX=7955 GN=eif4ea PE=1 SV=1,GO:0000340; GO:0003743; GO:0005634; GO:0005737; GO:0006406; GO:0006413; GO:0006417; GO:0016281; GO:0016607,mRNA export from nucleus [GO:0006406]; regulation of translation [GO:0006417]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nuclear speck [GO:0016607]; nucleus [GO:0005634],RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0005634; GO:0006913; GO:0043226,RNA binding; nucleus; nucleocytoplasmic transport; organelle
OG_05182,0.4743618904714352,OG_05182,FUN_023523-T1,Peve_00009062,Pocillopora_meandrina_HIv1___RNAseq.g3600.t2,three_way,64.48166666666667,FUN_023523-T1,Q4SQ06,,,,,35.9,78.0,1e-06,54.3,sp|Q4SQ06|NOP16_TETNG Nucleolar protein 16 OS=Tetraodon nigroviridis OX=99883 GN=nop16 PE=3 SV=1,,,,,,
OG_02114,0.474155793401425,OG_02114,FUN_008399-T1,Peve_00043600,Pocillopora_meandrina_HIv1___RNAseq.g6181.t1,three_way,83.61133333333333,FUN_008399-T1,P41823,,,,,35.0,300.0,9.3e-43,176.4,sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2,,,,,,
OG_07355,0.4741498237244171,OG_07355,FUN_033763-T1,Peve_00009255,Pocillopora_meandrina_HIv1___RNAseq.g28734.t1,three_way,65.53633333333333,FUN_033763-T1,Q6NRZ1,,,,,29.8,1444.0,1.4e-132,476.1,sp|Q6NRZ1|BLT3B_XENLA Bridge-like lipid transfer protein family member 3B OS=Xenopus laevis OX=8355 GN=bltp3b PE=2 SV=1,,,,,,
OG_00960,0.4740832931363737,OG_00960,FUN_004324-T1,Peve_00016500,Pocillopora_meandrina_HIv1___RNAseq.g11781.t1,three_way,60.91866666666666,FUN_004324-T1,Q9BDJ3,,,,,45.5,99.0,3.6e-20,99.0,sp|Q9BDJ3|THIO_CALJA Thioredoxin OS=Callithrix jacchus OX=9483 GN=TXN PE=3 SV=3,,,,,,
OG_04771,0.4740009281139571,OG_04771,FUN_022673-T1,Peve_00010102,Pocillopora_meandrina_HIv1___RNAseq.g4124.t2,three_way,59.6315,FUN_022673-T1,Q3U821,,,,,33.9,785.0,7.1e-103,376.7,sp|Q3U821|WDR75_MOUSE WD repeat-containing protein 75 OS=Mus musculus OX=10090 GN=Wdr75 PE=1 SV=1,,,,,,
OG_03437,0.4739109681872241,OG_03437,FUN_014496-T1,Peve_00037309,Pocillopora_meandrina_HIv1___RNAseq.g22808.t1,three_way,67.33000000000001,FUN_014496-T1,Q9UPY8,MARE3_HUMAN,,Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3) (EBF3) (End-binding protein 3) (EB3) (RP3),Homo sapiens (Human),41.6,250.0,1.1e-40,168.3,sp|Q9UPY8|MARE3_HUMAN Microtubule-associated protein RP/EB family member 3 OS=Homo sapiens OX=9606 GN=MAPRE3 PE=1 SV=1,GO:0005737; GO:0005815; GO:0008017; GO:0008104; GO:0015630; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0035372; GO:0042802; GO:0043539; GO:0045893; GO:0048471; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:0120283; GO:1905721,cell division [GO:0051301]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule [GO:0035372]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283],GO:0005815; GO:0005856; GO:0006355; GO:0007010; GO:0008092; GO:0043226; GO:0098772,microtubule organizing center; cytoskeleton; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle; molecular function regulator activity
OG_01218,0.4738973259080056,OG_01218,FUN_004899-T1,Peve_00015869,Pocillopora_meandrina_HIv1___RNAseq.g8673.t1,three_way,88.71466666666667,FUN_004899-T1,Q2KJG3,,,,,66.2,544.0,6.499999999999999e-222,771.5,"sp|Q2KJG3|SYNC_BOVIN Asparagine--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=NARS PE=2 SV=3",,,,,,
